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This thesis reports the application of computational modelling, NMR spectroscopy and 
stereospecific iterative homologation of boronic esters to the three-dimensional structural 
elucidation of flexible organic small molecules, and the design and synthesis of flexible 
molecules with tailored conformations.  
Firstly, the configuration of a recently isolated polyketide baulamycin A, which 
exhibits potent antibacterial activity, was reassigned using a combination of Density Functional 
theory (DFT) calculations, NMR spectroscopy and synthesis. In this work, DFT calculations 
were employed to predict the complex dynamic conformations of eight possible diastereomers 
of baulamycins and to compute the ensemble-averaged chemical shifts, 1H-1H scalar coupling 
constants and 1H-1H distances. Comparison between the computed NMR parameters of each 
diastereomer with the experimentally determined values eliminated 112 out of the possible 128 
diastereomeric candidates. Finally, synthesis allowed the relative and absolute configuration of 
baulamycin A to be positively identified.  
Secondly, inspired by the conformational control exerted by quaternary centres, a range 
of conformationally defined unnatural amino esters were designed with the aid of 
computational modelling. Two of the amino esters were synthesised and their solution state 
conformations were elucidated by a combination of DFT calculations and quantitative analysis 
of 1H-1H and 1H-13C scalar coupling constants. Their side chains are shown to take on defined 
orientations (syn-periplanar or turn a 120° corner) with controllable distances and could find 
application in areas such as drug design.  
Finally, factors controlling the helical screw-sense of hydrocarbons with all-syn 
contiguous methyl substituents was investigated. The solution-state conformational behaviour 
of hydrocarbons with different numbers of methyl substituents (from six to 11) was studied 
using a combination of DFT calculations and quantitative analysis of 1H-1H scalar coupling 
constants and 1H-1H distances. It was discovered that only hydrocarbons with even numbers of 
methyl substituents adopt regular helical conformation, whereas hydrocarbons with odd 
number of methyl substituents do not have a strong preference for a particular conformation. 
The preference of screw sense (if any) in each case was rationalised by the minimisation of 
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Chapter 1 Introduction 
1.1 Elements of conformational control in flexible molecules.  
The three-dimensional arrangements, or conformations, of organic molecules dictate 
their molecular properties such as chemical reactivities and molecular functions. The organic 
chemistry community took little notice of conformational behaviour of molecules and did not 
appreciate the importance of conformational analysis until the 1950s, when Derek Barton 
rationalised the chemical reactivities of steroids based on their preferred conformations.1-2 
Since then, conformational analysis has become a fundamental area in chemistry and has been 
applied to the study of reaction mechanisms, in the prediction of reaction outcome in total 
syntheses, and in the structural elucidation of natural products.  
Conformational analysis studies the energetic difference between conformational 
isomers arising from the free rotation around single bonds.3 For example, rotation of the central 
CC bond in ethane gives rise to conformations with different energies (Figure 1.1a and b), 
with the staggered conformer 1.1 being the minimum and the eclipsed conformer 1.2 being the 
maximum on a rotational energy diagram. The staggered conformer 1.1 is the lowest energy 
conformation due to the stabilising interactions between the CH bonding orbital (CH) and 
the adjacent CH antibonding orbital (CH) (Figure 1.1c). The eclipsed conformer 1.2 is the 
highest energy conformation because of the destabilising electronic repulsion of vicinal CH 
bonds and inefficient orbital overlap between the CH orbital and the adjacent CH orbital 
(Figure 1.1c). Although steric repulsion between the eclipsing hydrogens could also contribute 
to the high conformer energy associated with eclipsed conformer 1.2, steric factors are minor 
compared to hyperconjugation because hydrogen atoms are too small to impose severe steric 
clashes (Van der Waals radius of a hydrogen atom: 1.20 Å). This lack of steric repulsion is 





Figure 1.1: a, The eclipsed (1.2) and staggered (1.1) conformers of ethane with their relative conformer 
energies. b, Rotational energy diagram of ethane with the corresponding Newman projection for the 
maxima and minima. c, Orbital interactions in the eclipsed and staggered conformers of ethane. d, 
Space-filling model of the staggered (left) and eclipsed (right) conformers of ethane, showing lack of 
steric interaction. 
When the hydrogens in ethane are replaced by other substituents, such as methyl groups 
or heteroatoms, a combination of steric and electronic factors controls the conformation of 
these flexible small molecules. In this section, several steric and electronic factors which 
influence molecular conformations will be discussed.  
Gauche-butane interaction.  
In butane, the staggered conformations (1.3 and 1.4, Figure 1.2) which are free from 
eclipsing interactions are the minima in a rotational energy diagram as a result of minimising 
steric clashes between methyl groups and hydrogens. Conformer 1.4 with the two methyl 

































has the two methyl groups in gauche orientation was calculated to be 0.8 kcal mol−1 higher 
using ab initio methods (Møller–Plesset theory, MP4SDQ/6-31G(d)).5 Steric hindrance, rather 
than hyperconjugation, is the major contributing factor which affects the relative energies of 
these two conformers. The steric hindrance between two methyl groups shown in 1.3 is often 
referred to as a gauche-butane interaction.  
 
Figure 1.2: Staggered conformers of butane with the two methyl groups gauche (1.3) and antiperiplanar 
(1.4) to each other. The relative energies quoted were calculated using MP4SDQ 6-31G(d) level of 
theory.5 
Syn-pentane interaction. 
Steric hindrance also dictates the relative energies of pentane conformers (Figure 1.3). 
Staggered conformers arising from the rotation of the two central bonds (highlighted in blue, 
Figure 1.3) are considered and these four conformers of pentane are represented on a diamond 
lattice. Their relative energies were calculated using MP4SDQ/6-31G(d) level of theory.5 
Conformer 1.5, with both the central bonds adopting antiperiplanar conformations (ap ap), is 
the lowest in energy, followed by the conformer which has one of the two bonds adopting a 
gauche conformation (g+ ap, 1.6). Conformer 1.6 experiences a gauche interaction between the 
two methyl groups which has an enthalpic penalty of 0.8 kcal mol−1 as discussed previously 
(gauche-butane interaction). The next higher energy conformer 1.7 is 1.4 kcal mol−1 above the 
global minimum 1.5. The enthalpic cost of adopting conformer 1.7, which has two consecutives 
gauche+ dihedrals, is 0.2 kcal mol−1 smaller than twice the enthalpic penalty of the gauche-
butane interaction (2 × 0.8 = 1.6 kcal mol−1). The extra stabilisation associated with the g+ g+ 
conformer (1.7) was rationalised by the attractive van der Waals interactions between the 
terminal methyl groups. However, this attractive interaction becomes repulsive when the two 




backbone adopts a gauche followed by a gauche+ conformation (g g+). The close proximity 
of the terminal methyl groups (2.5 Å) results in high strain in this conformer (3.4 kcal mol−1) 
compared to the global minimum. Therefore 1.8 only has a 0.5% of conformer population at 
room temperature.5  
 
Figure 1.3: Conformational analysis of pentane. Relative energies of conformers were calculated using 
MP4SDQ 6-31G(d) level of theory.5 
The destabilising interaction observed in 1.8 is known as a syn-pentane interaction and 
has been used in the design of molecules with tailored conformations. Still et al. designed 
conformationally defined tetracyclic podand ionophores (Figure 1.4e), based on the principle 
of destabilising undesired conformers using syn-pentane interactions.6-7 According to MM2 
calculations, ring annellation of a polyether chain (Figure 1.4a), and the introduction of methyl 
substituents at specific positions with defined stereochemistry, reduced the number of low 
energy conformers to within 3 kcal mol−1 above the global minimum from ~ 1000 to 25 (Figure 
1.4c). Ring annellation provided covalent restriction, while the two methyl groups destabilised 
other accessible conformers by inducing the destabilising syn-pentane interactions between 
methyl groups and the endo CO or CC bonds (highlighted in red, Figure 1.4d). The bias 
toward a single conformation was further enhanced by destabilising other undesired 
conformers via the addition of another two methyl groups (Figure 1.4e and f). The tetracyclic 
ionophore Figure 1.4e) is a chiral version of 18-crown 6 (Figure 1.4b) and binds to 1-






Figure 1.4 The design of Clark Still’s podand ionophores.6-7  a, A polyether chain with poorly defined 
conformations. b, Structure of achiral 18-crown 6. c, Ring annellation of the polyether chain together 
with the introduction of two methyl groups. The conformational analysis of the segment in blue is shown 
on a diamond lattice (d). e, Structure of the tetracyclic podand ionophores with the dominant 
conformation represented on a diamond lattice (f).  
More recently, Aggarwal et al. reported the synthesis (section 1.4) and conformational 
analysis (section 1.3.4) of hydrocarbons with contiguous methyl substituents 1.9 and 1.10 
(Figure 1.5a and b, respectively).8 Due to the avoidance of syn-pentane interactions, The syn-
anti isomer 1.9 was designed to preferentially adopt a linear conformation, whereas the all syn 
isomer 1.10 was designed to fold into a helical conformation. (Figure 1.5c and d, respectively). 
The solution-state conformations of both compounds were confirmed by using a combination 





Figure 1.5 a, Chemical structure of the syn-anti isomer 1.9. b, Chemical structure of the all syn isomer 
1.10. c, The dominant linear conformation of 1.9 represented on a diamond lattice. d, The dominant 
helical conformation of 1.10 represented on a diamond lattice. 
Allylic strain (A1,3 and A1,2) 
Compared to the highest energy conformer of pentane (1.8) where the two terminal 
methyl groups have a CC distance of ~2.5 Å, the CC distances of the methyl groups in (Z)-
pent-2-ene (1.11) is even closer in space (~2.2 Å) because CC double bonds are shorter than 
CC single bonds. Therefore, the syn-pentane interaction between the methyl groups in 1.11 is 
even more costly and this strain is referred to as A1,3 allylic strain.  
 
Figure 1.6: Chemical structure of the highest energy conformations of pentane and (Z)-pent-2-ene with 
the CC distances between the terminal methyl groups labelled.  
Figure 1.7a illustrates the effect of allylic 1,3-strain on the conformational behaviour of 
(Z)-4-methylpent-2-ene 1.12. The relative energies of three conformers (1.12-1, 1.12-2 and 
1.12-3) were calculated using MP2/6-31G(d) level of theory.9 To avoid the A1,3 strain which 




the eclipsed conformer 1.12-2 which has the HCC=C dihedral angle within 0 ± 30°.9-10 
Unlike saturated hydrocarbons where staggered conformations are preferred, in unsaturated 
hydrocarbons (i.e. 1.12) the eclipsed conformation 1.12-2 is preferred due to the 
hyperconjugation of the C-H orbital to the 
*
C=C orbital (Figure 1.7b). Therefore, although the 
A1,3 strain could be avoided in the staggered conformer 1.12-3, it is less energetically 
favourable due to the lack of stabilising hyperconjugation interactions. In the case of 2,3-
dimethylbut-1-ene (1.13, Figure 1.7c), the avoidance of allylic 1,2 strain results in the 
preference for conformation 1.13-2.9  
Conformational preference in alkenes is a usually fine balance between the A1,3 and 
A1,2 strains, although A1,3 strain outweighs A1,2 strain due to a higher enthalpic penalty.  
 
Figure 1.7: a, Three conformers of (Z)-4-methylpent-2-ene 1.12 with their relative energies. Allylic 
A1,3 strain in conformer 1.12-1 is highlighted in red. b, Orbital interactions of the eclipsed (1.12-2) and 
staggered (1.12-3) conformations of 1.12. c, Two conformers of 2,3-dimethylbut-1-ene 1.13 with the 
allylic A1,2 strain in conformer 1.13-1 highlighted in blue. Relative energies of conformers were 
calculated using MP2/6-31G(d) level of theory. 9 
Hoffmann et al. demonstrated the design and synthesis of acyclic molecules with 
defined conformation utilising the conformational control exerted by synpentane interactions 
and A1,3 strain (Figure 1.8). Analysis of nJHH values of both molecules showed that 1.14 




opposite face, while 1.15 adopts a U-shaped conformation in which the two hydroxyl groups 
are on the same face.11  
 
Figure 1.8: Chemical structure of (a) 1.14 and 1.15 with (b) the observed major conformations for each 
compound.  
The effect of syn-pentane interactions and A1,3 strain on molecular conformation was 
also observed in the X-ray structure of zincophorin, an antibiotic ionophore which binds to zinc 
cations.12-13  
 
Figure 1.9: a, Chemical structure of zincophorin with regions controlled by A1,3 strain and syn-pentane 
highlighted. b, Crystal structure of zincophorin dimer binding to a zinc cation.14 c, Solid state 




In the A1,3 region, the proton is positioned in the eclipsed conformation to minimise 
A1,3 strain. This can be clearly seen from the crystal structure of the zincophorin dimer with a 
zinc cation (Figure 1.9b). In addition, the avoidance of syn-pentane interactions (Figure 1.9c) 
preorganises the orientation of the 1,3-polyol segment for efficient binding to zinc cations.  
Gauche effect 
As discussed, in acyclic saturated hydrocarbons the lowest energy conformers are the 
ones with the most sterically demanding substituents antiperiplanar to each other (X = Y = sp3 
carbon substituents, 1.16, Figure 1.10a). However, a gauche conformation 1.17 is preferred 
over the antiperiplanar conformation if X and Y are electronegative substituents (Figure 1.10b). 
This conformational preference is known as the gauche effect.15 For example, compounds 
containing FCCF, FCCO, and FCCN fragments (1.18 – 1.21, Figure 1.10b) all 
experience the gauche effect. By adopting the gauche conformation 1.17, the low-lying * 
antibonding orbital of the CF bond is aligned to the adjacent  bonding orbital of the C-H 
bond, thus allowing donation of electron density from the CH orbital to the *CF orbital (Figure 
1.10b). In the antiperiplanar conformation the *CF orbital is aligned with a less electron 
releasing CX orbital, leading to poor hyperconjugation. 
16-17 
When the atom Y is a chlorine atom (1.22, Figure 1.10), the antiperiplanar conformation 
is favoured instead in the gas-phase.18 This is because the increased dipole repulsion between 
the CF and CCl bonds outweighs the stabilisation provided by hyperconjugation. 
Nevertheless, MP2 calculations predicted that going from gas-phase to a polar environment 
(eg. acetone), the conformational preference of 1.22 will switch from antiperiplanar to the 
expected gauche conformation, due to the decreased energy penalty of the dipole repulsion in 





Figure 1.10: a, Newman projections of conformers with two nonhydrogen substituents antiperiplanar 
(1.16) and gauche (1.17) to each other. b, Newman projections of 1,2-disubstituted ethane in gauche 
and antiperiplanar conformations.  
The gauche effect is general and applied to XCCY systems where X and Y are 
heteroatoms such as nitrogen and oxygen atoms. The conformational preference induced by 
the gauche effect is important in the regulation of the concentration of Hypoxia Inducible 
Factor 1 alpha (HIF-1), which has been recognised as an important target for cancer therapy.19 
 
Figure 1.11: a, The exo and endo conformations of a proline residue in HIF-1. b, The exo and endo 
conformations of a hydroxyproline residue in HIF-1. The two key interactions shifting the 
conformational preference of the hydroxyproline is highlighted in red (CH → *CN) and blue (CH → 




(PDB: 1LQB)20 showing the binding between the hydroxyproline residue of HIF-1(in pink) and the 
histidine and serine residues of von-Hippel-Lindau protein (in blue).  
Upon hydroxylation of the proline residues of HIF-1 under normal cellular oxygen 
levels, the exo conformation is favoured due to the stabilisation provided by hyperconjugation 
between the CH and the *CO orbitals (highlighted in blue, Figure 1.11b), and between the CH 
and the *CN orbitals (highlighted in red, Figure 1.11b). The shift in the conformational 
preference triggers the binding of HIF-1to the von-Hippel-Lindau protein (blue, Figure 
1.11c), which allows polyubiquitination and subsequent degradation of HIF-1.21  
Dipoledipole interactions 
Although in 1,2-difluoroalkanes two fluorine atoms are in proximity due to the gauche 
effect, in 1,3-difluoroalkanes the two fluorine atoms repel each other due to the destabilising 
dipoledipole interactions between the two highly polarised CF bonds. This can be illustrated 
using 1,3-difluoropropane as an example (Figure 1.12). The relative energies of the four 
staggered conformers were calculated using MP2/6-31G(d,p) level of theory22 and it was found 
that the GG conformer is predicted to be the lowest in energy, presumably due to the 
stabilisation provided by two CH → *CF interactions. The next low energy conformer GA 
only contains one such interaction and conformer AA contains none. When the two highly 
polarised CF bonds are parallel to each other (ie. in GG’ conformer), this results in a 
destabilising dipoledipole interaction, which was predicted to have an energy penalty more 
than twice the energy of hyperconjugation stabilisation (2 × 1.16 = 2.32 kcal mol−1). Therefore, 
the dipoledipole interaction is a more dominant factor in controlling the conformation of 1,3-
difluorocompounds.  
 




Utilising the conformational control exerted by the gauche effect and dipoledipole 
interactions, multi-vicinal fluoroalkanes 1.23 and 1.24 with defined molecular conformations 
were designed and synthesised by O’Hagan et al..23 The X-ray structure of the all syn isomer 
1.23 showed that it adopted a helical conformation while the syn-anti isomer 1.24 adopted a 
linear conformation. The conformational preference of both 1.23 and 1.24 was a result of 
maximising the gauche orientation between adjacent fluorine atoms while minimising 1,3 
dipoledipole repulsions arising from parallel CF bonds. The solution-state conformational 
behaviour of 1.23 and 1.24 was also investigated using 1H-1H and 1H-19F scalar coupling 
constants. The preferred solution-state conformers in both compounds were found to be the 
same as that observed in the solid state.23 
 
Figure 1.13: a, Chemical structure of 1.23. b, X-ray crystal structure of 1.23 looking at the side, and 
down the helical wheel. c, Major conformation of 1.23 represented on a diamond lattice. d, Chemical 






Apart from the steric and electronic interactions discussed in this section, other non-
covalent interactions also affect molecular conformations. Hydrogen bonds, one of the 
strongest non-covalent interaction, are electrostatic interactions between a + hydrogen atom 
and the lone pair of an electronegative element such as oxygen and nitrogen.24 The strength of 
the interaction is highly dependent upon the nature of the donor and acceptor atoms, as well as 
the distance and angle between the donor and the acceptor atoms. A typical hydrogen bond (eg. 
ROH∙∙∙O=C, ~ 1.9 Å) has an energy of 5–10 kcal mol−1.25 In contrast, the CH- interaction 
between an aromatic  system (eg. benzene) and an aliphatic CH bond (eg. methane) is a lot 
weaker (1.03 – 1.13 kcal mol−1, Figure 1.14).26  
 
Figure 1.14: A selection of steric and electronic interactions. 
In summary, conformational control in small molecules is a delicate balance between 
steric and electronic interactions. The energy of the eclipsing interaction increases (H/H: 1 kcal 
mol−1, H/Me: 1.4 kcal mol−1, Me/Me: 4 kcal mol−1) with the increasing steric bulk of the 
substituents as illustrated in figure 1.14. Compared to syn-pentane interaction (3.5 kcal mol−1), 
A1,3 strain is slightly higher in energy (4.9 kcal/mol) due to the closer distance of the terminal 
methyl groups. Other non-covalent interactions including dipole-dipole, hyperconjugation 
(especially in the gauche effect) and CH- interaction between benzene and aliphatic CH bonds 




hydrogen bond interactions can possibly outweigh the destabilising interactions induced by 





1.2 Three-dimensional structural elucidation of small molecules using NMR 
spectroscopy. 
Three-dimensional structural determination is also essential in conformational analysis. 
Although X-ray crystallography has been used for decades to determine the conformation of 
molecules at the atomic level, other factors, such as crystal packing, could influence the 
observed solid-state conformation. Therefore, NMR spectroscopy has been used routinely to 
study the dynamic behaviour and three-dimensional structures of small molecules in solution.  
The elucidation of the 3D molecular structures consists of configurational and 
conformational analysis, which are interlinked. For a given molecular configuration, one could 
derive the preferred molecular conformations. At the same time, the knowledge of molecular 
conformations facilitates the configurational analysis by deducing the possible configurations 
of a given molecule.  
In this section, the use of NMR parameters including chemical shifts (), scalar 
coupling constants (J values) and nuclear Overhauser effect (nOe) for the determination of 
configuration and conformation of flexible molecules will be discussed.  
1.2.1 Chemical Shifts 
While the value of the chemical shift of a nucleus provides information of the nature of 
the substituents directly attached to the nuclei, it also provides information about the nucleus’ 
spacial environment. This forms the basis of the 13C acetonide method (Figure 1.15), first 
described by Rychnovsky in 1990 for the assignment of the relative stereochemistry of 1,3-
diols.27  
In this approach, the syn or anti 1,3-diols (1.25 and 1.26, respectively Figure 1.15) were 
derivatised to the corresponding syn or anti acetonides. Depending on the stereochemistry of 
the 1,3-diol of interest, the derivatised acetonide would adopt different conformations, which 
give characteristic 13C chemical shifts of the gem dimethyl groups, thus allowing the 
determination of the relative configuration of the 1,3-diol motif of interest.  
The syn acetonide adopts a chair conformation so the gem dimethyl groups are 
chemically inequivalent and have different 13C chemical shifts. The equatorial methyl group 
has a 13C chemical shift around 30.0 ppm while the axial methyl group has a 13C chemical shift 
around 19.6 ppm. On the other hand, the anti acetonide adopts a twist-boat conformation to 
avoid 1,3-diaxial interactions, thus both gem dimethyl groups are chemically equivalent and 




carbons could also be used to distinguish the syn and anti configurations. The acetal carbon of 
the syn acetonide has a 13C chemical shift around 98.5 ppm, while the one of the anti acetonide 
has a 13C chemical shift around 100.6 ppm. These characteristic chemical shifts of the gem 
dimethyl and the quaternary acetal carbons allows the assignment of the relative configuration 
(syn or anti) of 1,3-diol motifs.  
 
Figure 1.15: Derivatisation of the syn and anti 1,3-diol (1.25 and 1.26) using acetone, 2,2-
dimethoxypropane (DMP) and pyridinium p-toluenesulfonate (PPST) to yield the corresponding syn 
and anti acetonides. The 13C chemical shifts of the gem dimethyl groups and the acetal carbons are 
labelled.  
Although the 13C acetonide method originally described in 1990 allowed reliable 
assignment of the relative configuration of an isolated 1,3-diol motif, it is challenging to apply 
this approach to deconvolute the relative configuration of 1,3-polyol fragments in natural 
product, especially in the case of dermostatin A (1.27, Figure 1.16).28 Application of the 
original 13C acetonide method for the determination of the relative stereochemistry of the 1,3-
polyol fragment of dermostatin A only revealed the number of syn and anti acetonides present 
in the molecule. Due to the lack of information of “which acetonides were syn and which are 
anti”, the analysis of four derivatised acetonides 1.28 – 1.31 were required to reduce the number 
of possible stereoisomers of dermostatin A from 256 to six. Rychnovsky et al. showed that 
when the original 13C acetonide method was used in combination of advanced 2D NMR 
methods such as DQF-COSY, HMQC, and NOESY/ROESY experiments, the positions of the 




of only two of the four acetonides (1.30 and 1.31) allowed the unequivocal determination of 
the relative configuration of this polyol fragment.28  
Figure 1.16: Chemical structure of dermostatin A (1.27) with the corresponding acetonide derivatives 
of dermostatin A (1.28 – 1.31).  
There are several limitations associated with the acetonide approach. It might be 
challenging to recording a high quality 13C NMR spectrum with mass-limited samples due to 
the limited number of acetonides incorporated into the molecule. This could be circumvented 
by either the use of high field NMR instruments to record the 13C NMR spectrum or the use of 
labelled 1,3-13C2-acetone in the derivatisation step. A cheaper alternative would be to use 
characteristic NOE correlations for the configurational assignment. Another drawback of the 
acetonide method is the requirement for derivatisation, which is undesirable for mass-limited 
samples. 
Therefore, non-destructive techniques, or techniques which do not require 
derivationsation, such as the Universal NMR database (UDB) and J-based configurational 




a variety of polyols (Figure 1.17) with all possible stereochemistries to construct a database 
containing chemical shifts and 1H-1H coupling constants of each stereoisomer for the 
assignment of relative configuration of polyols.29 The NMR data (often chemical shifts) of the 
polyol region of interest is compared to the NMR data of the structurally similar fragments in 
the database, and this allows the determination of the relative stereochemistry of the natural 
product fragment. 
 
Figure 1.17: Representative examples of the polyol fragments in Kishi’s universal NMR database.29-32 
The use of the UDB for assigning relative stereochemistry of polyols was demonstrated 
using mycolactone B as an example (1.32, Figure 1.18). The truncated version of four 
diastereomers of the side chain of interest (C10’ – C16’ region of mycolactone B) were 
synthesised (1.33 – 1.36, Figure 1.18b) and the 13C and 1H chemical shifts of each diastereomer 
were compared to that of the natural product. The comparison was often presented as 
histograms in which the difference in chemical shifts between each diastereomer and the 
natural product (1.33-1.36−mycolacton B) are plotted as the y-axis. The synthetic diastereomer with 
the smallest Dis assigned to have the same relative stereochemistry as the natural product. 
For example, the comparison of 13C chemical shifts (C) showed that both diastereomers 1.33 
and 1.34 fitted well to the natural product data, while the other two diastereomers 1.35 and 1.36 
fitted less well (Figure 1.18c). Comparison of the 1H chemical shifts (H) revealed that 
diastereomer 1.33 provides the best fit to the natural product data (Figure 1.18d), thus this 
diastereomer was assigned to possess the same relative stereochemistry as the corresponding 





Figure 1.18: a, Chemical structure of mycolactone B (1.32) with the polyol region (C10’ – C6’) 
highlighted. b, Four structurally similar diastereomers (1.33 – 1.36) to the polyol fragment of 
mycolactone B 1.32 (C10’ – C6’ region). Comparison of the (c) 13C chemical shifts and (d) 1H chemical 
shifts of the four possible diastereomers (1.33 – 1.36) to the experimental values of the polyol region 




and mycolactone B 1.32 (right) between (R)- and (S)-DMBA-d13. *: For 1.34, H14’ have two chemical 
shifts and this is not the case in mycolactone B. Therefore, the comparison of H14’ was not made 
between 1.34 and that of mycolactone B. **Signal of H16’ overlapped with solvent peaks.  
Kishi et al. also demonstrated that the UDB approach could be extended to assign the 
absolute configuration of the C10’ – C16’ region of mycolactone B with the use of chiral 
deuterated solvents. Chemical shifts of 1.33 was measured in both deuterated R- and S- N,-
dimethylbenzylamine (DMBA) and the difference in chemical shifts (D = R − S) were 
compared to that of mycolactone B obtained in identical conditions. The comparison (Figure 
1.18e) showed that 1.33 presented the opposite trend compared to the natural product, 
suggesting that 1.33 is the enantiomeric form of the C10’ – C16’ region of mycolactone B. 
This allowed for the assignment of the absolute configuration of this fragment of mycolactone 
B.30 
The UDB approach is also used in the determination of the relative configuration of 
1,3,5-triol moieties (Figure 1.19). It was found that the chemical shift of the central carbon 
atom (C3, Figure 1.19a) is sensitive to the relative stereochemistry of the three hydroxyl groups. 
The syn-syn and anti-anti 1,3,5 triols could be differentiated solely on the basis of the chemical 
shifts of C3 but the syn-anti and anti-syn configurations could not be differentiated. 
Nevertheless, this approach has been applied to determine the relative configuration of longer 
alternating polyol structures which could be conceptually treated as a series of overlapping 
1,3,5-polyol segments. For example, the relative configuration of the alternating polyol 
segment of crypocaryol C (Figure 1.19b) was assigned using this approach33 and was later 
verified by total synthesis.34 This approach has also been applied to elucidate the relative 
configuration of the polyol segment of mycapolyol A (Figure 1.19c) containing 14 alternating 





Figure 1.19: a, Chemical shifts of C3 of 1,3,5-triols with different stereochemistries. b, Application of 
UDB in the determination of the stereochemistry of cryptocaryol C.33 c, Proposed configuration of 
mycapolyol A.35  
Successful application of the UDB approach in the assignment of relative configuration 
relies on comparing ‘like with like’ – not only the connectivity, but also the conformational 
behaviour of the motif of interest should closely match to the available fragments in the 
database. In the case of mycolactone B (Figure 1.18), all four synthetic isomers 1.33 – 1.36 
provide poor match to the chemical shifts of position 11’, presumably because position 11’ in 
all the synthetic fragments does not possess the same chemical or conformational properties as 
that of mycolactone B. To provide the best chance for successful application of UDB approach, 
synthesis of all diastereomers of the matching fragments which closely mimic the target natural 
product is required. Scenarios like this, such as the case of baulamycins (which will be 
discussed in chapter 2), the synthesis of all possible isomers is not always trivial, thus leading 
to poor cost/benefit ratio. 
Rather than generating a database by synthesising all possible stereoisomers of the 
stereo-undefined molecular fragments, the chemical shifts of all possible stereoisomers could 
be computed using quantum mechanical (QM) calculations. Chemical shift-based methods 




1.2.2 J values (1H-1H and 1H-13C scalar coupling constants) 
In 1959, Karplus showed that the vicinal 1H–1H scalar coupling constants in ethane 
(3JH-C-C-H) has a dependency on the HCCH dihedral angle based on valence bond 
calculations.36 After the pioneering work published by Karplus, several generalised Karplus-
type equations aiming to calculate vicinal coupling constants in organic molecules were 
proposed. One of the commonly used Karplus-type equations is described by Haasnoot, Leeuw 
and Altona (blue line, Figure 1.20a) which accounts for the effect of electronegativity and 
position of substituents on the vicinal coupling constants.37 Vicinal 1H–13C coupling constants 
(3JHC), which have a dependency on the HCC dihedral angle (red line, Figure 1.20a), are 
less routinely used in structural determination but complement the use of 3JHH and provide 
additional information where 3JHH is not applicable, such as the cases of quaternary centres. 
Generally speaking, larger vicinal J values are expected for coupled nuclei in an antiperiplanar 
orientation (3JHH = 9  – 12 Hz and 
3JHC =
 6-8 Hz respectively, = 180 °, Figure 1.20b) whereas 
smaller vicinal J values are expected for coupled nuclei in a gauche orientation (3JHH = 2 – 4 
Hz and 3JHC =
 1 – 3 Hz respectively, = 60°,Figure 1.20b).  
 
Figure 1.20: a. Correlation between 3JHH and the HCCH dihedral angle in ethane (blue line)37 and 
correlation between 3JHC and the HCCC dihedral angle in propane (red line)38. b, Expected large 
and small 2JHC in ethanol. 
Similar to vicinal H-C couplings (3JHC), two-bond H-C couplings also have a 






















analysis when C is substituted by electronegative groups such as a hydroxyl moiety (ie. 
X = OH, Figure 1.21a).39 When the proton (Hb) and hydroxyl group attached to the C are in 
a gauche orientation, a larger coupling constant (−5 – −7 Hz) is expected. On the other hand, 
when they are in an antiperiplanar orientation, a smaller coupling constant (0 – −2 Hz) is 
expected (Figure 1.21b).  
 
Figure 1.21: a, Correlation between 2JHC and the H-C-C-O dihedral angle in ethanol.39 b, Expected 
large and small 2JHC in ethanol.  
In terms of experimental measurements of J values, vicinal 1H – 1H scalar coupling 
constants (3JHH) can be measured from well-defined signals in a 1D 
1H NMR spectrum. For 
compounds with crowded 1H NMR spectra, several two-dimensional techniques such as 
double-quantum filtered COSY (DQF-COSY)40 and J-resolved experiments (PSYCHE-2D-
J)41 could be used to extract nJHH. 
Large nJHC such as one bond coupling (
1JHC) can be measured directly from the 1D 
1H 
NMR spectrum because they usually appear as satellites. However, the intensity of these 
satellites are weak due to the low abundance of 13C and can be further complicated by the 
satellites overlapping with other 1H resonances in the spectrum. Alternatively, nJHC can also be 
measured from coupled 13C spectra. However, it is a very insensitive technique and usually 
complex multiplets are observed for highly protonated carbon centres. It can also be difficult 
to assign nJHC for a given coupled partner. Therefore, two-dimensional techniques such as 
eCOSY, HSQMBC and EXSIDE were developed to measure nJHC.
42 Among all these 




















the data when compared to the values obtained from coupled carbon spectrum (mean averaged 
deviation: 0.14 Hz).44 However, EXSIDE experiments require selective irradiation of protons 
which are not coupled with each other, and this is not convenient when dealing with compounds 
with crowded 1H NMR spectra. To overcome this limitation, broad-band techniques such as 
HSQMBC could be used instead, although the nJHC values measured from HSQMBC spectra 
are slightly less accurate than those obtained from EXSIDE spectra (for example, mean 
averaged deviation = 0.35 Hz for in phase anti phase (IPAP) accordion HSQMBC44). 
The use of a combination of 3JHH, 
3JHC and 
2JHC to assign the relative configuration of 
acyclic compounds was reported by Murata et al..45 This method is known as “J-based 
configurational analysis” and can be used to determine the relative configuration of two 
adjacent or alternate stereogenic centres in acyclic systems. This approach relies on the 
characteristic patterns of spin-spin coupling constants yielded by each rotamer from the threo 
(syn) and the erythro (anti) configuration, as figure 1.22b illustrates. By comparing the 
magnitude of the expected scalar coupling constants of each rotamer to that of the 
experimentally observed values, the conformation, and subsequently the configuration, of the 
CC bond can be assigned. Additional NOE/ROE correlations are used to distinguish the anti 
rotamers from the opposite configuration because these rotamers cannot be unambiguously 





Figure 1.22. a, NMR parameters used in J-based configurational analysis. b, Two possible 
configurations (threo and erythro) with the corresponding rotamers and the magnitude of the expected 
nJHX of each rotamer in 1,2-methine systems.  
J-based configurational analysis has been used widely in literature46 as a routine method 
for the determination of the relative configuration of natural products. For example, it has been 
applied to elucidate the relative configuration of the C7 – C10 region of kalkitoxin 1.37 (Figure 
1.23), and the assignment was confirmed by total synthesis.47 It has also been applied to assign 
the relative configuration of the C5’ – C16’ region of a cytotoxic sulfolipid 1.38.48  
 
Figure 1.23: Chemical structure of (+)-kalkitoxin 1.37 and the C5’–C17’ region of a cytotoxic 




However, there are several limitations associated with J-based configurational analysis. 
Only staggered rotamers are considered and if the dihedral angle between the vicinal protons 
deviates by >15° from the ideal staggered angles (which is 60°), the magnitude of 3JHH will 
change substantially, from “small” to “medium”. This will affect the accuracy of the 
conformational analysis of a given dihedral. In addition, the range of 2JHC is narrow and the 
magnitude of the J values strongly depends on the substitution along the coupling pathway 
(substituent R1and R2, Figure 1.21).39 The final flaw of this approach is that all the dihedrals in 
a molecule are analysed in isolation, and inconclusive answers are obtained for cases where 
multiple conformers are in equilibrium, which will be detailed in chapter 2 of this thesis.  
1.2.3 Quantitative analysis of interproton distances using Nuclear Overhauser Effect 
(NOE) 
NOESY (Nuclear Overhauser Effect SpectroscopY) provides information of the spatial 
arrangement of protons and has been used for structure elucidation since the 1990s in either a 
qualitative49 (NOE/no NOE) or a semi-quantitative50(strong/medium/weak) fashion. 
Butts et al. demonstrated that 1H-1H distances can be accurately determined from 
correlations measured from both 1D and 2D NOE spectra for both rigid51 and flexible52 small 
molecules. This methodology assumes that in the fast molecular tumbling regime with a short 
experimental NOE mixing time (𝜏𝑚), the observed NOE intensity between a pair of protons 
(𝜂𝐼𝑆 between I and S) is only proportional to the IS cross relaxation rate (𝜎𝐼𝑆) as equation 1.1 
describes.  
 𝜼𝑰𝑺 = 𝝈𝑰𝑺𝝉𝒎 Equation 1.1 
The cross relaxation rate (𝜎𝐼𝑆) is inversely proportional to the distance between the pair 
of protons I and S to the sixth power (equation 1.2). If one assumes the values defining 𝑘 (𝛾 - 
gyromagnetic ratio, 𝜏𝑐 - rotational correlation time and 𝜔 - Larmour frequency) are constants, 
the observed NOE intensity (𝜂𝐼𝑆) is proportional to the distance between the pair of protons 
(𝑟𝐼𝑆 ). Therefore, the ratio of intensity of a pair of NOE signals ( 𝑛𝐼𝑆  and 𝑛𝑟𝑒𝑓 ) is also 
proportional to the ratio of their internuclear distances (𝑟𝐼𝑆 and 𝑟𝑟𝑒𝑓). By using a known rigid 
distance, which is insensitive to the change of conformer population, as a reference distance 
(𝑟𝑟𝑒𝑓, Equatoin 1.3), such as the distance between methylene protons (~ 1.78 Å), the distance 




determined by comparing the relative intensity of the peak of interest (𝑛𝐼𝑆 , Equarion 1.3) with 
the relative intensity of the peak corresponding to the rigid distance (𝑛𝑟𝑒𝑓, Equarion 1.3).
52 
 𝜎𝐼𝑆 = 𝑘𝑟𝐼𝑆















6  Equation 1.3 
The NOE intensities could be obtained from either 1D or 2D NOE/ROE spectra. In 
order to compare all the NOESY intensities taken from the same molecule, the Peak Amplitude 
Normalisation for Improved Cross-relaxation (PANIC)53 method was employed to correct for 
the differing rates of external relaxation for each proton. This was achieved by setting the 
integral of irradiated peaks to a fixed arbitrary value, usually 1000. 
For strychnine (Figure 1.24a), a mean absolute deviation of 3.5% (corresponding to 
~0.1 Å) and standard deviation of 2.7% were observed when comparing the experimentally 
determined NOE-distances (in C6D6) to those obtained from DFT calculations and X-ray 
crystallography. Although the overall fit was excellent, comparison of the interproton distance 
between H11b and H23b gave an error (14.9%) more than five times higher than the standard 
deviation. It was realised that the experimentally derived NOE-distance between H11b and H23b 
in C6D6 is 3.49 Å, which is shorter than the distances computed by DFT and measured from 
the X-ray crystal structure (4.10 and 4.12 Å, respectively). Since the observed NOE intensity 
is sensitive to short interproton distances (scaled with r−6), Butts et al. showed that the shorter 
experimental H11b-H23b distance was indicative of the presence of a second conformer which 
has a shorter H11b-H23b distance (Figure 1.24c). A combination of molecular mechanics 
conformational search and DFT calculations were used to locate the second conformer of 
strychnine, which was computed to have ~ 2.5% of conformer population and a short H11b-H23b 
distance (2.11 Å). This example demonstrated the use of NOE-distance analysis for quantifying 
conformer populations in solution and this offers opportunities to study the detailed 












Figure 1.24:a, Chemical structure of strychnine. The major (b) and minor (c) conformers of strychnine 
in solution with the distance between H11b and H23b (in Å) labelled. 
Apart from the isotropic NMR parameters discussed in this section (, J couplings and 
NOE-distances), other anisotropic NMR parameters, such as residual dipolar couplings (RDCs) 
and residual chemical shift anisotropies (RCSAs), could also be used for 3D structural 
elucidation. These anisotropic NMR parameters can be measured when the compound of 
interest is weakly aligned to the external magnetic field, with the aid of polymer gels swelled 
in deuterated NMR solvent as alignment media. The use of RCDs and RCSAs in structural 
elucidation of natural product complements the routinely used isotropic NMR parameters and 
it is a growing area of research. Unfortunately, a review of this field falls out of the scope of 
this thesis. Nevertheless, there are excellent articles in the literature that provide a general 





1.3 A hybrid approach using quantum mechanical calculations and NMR 
(QM/NMR) for 3D structural elucidation. 
Flexible small molecules often display time-averaged conformational behaviour in 
solution, due to the low interconversion barrier between conformers via CC single bond 
rotation (3 kcal mol−1 in the case of ethane for example, Figure 1.1a). As a result, the rate of 
interconversion is fast compared to the NMR timescale and only the time-averaged signals are 
observed by NMR spectroscopy. Although the time-averaged signals could in principle be 
resolved at low temperature which allows the determination of conformer population, this is 
not often possible for flexible small molecules. Although the observed weighted-average NMR 
properties (such as J values) could be used for conformational analysis of flexible molecules, 
this requires knowledge of the NMR properties and conformer population of individual 
conformers, which are not trivial to estimate.  
This challenge can be overcome by using quantum mechanical calculations to estimate 
conformer population and to compute the NMR properties (, J and internuclear distances) of 
individual conformers. The computed NMR properties of each conformer are Boltzmann-
averaged to give the ensemble-averaged NMR properties of the molecule of interest. 
Quantitative comparison between the ensemble-averaged NMR properties with the 
experimentally measured data allows detailed conformational analysis of flexible small 
molecules. This integrated approach using quantum mechanical calculations and NMR 
spectroscopy for structural elucidation is referred to as the QM/NMR approach (Figure 1.25) 
in this thesis.  






Figure 1.25: An outline of the QM/NMR workflow.  
1.3.1 Conformational analysis (stage a): generating a library of low energy conformers 
by conformational search using Molecular Mechanics (MM) calculations.  
One way to locate low energy conformers of a molecule is to employ molecular 
mechanics (MM) calculations. MM calculations treats molecules as a ‘ball and spring’ models. 
MM describes the strain energy of molecules as a sum of energies associate with bond 
stretching (Estretch), bond angle bending (Ebend) , torsional angle rotations (Etorsion) , electrostatic 
interactions (Ecolombic) and Van der Waals interactions (EVDW) as equation 1.4 describes.
58  
𝐸𝑠𝑡𝑟𝑎𝑖𝑛 = 𝐸𝑠𝑡𝑟𝑒𝑡𝑐ℎ + 𝐸𝑏𝑒𝑛𝑑 + 𝐸𝑡𝑜𝑟𝑠𝑖𝑜𝑛 + 𝐸𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑(𝑟), 
where 𝐸𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑(𝑟) = 𝐸𝑐𝑜𝑢𝑙𝑜𝑚𝑏𝑖𝑐 (𝑟) + 𝐸𝑉𝐷𝑊(𝑟)  Equation 1.4 
There are parameters associated with bond lengths, bond angles, torsional angles, as 
well as electrostatic properties and Van der Waals interactions between atoms. In the past few 
decades, several force fields were developed to describe these properties for different small 
organic molecules. MM259 and MM360 force fields were developed by Allinger et al. to 
calculate the strain energies of hydrocarbons. The Merck Molecular Force Field (MMFF), 
developed by Halgren, was parameterised based on results obtained from both ab initio 
calculations and X-ray crystallographic data of a range of organic molecules.61  
However, the low energy conformer located using MM minimisation calculations 
depends on the geometry of the input structure. In the case of butane, if the input geometry is 
structurally similar to the gauche conformer 1.3, minimisation of this input geometry would 
a. Conformational analysis 
(MM/DFT) 
b. Compute ensemble-averaged  
NMR parameters (, J, NOE) 
(DFT)  
c. Compare to experimental NMR data 




only give the gauche conformer 1.3 as the low energy conformer of butane. On the other hand, 
if the input geometry is structurally similar to the antiperiplanar conformer 1.4, minimisation 
of this input geometry would only give the antiperiplanar conformer 1.4 as the low energy 
conformer of butane. Therefore, to capture the lowest energy conformer (the global minimum) 
it is important to explore the entire potential energy surface of a molecule 
 
Figure 1.26: A schematic representation of MM minimisation calculations of butane.  
In addition, a global minimum geometry determined by MM calculations based on 
strain energies may not remain to be the global minimum once entropy and solvation are 
considered. Further, often several low energy conformers contribute to the solution state 
behaviour of a molecule. Therefore, generation of a library of conformers is required to locate 
all low energy conformers of a molecule, that is, all local minima on a potential energy surface.  
Two methods can be used to examine the conformational space of a molecule: MM 
conformational search and molecular dynamics simulation. In this thesis, only the former will 
be discussed in detail. Within MM conformational search, two approaches can be used: 
systematic and stochastic search. In the systematic search, either the Cartesian xyz coordinates 
of a molecule or the torsional angles of rotatable bonds are varied systematically. This leads to 
the examination of a very large number of conformers but most of these structures are high in 
energy due to destabilising steric interactions. Therefore it is time-consuming and not necessary 



































The stochastic search distorts the structure randomly and explores the conformational 
space in an iterative fashion. Figure 1.27 outlines one of the most frequently used methods 
(Monte Carlo Multi-Minimum (MCMM)). A starting structure is chosen and varied by either 
the distortion of Cartesian coordinates or torsional angles. The distorted structure is then 
minimised and the result is compared to the structure generated by the previous conformational 
search steps. The structure will either be stored as a new, unique structure or be discarded as a 
duplicate. This process is called Monte Carlo and the iteration of this process is called an 
MCMM search.63 Unlike the systematic search, there is no defined end point for the stochastic 
search and usually a large number of iterations, or large number of steps, is set to ensure the 
examination of a large number of conformers arising from random distortions and hence 
maximising the chance of locating all the low energy conformers. 
 





1.3.2 Conformational analysis (stage a): evaluating conformer population using Density 
Functional Theory (DFT) geometry optimisation and frequency calculations.  
After a conformational search, a library of conformers within a certain energy window 
above the global minimum is generated. DFT calculations are used to refine the geometries of 
conformers, and to compute the Gibbs free energies of conformers by taking into account zero-
point energy correction, entropy and solvation.64  
The physical properties such as the Gibbs free energy of a molecule, can be calculated 
by solving the time-independent Schrödinger equation (Equation 1.5), which encapsulates the 
physical behaviour of atoms and molecules, and describes the energy of a molecule as a 
function of the wave function.65 However, practically it is impossible to solve the Schrödinger 
equation for polyatomic systems due to the time and computation power required.66  
Ĥѱ = 𝐸ѱ  
Equation 1.5 The time-independent Schrodinger equation. Ĥ is the Hamiltonian operator, ѱ is the 
wave function of the quantum system and E is the energy of the state ѱ. 
While the Schrödinger equation can be simplified by the Born-Oppenheimer 
approximation67, which assumes that the electronic and nuclear motion in molecules can be 
separated due to the mass difference between electrons and nuclei, it is still challenging to solve 
the equation.  
Fortunately, Density Functional Theory (DFT) provides a more practical solution to 
this problem. Hohenberg and Kohn68 proposed that rather than trying to solve the Schrödinger 
equation itself to obtain the wave function, which describes the properties of a molecule, the 
Schrödinger equation can be reformulated to approximate the electron density of a molecule in 
order to determine the energy of a molecule. They also proposed that the initial approximation 
of the electron density, that is, the approximate solution to the Schrödinger equation, could be 
improved by an iterative process. Later, Kohn and Sham69 took this theory to the application 
stage, and formulated a method to find the approximate answer. Although the exact exchange-
correlation functional is unknown, approximate functionals  such as B3LYP70 and 
mPW1PW9171 were developed and each functional has its strengths and weaknesses. For 
example, B3LYP is the most widely used functional due to its excellent accuracy/cost ratio and 
yet it does not account for dispersion interactions, which sometimes give misleading results in 
transition state calculation in organometallic chemistry.72 The mPW1PW91 functional was 




al..46 In addition to functionals, different basis sets have also been developed as a mathematical 
description of atomic orbitals. The atomic orbitals, which can be used to build molecular 
orbitals, are approximated by either Slater-type orbitals or Gaussian-type orbitals. Polarisation 
functions and diffuse functions were also developed to better approximate the electron 
distribution and electron density of the atomic orbitals.  
1.3.3 Computing ensemble-averaged NMR parameters (, J couplings and NOE-distances) 
using DFT calculations (stage b).  
Prediction of NOE-distances is straight forward, and only the DFT-optimised 
geometries are required for computing internuclear distances. Prediction of chemical shifts is 
achieved by computing the magnetic shielding tensor (MST) values of each nucleus in the 
molecules of interest. The computed MST values can then be converted to chemical shift values 
by referencing to the MST values of tetramethylsilane (TMS) computed at the same level of 
theory. The gauge including atomic orbital (GIAO) method73 has been widely used to compute 
accurate MST values. The calculation of J couplings is a lot more resource-intensive because 
it requires the evaluation of four terms: fermi contact, diamagnetic spinorbit coupling 
component, paramagnetic spinorbit coupling component and spindipolar operator. The 
contribution of these four terms varies depending on the nature of the coupling pathway (eg. 
geminal, vicinal) and therefore the calculations of all four terms are required to accurately 
predict the total J values between two coupled nuclei.  
The computed NMR properties of all conformers are Boltzmann weighted based on the 
relative energies of the conformers to give the calculated ensemble-averaged NMR properties 
of a molecule. In the next section, examples of structural elucidation based on quantitative 
comparison between the ensemble-averaged NMR properties with the experimentally 
determined values will be discussed.  
1.3.4 Application of the QM/NMR approach in 3D structural elucidation (stages c and d) 
MAE-based comparison of computed vs experimental chemical shifts. 
Tantillo et al. reported the structural reassignment of aquatolide (Figure 1.28)74, a 
humulane-derived sesquiterpenoid lactone isolated from Asteriscus aquaticus in 1989. 
Aquatolide was originally assigned to have a rare [2]ladderane substructure on the basis of 1D 
and 2D NMR analysis75 (1.39, Figure 1.28a). To verify the originally proposed structure, 
Tantillo et al. computed the 1H and 13C chemical shifts of the originally reported structure 1.39 




data.74 The comparison of 13C chemical shifts showed a corrected mean averaged deviation 
(CMAD) of 7.23 ppm, with the largest deviation possessing a value of 24.33 ppm. The large 
discrepancy between the calculated and experimental data prompted Tantillo et al. to perform 
chemical shift based computational screening to elucidate the correct structure. This was 
achieved by computing the chemical shifts of 60 constitutional isomers arising from all possible 
[2+2] addition of the biosynthetic intermediate asteriscunolide C 1.40. Finally, 1.41 (revised 
structure, Figure 1.28) was found to match the natural product chemical shifts well (CMAD of 
C = 1.37 ppm with the largest deviation of 4.28 ppm) and was therefore assigned to be the 
structure of aquatolide. This assignment was further supported by the examination of nJHH, 
NOE correlations and X-ray crystal structure of the re-isolated natural product.74 It later 
confirmed by total synthesis76. 
 
Figure 1.28: The (a) proposed (1.39) and (b) revised (1.41) structure of aquatolide. Both could be 




When comparing the calculated chemical shifts to the observed values of the 
compounds of interest, the isomer showing the lowest error, that is, the lowest MAD value or 
the smallest error, would be assigned to be the matching isomer, such as in the case of 
aquatolide and examples discussed previously, for example, mycolactone B (Figure 1.18, 
section 1.2.1).  
Probability-based comparison of computed vs experimental chemical shifts (DP4 and 
DP4+). 
Although simple statistical analyses using R2, mean averaged deviation (MAD) and 
standard deviation (StDev) values reflect the quality of the fit for the comparison, these 
numbers do not infer how likely it is that the matching isomer actually possess the 
stereochemistry of the stereo-undefined natural product. In addition, when dealing with cases 
where all possible isomers give similar MAD values (such as the case of baulamycins in chapter 
2), the use of easy-to-perform statistical analysis for the comparison offers little advantage in 
discriminating possible stereoisomers. Smith and Goodman published the use of DP4 
probability for the stereochemical assignment of organic small molecules in scenarios where 
only one set of experimental data is available.77-78 Conformational search for possible 
stereoisomers were performed using the MMFFs forcefield in gas phase. The geometries 
obtained from MM calculations were then used to compute the magnetic shielding tensor (MST) 
values using the GIAO method, with B3LYP 6-31G(d,p) level of theory in gas phase. The 
computed MST values of each conformer were then Boltzmann averaged using the conformer 
energies calculated using DFT single point energy calculations with the same DFT method 
(B3LYP 6-31G(d,p)//MMFF). The ensemble-averaged MST values were converted to 
chemical shifts using the MST values of TMS computed using the same DFT method. The 
computed chemical shifts were then linearly scaled with respect to the experimentally observed 
values to remove systematic errors. Errors between the scaled chemical shifts of each nuclei 
and the experimental values (calc – exp, Figure 1.29) were converted to quantifiable 
probabilities of being the right answer using Bayes’s theorem, with the expected standard 
deviations () and degrees of freedom ().The  and  values used for calculating the DP4 
probabilities (H ppm, Cppm, H, C) were obtained by 
fitting 1717 13C chemical shifts and 1794 1H chemical shifts of 177 known organic compounds 
computed using the same DFT method described previously (B3LYP 6-31G(d,p)//MMFF) to 
a t distribution. Finally, probabilities calculated for all nuclei of each stereoisomer were 




To facilitate the use of DP4 probabilities in structural assignment of small organic molecules, 
an applet was made available at http://www.jmg.ch.cam.ac.uk/tools/nmr/DP4.77  
 
Figure 1.29: A schematic presentation (reproduced from literature78) of the DP4 probability.  
Smith and Goodman demonstrated the application of DP4 probability to the assignment 
of tricholomalide A 1.42 (Figure 1.30)77 Among 64 stereoisomers considered, the correct 
structure was assigned with very high confidence (99%). However, in the case of 
conformationally more flexible stereopentad 1.43 (Figure 1.30), DP4 probabilities often 
assigned the wrong stereoisomer with high confidence (>90%). The poor performance 
observed could be rationalised by the effect of improper description of solvent effects, which 
was not considered in the protocol, on conformer energies and the computed MST values. 
 
Figure 1.30: Application of DP4 probability in the stereochemistry assignment of 1.42 and 1.43.  
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In addition, there are other drawbacks of the DP4 probability. The first one is associated 
with the accuracy of the expected  values used in the calculation of probabilities, since the 
calculated chemical shifts used for the original fitting of the t distribution were computed using 
relatively low level of theory (B3LYP 6-31G(d,p)) in favour of  low computational cost. 
Although the accuracy of the  values might also be affected by the starting geometries, which 
were not re-optimised by DFT calculations.79 In addition, the use of linear scaled chemical 
shifts for all atoms in the DP4 protocol ignored the fact that systematic errors for atoms with 
different hybridisations (sp3 vs sp2) are different and should not be treated using the same linear 
scaling process. Furthermore, scaling the chemical shifts of the wrong answer to the 
experimentally observed values might give false positive results, in cases where the calculated 
chemical shifts of the wrong isomer accidentally fit well to the experimentally observed values. 
To address these issues, Sarotti et al. proposed an improved version of the DP4 
probability (DP4+)79. To obtain more accurate  values, 1219 13C and 1123 1H chemical shifts 
were computed on DFT optimised structures with 24 different levels of theory in gas phase and 
in implicit solvation (PCM). To address the issues with linear scaling for atoms with different 
hybridisations, another t distribution was fitted for sp2 carbons. In addition, unscaled chemical 
shifts could also be used to calculate DP4+ probabilities and this was achieved by subtracting 
the errors (calc – exp) with the expected mean  for the t distribution. To facilitate the use of 
DP4+ probabilities in structural assignment of small organic molecules, an Excel spreadsheet 
was made available as part of the supplementary information of the DP4+ publication.79 
Although DP4-based methods offer new alternatives in structural assignment of natural 
product, both protocols start with gas conformational search which may not properly predict 
the conformational behaviour of flexible molecules, essentially when solvation has a big impact 
on the conformational behaviour. As Smith and Goodman pointed out, there are cases, such as 
the stereopentad 1.43, where confident assignment of relative configuration is impossible 
solely based on chemical shifts.77 Therefore, the analysis of other NMR parameters such as 
scalar coupling constants and NOE-distances, are required for the unequivocal determination 
of molecular structures.  
Comparison using multiple NMR parameters (, J values and NOE-distances) 
Butts and Bifulco et al. reported the use of both DFT-computed 13C chemical shifts and 
quantitative NOE-distance analysis for the structural assignment of conicasterol F, which is a 




Two possible diastereomers 1.44 and 1.45 (Table 1.1) differing from the epoxy ring 
configuration were distinguished by quantitative NOE-distance analysis. Interproton distances 
of both diastereomers 1.44 and 1.45 were computed using DFT-optimised structures 
(mPW1PW91 6-31G(d)) and compared to the natural product NOE-distances derived from 1D-
ROESY spectra. The goodness of fit was evaluated by mean absolute deviation (MAD), and it 
was found that diastereomer 1.45 fit better to the natural product data, with a MAD value of 
3.0%, which correspond to approximately 0.1 Å. Therefore, diastereomer 1.45 was assigned to 
have the same relative configuration as the natural product. The NOE-distance derived 
configuration was further supported by the comparison of the calculated 13C chemical shifts 
(mPW1PW91 6-31G(d,p)// mPW1PW91 6-31G(d)) of both diastereomer 1.44 and 1.45 with 
the natural product experimental data (MAD value of C comparison for 1.45: 0.8, Table 1.1).  
Table 1.1: Comparison of NOE-distances and calculated chemical shifts of 1.44 and 1.45 to the natural 
product data.  




 MAD MAD 
NOE-distances 7.8% 3.0% 
C/ppm 3.7 0.8 
 
The QM/NMR approach has also been applied to study molecular conformations of 
flexible molecules. Harvey and Butts et al. 8 demonstrated the application of QM/NMR 
approach for studying the conformational behaviour of molecules with 10 contiguous methyl 
substituents 1.9 and 1.10 (Figure 1.5).8 As section 1.1 discussed, due to the avoidance of syn-
pentane interactions the all syn isomer 1.9 was designed to adopt a linear conformation while 
the syn-anti isomer 1.10 was designed to adopt a helical conformation. The truncated version 
of both isomers 1.46 and 1.47 (Figure 1.31a) were studied computationally by conformational 




F12//B3LYP-D2 6-311+G(d)). It was predicted that for isomer 1.46, 95% of conformers adopt 
a linear conformation while for isomer 1.47, 74% of conformers adopt a helical conformation. 
The DFT-predicted solution-state conformations for both compounds were confirmed by 
QM/NMR analysis using 1H-1H, 1H-13C scalar coupling constants and NOE-distances. For both 
compounds a good correlation was observed between the computed ensemble-averaged NMR 
parameters (mPW1PW91 6-311G(d,p)// B3LYP-D2 6-311+G(d)) and the experimental NMR 
data, with 1 Hz error in the comparison of J values and 5% error in the comparison of NOE-
distances.8  
 
Figure 1.31: a, Chemical structure of the syn-anti isomer 1.46 and all-syn isomer 1.47. b, correlation 
between the computed ensemble-averaged NMR data and the experimentally measured NMR data for 






1.4 Synthesis of molecules with tailored conformations enabled by 
stereospecific iterative homologation of boronic esters.  
With ever-increasing computing power and accuracy, the conformational behaviour of 
flexible small molecules can be routinely evaluated in silico, and their solution-state behaviour 
can be studied using a variety of NMR parameters discussed previously. However, one’s ability 
to generate flexible small molecules with defined conformations is often limited, not only by 
one’s understanding of conformational design, but also by the insufficient methods of 
stereoselective synthesis to create molecules with defined stereochemistry.  
Organoboron chemistry is an attractive approach to stereoselective chemistry since 
there are numerous methods for their preparation in enantioenriched form, and they can be 
transformed to other functional groups with high stereospecificity.81-82 Organoboron 
compounds, such as boranes (1.48, R3 = alkyl groups) and boronic esters (1.48, R3 = alkoxy 
groups) are electrophilic due to a vacant p-orbital on boron and can react with a nucleophile 
1.49, to form boronate complexes 1.50, as a result of the donation of a pair of electrons from 
the nucleophile to the vacant p-orbital on boron (Scheme 1.1).83 As a leaving group (LG, 1.49) 
is present on the nucleophilic carbon, and if one of the substituents on boron can orientate itself 
antiperiplanar to the leaving group LG, a 1,2-metallate rearrangement can occur to give the 
homologated organoboron species 1.51, with inversion of stereochemistry (Scheme 1.1).83  
 
Scheme 1.1 Formation of a boronate complex followed by 1,2-metallate rearrangement. 
Metal carbenoids are often used in the homologation of boronic esters and scheme 1.2 
outlines some selected examples from the literature. Matteson developed a substrate-controlled 
strategy for the homologation of boronic esters.84-89 In this method, boronic esters bearing a 
chiral diol ligand 1.52 were treated with dichloromethyl lithium in the presence of zinc chloride. 
The -chloro boronic ester 1.53 could undergo further boronate complex formation with a 
Grignard reagent, then 1,2-rearrangement, to generate the homologated product 1.54. Since the 




the diol ligand needs to be exchanged to the opposite enantiomer to allow for generation of the 
opposite enantiomer of the homologated product. Rather than using (dichloromethyl)lithium 
as a homologating agent, Hoppe et al. demonstrated the use of chiral lithiated carbamates 
instead.90 In this reagent-controlled approach, treatment of alkyl carbamate 1.55 with sec-
butyllithium in the presence of a chiral diamine ligand such as ()-sparteine, at 78 °C, gave 
an -oxygen-stabilised organolithium 1.56. This chiral, configurationally stable, organolithium 
carbenoid then reacted with B(OiPr)3, and the resulting boronic ester was transesterified, to 
give a chiral pinacol boronic ester 1.57. This was then transformed to the homologated product 
1.58 by the reaction with a Grignard reagent. Kocienski91 and Aggarwal83 developed the 
homologation of boronic esters in a single step, by the direct addition of a pinacol boronic ester 
to Hoppe’s lithiated carbamates.  
 
Scheme 1.2: Overview of homologations of boronic esters with lithium carbenoids. 
The potential of performing iterative homologation using Hoppe’s lithiated carbamates 
was investigated by the Aggarwal group (Scheme 1.3).92 It was shown that triple homologation 
of boronic ester 1.59 with lithiated carbamate 1.56 gave boronic ester 1.62 in good yield over 
three steps (77%) and good dr (93.3:2.2). The homologation could be performed with either 
the isolation of each intermediate boronic ester (1.60, 1.61, Scheme 1.3) or in an iterative 





Scheme 1.3: Iterative homologation of boronic ester 1.59 with lithiated carbamate 1.56. 
However, further homologation of boronic ester 1.62 with lithiated carbamate 1.56 lead 
to the formation of a mixture of starting material 1.62, desired product 1.63 and over 
homologated product 1.64 (Scheme 1.4a). A mechanism was proposed for this observation as 
scheme 1.4b illustrates. The lithiationborylation of 1.62 with lithiated carbamate 1.56 gave 
boronate complex 1.65, which generated the desired product 1.63 after 1,2-metallate 
rearrangement. However, if the 1,2-metallate rearrangement is slow, then the boronate complex 
1.65 can reverse back to the lithiated carbamate 1.56, which can react with product 1.63 again 





Scheme 1.4: a, Homologation of boronic ester 1.62 with lithiated carbamate 1.56. b, Proposed 
mechanism for the formation of over homologated product 1.64. 
To overcome the problems associated with reversible 1,2-metallate rearrangement, the 
Aggarwal group demonstrated that another motif, the tri-isopropyl benzoate (TIB ester), 
developed by Beak et al.93, could be used in place of carbamates. The TIB ester is a better 
leaving group so leads to a more facile 1,2-migration. In 2014, the Aggarwal group reported 
iterative homologations of boronic esters (assembly line synthesis) using -lithioethyl tri-
isopropyl benzoate to generate molecules with 10 contiguous methyl substituents with 
complete stereochemical control as scheme 1.5 illustrates.8 To generate the lithiated species 
(S)-1.67 in high er, ethyl tri-isopropylbenzoate 1.66 was lithiated in the presence of sec-BuLi 
and (−)- sparteine, which was trapped by trimethyltin chloride to give the -stannyl benzoate 
(S)-1.68 (91:9 er). The stannane (S)-1.68 can be recrystalised to very high levels of 
enantiopurity (99.9:0.1 er). The subsequent tinlithium exchange of this enantiomerically pure 
stannane (S)-1.68 using n-BuLi is a convenient way to access the highly enantioenriched 
lithiated species (S)-1.69. The opposite enantiomer of the stannane could be prepared using the 




1.69 and (R)-1.69 enabled the preparation of hydrocarbons with 10 contiguous methyl 
substituents (1.70 and 1.71) as single enantiomers and with only one column chromatography 
purification at the end of the homologation sequence. After further functionalisation of boronic 
ester 1.70 and 1.71, 1.9 and 1.10 were obtained (Figure 1.4, section 1.1) and they were shown 
to adopt either linear or helical conformations as discussed previously (sections 1.1 and 1.3.3).8  
 
Scheme 1.5: Aggarwal’s iterative homologation of boronic esters, referred to as the ‘assembly-line 
synthesis’. 
As matched and mismatched effects were not observed in this reagent-controlled 
strategy, the same methodology was applied to the total synthesis of two natural products (+)-
kalkitoxin and (+)-hydroxyphthioceranic acid.94 The fragments of both natural products were 
prepared with high stereocontrol and good yield. However, in the latter case, flash column 
chromatography was performed after every fourth homologation to ensure the efficiency of the 





Scheme 1.6: Application of assembly line synthesis in total synthesis of natural products.
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1.5 Conclusions 
Conformational analysis of flexible small molecules is an interdisciplinary area of 
research. This requires chemists’ understanding in stereoelectronic factors controlling 
molecular conformations, their ability to study the dynamic conformational behaviours of 
flexible molecules in solution using computational modelling and NMR spectroscopy, and their 
skills to synthesise molecules one have designed using advanced stereocontrolled synthetic 
methodology. The work described in this thesis aims at performing detailed conformational 
analysis of small flexible molecules using a combination of computational modelling, NMR 
spectroscopy and stereoselective iterative homologation of boronic esters. Conformational 
analysis was applied in the context of configurational assignment of highly flexible polyketide 
natural products (chapter 2), in the design and synthesis of molecules with defined 
conformations (chapter 3), and in the understanding of factors controlling helical screw-sense 




Chapter 2 : The Synergy of Computational Modelling, NMR 
Spectroscopy and Synthesis to Elucidate the Correct Structure of 
Baulamycins 
Parts of the work described in this chapter have been adapted from the following article: 
Nature, 2017, 547, 436. 
This project was conducted in collaboration with Dr. Jingjing Wu and Dr. Paula Lorenzo 
who have performed all the synthetic work. Parts of the synthetic work are included to 
provide a complete picture of the research. 
2.1 Introduction 
Baulamycin A and B were isolated in 2014 from Streptomyces tempisquensis, which 
was collected from sediments in Costa Rica.95 They were shown to be active against both gram-
positive and gram-negative bacteria and are active against superbug MRSA and Bacillus 
anthracis (IC50 values of baulamycin A: 130 M and 110 M). Two different modes of action 
of balamycin A in Staphylococcus aureus have been proposed: inhibition of siderophore 
synthesis95 and membrane damage96. The unique biological activities of the baulamycins 
provide an opportunity for the development of a new class of broad-spectrum antibiotics to 
potentially help overcome the threat of antimicrobial resistance.  
 
Figure 2.1: Sherman’s proposed relative configuration of baulamycins with fragment A highlighted by 
a red box and fragment B highlighted by a blue box.  
Due to their important biological activities, the Aggarwal group developed a 10-step 
enantioselective synthesis of the proposed structure of baulamycin A 2.1 (Figure 2.1). 
Unfortunately, both 1H and 13C spectra of the synthetic compound did not match those of the 
natural product (Figure 2.2). Further investigation of the literature reported spectra revealed 




stereogenic centres had been misassigned and re-evaluation of the relative configuration of the 
natural product was required.  
 
 
Figure 2.2: Comparison of a. 1H NMR (CD3OD, 500 MHz) and b. 13C NMR (CD3OD, 176 MHz) 
spectra of the synthetic proposed structure 2.1 (red) to that of the isolated baulamycin A (black). c. 
Zoom in of the 13C NMR spectrum from 17 to 47 ppm. 
In the original report, due to the limited availability of baulamycin A and B (3.6 mg 
and 2.1 mg, respectively), common structural elucidation techniques such as X-ray 
crystallography and chemical modification were precluded as means to gain stereochemical 
information of the natural product. Instead, the relative configuration of baulamycin A and B 
were elucidated entirely using J-based configurational analysis45,95 (chapter 1, section 1.2.2). 
Upon re-examination of Sherman et al.’s reported J-based configurational analysis95, it 
was realised that the relative configuration of the natural product should be 2.2 (Figure 2.3b), 
with a syn–syn–anti configuration in fragment A and an anti–syn configuration in fragment B. 
During our investigation, Guchhait et al. reported a 17-step synthesis of 2.1 and also found that 
the data of 2.1 did not match that of the natural product. Their re-examination of the literature 




preparing 2.2, they found that the experimental NMR data of 2.2 also did not match that of the 
natural product.97 
A limitation of J-based configurational analysis is that it does not fully account for 
molecular flexibility and conformer stability, conformational analysis of each bond in isolation 
can lead to a molecular conformation which is highly energetically unfavourable. To illustrate 
this point, a 3D model of compound 2.2 was constructed using the Sherman proposed J-based 
configurational analysis.95 In this model (Figure 2.3c), there are five syn-pentane interactions, 
each bearing an enthalpic penalty of 3.5 kcal mol−1 (Figure 2.3d). As a result, the literature 
proposed conformation has 17.5 kcal mol−1 (5 × 3.5 kcal mol−1) of destabilising syn-pentane 
interactions, making this conformation inaccessible at room temperature. Therefore, it should 
not be observable using room temperature NMR experiments. Simply, 2.2 requires an 
impossible conformation in order to satisfy the experimentally observed natural product NMR 
data.  
 
Figure 2.3: Literature proposed relative configurations of baulamycins and the limitation of J-based 
configurational analysis. a, Proposed structure (2.1) of baulamycin A. b, A diastereomer (2.2) of 
baulamycin A derived from the literature reported J-based configurational analysis with purple dots 
highlighting the revised stereocentres. c, A 3D conformation 2.2 proposed by Sherman95 with red arrows 
highlighting unfavourable syn-pentane type steric interactions. Arrows with a dotted line highlight steric 
clash between an sp2 and an sp3 centre, and arrows with a solid line highlight steric clash between two 




After the construction of the 3D model of 2.2 and thorough examination of both the 
PDF NMR spectrum and the original raw NMR data provided by David Sherman et al., we 
realised that several published J values were incorrectly reported, meaning inaccurate values 
were used in the original J-based configurational analysis. For example, the vicinal coupling 
constant between H14 and H13 was reported to be a large value (7.7 Hz). The magnitude of 
the reported coupling constants, together with interproton correlations observed in the ROESY 
spectrum, led to the conclusion that the stereochemistry of the C14-C13 bond is syn.95 However, 
the re-examination of the 1H NMR spectrum of the natural product revealed that the vicinal 
coupling constant between H14 and H13 should be 3.3 Hz, which is substantially smaller than 
the originally reported value (7.7 Hz).  
Taking the freshly extracted J values from Sherman’s raw NMR data, a new qualitative 
analysis was undertaken for the C1’-C14 and C14-C13 configurational assignment. In the 
Sherman reported configurational analysis of the C1’-C14 bond, H1’ and H14 were assigned 
to be anti-periplanar because a large vicinal coupling constant (6.8 Hz) was observed. Rotamer 
2.3 (from the syn configuration, Figure 2.4b) fits with this H1-H14 coupling. Together with the 
NOE correlations observed between the aromatic protons (attached to C2’) and H13, H13 and 
H1’, and H1’ and H15, the configuration of the C1’-C14 bond was assigned to be syn (Figure 
2.4b).95 
However, rotamer 2.4 (from the anti configuration, Figure 2.4g) also matches the 
magnitude of the natural product J values and lacks only a key NOE correlation between the 
aromatic protons (attached to C2’) and H13. The lacking NOE correlation could be provided 
by rotamer 2.5, which could be generated from bond-rotation of 2.4. Providing that rotamer 2.5 
is a minor conformation (<10% of global population), the magnitude of the Boltzmann 
averaged J values of rotamers 2.4 and 2.5 would be represented by rotamer 2.4, while both 
rotamers would contribute to the observed NOE correlations since the experimentally observed 
NOE signals are very sensitive to minor conformers (<10% population) with close interproton 
contacts54. Therefore, the anti configuration could also provide matching NMR data to the 
experimentally observed natural product data. A qualitative analysis, therefore, could not 
unequivocally determine the configuration of the C1’-C14 bond. A quantitative analysis is thus 
required to determine whether the predicted NMR data of the syn or the anti configuration fits 










c e Size of expected J values 
nJHX J values (size)  2.3 2.4  2.5 
3JH1’-H14 6.8 Hz (large) Large √ Large √  Small × 
3JH1’-C15 2.3 Hz (small) Small √ Small √  Small × 
3JH1’-C13 4.3 Hz (small) Small √ Small √  Large × 
2JH14-C1’ 4.9 Hz (large) Large √ Large √  Small × 
Figure 2.4: J-based configurational analysis of the C1’-C14 bond of baulamycins. a, Proposed 
configuration95 of fragment A of baulamycins, highlighting the bond of interest (C1’-C14) in pink; b, 
Conformation proposed by Sherman95, represented by a Newman projection with solid arrows 
indicating interproton NOE correlations observed in the natural product 2D ROESY spectrum; c J 
values (1H-1H and 1H-13C) of the natural product extracted from the 1H spectrum provided by Sherman 
et al.95 and an Accordion HSQMBC spectrum recorded using the synthetic baulamycin A; d, 2D 
structure of the syn configuration of the C1’-C14 bond, together with e, expected magnitude of J values 
of rotamer 2.3; f, 2D structure of the anti configuration of the C1’-C14 bond; g, Newman projections 
of the anti configuration with H1’-H14 trans (2.4) and gauche (2.5) to each other, together with e, the 
expected magnitude of J values for each rotamer. A green tick represents a match in magnitude between 
the expected J values of the rotamer and the experimentally observed natural product data, while a red 
cross represents a mismatch in the magnitude of J values. Solid arrows in b and g represent matching 
interproton NOE correlations to the experimentally observed natural product data, while the dotted 




Secondly, when several conformations are in equilibrium it is challenging to estimate 
the magnitude of the expected J values for a given configuration, which hampers the accuracy 
of J-based configurational analysis. As figure 2.5 outlines, no single rotamer of the C14-C13 
bond from either the syn or anti configuration provides the matching magnitude of J values to 
the natural product data, and the mismatched magnitude of J values suggests that neither 
rotamer is the major conformation. Therefore, the configuration of the C14-C13 bond could 
not be assigned using J-based configurational analysis. The same limitation was also observed 
by Paloma et al. for the configurational analysis of sapinofuranone A.98  
a d f 
 
  




Size of expected J values of each rotamer 
nJHX J values (size) 
3JH13-H14 3.3 Hz (small) Small √ Small √ Small √ Small √ 
3JH13-C1’ 2.8 Hz (small) Small √ Large × Small √ Large × 
3JH14-C12 3.8 Hz (small) Small √ Large × Large× Small √ 
2JH14-C13 5.0 Hz (large) Small × Large √ Large √ Small × 
Figure 2.5: J-based configurational analysis of C14-C13 dihedral of baulamycins. a, Proposed 
configuration95 of fragment A of baulamycins, highlighting the bond of interest (C14-C13) in pink; b, 
Conformation proposed by Sherman95, represented by a Newman projection with solid arrows 
indicating interproton NOE correlations observed in the natural product 2D ROESY spectrum; c, J 
values (1H-1H and 1H-13C) of the natural product extracted from the 1H spectrum provided by Sherman 




of the syn configuration of the C14-C13 bond; e, Newman projections of the syn configuration with 
H14-H13 gauche to each other and the expected magnitude of J values for this rotamer; f, 2D structure 
of the anti configuration of the C14-C13 bond; and g, Newman projection of the anti configuration with 
H14-H13 gauche to each other, together with the expected magnitude of J values for each rotamer. A 
green tick represents a match in magnitude between the expected J values of the rotamer to the 
experimentally observed natural product data, while a red cross represents a mismatch in the magnitude 
of J values. 
The key to achieving a reliable configurational analysis of flexible small molecules is 
to predict accurate NMR parameters of a given configuration of the molecule, and to 
quantitatively compare the calculated data with the experimentally measured data (QM/NMR 
approach, section 1.3). To obtain an accurate prediction of the Boltzmann averaged NMR data 
of a given configuration, quantum mechanics calculations could be employed to calculate the 
energies of all conformers, as well as to predict the Boltzmann averaged NMR parameters.46,99 
The comparison between the calculated Boltzmann averaged NMR data of different 
diastereomers and the natural product experimental data provides a quantitative assessment of 
the goodness of fit, which would then allow an unequivocal determination of the relative 






2.2 Results and Discussion 
2.2.1 Validation study: Calculation of the proposed structure 2.1/2.6.  
It will be challenging to model the conformational landscape of the baulamycins due to 
their flexible nature. Therefore, to establish whether the Boltzmann averaged calculated NMR 
properties would accurately describe the experimental coupling constants of a given 
diastereoisomer, NMR properties of the Sherman proposed structure with a phenyl and a 
methyl ketone end groups (2.6, Figure 2.6b) were calculated and compared to the experimental 
values of the corresponding synthetic product 2.1 prepared by Dr Jingjing Wu and Dr. Paula 
Lorenzo. 
 
Figure 2.6. Structure of 2.1/2.6 with atom labels. 
Conformational search of 2.6 using molecular mechanics (MM) with MMFFs 
forcefield100 with 500,000 iterations in gas phase generated 2086 conformations. Conformers 
which have the same backbone conformation but differ in the rotation of phenyl, hydroxyl and 
isopropyl groups were treated as the same conformation (see experimental section for details). 
After redundant conformer elimination, 1674 conformers remained and 98 of these conformers 
had a potential energy within 10 kJ mol−1 of the global minimum. These 98 conformers, 
together with another 98 higher energy conformers randomly selected from the remaining pool 
(10-21 kJ mol−1), were then reoptimised by Density Functional Theory (DFT) using 
mPW1PW91 functional and 6-31G (d) basis set in gas phase. To confirm that all 196 
conformers were local minima after the DFT geometry optimisation calculations, frequency 
calculations were performed using the same DFT methods and the Gibbs free energies of all 
conformers were computed.  
No significant conformational change was observed in this process. However, the 
relative energy of conformers changed dramatically upon going from MM to DFT calculations. 
For example, conformer 2.6-5, which has a relative MM potential energy of 19.9 kJ mol−1 




mol−1, Table 2.1) after DFT geometry optimisation and frequency calculations, and ultimately 
was identified as the dominant conformer (30.1%) after single point calculation at a higher 
basis set (6-311G (d,p)) and solvation correction (the Integral Equation Formalism Polarizable 
Continuum Model (IEF-PCM) continuum dielectric solvation model using methanol) by single 
point calculations. After single point calculations, Boltzmann population analysis was 
performed using the approximate DFTcalculated relative Gibbs free energies (∆𝐺𝑒𝑠𝑡
BS2,MeOH
, 
see equation 6.1 in experimental section) and it was found that the six lowest energy conformers 
have a combined population of 85.8%.  
Table 2.1 DFT calculated energies (in kJ mol−1) for the major conformers of 2.6 with a combined 
population of 85.8% with no population refinement. 








2.6-5 19.9 0.003% 5.6 0.0 30.1% 
2.6-8 16.4 0.011% 3.4 0.7 22.3% 
2.6-11 18.4 0.005% 6.5 1.3 17.8% 
2.6-18 18.6 0.005% 9.9 3.6 7.1% 
2.6-20 4.8 1.200% 0.0 4.4 5.1% 
2.6-25 20.9 0.002% 12.8 5.4 3.4% 
 
Conformers with intramolecular hydrogen bonding interactions between the three 
hydroxyl groups in fragment A dominate the DFT-determined conformations of this fragment 
(Figure 2.7), which is consistent with the molecular dynamics studies reported for the Sherman 
proposed structure 2.1.97 The six lowest energy conformers were then subjected to geometry 
reoptimisation using a larger basis set (6-311 G (d,p)) with methanol as implicit solvent and 
the NMR properties were calculated. Due to spectral overlap, it was challenging to extract 
accurate 1H-1H and 1H-13C coupling constants along the backbone for fragment B (C8-C4 
region, Figure 2.6b), therefore in the validation study only the comparison of the NMR 










 2.6-5 2.6-8 
∆∆𝐺est
BS2,MeOH
 0.0 0.7 





 2.6-11 2.6-18 
∆∆𝐺est
BS2,MeOH
 1.3 3.6 
Population% 17.8% 7.1% 
 
       
 2.6-20 2.6-25 
∆∆𝐺est
BS2,MeOH
 4.4 5.4 
Population% 5.1% 3.4% 
Figure 2.7. Selected conformers of 2.6 for NMR calculation. 
All experimental natural product NMR data were re-extracted from the NMR spectrum 
provided by Sherman et al. to provide high accuracy (error of  < 0.01 ppm and error of J < 
0.5 Hz) experimental data for use in the quantitative comparison.  
A good fit for the ‘matched comparison’ was observed between the calculated 
Boltzmann averaged 1H-1H coupling constants of 2.6 and the experimental data measured from 
the corresponding synthetic compound 2.1, with both mean absolute deviation (MAD) and 




Table 2.2: Comparison of the calculated Boltzmann averaged nJHH of 2.6 and the experimental 1H-1H 
scalar coupling constants of the C1’-C10 region for both synthetic 2.6 and baulamycin A with Mean 
Absolute Deviations (MAD, in Hz) and Standard Deviations (StDev, in Hz). 
H Hx Calc. 
nJHH 
of 2.6 /Hz 
Exp. nJHH 




Exp. nJHH of 
Baulamycin A /Hz 
Deviation from 
Baulamycin A /Hz 
H1' H14 1.8 3.7 1.9 6.8 5.0 
H14 H13 2.2 3.6 1.4 3.5 1.3 
H13 H12a 1.1 3.6 2.5 3.2 2.1 
H12b 9.1 9.1 0.0 10.0 1.0 
H12a H12b 14.6 14.1 0.5 14.1 0.5 
H11 2.2 4.3 2.1 4.5 2.3 
H12b H11 9.6 9.1 0.5 8 1.6 
H11 H10a 2.1 4.3 2.2 4.3 2.2 
H10b 9.1 8 1.1 8.0 1.2 
   MAD 1.4 MAD 1.9 
   StDev 1.4 StDev 2.0 
 
Slightly larger values of MAD and StDev (1.9 and 2.0 respectively, Table 2.2) were 
observed when the calculated coupling constants of 2.6 were compared to the natural product 
experimental data, indicating a less good fit for the ‘mismatched comparison’. Although the 
calculated value of H1’-H14 substantially deviates from that of the natural product (−5 Hz, 
Table 2.2), which suggests that 2.6 is unlikely to possess the stereochemistry of the natural 
product, the MAD value of the mismatched comparison only increased by 0.5 Hz. The impact 
of the large deviation was ‘diluted’ in the MAD-based comparison in which the absolute values 
of deviations were simply averaged. In order to give large deviations a higher weighting, the 
deviations were squared prior to averaging and the goodness of fit for all NMR parameters was 
evaluated by a statistical analysis using 2 (reduced) values, where an acceptable model must 
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  Equation 2.2 
where 𝑎𝑐𝑎𝑙
𝑖 is the Boltzmann averaged calculated NMR parameters (1H or 13C chemical shifts, 
J couplings, NOE-derived distances in flexible molecules), 𝑎𝑒𝑥𝑝
𝑖 is the experimentally 
measured value, and 𝜎2  is the square of the expected standard deviation of the NMR parameter 
compared. As χ2 values scale with the number of deviations used to calculate them, χ2 (reduced) 




deviations used to calculate the 𝜒2 value, and m is the number of parameters fitted. A list of 
values of n and m used for this study can be found in table 6.1 in the experimental section.  
Although there are no systematic studies reported for the expected standard deviation 
of NMR parameters (chemical shifts, J values and NOE-derived distances), one could define 
sensible values for the expected standard deviations (Table 2.3) based on related studies and 
Butts group in-house knowledge.  
Table 2.3: A summary of estimated standard deviations for comparison between computed and 
experimental chemical shifts, scalar coupling constants and 1H-1H distances 





nJHX (X=H or C) 1 Hz 44 
rnoe 5%101 
 
The χ2 (reduced) values for both the matched and mismatched comparison for all 
calculated Boltzmann averaged NMR parameters (H, C, 1H-1H and 1H-13C scalar coupling 
constants) are shown in Figure 2.8. Unlike the MAD-based comparison (Table 2.2), 2 (reduced) 
values are more discriminating in the comparison of 1H-1H coupling constants (2.8 for the 
matched and 5.7 for the mismatched comparison, Figure 2.8), and therefore this statistical 
analysis was also applied to the comparison of other NMR parameters (H, C, and 1H-13C 
scalar coupling constants).  
The calculated NMR parameters for fragment A (C1’-C10 region) of 2.6 are in 
moderate agreement with the experimental values of the synthetic compound 2.1 (χ2(reduced) 
= 2.1, 1.0, 2.8 and 1.0 for comparison of H, C, 1H-1H and 1H-13C scalar coupling constants, 
respectively). However, χ2(reduced) values for both H and 1H-1H scalar coupling constants 
comparisons deviate substantially from the ideal value of 1. The poorer fit suggests that the 
conformer population derived from approximate DFT-calculated energies might not be 
accurate enough to describe the experimental chemical shifts and scalar coupling constants 
perfectly. In order to examine the accuracy of DFT energy derived conformer populations, 
quantitative NOE-distance analysis is required because the ensemble-averaged interproton 
distances are very sensitive to both conformer population and interproton distances (Chapter 1, 




of compound 2.1 and thus it was not viable to probe the accuracy of the DFT-approximate 
conformer population on this validation system.  
a) Matched comparison: 2.6 vs 2.1 
 
b) Mismatched comparison: 2.6 to baulamycin A 
  
Figure 2.8. The fit for fragment A (C1’-C10) NMR parameters of diastereomer 2.6 to the a 
experimental data obtained from the corresponding synthetic compound 2.6 and to the b experimental 
data of the isolated natural product evaluated by 2 analysis without population refinement.  
In contrast, the calculated NMR properties of Sherman’s originally proposed 2.6 
provides a very poor fit to the experimental data of baulamycins (χ2(reduced) = 6.6, 12.1 and 
5.7 for comparison of H, C, 1H-1H and 1H-13C scalar coupling constants, respectively). This 
suggests that one could indeed identify the relative stereochemistry of baulamycins by the 
comparison of the computed NMR properties of diastereomers of interest to the experimental 
data of the natural product. 
Baulamycins contains seven stereogenic centres, which give rise to 128 possible 
stereoisomers. It is clearly not practical to synthesise all possible stereoisomers. Therefore, the 
QM/NMR hybrid approach (Chapter 1, section 1.3.4) will be applied to elucidate the relative 
configuration of baulamycins. First, conformational analysis will be performed using 
computational modeling on potential diastereomers of the natural product. The ensemble-
averaged NMR properties including 1H and 13C chemical shifts, 1H-1H and 1H-13C scalar 
coupling constants, and 1H-1H distances of the potential isomer, will then be computed. Finally, 
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of the isolated natural product re-extracted from the spectrum provided by Sherman et al.95will 
allow the unequivocal determination of the relative configuration of baulamycins. 
In order to reduce the number of isomers to be studied computationally, the molecule 
was considered in two halves (Figure 2.9a), fragment A (C1’-C10 region) and fragment B (C8-
C4 region) which were assumed to behave independently. The configuration of fragment A 
was first considered. By comparing the observed coupling constants of the vicinal protons of 
C1’-C14 in the synthetic proposed structure 2.1 (3JH1’-H14 = 3.5 Hz) to that of the natural product 
(3JH1’-H14 = 6.8 Hz)
95, we hypothesised that the originally proposed syn relationship between 
C1’ and C14 is more likely to be anti because of the large coupling constants observed, which 
is consistent with reports for related secondary benzylic alcohols (3JHH = 6.4 to 9.2 Hz, Figure 
2.9c). 
 
Figure 2.9: Coupling constants 3JHH reported for structurally related secondary benzyl alcohols with 
syn and anti configuration. a, Sherman’s proposed configuration and the experimental 3JH1’-H14. b, 1,3-
diols with syn configuration show small values for the corresponding coupling constants, 3JHH (~1.6 − 
2.3 Hz).102-103 c, 1,3-diols with anti configuration show large values for the corresponding coupling 




Therefore, the relative configuration of C1’ and C14 was set as anti. The NMR 
properties of the four diastereomers (Figure 2.10b) which arise from the variation of the 
stereochemistry of the hydroxyl groups at C13 and C11 will be studied with Sherman’s 
proposed fragment B configuration. The computationally derived fragment A will then be 
incorporated into all four variations of fragment B (Figure 2.10d) in a subsequent analysis of 
fragment B’s configuration.  
 
Figure 2.10. A list of diastereomers to be studied. a, Sherman’s proposed configuration of baulamycin 
A.95 b, The relative stereochemistry of isomers whose Boltzmann averaged NMR parameters will be 
computed using Sherman’s proposed fragment B. c, Generic structure of baulamycin A, which will 
consist with a computationally derived fragment A and four variations of fragment B. d, The relative 
stereochemistry of isomers whose Boltzmann averaged NMR parameter will be computed with the 





2.2.2 QM/NMR analysis of fragment A configuration starting from conformational 
search in gas phase (compounds 2.6, 2.7, 2.8, 2.9 and 2.10) 
The freshly extracted set of accurate experimental NMR data including chemical shift, 
1H-1H scalar coupling constants and 1H-1H distances were used for the QM/NMR analysis. 
Although the HETLOC spectrum, which provides 1H-13C scalar coupling constants, was also 
provided, the accuracy of the J values obtained from HETLOC spectrum is untested. Therefore, 
1H-13C scalar coupling constants were not used in the initial study which instead focused on 
the analysis of 1H-1H coupling constants and 1H-1H distances for the analysis of the C10-C1’ 
regions (fragment A, Figure 2.11a).  
Conformational analysis of diastereomers 2.7 – 2.10 (Figure 2.11b) using molecular 
mechanics performed in gas phase found between 650 and 2455 conformations for each 
diastereomer. For each diastereomer, low-energy conformers (~84–196 conformers) were 
submitted to sequential DFT geometry optimisation and free-energy calculations as discussed 
in the validation study section (Figure 2.11c). The resulting low-energy conformers that were 
predicted to comprise 85 – 97% of the conformer populations of diastereomers 2.7 – 2.10 (6–
26 conformers per diastereomer) were subjected to DFT calculations for the prediction of NMR 
properties for the C10–C1’ regions (fragment A).  
Both the calculated 1H-1H scalar coupling constants and NOE-derived 1H-1H distances 
of diastereomer 2.6 – 2.10 were compared to the corresponding experimental data of the natural 
product (baulamycin A) using 2 analysis (Figure 2.11d). Based on the comparison of 1H-1H 
scalar coupling constants, there is a moderate fit for 2.7 and 2.10 isomers (2 (reduced) = 2.2 
and 2.1 respectively), and poor fits for 2.6, 2.8 and 2.10 isomers ((2 (reduced) = 5.7, 3.9 and 
5.4 respectively). However, all isomers show a very poor fit (2 (reduced) > 8) to the 
experimental 1H-1H distances derived from the 2D-ROESY spectrum provided by Sherman et 






Figure 2.11. Analysis of the relative configuration of C1’-C10 region (fragment A) before population 
refinement. a, Sherman’s proposed configuration of baulamycin A; b, The relative configurations of 
diastereomers computed for the study of fragment A; c, An overlay of conformations of isomer 2.10 
analysed by DFT; d, Comparison of both Boltzmann averaged computed 1H-1H scalar coupling 
constants and 1H-1H distances* to the experimental data of baulamycin A using 2 analysis.  
If the experimentally derived NOE-distances from the 2D ROESY spectrum provided 
by Sherman et al.95 are an accurate reflection of the conformational landscape of the natural 
product, then the poor fit for 1H-1H distances for all isomers suggests the DFT energy-derived 
conformer population is not accurate enough to describe the conformational landscape of the 
matching isomer. This is because quantitative NOE-distance analysis is too sensitive to 
conformer populations and interproton distance (scales with r−6).54  
To correct the conformer populations (and thus the ensemble-averaged NMR 
parameters), the conformer populations for 2.6 – 2.10 were refined based on the experimental 
                                                 
* For each diastereomer, the reference distance used for NOE-derived distances were further optimised to give the 
best possible fit to the natural product data. Therefore, the 2 (reduced) values reported here differ slightly from 




1H-1H distances of the natural product extracted from the 2D ROESY data provided by 
Sherman et al.95 to obtain the best possible fit.  
The conformers sampled by DFT for 2.6 – 2.10 (183, 97, 161, 153 and 84 conformers 
respectively) were clustered based on the four dihedral angles of the main chain in fragment A: 
f1-f4 (around the C1’-C14, C14-C13, C13-C12 and C12-C11 bonds respectively, Figure 
2.12a). The populations of the resulting clusters (26, 13, 16, 29 and 17 respectively for 2.6 – 
2.10) were then refined by altering their relative ΔG values in a Generalised Reduced Gradient 
(GRG) non-linear least squares optimisation of the standard deviation between experimental 
and calculated NOE-distances (using the Solver element in Microsoft Excel 2016). In order to 
ensure physical and chemical sense in the refinement, a constraint (Σ(ΔΔG)2 = 400) was 
enforced to prevent unreasonably large changes in ΔG (not greater than 20 kJ mol−1) away from 
the original DFT-calculated energies. The values of f, initial populations of these clusters, the 
resulting ΔΔG and the refined populations for each diastereomer are listed in table 6.32 in the 






Abbreviation used Range of Dihedral Angles 
sp (synperiplanar) 30°≤ f <30° 
g+ (gauche+) 30°≤ f <90° 
+ac (+ anticlinal) 90°≤ f <150° 
ap (antiperiplanar) ±150°≤ f <180° 
ac ( anticlinal) 90°< f <150° 
g (gauche-) 30°< f ≤90° 
 
Figure 2.12: a, Generic structure of diastereomers studied for fragment A analysis; b, Abbreviation of 
six clusters and the corresponding range of dihedral angles. 
The refined ensemble-averaged 1H-1H distances were compared to the natural product 
data and there is an excellent fit for both 2.9 and 2.10 (2 (reduced) = 1.4 and 1.6 respectively) 
while the remaining isomers 2.6, 2.7 and 2.8 had poor fit (2 (reduced) = 5.1, 4.8 and 5.4, 
respectively). Comparison of the refined 1H-1H scalar coupling constants revealed that both 2.6 
and 2.10 provide a good fit (2 (reduced) = 1.6 and 1.5 respectively), 2.7 and 2.8 provide a 
moderate fit (2 (reduced) = 2.4 and 2.1, respectively), and 2.9 provides an unreasonable fit. 
(2 (reduced) = 6.2). Therefore, 2.10 (anti–anti–syn) is the only isomer which simultaneously 




(Σ(ΔΔG)2 = 400) applied, compounds 2.6, 2.7 – 2.9 do not possess the correct fragment A 
stereochemistry and therefore the relative configuration of fragment A was assigned to be anti–
anti–syn, rather than the all syn configuration originally proposed.  
 
Figure 2.13 Analysis of the relative configuration of C1’-C10 region (fragment A) after population 
refinement. a, Sherman’s proposed configuration of baulamycin A. b, The relative configurations of 
diastereomers computed for the study of fragment A. c, Comparison of both Boltzmann averaged 
computed 1H-1H scalar coupling constants and 1H-1H distances† to the experimental data of baulamycin 
A using 2 analysis; d, An overlay of conformations of isomer 2.10 (with a combined population of 
92%) used for scalar coupling constant calculations. 
Notably, comparison of calculated chemical shift (both 1H and 13C) with the 
experimental data of the natural product using methods described by Willoughby et al.107 and 
Goodman et al. 77 was found to be non-discriminating. Figure 2.14 shows the results of the 
comparison between the calculated scaled chemical shifts (H and C) of compound 2.6 – 2.10 
                                                 
† For each diastereomer, the reference distance used for NOE-derived distances were further optimised to give the 
best possible fit to the natural product data. Therefore, the 2 (reduced) values reported here differ slightly from 




after NOE based population refinement and the experimental chemical shifts of baulamycin A 
using methods reported by both Willoughby et al.107and Goodman et al.77. 
 
Figure 2.14: Comparison of calculated chemical shifts to the natural product experimental data. a, 1H 
and 13C chemical shifts of the C1’-C11 fragment. Mean absolute deviation (MAD) is plotted with the 
corresponding values above. b, Results of DP4 analysis using proton data only (top), using carbon data 
only (middle), and using both carbon and proton data (bottom). The size of the bar represents the 
probability (in percentage) of a given diastereoisomer being the ‘correct answer’ based on the five 
candidate structures compared. DP4 results using proton data only: 2.6: 29.6%, 2.7: 10.4%, 2.8: 0.1%, 
2.9: 1.8%, 2.10: 58.1%. DP4 results using carbon data only: 2.6: 47.7%, 2.7: 31.6%, 2.8: 3.6%, 2.9: 
0.4%, 2.10: 16.7%. DP4 results using both proton and carbon data: 2.6: 52.0%, 2.7: 12.2%, 2.8: 0.0%, 
2.9: 0.0%, 2.10: 35.8%. 
For the Willoughby-style analysis, only the mean absolute deviations (MAD) were used 
for comparison. For comparison of 1H chemical shifts, Willoughby et al. suggests that the 
correct answer should have an MAD less than 0.1 ppm and an incorrect answer can be 
identified by an MAD greater than 0.2 ppm. Figure 2.14c suggests that the anti–syn–anti (2.8) 
isomer is unlikely to be the correct (MAD = 0.22 ppm), but the rest of the isomers have similar 
MAD values (MAD = 0.13 - 0.16 ppm) and therefore could not be discriminated. Although 
Willoughby et al. did not discuss the MAD values for the comparison of 13C chemical shifts, it 
was found that syn–syn–syn (2.6), anti–syn–syn (2.7) and anti–anti–syn (2.10) isomers all have 
comparable and reasonable MAD values (MAD = 0.6, 0.7 and 1.0 respectively) and so 13C 
chemical shift is not considered to provide a clear discrimination between these structures. 
The DP4 analysis of chemical shifts (Figure 2.14d) described by Goodman et al. 
determines the likelihood of an isomer being the matching isomer by the distribution of 




discrimination between diastereoisomers, no candidate shows a high probability (>95%) of 
matching on the basis of the DP4 analysis alone.  
These results highlight the fact that care must be taken for NMR-based stereochemical 
analysis of dynamically complex flexible molecules.  
To verify the computationally derived fragment A configuration experimentally, 2.11 
(Figure 2.15) was synthesised by Dr. Paula Lorenzo and Dr. Jingjing Wu. Comparison of the 
NMR spectra between 2.11 with that of the natural product revealed that while the signals in 
the C1’-C10 region (fragment A) fitted very closely to the natural product data, a substantial 
difference in the C8-C2 region (fragment B) remained (Figure 2.15). Therefore, the relative 
configuration of fragment A could indeed be assumed to be anti–anti–syn, rather than the all 
syn configuration originally proposed. At this stage, the QM/NMR analysis has identified the 
relative configuration of four out of seven stereogenic centres, thus reducing 128 possible 







Figure 2.15. Chemical structure of 2.11 and the comparison of a. 1H NMR (CD3OD, 500 MHz) and b. 
13C NMR (CD3OD, 176 MHz) spectra of 2.11 (red) and baulamycin A (black). c. Zoom in of the 13C 





2.2.3 Population change of fragment A after NOE-refinement of 2.10.  
Having established the relative configuration of fragment A of baulamycins, the change 
in conformational landscape of the fragment A matching isomer 2.10 after population 
refinement was investigated. The 84 conformers sampled by DFT calculations were divided 
into 17 clusters based on the dihedral angles of fragment A as described before and the relative 
Gibbs free energies (ΔG) were adjusted using Σ (ΔΔG)2 =400 as a constraint. After population 
refinement, conformer 2.10-1 remains the lowest energy conformer but the number of 
conformers with a relative Gibbs free energy within 10 kJ mol−1 of the global minimum 
increased from 11 to 26, so the overall conformer population of 2.10 became more complex. 
The DDG of four clusters changed substantially as figure 2.16a shows (7.2, −15.4, −5.7 and 6.3 
kJ mol−1 for clusters 4, 6, 9, and 13 respectively). Within these four clusters, clusters 4 and 13 
represent conformers with all three hydroxyl groups hydrogen bonded to each other (Figure 
2.17c and d), while clusters 6 and 9 represent conformers with only two out of the three 
hydroxyl groups hydrogen bonded to each other (Figure 2.17e and f). Notably, the DG of 
groups 4 and 13 are increased ~ 6 kJ mol−1 by NOE fitting while the energies of both groups 6 
and 9 decreases by > 5 kJ mol−1. (Figure 2.16a).  
  
Figure 2.16: a, The change in relative Gibbs free energy (DDG) of each cluster after population 
refinement. b The comparison of the combined population of each cluster before and after population 
refinement.  
Figure 2.17a shows the comparison between the calculated 1H-1H distances of 2.10 and 
the NOE derived experimental 1H-1H distances of the natural product before population 
refinement. A poor fit was observed (R2 = 0.45, MAD = 9%, StDev = 15% and 2 (reduced) = 
9.5) due to two outliers, which correspond to the distances between H1’-H12a and H14-H11 















































































































































































































































2.10-2 (from cluster 4) 
 
2.10-1(from cluster 13) 
e f 
 
2.10-5(from cluster 6) 
 
2.10-3 (from cluster 9) 
Figure 2.17: Comparison of DFT calculated and experimental 1H-1H distances of compound 2.10 (a) 
before and (b) after population refinement. The ideal fit (calculated distances = experimental distances, 
y = x) is shown as solid black lines and the goodness of fit is evaluated by the mean absolute deviation 
(MAD), standard deviation (StDev) and 2 analysis using 2 (reduced) values. c, A representative 
conformer from cluster 4 with the distance between H1’-H12a and H14-H11 labelled (4.30 and 4.19 Å, 
respectively). d, A representative conformer from cluster 13 with the distance between H1’-H12a and 
H14-H11 labelled (4.23 and 4.75 Å, respectively). e, A representative conformer from cluster 6 with the 
distance between H14-H11 labelled (2.34 Å). f, A representative conformer from cluster 9 with the 


























































In both cases, the experimental distances are shorter than the DFT estimated distances, 
which suggests that experimentally the population of conformers with short H1’-H12a and H14-
H11 distances are higher than what was predicted by DFT calculations. Indeed, cluster 6 and 9, 
which have conformers with short H1’-H12 and H14-H11 distances (< 2.5 Å, Figure 2.17e and f) 
were calculated to have only 0.31% of the global population, while the dominant conformations 
(cluster 4 and 13, 88% of the global population, Figure 2.16b), which have all three hydroxyl 
groups hydrogen bonded to each other, show long distances (>4 Å, Figure 2.17c and d). As a 
result, the ensemble-averaged distances derived from the DFT-approximate conformer 
population showed long H1’-H12a and H14-H11 distances (>4 Å). 
To minimise the deviation of the comparison of these two distances, the population of 
cluster 6 and 9, which have conformations with short H1’-H12a and H11-H14 distances, were 
therefore increased from 0.00% and 0.31% to 14% and 24% respectively by NOE-based 
population refinement (Figure 2.16b). It is worth noting that while the fit for the comparison 
of these two distances has improved substantially, the good fit for the comparison of other 
distances remained, thus a substantial improvement was observed for the overall fit between 
the calculated and experimental distances of 2.10 (R2 = 0.79, MAD = 5%, StDev = 6% and 2 
(reduced) = 1.7, Figure 2.17b).  
Clearly, the energies of conformers were poorly predicted either at the MM or the 
subsequent DFT calculations. If MM over-estimates the enthalpic benefit of forming 
intramolecular hydrogen bonds, this would result in under-representation of conformations 
which have less than two hydrogen bonding interactions between the three hydroxyl groups. 
Consequently, these conformations are not heavily represented in the subsequent DFT 
calculations. If the chosen DFT methods (discussed in validation study) are insufficient for 
calculating accurate conformer energies associated with intramolecular hydrogen bonding 
interactions, then better methods for calculations should be devised, since an adjustment of the 
calculated DFT conformer energies by 15 kJ mol−1 is outside the bounds of expected chemical 
accuracy (~ 4 kJ mol−1). 
To investigate this discrepancy, the calculated energies of conformers 2.10-2 and 2.10-
1 (Figure 2.17c and d), which were ultimately found to have energies within 10 kJ mol−1 of the 
global minimum after population refinement (DG = 8.3 and 4.1 kJ mol−1, respectively, Table 




At the MM stage, both conformers 19 and 34 were calculated to have relative potential 
energies within 10 kJ mol−1 of the global minimum (DEMM = 8.0 and 9.2 kJ mol−1, respectively, 
Table 2.4) and were therefore captured in the subsequent DFT calculations. However, both 
conformers were calculated to have very high energies by DFT, with the relative Gibbs energy 
(DGDFT > 13 kJ mol−1, Table 2.4) above 10 kJ mol−1 of the global minimum, even with solvent 
correction by the mean of single point energy calculations (IEFPCM, methanol).  
Although the ‘fault’ seems to lie in the DFT stage, it is unclear whether the ‘fault’ was 
caused by inappropriate choice of DFT calculation methods for dealing with intramolecular 
hydrogen bonding interactions, or the starting geometry for DFT calculations are genuinely 
energetically less favourable in protic solvent. Both conformers 19 and 34 show intramolecular 
H-bonding interaction between one of the three hydroxyl groups in fragment A and the ketone 
in fragment B (Figure 2.17e and f, respectively). This intramolecular H-bonding in protic 
solvent (methanol in this case) seems somewhat unlikely based on chemical intuition, and this 
could be the reason why both conformers were calculated to be high in energy by DFT even 
with implicit solvent correction (IEFPCM, methanol).  
Table 2.4: Relative potential energies calculated by MM (DEMM), relative Gibbs free energies 
calculated by DFT (DGDFT), and the relative Gibbs free energies obtained after population refinement 
(DGrefinement) of conformers 19 and 34. 
Conformer DEMM/ kJ mol−1 DGDFT/ kJ mol−1 DGrefinement/ kJ mol−1 
19 8.0 25.1 4.1 






2.2.4 Effect of implicit octanol on QM/NMR analysis of fragment A (compounds 2.6, 2.7, 
2.8, 2.19 and 2.10) 
The possibility of this discrepancy occurring in the MM conformational search stage 
was also examined, since the original MM conformational analysis was performed in gas phase. 
Out of the choices of implicit solvent available in the Maestro conformational search software 
(chloroform, octanol, water)108, octanol would be the closest mimic to methanol, which is the 
solvent used for experimental NMR analysis.  
Therefore, conformational analysis of 2.10 using MM was repeated in octanol and 
found 3670 non-redundant conformations. Amongst these conformations, 107 conformations 
are below 10 kJ mol−1 of the global minimum (c.t. 1353 conformers were found in gas phase, 
section 2.2.2). In the gas phase conformational search, conformers with no hydrogen bonds 
between the three hydroxyl groups (Figure 2.18c) were not present within 10 kJ mol−1 of the 
global minimum (Figure 2.18a), while 5 of these conformers were captured in the octanol 
conformational search (Figure 2.18b). The inclusion of implicit octanol in the conformational 
search has decreased the energies of conformations which do not have hydrogen bonds between 
hydroxyl groups (Figure 2.18a and b). This confirms that there is a bias towards the hydrogen 
bonded conformers when solvent polarity is ignored. It is likely that including explicit solvent 
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Figure 2.18: Analysis of fragment A conformations using conformers generated from a conformational 
search in gas phase and b conformational search with implicit octanol as solvent; c, d, and e are 
representative examples of conformers with none, one, or two hydrogen bond interactions (shown in 
blue dotted lines) between the hydroxyl groups in fragment A.  
Although conformers above 10 kJ mol−1 of the global minimum are still partially 
captured by random sampling, conformers with high MM energies could easily be neglected 
due to the sheer number of conformations. Therefore, having a more diverse set of 
conformations within 10 kJ mol−1 of the global minimum would be desirable, since all 
conformations below this energy threshold would be subjected to the subsequent DFT 
calculations.  
With a greater diversity of conformations in hand, the impact of including implicit 
octanol at the first stage of conformational analysis (ie. MM conformational search) on the 
resulting DFT predicted ensemble-averaged 1H-1H coupling and 1H-1H distances was 
investigated. For 2.10, the 107 conformers below 10 kJ mol−1 of the global minimum, together 
with another 107 conformers randomly selected from the remaining pool (10-21 kJ mol−1 of 
the global minimum), were subjected to the subsequent geometry optimisation, frequency 
calculation and NMR prediction using DFT as previously described. 
Both the calculated ensemble-averaged 1H-1H scalar coupling constants and 1H-1H 
distances were compared to the natural product experimental data using 2 analysis. While 
moderate fit was observed for the comparison of 1H-1H scalar coupling constants (2 (reduced) 
= 3.0, Figure 2.19b), poor fit was again observed for 1H-1H distance comparison (2 (reduced) 
= 5.3, Figure 2.19b). This result is similar to that obtained starting from the conformational 
search in gas phase (Section 2.2.2). Although the fit for 1H-1H distances has somewhat 




conformational search, with a 2 (reduced) value reducing from 9.1 to 5.3, the fit still deviates 
substantially from the ideal fit so population refinement is still required to correct for conformer 
population.  
 
Figure 2.19: a, Chemical structure of 2.10. b, Comparison of both Boltzmann averaged computed 1H-
1H scalar coupling constants and 1H-1H distances to the experimental data of baulamycin A using 2 
analysis; c, Comparison of both Boltzmann averaged computed 1H-1H scalar coupling constants and 
1H-1H distances (based on refined conformer population obtained using different constraints) to the 
experimental data of baulamycin A using 2 analysis. 
Next, the impact of varying the population refinement constraint was investigated to 




was optimal, and what would happen if the constraint was loosened to a point where over-
fitting could occur.  
Conformations which were generated from octanol conformational search were chosen 
for this study because of the increased diversity of fragment A conformations (Figure 2.18b). 
The 214 conformations sampled by DFT were divided into 20 clusters based on the dihedral 
angle criteria described previously (Figure 2.12, also see table 6.43 in the experimental section 
for the corresponding dihedral sequence for each cluster). Population refinement were 
performed using eight different constraints (Σ(ΔΔG)2 = 25, 100, 225, 400, 625, 900, 1600 and 
2500, Figure 2.19c), which corresponds to the maximum change of DG for a particular cluster 
(out of the 20 clusters) from 5, 10, 15, 20, 25, 30, 40 and 50 kJ mol−1. As the constraint increases 
from zero to 400, the fit for 1H-1H distances improves substantially, with the 2 (reduced) 
values reduceing from 5.3, which is a very poor fit, to 0.9, which is very close to the ideal fit 
(Figure 2.19c). In addition, the fit for 1H-1H coupling also improves from a moderate (2 
(reduced) = 3, Figure 2.19) to good (2 (reduced) = 1.3, Figure 2.19c). Interestingly, when the 
constraint was increased beyond 400, no substantial improvement in the fit of 1H-1H was 
observed, indicating that overfitting might occur when a constraint of Σ(ΔΔG)2 greater than 
400 was used. However, in this case overfitting does not result in the erosion of the good fit in 
the comparison of 1H-1H scalar coupling constants, so the exact point when overfitting has 
occurred could not be determined. Therefore, the smallest constraint one could use to obtain 
the optimal fit lies somewhere around 225 and 400 and the constraint chosen originally (Σ 
(ΔΔG)2 =400) seems to be reasonable.  
Having established a sensible constraint for population refinement (Σ(ΔΔG)2 = 400), 
conformational analysis of diastereomers 2.6 – 2.10 (Figure 2.11 a and b) using molecular 
mechanics was performed again using implicit octanol as solvent. For each diastereomer, 
between 2428 and 8794 conformations were found and the low-energy conformers (88-564 
conformers) for each diastereomer were subjected to the subsequent geometry optimisation, 
frequency calculation and NMR prediction using DFT as described previously. 
Both the calculated ensemble-averaged 1H-1H scalar coupling constants and NOE-
derived 1H-1H distances of diastereomer 2.6 – 2.10 were compared to the corresponding 
experimental data of the natural product (baulamycin A) using 2 analysis (Figure 2.20c). The 





Figure 2.20: Analysis of the relative configuration of C1’-C10 region (fragment A) starting from 
octanol conformational search. a, Sherman’s proposed configuration of baulamycin A. b, The relative 
configurations of diastereomers computed for the study of fragment A. Comparison of both Boltzmann 
averaged computed 1H-1H scalar coupling constants and 1H-1H distances to the experimental data of 
baulamycin A using 2 analysis c before population refinement and d after population refinement. e, 
The change in relative Gibbs free energy of the eight clusters after population refinement. f, Conformer 




Based on the comparison of 1H-1H scalar coupling constants, there is a moderate fit for 
2.7, 2.8 and 2.10 isomers (2 (reduced) = 2.7, 2.7 and 3.0, respectively), and no reasonable fit 
for 2.6, 2.9 isomers ((2 (reduced) = 5.3 for both isomers). Again, all isomers show a very poor 
fit (2 (reduced) > 5) to the experimental 1H-1H distances derived from the 2D-ROESY 
spectrum provided by Sherman et al.95 and no candidate fit both sets of experimental data 
simultaneously.  
Next, population refinement was also applied to all diastereomers to correct for the 
DFT-approximate conformer population as described previously. The conformers sampled by 
DFT for 2.6 – 2.10 (564, 88, 204, 124 and 214 conformers, respectively) were clustered based 
on the four dihedral angles of the main chain in fragment A as discussed before (Figure 2.12) 
and a constraint of Σ(ΔΔG)2=400 was used for the refinement.  
NMR properties were then recomputed based on the refined conformer population for 
each diastereomer. Figure 2.20d shows the comparison of 1H-1H scalar coupling constants and 
1H-1H distances between the calculated data and the natural product experimental data. 
Comparison of 1H-1H distances showed that 2.6, 2.9 and 2.10 fit well to the natural product 
data (2 (reduced) = 1.5, 1.5 and 0.9, respectively) while 2.7 and 2.8 show poor fit (2 (reduced) 
= 4.1 and 5.2, respectively). Comparison of the 1H-1H scalar coupling constants revealed that 
2.8 and 2.10 provide a good fit (2 (reduced) = 1.3 and 0.9, respectively), 2.6 and 2.7 provide 
a moderate fit (2 (reduced) = 2.0 and 2.5, respectively, Figure 2.20), and a poor fit for 2.9 (2 
(reduced) = 7.4, Figure 2.20). As a result, both 2.6 and 2.10 could be considered as viable fits 
for both sets of experimental NMR data for fragment A.  
Interestingly, the fit of 1H-1H distances of 2.6 (the originally proposed configuration by 
Sherman et al.), which previously could not be fitted using gas phase conformers (section 
2.2.2 ), could now be fitted to the natural product data well (2 (reduced) = 1.5, Figure 2.12d) 
when population refinement was performed using conformations obtained from octanol 
conformational search, due to the increased diversity of conformations obtained by including 
implicit octanol in the MM conformational search. For example, in the newly sampled eight 
clusters, cluster 6 was brought down in energy (DDG = −8.4 kJ mol−1, Figure 2.20e) by 
population refinement, with one of the conformers from this cluster (conformer 5515, Figure 
2.11f) became the new global minimum and the population of this cluster increased from 0% 
to 17%. Examination of the fragment A conformation of this cluster reveals that conformations 




H12a = 2.15 Å, Figure 2.20f), which is required to match the natural product experimental data 




2.2.5 QM/NMR Analysis of fragment B (compounds 2.10, 2.12, 2.13 and 2.14) 
Computational analysis of the C8-C4 region (fragment B) was also performed, albeit 
without population refinement due to lack of usable NOE correlations. Therefore, the 
calculated 1H and 13C chemical shifts, together with 1H-1H scalar coupling constants without 
population refinement were used for the analysis of fragment B.  
Conformational analysis of diastereomers 2.10 and 2.12– 2.14 (Figure 2.21b) using 
molecular mechanics performed in gas phase found between 466 and 1641 conformations for 
each diastereomer. Low-energy conformers for each diastereomer (~84–152 conformers) were 
submitted to sequential DFT geometry optimisation and free-energy calculations. The resulting 
low-energy conformers that were predicted to make up 80% of the conformer populations of 
diastereomers 2.10 and 2.12– 2.14 (9–15 conformers per diastereomer) were subjected to DFT 
calculations for the prediction of NMR properties for the C8–C4 regions (fragment B, Figure 
2.21a).  
The Boltzmann averaged NMR properties were computed for the selected conformers 
of compound 2.10 and 2.12– 2.14. The ensemble-averaged calculated chemical shifts (H, C) 
and 1H-1H scalar coupling constants of the C4-C8 fragment for each candidate was compared 
to the experimental values of the natural product using χ2 analysis (Figure 2.21c). Although 
isomer 2.10 shows the best fit (2 (reduced) = 0.6, 0.5 and 0.9 for H, C and nJHH, respectively), 
the 1H and 13C spectrum of the synthetic isomer 2.10 does not fully match to that of the natural 
product, as discussed previously. The discrepancy observed suggests that isomer 2.10 is not 
the natural product and the configuration of fragment B is not anti–anti. It was found that 
intramolecular hydrogen bonded conformers (hydrogen bonded between the terminal ketone 
and C11-C14 hydroxyl groups, Figure 2.21) were over-represented in the initial MM 
conformational search of 2.10 and 2.12– 2.14 while conformers which did not contain the H-
bond were estimated by MM to have very high energies (and thus were not heavily represented 
in subsequent DFT procedures) despite the latter ultimately being found to have low, solvated 
free energies. Crucially the hydrogen-bonded forms had substantially different fragment B 
conformations to the non-hydrogen-bonded forms, suggesting a source for the poor fit between 





Figure 2.21. Analysis of the relative configuration of the C8-C4 region (fragment B). a, Isomer of 
baulamycin with computationally derived fragment A. b, Four possible stereoisomers of fragment B 
which were computed. c, χ2 analysis comparing computed chemical shifts (1H and 13C) and 1H-1H scalar 
coupling constants with the experimental values of the natural product. d, Lowest energy conformation 
of 2.14, dominated by the intramolecular hydrogen bond between the carbonyl carbon from fragment 
B and the hydroxyl group(s) in fragment A. 
In order to provide a proper description of the conformational landscape of fragment B, 
conformational analysis of diastereomers 2.10 and 2.12– 2.14 (Figure 2.22b) using molecular 
mechanics was performed in implicit octanol and found between 2086 and 8407 conformations 
for each diastereomer. Low-energy conformers for each diastereomer (~214–304 conformers) 
were submitted to sequential DFT geometry optimisation and free-energy calculations. The 
resulting low-energy conformers that were predicted to make up 80% of the conformer 
populations of diastereomers 2.10 and 2.12– 2.14 (15–33 conformers per diastereomer) were 
subjected to DFT calculations for the prediction of NMR properties for the C8–C4 regions 





Figure 2.22. Analysis of the relative configuration of the C8-C4 region (fragment B). a, Isomer of 
baulamycin with computationally derived fragment A configuration. b, Four possible stereoisomers of 
fragment B which were computed. c, χ2 analysis comparing computed chemical shifts (1H and 13C) and 
1H-1H scalar coupling constants with the experimental values of the natural product. For the comparison 
of 1H-13C scalar coupling constant using data measured from the synthetic (+)-baulamycin A 2.17 see 
table 6.58 in the experimental section.  
Based on 1H-1H scalar coupling constants, 2.10 and 2.12 fit poorly with the natural 
product experimental data (2 (reduced) = 4.7 and 8.6, respectively), while both 2.13 and 2.14 
provide a good fit (2 (reduced) = 1.6 for both isomers). Based on the analysis of both 1H and 
13C chemical shifts, it appears that 2.14 fits much better to the natural product experimental 
data (2 (reduced) = 0.2 and 0.6 for H and C, respectively) while 2.13 fits less well (2 (reduced) 
= 0.9 and 2.9, respectively).  
Without conformer population refinement, one could not be confident that 2.14 would 
indeed simultaneously match all the NMR data of the natural product and possess the same 
fragment B configuration as the natural product. In parallel to the computational analysis, Dr. 
Jingjing Wu and Dr. Paula Lorenzo in the Aggarwal lab sought to determine the relative 
configuration of fragment B through synthesis. The idea was to exploit a reagent-controlled 
assembly-line synthesis8 to generate an encoded mixture containing all four diastereomers of 
fragment B. The identity of each diastereomer in the mixture would be indicated by its relative 
population and thus the intensities of their peaks in a 13C NMR spectrum. By comparison of 
the 13C NMR spectrum of the mixture to that of the natural product, the identity of the natural 





Figure 2.23. Determination of the relative stereochemistry of fragment B by assembly-line synthesis. 
a, synthesis of the encoded mixture of baulamycin A diastereomers (by virtue of known but inequivalent 
amounts of each isomer). b, Comparison of the mixture 13C NMR spectrum (C6 and C21, red) with that 
of the natural product (black) indicating a match for signals corresponding to 2.14. 
In order to accurately quantify the mixture using NMR spectroscopy, the ratio between 
the four diastereomers was designed to be 46:25:18:10, where the difference in peak intensity 
is maximised. The desired ratio of diastereomers was achieved using different er values 




(discussed in Chapter1, Section 1.4) with primary boronic ester 2.15 to construct the C8, C6 
and C4 stereocentres (Figure 2.23a). After the assembly-line synthesis, the mixture was 
coupled to the computationally derived fragment A to give a mixture of baulamycin A 
diastereomers with the desired ratio. The comparison of the 13C NMR to that of the natural 
product at C6 and C21 revealed that chemical shifts of the diastereomer with the highest 
population (~46%, Figure 2.23b) matches very closely to that of the natural product. Therefore, 
in agreement with the DFT calculations, the relative configuration of fragment B is syn–syn, 
not anti–anti as originally proposed.   
With the relative configuration within each fragment established, the configuration between 
C11 and C8 (anti or syn, Figure 2.24) was solved by synthesis. Compound 2.16 (C11/C8 anti) 
and 2.17 (C11/C8 syn) were synthesised. Although both compounds match the 13C NMR 
spectrum of the natural product closely, there are significant differences in the 1H NMR 
spectrum between 2.16 and that of the natural product for H-9 (2.16: 1.47 and 1.05 ppm; 
baulamycin A: 1.33 and 1.19 ppm) and H-10 (2.16: 1.48 and 1.33 pm; baulamycin A: 1.43- 
1.38 ppm), whereas the 1H NMR spectrum of 2.17 match up perfectly with that of the natural 
product. However, the optical rotation of the synthetic matching diastereomer 2.17 is positive 
([𝛼]𝐷
20= +6.25 (c 0.8, MeOH)) whereas the reported value of the isolate natural product is 
negative ([𝛼]𝐷
20= −10.3 (c 0.2, MeOH)). Therefore, the enantiomer of 2.17 was prepared and 













Figure 2.24. Determination of the relative configuration between C11 and C8. Top: 1H NMR of 
synthetic 2.16 with C11-C8 anti. Middle: 1H NMR of the isolate baulamycin A provided by Sherman 






2.3 Conclusions and Future work 
2.3.1 Conclusions 
In conclusion, the relative and absolute configuration of baulamycins was revised using 
a combination of computation, NMR and synthesis. We have shown that by performing a 
detailed computational analysis of the NMR properties of 8 diastereomers, we were able to 
confidently exclude 112 out of 128 possible stereoisomers for baulamycin without heavily 
relying on chemical synthesis. While the lack of NMR data hindered the analysis of the relative 
configuration of fragment B, assembly-line synthesis allowed the rapid access to the correct 
relative configuration of fragment B. Finally, synthesis established the relative configuration 
between both fragments and the absolute configuration of the natural product.  
 
Figure 2.25. Structures of the originally proposed95 and revised structures. 
From this work, it is apparent that structural elucidation of flexible, acyclic natural 
products using either empirical J-based configurational analysis or solely the comparison of 
chemical shifts is inadequate due to the complex conformational landscape of these molecules. 
Further development in the accuracy of conformational analysis and the calculation of NMR 
parameters by computation, together with new NMR experiments for accessing hard-to-
measure NMR properties, would allow one to determine the relative configuration of acyclic 





2.3.2 Future work 
It appears that the inclusion of implicit solvent in the initial molecular mechanics 
conformational search made a significant difference to the resulting DFT calculated ensemble-
averaged NMR data (1H-1H scalar coupling constants and 1H-1H distances) Therefore, running 
the initial conformational search and the subsequent DFT calculations in explicit solvent should 
further improve the accuracy of the conformational analysis by properly accounting for 
energies of intramolecular hydrogen bonding interactions.  
Although population refinement could be used (to an extent) to correct the DFT 
approximate conformer energies based on the natural product 1H-1H distances, care should be 
taken when applying this approach with an incomplete set of conformations. As section 2.2.4 
discussed, comparison of 1H-1H distances of 2.6, which was previously ‘unoptimisable’ 
(section 2.2.2), could be ‘optimised’ with a more diverse set of fragment A conformations. This 
result highlights the limitation of the randomly sample conformations by subsequent DFT 
calculations because it solely relies on chance to locate conformers which will eventually 
become low in energy at the stage of DFT calculations. Obviously, the ideal solution would be 
to perform DFT calculations on every single conformation found by molecular mechanics 
conformational search. However, this is a highly time-consuming and resource-intensive task 
when dealing with several diastereomers of a highly flexible small molecule, such as the case 
of baulamycins. Therefore, a sampling method should be devised to sample the maximum 
diversity of the conformational landscape of a given molecule. One way to achieve this would 
be doing a combination of molecular mechanics and molecular dynamics conformational 
search to maximise the chance to locate all local minima of a molecule, then cluster the output 
conformations based on structural similarity. 
Now having access to some amount (~3 mg) of the natural product via chemical 
synthesis, it is possible to collect more NMR data of the natural product to determine the 
relative configuration of fragment B, as well as the relationship between fragment A and 
fragment B without the use of synthesis.  
Due to the lack of resolution of the 2D-ROESY provided by Sherman et al., quantitative 
NOE-distance analysis and the subsequent NOE-based population refinement of fragment B 
isomers were not viable. In theory, one could record a very high resolution 2D-ROESY using 
appropriate relaxation delay in a high field NMR instrument (> 700 MHz) and try to extract a 




will not only allow us to apply the NOE-based population refinement to a different motif, but 
also to access the accuracy of the DFT-derived conformer population of isomers computed for 
fragment B.  
Lastly, it will be interesting to record NMR data of baulamycins in anisotropic 
conditions to obtain residual dipolar couplings, which provide global information of molecular 
conformation(s), and to explore the used of residual dipolar couplings in the determination of 
relative configuration of baulamycins, especially the determination of the relationship (syn/anti) 




Chapter 3 tert-Butyl group: effect on molecular conformation 
3.1. Introduction and project outline. 
In the 1990s, Alder and co-workers realised that the CquaternaryCCC bond (C3C4 of 
3.1, Scheme 3.1a) can only adopt an antiperiplanar conformation based on the MM2 calculation 
results of CEr4 and CPr4 together with examination of the crystal structure of several 
tetraammonium salts, including Et4N
+, nPr4N
+ and nBu4N
+.110 The conformational preference 
of the C2C3C4C5 dihedral arises from the avoidance of syn-pentane interactions5 between 
the C1C2 bond and the terminal methyl group (C5). Since the quaternary centre (C2) is free 
to rotate around the C2C3 bond and the resultant rotamers are energetically degenerate, there 
is always a CC bond in place to induce destabilising syn-pentane interactions, thus the C2C3 
bond can only be antiperiplanar to the C4-C5 bond. This phenomenon is known as the tert-
butyl effect.13,110-112  
 
Scheme 3.1: a, Conformational control exerted by a quaternary centre in the case of CPr4 3.1. b, 
Chemical structure of 4,4-dimethylheptane. c and d, Possible diamond lattice conformers of 4,4-
dimethylheptane with the arrangement of the  bonds (anti or gauche) highlighted in red. 
The same effect could also be observed in the case of 4,4-dimethylheptane (Scheme 
3.1b), where the chains continue on both sides of a quaternary centre.113 The two  dihedrals 
can only adopt an antiperiplanar conformation with respect to the quaternary centre but the  
dihedrals can adopt either anti or gauche conformations (Scheme 3.1c and d). Therefore, the 




cases where the conformation of the  bond is controlled, or the quaternary centre is placed at 
the terminal position of the chain. 
 
Scheme 3.2: Three possible diamond lattice conformers of 2,2-dimethyl hexane 3.2. 
Although the quaternary centre has exquisite control over the conformation of the 
CquaternaryCCC bond (C3C4, Scheme 3.1a), the control in conformation diminishes as one 
moves away from the quaternary centre. In the case of 3.2 (Scheme 3.2), the C4C5 bond could 
adopt either an anti or gauche conformation because the terminal methyl group (C6) could be 
placed at either one of the three positions on a diamond lattice due to the lack of destabilising 
syn-pentane interactions. The diminishing control in conformation was observed in the 
examination of the crystal structures of nBu4N
+ salts by Alder and co-workers110, as well as the 
NMR studies of compound 3.3 (Figure 3.1) by Hoffmann and co-workers.112-113  
Compound 3.3 (Figure 3.1a) bearing a terminal quaternary centre was designed to have 
a helical conformation. Its conformational behaviour in solution was investigated using 1H-1H 
scalar coupling constants. Due to spectral overlap, only the J values of one of the diastereotopic 
protons at the C4 and C6 positions were extracted. H4 has vicinal coupling constants of 10.3 
and 2.2 Hz and the magnitude of the values suggests a high preference of a single conformation 
in segment A. Slightly ‘averaged’ vicinal coupling constants were measured from H6 (9.0 and 
4.4 Hz), which implies a slight reduction in conformational preference in segment B.112-113. 
This experimental observation is further supported by calculation results of 3.4 – 3.6 (Figure 
3.1b) using MM3 force field, which showed a dramatic decrease for the preference of the 
dominant helical conformation with longer chain length, attributed to the diminishing 





Figure 3.1: a, Chemical structure of 3.3 and its designed diamondlattice type conformation.112-113 b, 
Carbon chains bearing a terminal tBu group and syn-1,3-dimethyl units with the calculated population 
of the conformational preference of a single dominant conformation.112  
To achieve remote conformational control of extended hydrocarbon scaffolds, one 
could place quaternary centres at both ends of the chains to exert conformational control from 
both directions. The NMR analysis of Me3N
+(CH2)nN
+Me3 type ions (Figure 3.2a) in D2O 
performed by Dufourcq and co-workers showed that when the two nitrogen quaternary centres 
are separated by three carbon units (i.e. n = 3, 3.7, Figure 3.2a), only a single conformation is 
dominant in solution, with dihedrals a and b adopting anti conformations. Unfortunately, as 
discussed before, the conformational control exerted by nitrogen quaternary centres diminishes 
with increasing distance from the centres, thus when there are more than three carbon units 
between both quaternary centres, such as in the case of 3.8 and 3.9 (Figure 3.2a), more 
conformations are accessible due to free rotation of the central bond (bond d in 3.8 and bonds 





Figure 3.2: a, Preference of dihedral angles (fa – fe) derived from NMR studies of a series of 
Me3N+(CH2)nN+Me3 type ions in D2O.114 b, Chemical structure of 2,2,6,6-tetramethylheptane 3.10. c, 
Dominant conformation represented on a diamond lattice with syn-pentane interactions (red arrows) 
highlighted in unfavourable conformations.  
Alder and co-workers have proposed that by having two terminal carbon quaternary 
centres three carbons away from each other, one single conformation dominates. This is 
because the tBu groups reinforce the conformation of the backbone from both directions and 
destabilise conformations with a non-linear backbone with syn-pentane interactions (Figure 
3.2c). Although changing from nitrogen to carbon quaternary centres would change the 
enthalpic penalty of syn-pentane interactions due to different XqC bond lengths, the CC bond 
length is somewhat similar to the NC bond length (1.54 and 1.49 Å, respectively), therefore 
3.10 should have a very similar conformational preference as 3.7 and should adopt a single 
conformation with a linear backbone (Figure 3.2b).110-111 
Therefore, 3.10 could be used as a scaffold for the design of other molecules with 
tailored conformations. The syn isomer 3.11 would have both the ester and carbamate 
substituents syn periplanar to each other (“U-shape”), while the anti isomer 3.12 would have 
both substituents turning a 120° corner (“L-shape”). The ester and carbamate groups were 





Scheme 3.3: Chemical structure and the expected diamond lattice conformation of 3.10, 3.11 and 3.12. 
In this report, 3.11 (U-shaped molecule) and 3.12 (L-shaped molecule) will be 
synthesised using lithationborylation methodology followed by functional group 
transformations. Their solutionstate behaviours will be elucidated by quantitative analysis of 
1H-1H, 1H-13C scalar coupling constants and NOE-derived 1H-1H distances using QM/NMR 
approach. It would be particularly interesting to establish the dominant conformation of 3.11 
(U-shape), since the substituents also impose a destabilising syn-pentane interaction.  
As discussed earlier, the conformational control exerted by both quaternary centres at 
the ends of the chain diminishes when there are more than three carbon units between the 
quaternary centres. It might be possible to regain the conformational control of the central 
bond(s) in 3.13 and 3.14 by adding destabilising syn-pentane interactions in undesired 
conformations. This in principle can be achieved by introducing substituents at specific 
positions with suitable stereochemistry. A combination of diamond lattice analysis and 
computational modelling will be used to guide the design of substituted analogues of 3.13 and 
3.14. Candidates showing strong preference (>80% of global population) towards a particular 
conformation by computational modelling will be synthesised and their solutionstate 
behaviour will be studied using QM/NMR approach.  
 
Scheme 3.4: Structure of 3.10, 3.13 and 3.14 with different numbers of methylene units between two 




3.2 Results and Discussion 
Development of synthetic methodology and QM/NMR analysis of U-shaped and L-shaped 
molecules (Compounds 3.11 and 3.12). 
3.2.1 Synthesis of 3.11 and 3.12.  
To synthesise both target compounds 3.11 and ent-3.12, two retrosynthetic routes were 
proposed, utilising the reagent controlled lithiationborylation methodology developed by the 
Aggarwal group8, as scheme 3.5 outlines.  
 
Scheme 3.5: Retrosynthetic analysis based on (a) bidirectional chain growth approach and (b) 
unidirectional chain growth approach.  
In the bi-directional chain growth approach (Scheme 3.5a), the ester functionality 
would be unmasked via oxidation of terminal alkene 3.15 followed by methylation of the 
resultant carboxylic acid. The carbamate group would be installed via a stereospecific 
amination of the boronic ester in 3.15.115-116 The key intermediate 3.15 could be generated via 
desymmetrisation of a C2 symmetric bis (boronic) ester 3.16 using Zweifel oliefination117, and 




diborylmethane 3.17 with the requisite carbenoid 3.18.118 Although the bidirectional approach 
is only suitable for the enantioselective synthesis of ent-3.12 (L-shaped), it is a short route to 
gain access to one of the two target molecules. 
In the uni-directional approach (Scheme 3.5b), the ester functionally would be 
introduced via oxidation of a 4-methoxyphenyl group using RuCl3 in the presence of 
NaIO4.
94,119 Again, functional group interconversion of the carbamate would give the 
secondary boronic ester 3.19, which can be constructed using assembly line synthesis with the 
requisite carbenoids starting from 4-methoxyphenyl pinacol boronic ester 3.20.  
For both routes the starting boronic ester could be synthesised following literature 
procedures8,120 and the ClCH2Li carbenoid 3.21 could be generated in situ by the addition of 
nBuLi to bromochloromethane at 78 °C.94 This only leaves with the synthesis of chiral 
building block 3.18 and 3.22, with either Hoppe-type carbamate or Beak-type benzoate leaving 
groups. 
Since asymmetric deprotonation of carbamates usually gives greater enantioselectivity 
(er ~ 98:2)90,121-123 than that of the corresponding benzoate (er ~ 95:5)93,124-125, the use of 
Hoppe-type carbamates as the leaving group was first considered. Unfortunately, Hoppe and 
co-workers demonstrated that neopentyl carbamate 3.23 could not undergo asymmetric 
deprotonation (within 4 hours) when ()-sparteine 3.24 was used as the diamine ligand 
(Scheme 3.6).126 Although the deprotonation is possible using a sterically less demanding 
diamine ligand 3.25, the enantioselectivity of the lithiation was moderate (89.5:10.5, Scheme 
3.6), which is undesirable for the development of the enantioselective synthesis of the target 





Scheme 3.6: Asymmetric deprotonation of neopentyl carbamate 3.23 using either 3.24 or 3.25 as the 
diamine ligand. 
Fortunately, the neopentyl benzoate 3.26 undergoes steady asymmetric deprotonation 
with high enantioselectivity (er ≥99:1)127 when (+)-sparteine is used as the diamine ligand, 
despite the fact that the -proton of both 3.23 and 3.26 have similar pKa values.128 The resultant 
lithiated species could then be trapped directly by a boronic ester with a very long borylation 
time (t1/2 = 296 minutes, ~5 hours) to generate the homologated product 3.27. Crucially, the 
use of excess organolithium base, which is required for efficient deprotonation of benzoate 
3.26, is undesirable for the homologation with precious boronic esters. Therefore, there is a 
need to develop a stable, convenient precursor of both enantiomeric forms of the neopentyl 
carbenoids. 
 
Scheme 3.7: Asymmetric deprotonation of neopentyl benzoate 3.26 using (+)-sparteine followed by 
trapping with phenyl ethyl pinacol boronic ester to give the homologated product 3.27 after oxidation. 
The Aggarwal group has reported the use of both -sulfinyl129 and -stannyl8 benzoates 
(cf. 3.28 and (S)-3.29, respectively, Scheme 3.8) as bench-stable carbenoid precursors for the 
stereospecific homologation of boronic esters. For both classes of precursors, the carbenoid is 
unmasked by either sulfoxide or tinlithium exchange to give the configurationally stable 





Scheme 3.8: Two carbenoids precursors of neopentyl carbenoids (S)-3.30. 
While the -stannyl ethyl benzoates could be accessed in very high enantiopurity 
(> 99.9:0.1) via recrystallisation and used for the synthesis of molecules with 10 contiguous 
methyl stereogenic centres as single diastereomers (discussed in section 1.4), there are several 
drawbacks associated with the use of -stannyl alkyl benzoates. First of all, in order to access 
these building blocks in very high enantiopurity, the -stannyl alkyl benzoates must be 
crystalline solids. However, the physical state of the stannyl compounds are highly dependent 
on the nature of the pendant alkyl group. More importantly, in order to generate both 
enantiomers of the -stannyl alkyl benzoate the use of both enantiomeric forms of sparteine is 
required. However, it is increasingly difficult to access the ()-enantiomer of sparteine. 
Together with the toxicity associated with organotin compounds, the use of -sulfinyl 
benzoates 3.28 as a precursor is very attractive because its synthesis does not require both chiral 
diamine ligands or highly toxic reagents. In addition, the syn isomer of -sulfinyl benzoates is 
usually a crystalline solid, thus allowing access to enantiopure building blocks via 
recrystallisation.  
The preparation of the -sulfinyl benzoates began with the synthesis of the neopentyl 
benzoate 3.26 by a Mitsunobu reaction between 2,4,6-triisopropyl benzoic acid 3.31 and 
neopentyl alcohol (93% yield, Scheme 3.9a). The benzoate 3.26 was lithiated in the presence 
of tetramethylethylenediamine (TMEDA) followed by trasmetallation using MgBr2∙OEt2 to 
generate the corresponding magnesium carbenoids 3.32, which was then trapped by Andersen’s 
sulfonate to generate both syn and anti -sulfinyl benzoates 3.28 and 3.33 in high enantiopurity 
with inversion of stereochemistry at the sulfur centre. The er of the syn isomer 3.28 could be 





Scheme 3.9: Synthesis of neopentyl benzoate 3.26 and both diastereomers of -sulfinyl benzoates 3.28 
and 3.33. 
The use of -sulfinyl benzoate 3.28 in lithiationborylation was investigated by Dr. 
Murat Kucukdisli in the Aggarwal group (Scheme 3.10a). When tBuLi was added to a mixture 
of boronic ester 3.34, -sulfinyl benzoates 3.28 and N,N,N′,N′′,N′′-
pentamethyldiethylenetriamine (PMDTA) in THF at −78 °C, the homologated product was not 
observed and only the neopentyl benzoate 3.26 (protodesulfinylation of the carbenoid precursor) 
was isolated. This suggests that the formation of the boronate complex 3.36 was slower than 
expected due to the hindered nature of the lithiated species (S)-3.30. Thus, the dominant 
pathway of the reaction was the protonation of the lithiated species (S)-3.30, presumably by 
the acidic -proton of sulfinyl benzoate 3.28 or adventitious H2O. To circumvent the quenching 
of the lithiated species (S)-3.30 by the sulfinyl benzoate 3.28, an inverse addition protocol was 
performed in which the -sulfinyl benzoate 3.28 was added to a mixture of tBuLi and PMDTA 
in Et2O followed by the addition of boronic ester 3.34. The desired homologated product 3.35 






Scheme 3.10: Application of -sulfinyl benzoate 3.28 in lithiationborylation reactions. a: Reaction 
between the -sulfinyl benzoate 3.28 and boronic ester 3.34. b, Proposed competing reaction pathway 
which lead to reduced stereoselectivity observed in homologated product 3.35. 
The reduced stereoselectivity arises from a competing reaction pathway in which the 
racemic lithiated species rac-3.30 is generated and engages in boronate complex formation 
with the boronic ester 3.34 (Scheme 3.10b). Due to steric hindrance of 3.28, the rates of both 
sulfoxidelithium exchange and the subsequent reaction of (S)-3.30 with boronic ester 3.34 are 
slow. Therefore, newly generated chiral carbenoid (S)-3.30 could deprotonate the acidic -




3.26, which could be deprotonated by tBuLi to generate racemic carbenoid rac-3.30 (pathway 
A, Scheme 3.10b). The deprotonation of the unreacted chiral -sulfinyl benzoate 3.28 
generates an achiral anion 3.37, which could be protonated by an internal proton source (for 
example 3.26) and subsequently undergo sulfoxidelithium exchange to generate the racemic 
carbenoid rac-3.30 (pathway B, Scheme 3.10b). The racemic lithiated species rac-3.30 
ultimately leads to the formation of racemic homologated product and the observed erosion in 
er.  
Next, the possibility of using -stannyl neopentyl benzoate in the lithiationborylation 
reaction sequence was considered. Since the -deprotonation/reprotonation racemisation 
pathways observed for sulfoxide have not been observed with -stannyl benzoate system, the 
use of the -stannyl neopentyl benzoate should deliver the homologated product in perfect 
enantiospecificity.8 
The -stannyl neopentyl benzoate (R)-3.29 was therefore synthesised by the lithiation 
of the neopentyl benzoate 3.26 in the presence of sBuLi (1.6 equivalents) and (+)-sparteine (1.6 
equivalents) in anhydrous Et2O at 78 °C for 24 hours followed by trapping with Me3SnCl. 
The desired stannane (R)-3.29 was obtained in good yield and with high enantioselectivity 
(92%, er 97.5:2.5, Scheme 3.11). The opposite enantiomer was synthesised by using ()-
sparteine in place of (+)-sparteine with identical yield and similar er (98:2). Unfortunately, both 
enantiomers of -stannyl neopentyl benzoate are viscous oils and therefore cannot be re-
crystallised to further improve their er.  
 
Scheme 3.11: Synthesis of -stannyl neopentyl benzoate (R)-3.29.  
With the -stannyl neopentyl benzoates in hand, the bidirectional chain growth 
approach was first considered and the reaction between the lithiated species (R)-3.30 and 
diborylmethane 3.17 was investigated (Scheme 3.12a). It was shown by the Aggarwal group 
that the reaction between diborylmethane 3.17 and a hindered carbenoid, for example the ones 




single-addition product 3.38, whereas the reaction between 3.17 and an unhindered carbenoid, 
generated under diamine free conditions (X = Et2O, Scheme 3.12b) would give double-addition 
product 3.39.118 Although the lithiated species (R)-3.30 would be generated under diamine free 
conditions via tinlithium exchange, it is sterically demanding and therefore it was not clear 
whether the reaction between (R)-3.30 and 3.17 would give single- or double-addition product.  
 
Scheme 3.12: a, Retrosynthetic analysis of bi-directional chain growth approach. b, 
Lithiationborylation reaction between benzoate 3.40 with diborylmethane 3.17 in the presence of a 
diamine ligand (X = (+)-sparteine) or under diamine-free (X = Et2O) conditions.  
The lithiationborylation reaction between diborylmethane 3.17 and -stannyl 
benzoates (R)-3.29 (Figure 3.3a) was monitored by the change of the carbonyl stretching 
frequencies (C=O) using in situ IR spectroscopy. The result was represented by plotting the 
concentration of each species observed in the reaction sequence (-stannyl benzoates (R)-3.29, 




The solution of -stannyl benzoate (R)-3.29 in Et2O displayed a strong absorbance 
(C=O) at 1712 cm1. The addition of nBuLi to the solution initiated the tinlithium exchange 
process and the above-mentioned signal (1712cm1) steadily disappeared with the appearance 
of a new signal at a lower wavenumber (1634 cm1) corresponding to the lithiated species (R)-
3.30. The tinlithium exchange was complete in ~1.5 hours and was found to be quicker 
towards (i.e. auto catalysis) the end of the exchange, reasons for which are currently unclear. 
Next, a solution of diborylmethane 3.17 in anhydrous diethyl ether was slowly added to the 
solution of lithiated species (R)-3.30 at 78 °C and the formation of the boronate complex 3.41 
(1658cm1) was found to be instantaneous (<15 s). Only ~50% of the lithiated species (R)-3.30 
was consumed, thus only one out of the two pinacol boronic esters engaged in boronate 
complex formation with the hindered lithiated species (R)-3.30 to generate intermediate 3.41 
(Figure 3.3c). Formation of the second boronate complex at the other unreacted boron centre 
was not observed at 78 °C with prolonged borylation time (3 hours) and at elevated reaction 
temperature (from 78 °C to 65 °C). Finally, the reaction was warmed to room temperature 
and stirred overnight for 1,2-migration to occur. The expected single-addition product 3.42 was 
isolated together with the secondary boronic ester 3.43, which was generated via the 
fragmentation pathway, in moderate yields (33% each). Unfortunately, the addition of Lewis 
acid (MgBr2 in anhydrous methanol) in the hope to promote the desired 1,2-migration pathway 
led to the formation of the secondary boronic ester 3.43 as the major product (52% isolated 






Figure 3.3: a, lithiationborylation reaction investigated using react-IR spectroscopy. b, Traces of 
different species (blue: -stannyl benzoates (R)-3.29; red: lithiated species (R)-3.30; green: boronate 
complex 3.41) obtained from the react-IR study. c, Proposed reaction pathways which lead to the 




Although the single-addition product 3.42 could be subjected to another 
lithiationborylation reaction with lithiated species (R)-3.30 and the less hindered primary 
boronic ester might preferentially undergo boronate complex formation, the fragmentation 
product 3.43 could not be eliminated and the single-addition product 3.42 was obtained in low 
yield (33%). Therefore, the bidirectional chain growth approach was abandoned and the 
unidirectional chain growth approach (Scheme 3.5b) was investigated instead. 
As scheme 3.13 shows, the proposed synthesis of would start from boronic ester 3.20 
and each carbon unit would be introduced using the requisite carbenoids for 
lithiationborylation to deliver the key intermediates 3.19 and 3.44. Boronic ester 3.19 will 
then be converted to carbamate 3.45, using a stereospecific amination procedure developed by 
Morken and co-workers115-116, and the electron-rich 4-methoxy phenyl group will be oxidised 
using RuCl3 in the presence of NaIO4 to yield the carboxylic acid 3.46. 
94,119 Methylation of 
the acid 3.46 using TMSCHN2 would deliver the target compound 3.11 for QM/NMR analysis. 






Scheme 3.13: Proposed synthesis of the unidirectional approach starting from 4-methoxyphenylboronic 
acid pinacol ester 3.20. 
A small scale lithiationborylation reaction (0.2 mmol) between boronic ester 3.20 and 
-stannyl benzoate (R)-3.29 delivered the desired homologated product 3.47 in quantitative 
yield and high stereoselectivity (99.1% yield and 100% es, Scheme 3.14). Matteson 
homologation with 3.21, which was generated in situ from bromochloromethane and nBuLi, 
led to the one carbon homologated boronic ester 3.48 with high conversion (>99%, monitored 





Scheme 3.14: Homologations of boronic ester 3.20. Conditions for Matteson homologation: 
bromochloromethane (3 eq), nBuLi (2.5 eq), Et2O (0.25 M of boronic ester), 78 °C for 20 minutes, 
then warm to room temperature for 1 hour. 
However, when the Matteson homologation was performed to deliver boronic ester 
3.48 on a larger scale (3.30 mmol, entry 2, Scheme 3.15), over homologated product 3.49 was 
also formed and the separation of these products was very challenging. Therefore, the 
possibility of eliminating the formation of over homologated product 3.49 was investigated. 
Reduction of the reaction concentration may lead to slight increase in the formation of 
the desired product 3.48, and a reduction of over homologated product 3.49 (entry 3, Scheme 
3.15). It was thought that reducing the equivalents of the reactive lithiated species 3.21 would 
eliminate the possibility of the desired homologated product 3.48 undergoing further reaction 
to generate the undesired over homologated product 3.49. Unfortunately, this led to the 
formation of a mixture containing unreacted starting boronic ester 3.47, desired product 3.48 
and over homologated product 3.49 (entry 4, Scheme 3.15). These two experiments suggest 
that reducing the reaction concentration lowered the amount of over homologated product 3.49 
and a large excess of lithiated species 3.21 (2.5 eq) was required for full conversion of the 




Scheme 3.15: Optimisation of the Matteson homologation of 3.47 to form 3.48. 
Apart from the efficiency of heat transfer, one of the key differences between the small-
scale and the large-scale Matteson homologations is the time the reaction mixture was left at 
78 °C. Since the lithiated species 3.21 is very unstable even at 78 °C, nBuLi was added very 
slowly to the reaction mixture (1.2 mL/h) to avoid its decomposition. The formation of the over 
homologated product 3.49 suggests that during the formation of 3.21 at cryogenic temperature 
(< 70 °C), some of the boronate complex 3.50 underwent 1,2-migration to give the desired 
homologated product 3.48, which then reacted with another lithiated species 3.21 to give the 
over homologated product 3.49 (Scheme 3.16).  
 
Scheme 3.16: Proposed mechanism for the formation of over homologated product 3.49. 
The solution to overcome this problem is to reduce the amount of 1,2-migration of the 
boronate complex 3.50 by shortening the reaction time at cryogenic temperature. This was 




78 °C to 95 °C). This set of conditions led to product formation with good selectivity towards 
the desired product 3.48 (entry 5, Scheme 3.15).  
Reaction between boronic ester 3.48 and the (R) enantiomer of the -stannyl benzoate 
(R)-3.29 gave the syn isomer 3.19 in moderate conversion (recovered 25% starting boronic 
ester 3.48) and moderate isolated yield with good diastereoselectivity (66%, dr 95:5, entry 1, 
Scheme 3.17). The moderate conversion suggests that the boronate complex formation is 
reversible, presumably due to the hindered nature of the intermediate boronate complex. 
Therefore, the use of a Lewis acid additive (MgBr2 in anhydrous methanol) to accelerate the 
rate of the desired 1,2-migration pathway130 was explored. Pleasingly, the syn isomer 3.19 was 
obtained in good yield and good diastereoselectivity (73%, dr 95:5, entry 3, Scheme 3.17a). 
The same results (in terms of product yield and diastereoselectivity) could also be obtained 
when only 1.5 equivalents of -stannyl benzoates (R)-3.29 was used (entry 4, Scheme 3.17). 
The anti isomer 3.44 was synthesised using the (S) enantiomer of the -stannyl benzoate (S)-
3.29 with no Lewis acid additive and the product was obtained in good yield and high 





Scheme 3.17: a, Optimisation of lithiationborylation reaction between boronic ester 3.48 and -
stannyl benzoate (R)-3.29. * Equivalents of nBuLi added: 1.45. b, Lithiationborylation reaction 
between boronic ester 3.48 and stannane -stannyl benzoate (S)-3.29. 
With both key intermediates in hand, the amination of the syn isomer 3.19 was 
investigated using the first-generation conditions reported by Morken and co-workers, as 
scheme 3.18a illustrates115. First, methoxyamine 3.51 (Scheme 3.18b) was deprotonated by 
nBuLi to generate lithiated methoxyamine as the active aminating reagent, which then reacted 
with the boronic ester 3.19 to generate boronate complex 3.52. The 1,2-migration of 3.52 at 
elevated temperature would generate intermediate 3.53 which could be converted to the desired 
carbamate 3.43 after Boc protection. However, the amination of 3.19 using the first-generation 
conditions only delivered the desired product 3.43 with moderate conversion (recovered 48% 
starting material) and low isolated yield (30%, Scheme 3.18a). This suggests that the 
association of the boronic ester 3.19 and the aminating reagent was inefficient owing to the 
steric hindrance of the boronic ester. Therefore, upon heating the aminating reagent might 
decompose to give the nitrene 3.54 prior to the association with the hindered boronic ester, 




To achieve efficient amination of 3.19, transformation of boronic ester 3.19 to the 
corresponding borane 3.55 was investigated in the hope that this would alleviate the steric 
hindrance and increase the electrophilicity of the boron centre, thus allowing efficient 
amination with other aminating reagents such as chloramine (H2NCl).
131 Unfortunately 
formation of borane 3.55 was not observed by 11B NMR when methyl magnesium bromide 
was added to boronic ester 3.19, presumably owing to the steric hindrance of the boronic ester.  
 
Scheme 3.18: a, Attempts of stereospecific amination of syn isomer 3.19. b, Proposed reaction 
mechanisms of amination conditions developed by Morken and co-workers. 115-116  
Fortunately, Morken and co-workers published improved amination conditions (2nd 
generation conditions) for sterically demanding boronic esters (Scheme 3.18b).116 




so that the base could only deprotonate methoxyamine once the hydrogen is acidified by the 
coordination of methoxyamine to boron. The avoidance of the lithiated methoxyamine allowed 
the use of the higher temperatures required for more challenging aminations. Using a modified 
version of the reported second generation conditions, target compound 3.43 was obtained in 
good yield and the stereochemical integrity was preserved.  
With the carbamate 3.43 in hand, the oxidation of the 4-methoxy phenyl group to a 
carboxylic acid moiety was investigated (Scheme 3.19). Unfortunately, formation of the 
desired carboxylic acid 3.46 was not observed in the crude reaction mixture (analysed by 13C 
NMR) after treatment with RuCl3 and NaIO4. Instead, incomplete conversion together with 
non-specific decomposition of the starting material was observed. This transformation was not 
investigated further due to the lack of synthetic methods for the oxidation of 4-methoxyphenyl 
groups to carboxylic acids.  
 
Scheme 3.19: Oxidation of the 4-methoxyphenyl group using a catalytic amount of RuCl3 in the 
presence of NaIO4.  
A solution to the problem would be to use a different functional group as a precursor to 
the carboxylic acid, as scheme 3.20 outlines. The carboxylic acid functionality could be 
accessed via either ozonolysis of an alkene or oxidation of a primary alcohol. Again, the 
carbamate moiety could be installed by stereospecific amination of a boronic ester to give 
boronic esters 3.56 and 3.57, which could be generated using lithiationborylation reactions 





Scheme 3.20: Modified retrosynthetic analysis of unidirectional chain growth approach starting from 
boronic esters with masked oxygen functionality. 
The use of commercially available vinyl pinacol boronic ester 3.58 was first considered 
and the lithiationborylation reaction between 3.56 and the -stannyl ethyl benzoates (R)-1.68 
was investigated by Dr Teerawut Bootwicha in the Aggarwal group (Scheme 3.21). 
Unfortunately, the 1,2-migration of the resultant boronate complex 3.60 was difficult, for 
reasons unknown, and only moderate conversion (50%) was observed, even with the use of a 
Lewis acid to enhance the efficiency of 1,2-migration. This suggests the use of boronic ester 
3.58 as the starting point of the synthesis is not ideal for the future development of the iterative 
synthesis of the target compounds. Therefore, the use of boronic ester 3.59 bearing a protected 
oxygen moiety was investigated. 
 
Scheme 3.21: Lithiationborylation reaction between vinyl pinacol boronic ester 3.58 and -stannyl 
ethyl benzoates (R)-1.68 as investigated by Dr. Teerawut Bootwicha. 
Boronic ester 3.59 was synthesised by reacting boronic ester 3.61 with sodium benzyl 
alkoxide, which was generated by deprotonating benzyl alcohol with sodium hydride in DMSO. 
The use of DMSO as solvent turned out to be crucial for high conversion (~80%)132 because 




in low conversion (<30%). Due to incomplete conversion, product 3.59 was obtained together 
with benzyl alcohol generated by the protonation of any unreacted sodium benzyl alkoxide. 
Due to the instability of 3.59 on silica, the product could not be purified by flash column 
chromatography. Although distillation could separate both compounds, it was found to be non-
reproducible and sometimes benzyl alcohol could not be completely removed from the reaction 
mixture. Pleasingly, it was found that benzyl alcohol could be completely removed by 
repeatedly (four times) washing the crude mixture (dissolved in pentane) with water.  
 
Scheme 3.22: Preparation of boronic ester 3.59. 
With pure boronic ester 3.59 in hand, the first homologation was investigated, and the 
desired homologated product 3.62 was isolated in good yield and stereoselectivity (Scheme 
3.23a). It was found that the addition of methanol at the end of borylation prevented the 
formation of side product 3.63 by protonating any unreacted lithiated neopentyl benzoates 
(Scheme 3.23b). Although 3.63 was isolated in a small amount (<5%), eliminating the 
formation of 3.63 allowed easy purification of the desired product 3.62. In addition, solvent 






Scheme 3.23: a, Lithiationborylation reaction between boronic ester 3.59 and -stannyl neopentyl 
benzoates (R)-3.29. b, Proposed mechanism of the formation of side product 3.63.  
Next, Matteson homologation using boronic ester 3.62 was investigated. This reaction 
poses potential challenges because, apart from the desired 1,2-migration pathway,-
elimination could also occur due to the presence of an oxygen-based leaving group  to the 
boronic ester in the intermediate boronate complex 3.64 (Scheme 3.24a). The competing-
elimination pathway is undesirable and could lead to catastrophic decomposition of 3.64 
(Scheme 3.23a).136 
The Aggarwal laboratory has previously shown that it is possible to perform Matteson 
homologation with high efficiency in the presence of oxygen moieties at the  position when 
iodide was used as the leaving group (Scheme 3.24b).137 With the encouraging literature 
precedent, Matteson homologation of boronic ester 3.62 was performed using the optimised 
conditions developed for the 4-methoxyphenyl analogue (3 eq bromochloromethane, 2.5 eq 
nBuLi, 0.25 M of boronic ester in anhydrous Et2O at −78 °C for 0.2 mmol scale, Scheme 3.24c). 
The desired product 3.65 was isolated in good yield (86-89%) and no benzyl alcohol was 
observed in the crude reaction mixture, suggesting the competing -elimination pathway did 





Scheme 3.24: a, Two possible reaction pathways for boronate complex 3.64. b, Literature precedent137 
of Matteson homologation using boronic ester with potential leaving group at the position  to the 
pinacol boronic ester group. c, Matteson homologation of boronic ester 3.62. 
Finally, the syn isomer 3.57 was synthesised in good yield and diastereoselectivity 
(69%, dr 95:5, Scheme 3.25a) by lithiationborylation reaction between boronic ester 3.65 and 
the (R) enantiomer of the -stannyl benzoate (R)-3.29.  
 
Scheme 3.25: Synthesis of 3.57. 
The syn isomer 3.57 was subjected to amination using the optimised conditions and the 
benzyl group was removed by hydrogenation using palladium on charcoal under an H2 
atmosphere, providing primary alcohol 3.66 as a single diastereomer in good yield after 





With the alcohol 3.66 in hand, the direct oxidation of the primary alcohol to the 
carboxylic acid 3.46 was investigated. Unfortunately, under TEMPO catalysed oxidation 
conditions the reaction either did not proceed or gave a complex mixture of products with a 
trace amount of desired product 3.11 isolated after methylation (<5% yield) in low purity. 
(Scheme 3.26)  
 
Scheme 3.26: Attempted direct oxidation of primary alcohol to 3.66 to carboxylic acid 3.46, followed 
by methylation using TMSCHN2 of the reaction crude mixture. 
Next, stepwise oxidation (alcohol → aldehyde → carboxylic acid) was considered and 
the oxidation of primary alcohol 3.66 to aldehyde 3.67 was investigated. Under both Swern 
and DMP oxidation conditions, the desired aldehyde 3.67 was not obtained, instead, a cyclised 





Scheme 3.27: Oxidation of primary alcohol 3.66 to aldehyde 3.67 under Swern (entry 1) and DMP 
(entry 2) oxidation conditions.  
The cyclised product 3.68 could be generated via a 5-exo-trig cyclisation of the 
carbamate nitrogen onto the aldehyde carbonyl followed by the loss of water (Scheme 3.28). 
The preferential formation of 3.68 via this pathway was surprising, since the carbamate 
nitrogen should be a poor nucleophile due to significant donation of the lone pair electron 
density to the adjacent carbonyl group. However, the syn isomer with two quaternary centres 
separated by three carbons, such as aldehyde 3.67, was designed to have two substituents syn 
periplanar to each other. Therefore, the energetic cost for the two reactive ends in aldehyde 
3.67 to be close in proximity is low and the rate of intramolecular cyclisation was enhanced, 
leading to the preferential formation of the cyclised product 3.68. 
 
Scheme 3.28: Proposed mechanism of the formation of 3.68.  
Acceleration of the rate of intramolecular cyclisation due to the effect of tert-butyl 
groups on molecular conformation has been reported for the 3.69 type of system, which 
undergoes an intramolecular Diels-Alder reaction upon heating in benzene at 80 °C (Figure 
3.4a). When the ‘anchoring’ R group is a tert-butyl group (instead of a proton), both the furan 
and the alkyne moieties would orientate anti to the tert-butyl group (for the reasons discussed 
in section 3.1) and as a result they would be syn periplanar to each other and therefore close in 




tert-butyl ‘anchoring’ R group, the conformational preference of 3.69b (R=tBu) leads to a 240-
fold rate enhancement.138  
 
Figure 3.4: a, Intramolecular Diels-Alder reaction between furan and alkyne and the relative rates of 
cyclisation.138 b, Carbon chain with a tBu anchor in the middle of the chain.  
Although the formation of hemiaminal 3.70 could be rationalised by the conformational 
preference of the aldehyde 3.67, it was not entirely clear what the driving force for the loss of 
water to deliver the cyclised product 3.68 was. One could reason that under other oxidation 
conditions perhaps the loss of water would not occur so that the hemiaminal 3.70 could be 
further oxidised to the lactam 3.71, which could be hydrolysed to deliver the desired carboxylic 
acid 3.46. 
 
Scheme 3.29: Proposed alternative reaction pathway of oxidation of alcohol 3.66. 
It was found that oxidation of the primary alcohol under Stahl oxidation conditions, 
using catalytic amount of copper(I) and 9-azabicyclo[3.3.1]nonane N-oxyl (ABNO)139, 
delivered the desired product as a mixture of aldehyde 3.67 and hemiaminal 3.70 (1:4 ratio in 




aldehyde. The mixture of aldehyde and hemiaminal could be further oxidised to yield the 
lactam 3.71 by using an O2 balloon and elevated temperature (70 °C). However full conversion 
was not observed presumably due to catalyst inhibition for unknown reasons. To ensure full 
conversion of the reaction (thus allowing easy purification by column chromatography), all 
catalytic components were reloaded every two hours until the reaction had gone to completion.  
 
Scheme 3.30: Oxidation of primary alcohol 3.66 under Stahl oxidation conditions. NMI: N-
methylimidazole.139  
With sufficient material in hand, the hydrolysis of lactam 3.71 which would deliver the 
desired carboxylic acid 3.46 was investigated (Scheme 3.31). When the reaction was performed 
using LiOH in THF, no conversion was observed at 0 °C and room temperature (entry 1 and 2, 
Scheme 3.31). When a 1:1 mixture of THF and methanol was used as the reaction solvent, 
epimerisation of starting material was observed by 1H NMR of the crude reaction mixture 
(entry 3, Scheme 3.31). This observation suggests that in a 1:1 mixture of THF and methanol, 
the basicity, rather than the nucleophilicity, of LiOH was enhanced, thus leading to 
deprotonation of the acidic -proton of 3.71, resulting epimerisation. 
Next, the use of LiOOH for the hydrolysis of lactam 3.71 was investigated, because it 
is more nucleophilic due to the -effect140, and less basic (pKa of [HOOH] = 11.6, compared 
to pKa of [HOH] = 15.8.)
141. Indeed, a trace amount of product was detected by LC-MS with 
the use of LiOOH at 0 °C (entry 4, Scheme 3.31). However, the efficiency of the hydrolysis 
could not be further improved by either performing the reaction at room temperature or with 




mixture at 60 °C overnight lead to epimerisation of starting material 3.71 (entry 7, Scheme 
3.31).  
 
Scheme 3.31: Attempts to hydrolyse lactam 3.71. 
The use of both hydroxide- or hydrogen peroxide-based nucleophiles were ineffective 
in the hydrolysis of lactam 3.71, owing to the steric hindrance of the substrate. Therefore, the 
transformation of lactam 3.71 to the less sterically hindered thioester derivative was considered. 
Evans and co-workers reported the use of this approach for the removal of the chiral auxiliary 
in a sterically demanding substrate 3.72, which did not undergo hydrolytic cleavage when 
LiOOH was used. The thioester derivative 3.73 was obtained in good yield (85%) and the 
subsequent hydrolysis using LiOOH delivered the desired carboxylic acid 3.74 in quantitative 
yield.142  
 




Encouraged by the work done by David Evans and co-workers, the same conditions 
were applied to lactam 3.71 (5.0 mg scale) to synthesise the corresponding thioester derivative 
3.75 for easier hydrolysis. Unfortunately, only the product arising from the cleavage of the Boc 
protecting group (3.76) was isolated in 51% yield.  
 
Scheme 3.33: Reaction between lactam 3.71 and LiSEt.  
As discussed, all attempts to hydrolyse the lactam 3.71 failed due to steric hindrance. 
Therefore, an alternative approach was considered: if one could prevent the nucleophilic attack 
of the nitrogen of the carbamate at the aldehyde carbonyl, no cyclised product would form and 
the free aldehyde should be easily oxidised to the carboxylic acid. Therefore, carbamate 3.77 
was subjected to another Boc-protection to yield 3.78 (Scheme 3.34). Again, due to the steric 
hindrance of 3.77 conventional methods (Boc2O, DMAP in MeCN) for the second Boc-
protection were unsuccessful. Finally, the desired product 3.78 was obtained in good yield 
(79%) using a modified literature procedure143. The use of DMAP was found to be essential 
for good conversion and the use of exactly one equivalent of nBuLi was crucial for eliminating 
a side product which was thought to arise from the deprotonation of the aromatic protons of 
the benzyl group.  
 
Scheme 3.34: Second Boc protection of 3.77 followed by deprotection of the benzyl group.  
Primary alcohol 3.79 was synthesised and the oxidation to the aldehyde was performed 




yield (78%, Scheme 3.35a) and Pinnick oxidation of the aldehyde smoothly delivered the desire 
carboxylic acid 3.81. The crude carboxylic acid 3.81 was subjected to methylation using 
TMSCHN2 to deliver the methyl ester 3.82 in 77% yield over two steps. One of the Boc 
protecting groups was removed using TFA in DCM to deliver the U-shaped molecule 3.11 as 
a solid (Scheme 3.35b). 
 
Scheme 3.35: a, Stahl oxidation of 3.79. b, Pinnick oxidation of 3.80 followed by methylation of 
carboxylic acid 3.81 and the removal of one of the Boc protecting group to deliver U-shaped molecule 
3.11. 
The solid-state structure of 3.11 was obtained via X-ray crystallography. Gratifyingly, 
the backbone conformation is linear with the two substituents synperiplanar to each other as 





Figure 3.5: X-ray crystal structure of 3.11. Thermal ellipsoids are shown at 50% probability. 
Having established the synthetic route to prepare the syn isomer 3.11, the optimised 
conditions were applied to the synthesis of the anti isomer 3.21. Starting from boronic ester 
3.62, homologation with 3.21 followed by reaction with the (S) enantiomer of the -stannyl 
benzoate (S)-3.29 delivered the key intermediate 3.83 in good yield and diastereoselectivity 
(66%, dr 96:4, Scheme 3.36) 
 
Scheme 3.36: Synthesis of boronic ester 3.83 by iterative homologation of 3.62.  
The key intermediate 3.83 was then subjected to the identical synthetic sequence 
described for the syn isomer (Scheme 3.37). Amination, second Boc protection and benzyl 
group deprotection gave primary alcohol 3.84. Further functional group interconversions 









3.2.2 QM/NMR analysis of U-shaped molecule 3.11.  
The solution-state conformational behaviour of 3.11 was investigated using QM/NMR 
approach. A Monte Carlo conformational search using MM calculations with MMFFs force 
field and chloroform as implicit solvent was performed (see experimental section for details). 

















0.0 7.1 9.3 14.1 
Population 
(298 K) 
92.2% 5.3% 2.2% 0.3% 
Figure 3.6: a, Chemical structure of 3.11 and the DFT calculated conformational behaviour represented 
by a bubble plot. b, Overlaid structures of major conformers 3.11-1, 3.11-2 and 3.11-3. c, Major 




All conformers were subjected to subsequent DFT geometry optimisation and 
frequency calculations using mPW1PW91 functional with 6-311G (d,p) basis set and 
chloroform as implicit solvent (IEFPCM). Values of relative Gibbs free energy (DG) of each 
conformer were used to calculate conformer populations. 
The DFT predicted conformational behaviour of 3.11 is represented by a bubble plot 
(Figure 3.6a). The angles of dihedral in the backbone (f1 and f2, Figure 3.6a) and between the 
substituents (f3, Figure 3.6a) are shown and the size of the bubbles is proportional to the 
calculated Boltzmann population of that conformation.  
The three dominant conformers 3.11-1, 3.11-2 and 3.11-3 all adopt the designed U-
shape conformation (Figure 3.6b) and have a combined population of 99.7% (Figure 3.6c). In 
all three conformers, f1 and f2 adopt anti conformations (Boltzmann averaged f = 155 and 
184°) with respect to the peripheral quaternary centres. The ester and the carbamate 
substituents are approximately syn periplanar to each other with a dihedral angle of −20°. The 
deviation of f1 (155°) and f3 (−20°) from the ideal angles of anti and syn periplanar 
conformations (180° and 0° respectively) alleviates the destabilising syn-pentane interaction 
between the ester and the carbamate groups.  
The DFT predicted conformational behaviour of 3.11 also highlights the extent of 
conformational control provided by both peripheral quaternary centres. The first lowest energy 
conformer with a non-linear backbone (conformer 3.11-4, Figure 3.6c) has a DG of 15 kJ mol−1 
above the global minimum (0.3% of global population) with an distorted syn-pentane 
interaction between the methyl group of the one of the peripheral tBu groups and the CC bond 
of the backbone (Figure 3.6c).  
To verify the major conformations of 3.11 in solution, QM/NMR analysis was 
performed using 1H-1H and 1H-13C scalar coupling constants. The NMR parameters of the three 
dominant conformers (3.11-1, 3.11-2 and 3.11-3, Figure 3.6) were computed by DFT using 
mPW1PW91 functional with 6-311G (d,p) basis set and chloroform as implicit solvent 
(IEFPCM). The experimental 1H-1H scalar coupling constants were extracted from the 1D 1H 
NMR spectrum and the 1H-13C scalar coupling constants were measured from the traces 





A good agreement was observed for the comparison between the calculated ensemble-
averaged 1H-1H and 1H-13C scalar coupling constants and the experimentally determined values 
(Figure 3.7) with root mean square deviation of 1.0 Hz for the comparison of 1H-1H scalar 
coupling constants and 0.41 Hz for the comparison of 1H-13C scalar coupling constants. The 
excellent correlation between the calculated ensemble-averaged scalar coupling constants and 
the experimental data confirms that indeed the solution-state major conformation of 3.11 is the 
designed U-shape conformation.  
 
Figure 3.7: Correlation between the calculated and the experimentally determined 1H-1H and 1H-13C 
scalar coupling constants. Purple dots represent the comparison of 1H-1H scalar coupling constants 
while red dots represent the comparison of 1H-13C scalar coupling constants.  
To investigate the detailed conformational behaviour of 3.11, quantitative NOE 
analysis is required. However, due to the presence of rotameric signals of all proton resonances, 
the observed NOE intensities were complicated by chemical exchange between the irradiated 































3.2.3 QM/NMR analysis of L-shaped molecule 3.12.  
A MM Monte Carlo conformational search of 3.12 (L-shaped) was performed using the 
identical protocol described for 3.11 and found 26 conformers within 21 kJ mol−1 of the global 
















DG/kJ mol−1 0.0 9.5 12.9 
Population 
(298 K) 
97.0% 2.1% 0.5% 
Figure 3.8: a, Chemical structure of 3.12 and the DFT calculated conformational behaviour represented 
by a bubble plot. b, Overlaid structures of conformer 3.12-1, 3.12-2 and 3.12-3. c, Major conformation 
represented on a diamond lattice, DFT optimised structures, DG and population at 298 K. Hydrogens 




The DFT predicted conformational behaviour of 3.12 was represented by a bubble plot 
(Figure 3.8a). The three dominant conformers 3.12-1, 3.12-2 and 3.12-3 (Figure 3.8d) all adopt 
the designed L-shaped conformation (Figure 3.8b) and have a combined population of 99.6% 
(Figure 3.8c). In all three conformers, f1 and f2 adopt anti conformations (Boltzmann averaged 
f = 172 and 169°) with respect to the peripheral quaternary centres. The ester and the carbamate 
substituents turn a corner with a dihedral angle of −116° (i.e. 224° in Figure 3.8a). Unlike the 
U-shaped molecule 3.11, the values of the backbone dihedral angles (f1 and f2, Figure 3.8a) in 
3.12 are closer to the ideal value for the anti conformation (180°), presumably due to the 
absence of syn-pentane interactions between the ester and the carbamate groups.  
To verify the DFT-predicted major conformations of 3.12 in solution, QM/NMR 
analysis was performed using 1H-1H and 1H-13C scalar coupling constants. The NMR 
parameters of the three dominant conformers (3.12-1, 3.12-2 and 3.12-3, Figure 3.8d) were 
computed using the methods described for 3.11 and the corresponding experimental NMR data 
were extracted as described for 3.11. Again, an excellent agreement was observed for the 
comparison between the calculated ensemble-averaged 1H-1H and 1H-13C scalar coupling 
constants and the experimentally determined values (Figure 3.9), therefore indicating that the 
solution-state major conformation of 3.12 is the designed L-shaped conformation.  
 
Figure 3.9: Correlation between the calculated and the experimentally determined 1H-1H and 1H-13C 
scalar coupling constants. Purple dots represent the comparison of 1H-1H scalar coupling constants 
























In summary, QM/NMR analysis showed that both 3.11 and 3.12 have a very high bias 
towards the desired U- and L-shaped conformations. With this encouraging result, remote 





Designing conformationally biased molecules with terminal tert-butyl groups separated 
by four carbon units (Compounds 3.13, 3.86 – 3.99) 
3.2.4 Conformational analysis of 3.13. 
As discussed in section 3.1, the conformational control provided by both terminal 
quaternary centres declines when the two quaternary centres are separated by more than three 
carbon units. (Figure 3.2a). The extent of the loss in conformational control has not yet been 
quantified so the conformational behaviour of 3.13 (Scheme 3.38) was studied computationally. 
 
Scheme 3.38: Terminal tBu groups separated by three (3.10) and four methylene units (3.13). 
A MM Monte Carlo conformational search and DFT calculations were performed on 
3.13 using procedures described previously (section 3.2.2) and found four conformers within 
15.0 kJ mol1 of the global minimum. Two of them have syn-pentane interactions and therefore 
have high relative Gibbs free energies above the global minimum (13.0 and 14.5 kJ mol−1, 
respectively). The other two conformers, 3.13-1 and 3.13-2 (Figure 3.10b and c), have relative 
Gibbs energies within 10.0 kJ mol1 of the global minimum thus dominating the conformer 
population of 3.13.  
Due to the symmetry of 3.13, 3.13-2 also has a degenerate mirror image conformer 
(3.13-3) which was eliminated by the initial MM conformational search. Therefore, 3.13-3 was 
created manually to account for degeneracy in Boltzmann population calculation. 
Compared to the conformational landscape of 3.10 in which conformers with a linear 
backbone heavily populated (100% of global population, Scheme 3.38), the conformer 
population of 3.13 is more complex (Figure 3.10a). Although conformer 3.13-1 (Figure 3.10c) 
with a linear backbone is still the lowest energy conformer (blue dots, Figure 3.10a), it only 
has 63.1% of the global population due to the a small energy difference (DG = 3.1 kJ mol1) 
between this conformer and the next lowest energy conformers (3.13-2 and 3.13-3, Figure 
3.10c) which have backbone dihedral angles of ap g− ap and ap g+ ap. The diminishing 




which suggested that 3.13 should adopt multiple conformations based on the examination of 
nBu4N
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 3.13-1 (ap ap ap) 3.13-2 (ap g− ap) 3.13-3 (ap g+ ap) 
DG/kJ mol−1 0.0 3.1 3.1 
Population 
(298 K) 
63.1% 17.9% 17.9% 
Figure 3.10: a, Chemical structure of 3.13 and the DFT predicted conformational landscape represented 
by a bubble plot. Blue dots represent conformer 3.13-1, red dots represent conformer 3.13-2 and green 
dots represent conformer 3.13-3. b, 3D structure of 3.13-1, 3.13-2 and 3.13-3. c, Major conformers of 
3.13 represented on a diamond lattice together with the corresponding relative Gibbs free energies (DG) 




3.2.5 Conformational analysis of 3.86 and 3.87. 
Next, the possibility of enhancing the conformational bias towards a linear backbone 
conformation by introducing substituents at specific positions with appropriate stereochemistry 
was considered. Since the three lowest energy conformers 3.13-1, 3.13-2 and 3.13-3 dominant 
the conformer population of 3.13 and have a combined population of 98.9%, only these three 
conformers were taken into consideration for the diamond lattice analysis.  
Introduction of a methyl substituent adjacent to the quaternary centre would generate 
3.85 (Figure 3.11a) and induce a destabilising syn-pentane interaction in the conformer with 
backbone dihedral angles of ap g− ap (3.85-2, Figure 3.11b). Although 3.85 should show an 
enhanced bias towards the conformer with a linear backbone (3.85-1, Figure 3.11b), the other 
conformer with backbone dihedral angles of ap g+ ap (3.85-3, Figure 3.11b) would still 
populate to an extent at room temperature due to the lack of destabilising syn-pentane 
interactions. 
 
Figure 3.11: a, Introduction of a methyl substituent to 3.13. b, Predicted conformers of 3.13 and 3.85 
represented on a diamond lattice with syn-pentane interactions highlighted using red arrows. 
To verify the conformational behaviour predicted by diamond lattice analysis of 3.85 




performed on 3.85 using procedures described previously (section 3.2.2). DFT calculations 
predicted that indeed the population of the conformation with a linear backbone (ap ap ap ap, 
Figure 3.12) has increased from 63.1% to 78.9% with the introduction of a methyl group. The 
other conformer which contributes 16.0% to the global population has backbone dihedral 
angles of ap g+ ap (3.85-3, Figure 3.12b and c) as expected based on the diamond lattice 









 3.85-1 (ap ap ap) 3.85-3, (ap g+ ap) 
DG/kJ mol−1 0.0 4.0 
Population (298 K)  78.9% 16.0% 
Figure 3.12: a, Chemical structure of 3.85 and the DFT predicted conformational landscape represented 
by a bubble plot. Blue dots represent conformer 3.85-1, red dots represent conformer 3.85-3 and other 
colour dots represent minor conformers which have a combined population of 5.1%. b, 3D structure of 
3.85-1 and 3.85-3. c, Major conformers of 3.85 represented on a diamond lattice together with the 




If the conformer with backbone dihedral angles of ap g+ ap (for example, 3.85-3, 
Figure 3.12b and c) could be destabilised by the introduction of another substituent, the 
preference to adopt a linear backbone conformation should be further enhanced. The diamond 
lattice analysis (Figure 3.13) suggested that if another substituent (R2) was introduced anti to 
the existing one (R1), this would create 3.86 (Figure 3.13b) and the conformer with backbone 
dihedral angles of ap g+ ap (3.86-2, Figure 3.13b) should be destabilised by a syn-pentane 
interaction between the C-R2 bond and the backbone C-C bond (highlighted in red, Figure 
3.13b). Therefore, 3.86 should have a very strong preference to adopt the conformer with a 
linear backbone (3.86-1, Figure 3.13b). 
In contrast, if the substituent R2 is introduced syn to the existing R1 substituent (Figure 
3.13c), this configuration of R2 would not induce any destabilising syn-pentane interactions 
and therefore 3.87 should have two accessible backbone conformations (3.87-1 and 3.87-2, 
Figure 3.13c) and no strong bias towards either one would be achieved.  
 
Figure 3.13: Introduction of another substituent (R2) anti (3.86) or syn (3.87) to the existing substituent 
(R1). The chemical structure and conformers of 3.85, 3.86 and 3.87 are represented on a diamond lattice 
with the induced destabilising syn-pentane interaction highlighted in red.  
3.2.6 QM analysis of 3.88 and 3.89.  
The synthesis of 3.86 and 3.87 requires the use of the chiral -stannyl neopentyl 




the chiral -stannyl neopentyl benzoates (R)-3.29 generated using the more abundant (+)-
sparteine, conformational analysis and synthesis of the enantiomers of 3.86 and 3.87 (3.88 and 










3.88-1, 3.88-2 and 3.88-3 
(ap ap ap) 
3.88-4 
(g− ap ap) 
3.88-5 
(ap ap −ac) 
DG/kJ mol−1 0, 2.5 and 3.7 respectively 5.5 8.4 
Population 
(298 K) 
88.1%* 5.9% 1.9% 
Figure 3.14: Chemical structure of 3.88 and the DFT predicted conformational landscape represented 
by a bubble plot. Blue dots represent conformer 3.88-1, 3.88-2 and 3.88-3 because they all have a linear 
backbone conformation. Red dots represent conformer 3.88-4 and other colour dots represent minor 
conformers which have a combined population of 6.0%. b, 3D structure of 3.88-1, 3.88-2 and 3.88-3 




together with the corresponding relative Gibbs free energies (DG) and population at 298 K. The 
distorted syn-pentane interactions in minor conformers (3.88-4 and 3.88-5) are highlighted in red. *: 
Combined population of conformer 3.88-1, 3.88-2 and 3.88-3. Hydrogens are omitted for clarity.  
A MM Monte Carlo conformational search and DFT calculations were performed on 
3.88 using procedures described previously (section 3.2.2). The DFT-predicted dominant 
conformers are 3.88-1, 3.88-2 and 3.88-3 (Figure 3.14b and c) and they all possess a linear 
backbone conformation and only differ in the rotation of the pendant methyl ester and 
carbamate groups. In the dominant conformation, the substituents are antiperiplanar to each 
other, creating a ‘Z-shaped’ molecule. 
Compared to 3.85, which has one substituent on the backbone and has 78.9% of 
conformers with a linear backbone conformation, 3.88, which has two substituents on the 
backbone anti to each other, shows a higher preference towards conformations with a linear 
backbone (88.1% population) and this is in line with what was predicted based on the diamond 
lattice analysis (Figure 3.13b). Compared to 3.13, which has no substituent on the backbone, 
the introduction of two substituents adjacent to both quaternary centres in anti configuration 
enhanced the preference towards conformations with a linear backbone by 25%. Although the 
enhancement is substantial, minor conformers such as 3.88-3 and 3.88-4 still populate at room 
temperature (5.9% and 1.9% respectively, Figure 3.14c) because the distorted syn-pentane 
interactions observed in both conformers have a lower energy penalty than for a ‘perfect’ syn-
pentane and are therefore less destabilising.  
In contrast, 3.89 should not have a preference towards a particular conformation based 
on the diamond lattice analysis (Figure 3.13c). To validate this hypothesis, a MM Monte Carlo 
conformational search and DFT calculations were performed on 3.89 using procedures 
described previously (section 3.2.2). Surprisingly, DFT calculations predicted that 3.89 has a 
strong preference (89.6% population) to adopt the conformer with a linear backbone (ap ap ap 
ap, Figure 3.15a). in which the two substituents are gauche to each other (f4~ 60°C, Figure 
3.15a). The DFT prediction contradicts the diamond lattice analysis, suggesting that the 
diamond lattice analysis (Figure 3.13) does not properly account for the effect of bulky, non-















3.89-1, 3.89-2 and 3.89-5 
(ap ap ap) 
3.89-3 and 3.89-4 
(ap g− ap) 




Figure 3.15: Chemical structure of 3.89 and the DFT predicted conformational landscape represented 
by a bubble plot. Blue dots represent conformer 3.89-1, 3.89-2 and 3.89-5 and green dots represent 
conformer 3.89-3 and 3.89-4. Other colour dots represent minor conformers which have a combined 
population of 2.0%. b, 3D structure of 3.89-1, 3.89-2 and 3.89-5 (overlaid) together with 3.89-3 and 
3.89-4 (overlaid). c, Major conformers of 3.89 represented on a diamond lattice together with the 




backbone conformation at 298 K. Hydrogens of conformers 3.89-1, 3.89-2 and 3.89-5 are omitted for 
clarity.   
Summary of sections 3.2.4 – 3.2.6 
As discussed, the conformational control exerted by quaternary centres diminishes with 
increasing chain length. DFT calculations predicted that going from 3.10 to 3.13, the preference 
towards the linear backbone conformation decreased from 100% to 63.1% (Figure 3.10c), 
because the central dihedral (in blue, Scheme 3.9) could adopt either the ap, g+ or g−, 
conformations. 
The conformational bias towards the linear backbone conformation could be restored 
by inducing destabilising syn-pentane interactions with substituents at specific positions with 
suitable stereochemistry. DFT calculations predicted that the introduction of a methyl group 
adjacent to a quaternary centre would increase the bias towards the linear backbone 
conformation from 63.1% to 78.9% (3.85-1, Figure 3.12). The introduction of a second 
substituent based on diamond lattice analysis suggested that while the anti isomer 3.86 should 
preferentially adopt the linear backbone conformation, the syn isomer 3.87 should adopt two 
conformations (Figure 3.13). However, when the methyl substituents were replaced by ester 
and carbamate moieties, DFT calculations predicted that both the anti isomer 3.88 and the syn 






3.2.7 Synthesis of 3.88. 
The Z-shaped molecule 3.88 was synthesised to confirm the DFT-predicted molecular 
conformations. Matteson homologation of boronic ester 3.65 did not go to completion (93-97% 
conversion, Scheme 3.39) but due to time constraints, the Matteson homologation was not 
optimised and the crude material containing boronic esters 3.65 and 3.90 were subjected to 
another lithiationborylation reaction with the R enantiomer of the -stannyl benzoate (R)-3.29. 
The desired boronic ester 3.91 could be isolated from a crude mixture which also contained 
3.11 (U-shaped molecule) by flash column chromatography.  
 
Scheme 3.39: Matteson homologation of boronic ester 3.65 followed by lithiationborylation reaction 
with (R)-3.29 to generate key intermediate 3.91. 
The 1H NMR spectrum of 3.91 is relatively dispersed and 1H-1H scalar coupling 
constants of protons along the backbone (C6 – C9 region, Scheme 3.39) were extracted. The 
magnitude of the experimentally measured 1H-1H scalar coupling constants of 3.91 fits well 
with the magnitude of the designed major conformation (Z-shape) with the benzyl group and 
pinacol boronic ester antiperiplanar to each other (Table 3.1). Therefore, the two substituents 
are far away from each other and no cyclisation reaction should occur between the two ends 





Table 3.1: Predicted major conformation of 3.91 represented on a diamond lattice, together with the 
expected magnitude of 1H-1H scalar coupling constants in the C6 – C9 region and the experimentally 
measured values.  
 
HA HB Magnitude of the expected J values Experimental J values/ Hz 
H9 H8a Small 2.9 
H9 H8b Big 9.2 
H8a H7b Small 4.6 
H8a H7a Big 12.6 
H8b H7b Big 12.0 
H8b H7a Small 4.0 
H6 H7b Big 12.2 
H6 H7a Small 3.4 
 
To verify this hypothesis, boronic ester 3.91 was transformed to the carbamate 3.92 
using the optimised conditions described previously (Scheme 3.40). The benzyl group was 
deprotected in the absence of the second Boc protecting group to yield primary alcohol 3.92. 
Stahl oxidation of primary alcohol 3.93 indeed exclusively yielded aldehyde 3.94, which was 
oxidised and methylated to deliver the Z-shaped molecule 3.88 in good yield (90%). However, 
signal overlap of the methylene protons in 3.88 hindered the extraction of adequate amounts of 
nJHH from the 
1H NMR spectrum to determine the major conformation of the backbone. 
Unfortunately, due to time constraints a full set of DFT NMR calculations of the Z-shaped 
molecule 3.88 was not undertaken and additional NMR experiments such as 1D-TOCSY and 
Accordion-HSQMBC were not performed to record additional nJHH and 
nJHC. Therefore, 
QM/NMR analysis of the Z-shape molecule 3.88 could not be conducted to study its solution-
state conformational behaviour. Nevertheless, the nJHH of the intermediate boronic ester 3.91, 




to adopt the designated Z-shaped conformation. Therefore, the final product 3.88 should also 
adopt the designated Z-shaped conformation. 







Designing conformationally biased molecules with terminal tert-butyl groups separated 
by five carbon units. (Compounds 3.14, 3.95 – 3.105) 
3.2.8 Conformational analysis of 3.14. 
The introduction of another methylene group to 3.13 generates 3.14 (Figure 3.16) which 
should in theory have 32 = 9 possible conformations due to the free rotation of the two central 
bonds (highlighted in blue, Figure 3.16). Only seven out of the nine conformers would be 
populated at room temperature because two of them would be destabilised by syn-pentane 
interactions, indicated by a g+ dihedral angle followed by a g− dihedral angle.  
 
Figure 3.16: Terminal tBu groups separated by three (3.10), four (3.13) and five methylene units (3.14). 
A MM Monte Carlo conformational search and DFT calculations were performed on 
3.14 using procedures described previously (section 3.2.2). It was found that three conformers 
(3.14-1, 3.14-4 and 3.14-6, Figure 3.17) have relative Gibbs free energies (DG) within 
10 kJ mol−1 of the global minimum. Again, degenerate conformers (3.14-2, 3.14-3, 3.14-5 and 
3.14-7, Figure 3.17) were generated manually for the accurate description of conformer 
population.  
When there are five methylene groups between the terminal tert-butyl groups, the 
preference for a particular conformation decreases to less than 40%. Although conformer 
3.14-1 with a linear backbone conformation is still the global minimum (Figure 3.17), it only 
has 37.6% population and the conformer population is even more complex. Therefore, it is 
more challenging to restore conformational control in 3.14-type scaffold in which the two 












3.14-1, (ap ap ap ap)









 3.14-2 3.14-3 3.14-4 
 (ap g+ap ap) (ap g− ap ap) (ap ap g+ ap) 
DG/kJ mol−1 2.63 2.63 2.63 
Population 
(298 K) 







 3.14-5 3.14-6 3.14-7 
 (ap ap g
− ap) (ap g+ g+ ap) (ap g− g− ap) 
DG/kJ mol−1 2.63 5.38 5.38 
Population 
(298 K) 




Figure 3.17: Chemical structure of 3.14, the DFT predicted conformational landscape represented by a 
bubble plot, 3D structures of major conformers of 3.14 and the corresponding relative Gibbs free 
energies (DG) and population at 298 K for each conformer. Different colour dots represent conformers 





3.3.9 Conformational analysis of compounds 3.95 – 3.105 
Imposing conformational bias in an even longer, five-carbon chain was investigated. 
The seven low energy conformations (3.14-1 – 3.14-7, Figure 3.17) were considered in the 
initial diamond lattice analysis of 3.14 (Figure 3.18). Although the introduction of a methyl 
group adjacent to the quaternary centre induces destabilising syn-pentane interactions in two 
conformers with backbone conformations of ag+aa and ag+g+a (3.95-2 and 3.95-6 
respectively, Figure 3.18b), the other seven conformers do not possess such destabilising 
interactions, thus will still populate substantially at room temperature. Therefore, based on 









3.95-1 3.95-2 3.95-3 3.95-4 
(ap ap ap ap) (ap g+ ap ap) (ap g− ap ap) (ap ap g+ ap) 





3.95-5 3.95-6 3.95-7  
(ap ap g− ap) (ap g+ g+ ap) (ap g− g− ap)  
√ × √  
Figure 3.18: a, Chemical structure of 3.95. b, Diamond lattice analysis of the seven potential 
conformers of 3.95. Destabilising syn-pentane interactions induced by the introduction of a methyl 
group were highlighted using red arrows.  
To destabilise more conformations, another methyl group was introduced adjacent to 




introduction of the second methyl group syn to the existing one induces destabilising syn-
pentane interactions in four out of seven conformations (3.96-2, 3.96-5, 3.96-6 and 3.96-7, 
Figure 3.19). Therefore, 3.96 should show a higher bias towards a particular conformation 








3.96-1 3.96-2 3.96-3 3.96-4 
(ap ap ap ap) (ap g+ ap ap) (ap g− ap ap) (ap ap g+ ap) 





3.96-5 3.96-6 3.96-7  
(ap ap g− ap) (ap g+ g+ ap) (ap g− g− ap)  
× × ×  
Figure 3.19: a, Chemical structure of 3.96. b, Diamond lattice analysis of the seven potential 
conformers of 3.96. Destabilising syn-pentane interactions induced by the introduction of methyl groups 
were highlighted using red arrows. 
To further enhance the conformational bias of 3.96, another methyl group was 
introduced in the centre of the chain (3.97, Figure 3.20). The introduction of the central methyl 
group anti to the existing ones should induce destabilising syn-pentane interactions in the 
conformers with backbone dihedral angles of ap g− ap ap and ap ap g+ ap. As a result, 
conformers 3.97-3 and 3.97-4 (Figure 3.20) should no longer populate at room temperature and 
therefore 3.97 would have a very strong preference (>80% of population) to adopt the 










3.97-1 3.97-2 3.97-3 3.97-4 
(ap ap ap ap) (ap g+ ap ap) (ap g− ap ap) (ap ap g+ ap) 




3.97-5 3.97-6 3.97-7  
(ap ap g− ap) (ap g+ g+ ap) (ap g− g− ap)  
× × ×  
Figure 3.20: a, Chemical structure of 3.97. b, Diamond lattice analysis of the seven potential 
conformers of 3.97. Destabilising syn-pentane interactions induced by the introduction of methyl groups 
were highlighted using red arrows.  
To verify the conformational behaviour of 3.97 predicted by diamond lattice analysis, 
conformational analysis of the analogue 3.98 (Figure 3.21) with the peripheral methyl groups 
replaced by ester and carbamate moieties were studied using the MM Monte Carlo 
conformational search and DFT methods as discussed previously (section 3.2.2). DFT 
calculations predicted that indeed conformers with a linear backbone (3.98-1 and 3.98-3, Figure 
3.21) dominate the conformer population of 3.98 with a combined population of 93.5%. The 
ester and carbamate groups are approximately syn periplanar to each other with a dihedral angle 
around −20°. Compared to 3.14 which has no substituents on the backbone and has 37.6% of 
conformers adopting the linear backbone conformation, the introduction of three substituents 
increases the preference to adopt the conformation with a linear backbone by 55.9% (3.98, 




The first dihedral angle of the backbone (f1) in the minor conformer 3.98-2 is +148° 
and this deviates from the ideal angle of 180° if the first bond would adopt an antiperiplanar 
conformation. As a result, the syn-pentane interaction observed between the CC bond of the 
substituent and that of the backbone would have a smaller energetic penalty than expected thus 











   
 3.98-1 3.98-2* 3.98c-3 
 (ap ap ap ap) (+ac g+ ap ap) (ap ap ap ap) 
DG/kJ mol−1 0 7.2 9.6 
Population 
(298 K) 
91.6% 5.0% 1.9% 
Figure 3.21: a, Chemical structure of 3.98 and the DFT predicted conformational landscape represented 
by a bubble plot. Blue dots represent conformer 3.98-1 and c because they all have a linear backbone 
conformation (ap ap ap ap). Purple dots represent conformer 3.98-2 and other colour dots represent 




3.98-3. c, 3D structure of 3.98-1, 3.98-2 and 3.98-3. d, Major conformers of 3.98 represented on a 
diamond lattice together with the corresponding relative Gibbs free energies (DG) and population at 
298 K. *: Conformer 3.98-2 could not be truly represented on a diamond lattice because the first dihedral 
angle deviates from the ideal angle for an sp3 carbon atom so the diamond lattice representation is for 
visualisation purpose only. The distorted syn-pentane interactions in conformer 3.98-2 is highlighted 
using a red arrow.  
The conformational landscape of the diastereomer 3.99 with two peripheral methyl 
groups in anti configuration was also considered (Figure 3.22). Based on the diamond lattice 
analysis, four out of seven conformers would still populate substantially at room temperature 







3.99-1 3.99-2 3.99-3 3.99-4 
(ap ap ap ap) (ap g+ ap ap) (ap g− ap ap) (ap ap g+ ap) 





3.99-5 3.99-6 3.99-7  
(ap ap g− ap) (ap g+ g+ ap) (ap g− g− ap)  
√ × √  
Figure 3.22: a, Chemical structure of 3.99. b, Diamond lattice analysis of the seven potential 
conformers of 3.99. Destabilising syn-pentane interactions induced by the introduction of methyl groups 
were highlighted using red arrows.  
In addition to introducing substituents to the positions adjacent to the quaternary centres, 




the methyl groups of the isopropyl group are free to rotate, in some conformers no matter what 
position the isopropyl group adopts, there will be an unavoidable syn-pentane interaction.  
Therefore, these conformations will be destabilised regardless of the exact position the 
isopropyl group since there will always be a methyl occupying a suitable position to induce the 
destabilising syn-pentane interactions. For example, the conformer with a linear backbone 
(3.100-1, Figure 3.23) will be destabilised by at least one syn-pentane interactions and the same 
logic also applies to conformer 3.100-2 and 3.100-4. The remaining four conformations (3.100-
3, 3.100-5, 3.100-6 and 3.100-7) could all in theory accommodate the isopropyl group without 
any destabilising syn-pentane interactions, however it is unclear whether they would populate 
heavily at room temperature because the rotation of the isopropyl group could still induce 







3.100-1 3.100-2 3.100-3 3.100-4 
(ap ap ap ap) (ap g+ ap ap) (ap g− ap ap) (ap ap g+ ap) 




3.100-5 3.100-6 3.100-7  
(ap ap g− ap) (ap g+ g+ ap) (ap g− g− ap)  
× ? ?  
Figure 3.23: a, Chemical structure of 3.100. b, Diamond lattice analysis of the seven potential 
conformers of 3.100. Destabilising syn-pentane interactions induced by the introduction of the isopropyl 




The conformational distribution of the enantiomer 3.101 was also analysed (Figure 3.24) 
and found to be same to that of 3.100. Although both 3.100 and 3.101 are meso compounds 
and are therefore equivalent, their conformations were considered separately because 
subsequent combination of 3.99 and 3.100 (page 153-154) required the change in 







3.101-1 3.101-2 3.101-3 3.101-4 
(ap ap ap ap) (ap g+ ap ap) (ap g− ap ap) (ap ap g+ ap) 





3.101-5 3.101-6 3.101-7  
(ap ap g− ap) (ap g+ g+ ap) (ap g− g− ap)  
? ? ?  
Figure 3.24: a, Chemical structure of 3.101. b, Diamond lattice analysis of the seven potential 
conformers of 3.101. Destabilising syn-pentane interactions induced by the introduction of the isopropyl 
group were highlighted using red arrows.  
Based on the diamond lattice analysis of 3.99, 3.100 and 3.101, one would expect that 
the combination of these scaffolds would lead to the generation of molecules with a single 
dominant conformation. For example, the combination of 3.99 and 3.100 would generate 3.102 
(Figure 3.25a). Unfavourable backbone conformations of 3.99 predicted by diamond lattice 
analysis (3.99-2 and 3.99-4, Figure 3.22) should be unfavourable in 3.102. Therefore, for 3.102 




Similarly, unfavourable conformations of 3.100 predicted by diamond lattice analysis (3.100-
1, 3.100-2 and 3.100-4) again should also be unfavourable in 3.102. Therefore, on top of 
conformers with backbone dihedral angles of ap g+ ap ap and ap ap g+ ap, conformers with 
backbone dihedral angles of ap ap ap ap would also be disfavoured in 3.102.  
Therefore, only three types of conformer with backbone dihedral angles of ap g− ap ap, 
ap ap g− ap and ap g− g− ap needs to be considered for the diamond lattice analysis (Figure 
3.25). The combination of the terminal methyl groups with the central isopropyl group creates 
syn-pentane interactions between the substituents and this leads to the destabilisation of 
conformers 3.102-5 and 3.102-7. As a result, 3.102 should have a very high preference to adopt 







3.102-3 3.102-5 3.102-7 
(ap g− ap ap) (ap ap g− ap) (ap g− g− ap) 
√ × × 
Figure 3.25: a, Chemical structure of 3.102. b, Three potential conformers considered for the diamond 
lattice analysis of 3.102.  
To verify the conformational behaviour of 3.102 predicted by diamond lattice analysis, 
conformational analysis of the analogue 3.103 (Figure 3.26) with the methyl substituents 
replaced by ester and carbamate moieties was performed using the MM Monte Carlo 
conformational search and DFT calculations as described previously (section 3.2.2). DFT 
calculations predicted that indeed conformations with backbone dihedral angles of ap g− ap ap 
(Figure 3.26b, c and d) dominate the conformer population of 3.103 with a combined 
population of 97.3%. The ester and carbamate groups are syn to each other with dihedral angles 
in the range from −20° to −45°. The enhancement of conformational preference observed in 




anti relationship. Compared to 3.14, which has no substituents on the backbone and only has 
13.0% of conformers adopting the conformation with backbone dihedral angles of ap g− ap ap, 
the introduction of substituents increases the preference to adopt conformations with backbone 











 3.103-1 and 3.103-2 3.103-3 and 3.103-6 3.103-4, 3.103-8 
 (ap g− ap ap) 
DG/kJ mol−1 
0 and 2.1 
respectively 
3.1 and 10.7 
respectively 
8.3 and 11.7 respectively 
Population 
(298 K) 
78.7% 16.2% 2.4% 
Figure 3.26: Chemical structure of 3.103 and the DFT predicted conformational landscape represented 
by a bubble plot. Conformers adopting similar backbone conformations (ap g− ap ap) but differ in the 
rotation of substituents are represented in different shades of orange dots. Green dots represent minor 




3.103-3, 3.103-4, 3.103-6 and 3.103-8. c, 3D structure of 3.103-1 and 3.103-2 (overlaid), 3.103-3 and 
3.103-6 (overlaid) together with 3.103-4 and 3.103-8 (overlaid). d, Major conformers of 3.103 
represented on a diamond lattice together with the corresponding relative Gibbs free energies (DG) and 
population at 298 K. The syn-pentane interactions in conformer 3.103-4 and 3.103-8 are highlighted 
using a red arrow.  
If 3.99 is combined with 3.101 instead, this would generate 3.104. Again, the 
unfavourable conformations observed in both 3.99 and 3.101 would also be disfavoured in 
3.104. This led to the consideration of the remaining two accessible conformations with 
backbone dihedral angles of ap ap g− ap and ap g− g− ap (3.104-5 and 3.104-7, respectively, 







(ap ap g− ap) (ap g− g− ap) 
√ × 
Figure 3.27: a, Chemical structure of 3.104. b, Two potential conformers considered for the diamond 
lattice analysis of 3.104.  
To verify the conformational behaviour of 3.104 predicted by the diamond lattice 
analysis (Figure 3.27), conformational analysis of the analogue 3.105 (Figure 3.26) with the 
methyl substituents replaced by ester and carbamate moieties were studied using the MM 
Monte Carlo conformational search and DFT calculations as described previously (section 
3.2.2). DFT calculations predicted that indeed conformations with backbone dihedral angles of 
ap ap g− ap dominate the conformer population of 3.105 with a combined population of 87.2%. 
The ester and carbamate groups are syn to each other with the dihedral angle (f5, Figure 3.28a) 

















3.105-3, and 3.105-4 
3.105-5 and 3.105-8 3.105-9 
 (ap ap g− ap) (ap g− g− ap) 
DG/kJ mol−1 
0.0, 0.8, 1.9 and 1.9 
repectively 





80.4% 6.8% 1.5% 
Figure 3.28: a, Chemical structure of 3.105 and the DFT predicted conformational landscape 
represented by a bubble plot. Conformers 3.105-1, 3.105-2, 3.105-3, 3.105-4, 3.105-5 and 3.105-8 have 
very similar backbone conformation and only differ in the rotation of the substituents and the dihedral 




Blue dots represent minor conformers 3.105-9 and the rest of the dots represent minor conformers which 
have a combined population of 11.3%. b, Overlay of conformers 3.105-1, 3.105-2, 3.105-3, 3.105-4, 
3.105-5 and 3.105-8. c, 3D structure of 3.105-1, 3.105-2, 3.105 -3, 3.105-4 (overlaid), 3.105-5, 3.105 -
8 (overlaid) and 3.105-9. d, Conformers of 3.105 represented on a diamond lattice together with the 
corresponding relative Gibbs free energies (DG) and population at 298 K. The syn-pentane interactions 
in conformer 3.105-9 is highlighted using a red arrow. 
Unlike the exquisite conformational preference (97.3% population of a single backbone 
conformation) observed in 3.103, 3.105 shows a slight reduced preference towards the designed 
conformation (87.2% population, Figure 3.28). This is because other conformations, which do 
not have ideal angles of a sp3 carbons (109.5°), were not considered in the initial diamond 
lattice analyses and were ultimately found to populate to some extent by DFT calculations (e.g. 
1% population each). In addition, although the qualitative diamond lattice analysis (Figure 3.27) 
suggested that conformers with backbone dihedral angles of ag−g−a should be destabilised by 
a syn-pentane interaction, DFT calculations predicted that such conformers (3.105-9, Figure 
3.28c and d) would have a population of 1.5%, which is higher than what was expected. 
Therefore, the qualitative diamond lattice analysis failed to provide a quantitative 
representation of how destabilising the induced syn-pentane interaction would be when the 
methyl substituents were replaced by other groups. 
Summary of section 3.2.8 and 3.2.9. 
As discussed, when the two terminal quaternary centres are separated by five methylene 
groups (3.14, Figure 3.16), the conformational preference towards a particular conformation 
was less than 40% and the conformer population became more complex (Figure 3.17). Again, 
by inducing destabilising syn-pentane interactions, 3.98, 3.103 and 3.105 were designed and 
they all have strong the conformational preference (>87% population) towards a single 
backbone conformation with the substituents pointing towards the same face (i.e. U-shaped 
molecules) were designed. All the U-shaped molecules designed so far shows different 
distances between the ester and carbamate substituents, ranging from 2.57 – 5.13 Å as figure 




























3.3. Conclusions and Future work 
3.3.1 Conclusions 
In summary, a unidirectional synthetic approach based on lithiationborylation 
methodology was developed to prepare the U-shaped (3.11), L-shaped (3.12) and Z-shaped 
(3.88) molecules. The solution-state behaviour of both the U-shaped (3.11) and L-shaped (3.12) 
molecules were studied using a QM/NMR approach with 1H-1H and 1H-13C scalar coupling 
constants. It was found that both 3.11 and 3.12 have a very high preference to adopt the 
designed conformation with >99% of global population.  
Remote conformational control using quaternary centres at both ends of a linear chain 
was explored. Although DFT calculations showed that the conformer population of 3.13 and 
3.14 are complex, the conformational preference towards a single backbone conformation 
could be restored by introducing substituents at specific positions with appropriate 
stereochemistry. Based on the principle of inducing destabilising syn-pentane interactions, 
several molecules with tailored conformations (Table 3.2) were designed using a combination 
of diamond lattice analysis and MM/DFT calculations. Although the diamond lattice analysis 
was found to be sufficient to predict the preference of molecular conformations in a qualitative 
way in most cases, it does not take into account the impact of bulky substituents (such as a Boc 
protecting group) and this may lead to contradictive prediction of conformational behaviour of 













Table 3.2: A list of molecules designed with tailored conformations as discussed.  













3.3.2 Future work 
Although the major conformations of the U-shaped (3.11) and L-shaped (3.12) 
molecules were confirmed by QM/NMR analysis using 1H-1H and 1H-13C scalar coupling 
constants, quantitative NOE analysis to gain detailed insight of the conformational landscapes 
of both molecules were not performed due to the complications arising from rotamers. If one 
could develop a method for the quantitative NOE analysis using conformationally defined 
molecules (i.e. 3.11 and 3.12), this methodology could be applied to study the conformational 
behaviour of other small molecules which have carbamate rotamers.  
While the Z-shaped molecule 3.88 was synthesised, the QM/NMR analysis was not 
performed due to time constraints. Therefore, QM/NMR analysis is required to verify the DFT 
predicted major conformations of 3.88. In addition, the synthesis and QM/NMR analysis of 
both 3.99 and the corresponding free amine are required to determine whether the introduction 
of a bulky substituent (i.e. NHBoc) has indeed enhanced the conformational preference of the 
molecule as DFT calculations predicted. To confirm the DFT predicted U-shaped molecules 
with tuneable distances between the substituents, the synthesis and QM/NMR analysis of 3.98, 
3.103 and 3.105 are required.  
After the synthesis and QM/NMR analysis of all molecules designed up to date, their 
use as linker units in bifunctional small-molecule protein degraders, known as PROteolysis 
TArgeting ChimeraS (PROTACs), will be explored. A functional PROTAC for selective 
protein degradation contains three components (Scheme 3.41a): a small-molecule ligand which 
binds to the target protein of interest (in blue, Scheme 3.41a), another small-molecule ligand 
which binds to an E3 ubiquitin ligase (in purple, Scheme 3.41a), and a linker unit (in pink, 
Scheme 3.41a) which connects the two ligands. Upon binding of a PROTAC with both the 
target protein and an E3 ligase, the formation of new proteinprotein interactions between the 
target protein and the E3 ubiquitin ligase enables the ubiquitin tagging and subsequent 
proteasomal degradation of the target protein of interest.145  
While several small-molecule ligands have been developed to engage both target 
proteins of interest and E3 ubiquitin ligase, no studies were performed to study the relationship 
between the conformations of the linker and the efficiency of PROTAC for selective protein 
degradation. Therefore, the incorporation of molecules with defined conformations, such as the 
ones discussed in this chapter, would offer valuable insight into the role of linker conformations 




3.106 (Scheme 3.41a) could be replaced by an analogue of Z-shaped molecule (3.88, Figure 
3.14) to generate another PROTAC analogue 3.107. This analogue will not only allow one to 
study the conformational integrity of the linker unit when the substituents are large, but also to 
gain insight of the relationship between the linker conformation(s) and the physiochemical 
properties as well as potency of the PROTAC.  
 
Scheme 3.41: a, Literature reported PROTAC 3.106.146 b, a PROTAC analogue 3.107 with 




Chapter 4 Investigation of factors controlling the helical screw-
sense preference of all-syn methyl-substituted hydrocarbons  
This project was conducted in collaboration with Johan A. Pradeilles who performed all the 
synthetic work and proposed the theoretical models (in section 4.2.1 and 4.2.4). The models 
and parts of the synthetic work are included to provide a complete picture of the research. 
4.1. Introduction and project outline. 
Helical structures, such as double-stranded DNA and -helical peptides, are prevalent 
in Nature. For biopolymers, the formation of helical conformation does not only allow the 
efficient packing of genetic information,147 as in DNA, but also displays functional groups at 
specific orientations, in the case of -helical peptides, to maximise their interactions with other 
biological targets to regulate cellular functions.148 Chemists have also designed, synthesised 
and studied non-peptidic helical molecules to take advantage of their chirality to induce 
asymmetry in organic synthesis149 and to utilise their predictable molecular conformation for 
the development of chemical probes and inhibitors for interrogation and regulation of 
biological function of proteins150. 
Most of the non-peptidic helical scaffolds, such as achiral polyisocyanates, polysilanes 
and polyacetylenes, form equal populations of left-handed (M type) and right-handed (P type) 
helices. These helical polymers have low helix inversion barriers and therefore the M and P 
helices rapidly interconvert and exist as a dynamic mixture in solution.151 Since the helical 
screw-sense (M or P helices) of helical scaffolds dictates molecular function, reversible 
interconversion between M and P helices in dynamic helical scaffolds, either via the change of 
solvent or other external stimuli such as light, allows modulation of molecular function.  
For achiral helical scaffolds, the addition of chiral units induces a preference towards 
the M or P screw-sense. Suginome et al. have demonstrated the use of a chiral polyquinoxaline-
based phosphine ligand (4.1), which folds into either the M or P helix depending on the choice 
of solvent, in the palladium catalysed asymmetric hydrosilylation of styrenes (Figure 
4.1).152When the hydrosilylation reaction (Figure 4.1) was performed in chloroform, chiral 
ligand 4.1 adopted a P helical conformation and the reaction gave product in good yield with 
very high enantioselectivity (93% yield and 93% ee, Figure 4.1). When the screw-sense of 4.1 
was inverted from P to M by heating at 60°C in a 2:1 mixture of 1,1,2-tetrachloroethane (TCE) 




mixture of 1,1,2-TCE and toluene gave product in the opposite configuration with similar yield 
and enantioselectivity.  
 
Figure 4.1: Solvent induced helical switch of a polyquinoxaline-based phosphine ligand (4.1), which 
can be used as a chiral ligand for a palladium catalysed hydrosilylation of styrene.  
Clayden et al. have shown the use of a photoswitchable azobenzene moiety to control 
the helicity of a poly(aminoisobutyric acid) backbone, difluoroAiB (4.2, Figure 4.2), in lipid 
membranes.153 The population distribution between the M and P helices was quantified by the 
difference in chemical shifts of the diastereotopic fluorine atoms at the C-termini in the fast 
exchange regime (ie. at a rate of greater than 6000 s−1 for this particular example153). When the 
azo unit adopted an E configuration, 4.2 preferentially folded into the M helix ((E,M)-4.2) with 
approximately 60-65% population. Upon irradiation using an LED with a wavelength of 365 
nm, the azo unit isomerised from the E to Z configuration and this altered the geometry of the 
hydrogen bonding network along the polymer backbone, leading to a “more equal population” 
of M and P helices.153 Subsequent irradiation using an LED with a wavelength of 455 nm 
isomerised the azo unit from the Z back to E configuration, restoring the conformational 






Figure 4.2: Light induced helical switch of difluoro AiB 4.2.153 
As discussed in the introduction (Sections 1.1, 1.3.3 and 1.5, Chapter 1), the Aggarwal 
group has developed the synthesis of hydrocarbons with 10 contiguous methyl substituents. 
The all-syn isomer 1.10 was shown to adopt a helical conformation. It was found that the 
preferred screw-sense of the all-syn isomer depends on the environment and the size of the end-
group. In the solution state, alcohol 1.10 was found to be a right-handed (P) helix, whereas in 
the solid state the para-nitrobenzoate derivative of 1.10 was found to be a left-handed (M) 
helix.8 The different helical screw-sense observed indicated the possibilities of developing a 
new class of helical scaffold which could reversibly switch between the M and P helical forms 
by chemical modification of the end groups. Although crystal packing was thought to control 
the helicity of the benzoate derivative of 1.10 in the solid state, the relationship between the 
nature of the end groups (ie. para-nitrobenoate and alcohol moieties) and the observed helical 
screw-sense was unclear in solution state.  
A model which predicts the helical screw-sense based on the steric effect of the end 
groups was proposed by Huc et al..154 The helical screw-sense of a series of achiral quinoline-
derived oligoamide foldamers with different end groups was studied using a combination of 
X-ray crystallography, NMR and circular dichroism spectroscopy. It was found that the 
introduction of a chiral end group, such as the (R) enantiomer of -methylbenzylamine (Figure 
4.3a) induced the oligoamide foldamer to preferentially adopt the M helical form with an M to 
P helical population ratio of 10 to 1. Examination of the X-ray crystal structures of 4.3 and 
other oligoamide foldamers with different end groups revealed that, for the chiral centre at the 
end group, the large group (aryl) pointed away from the helix, the medium group (methyl) 




the chiral centre was assigned based on steric criteria (Rs, Ss) with the largest substituents 
having the highest priority (helix > aryl > methyl > H), rather than using the usual 
CahnIngoldPrelog rules, it was found that oligoamide foldamers with Rs centres at the 
terminal group always adopted the M helical form, whereas the ones with Ss centres at the 
terminal group always adopted the P helical form.154  
 
Figure 4.3: a, Chemical structure of quinoline derived oligoamide 4.3 with a chiral end group which 
has Rs configuration. b, Huc’s model.154 
Although the model proposed by Huc et al. offered insights into the relationship 
between the steric effect of the chiral end group and the preferred helical screw-sense of the 
achiral backbones of the quinoline-derived oligoamide foldamers, it could not be directly 
applied to the analysis of the all-syn isomer 1.10, which has a chiral hydrocarbon backbone, 
which might dictate the inherent preference towards a particular helical screw-sense.  
Therefore, a new model is required to establish the relationship between the 
configuration of all-syn methyl-substituted hydrocarbons and any inherent preference of the 
helical screw-sense. To validate the proposed model, such a hydrocarbon will be designed, 
synthesised and its preferred helical screw-sense in solution state will be studied using the 
QM/NMR approach. Having established the inherent preference, the relationship between the 
nature of the end group and the preferred helical screw-sense will be studied to enable the 
design and preparation of a hydrocarbon-based system with reversible switching between the 






4.2 Results and Discussion 
4.2.1 Theoretical model for predicting the preferred helical screw-sense.  
Mr. Johan A. Pradeilles proposed that the minimisation of gauche interactions 
controlled the helicity of 4.4 (Figure 4.4a) in the solution state. In the case of both the M and P 
helices (Figure 4.4b), three gauche interactions occur between the non-hydrogen substituents 
for an ap backbone dihedral angle, whereas only two gauche interactions occur for both g+ and 
g– backbone dihedral angles. (Figure 4.4c) The total numbers of gauche interactions between 
non-hydrogen substituents can then be counted for both M and P helices. It was found that M 
helix 4.4-1 has 23 gauche interactions whereas the P helix 4.4-2 only has 22 gauche 
interactions. Therefore, the P helix 4.4-2 is lower in energy, thus dominating the conformer 
population of 4.4 in solution.  
 
Figure 4.4: a, Chemical structure of 4.4. b, M and P helices (4.4-1 and 4.4-2, respectively) represented 
on a diamond lattice with the corresponding dihedral angle sequences of the backbones and the total 
number of gauche interactions between the non-hydrogen substituents. c, Newman projections 




respectively) of the M helix together with the first bond (adopting g− conformation) of the P helix. 
Gauche interactions between non-hydrogen substituents are highlighted in red.  
4.2.2 QM/NMR analysis of compounds with even numbers of contiguous methyl 
substituents (4.5, 4.9 and 4.10)  
To validate the model proposed by Mr. Johan A. Pradeilles, a C2 symmetric compound 
4.5 (Scheme 4.1) bearing alkyne moieties as small non-hydrogen end groups were designed as 
the model compound for the QM/NMR analysis. Synthesis of 4.5 started from a rhodium-
catalysed asymmetric diboration155 of trans-butene to deliver the 1,2-(bis boronic ester) 4.6 in 
perfect enantioselectivity. Bidirectional homologation of the 1,2-(bis boronic ester) 4.6 with 
the enantioenriched carbenoid (R)-1.69 and then (S)-1.69 generated from the corresponding 
stannyl compounds via tinlithium exchange gave the homologated bis boronic ester 4.7, 
which was converted to the target compound 4.5 using an alkynylation procedure developed 
by the Aggarwal group.156  
 
Scheme 4.1: Synthesis of target model compound 4.5. nbd, nobornadiene; acac, acetylacetonate; cat, 
catacolato; pin, pinacolato; TIB, 2,4,6-triisopropylbenzoyl; LDA: lithium diisopropylamide. 
4.2.2.1 Analysis of experimental 1H-1H scalar coupling constants.  
With the compound in hand, the NMR analysis of 4.5 was investigated. The 
experimental measurements of nJHH values from the 1D 
1H NMR spectrum was straight 
forward for most of the protons, except the ones closest to the symmetry axis bisecting the 
molecule due magnetic inequivalence. For example, in 4.5 (Figure 4.5a) proton H11 and H13 
are chemically equivalent and have the same chemical shifts. However, 3JH11-H9 is different 
from 4JH13-H9, thus H11 and H13 are magnetically inequivalent to each other. The H11/H13 signal 




accurately using the spin simulation module implemented in MestreNova (Figure 4.5b). This 
is due to the high sensitivity of the line shape to the H11-H13 coupling, as well as the D of the 
magnetically inequivalent nuclei. Although J coupling values of symmetry related protons can 
be extracted from signals of rare isotope satellites (for example 13C)157, in the case of 4.5 the 
satellites of the H11/H13 peak are overlapped with other signals in the spectrum, therefore the 
coupling constant between H11 and H13 was not extracted and the dihedral relationship between 




Figure 4.5: a, Structure of 4.5, with H11, H9 and H13 highlighted as A, B’ and A’. b, Experimental 1H 
NMR spectrum showing the H11/H13 multiplet in red, and the spin-simulated multiplet in black.  
4.2.2.2 Analysis of the experimental 1H-1H NOE-distances.  
Before the determination of NOE-distances using correlations obtained from 1D NOE 
spectra, the analysis of NOE-distances was first considered because special considerations 
must be taken of the symmetry-breaking NOEs in C2 symmetric and meso compounds. For 
example, in the case of 4.5 (Figure 4.6a), the inter-subunit correlation between H7 and H11 (HA-
HB, Figure 4.6c) could not be distinguished from the intra-subunit correlation between H7 and 
H13 (HA-HB’, Figure 4.6c), because both H11 (HB) and H13 (HB’) are chemically equivalent so 
both H7-H11 and H7-H13 correlations are observed at the same chemical shift (Figure 4.6b). 
Since H7 and H17 are chemically equivalent, irradiation of H7 also irradiates H17. As a result, 
the observed NOE correlation upon irradiation of H7 and H17 (HA and HA’) consists of the 
following four components: H7-H11 (HA-HB), H7-H13 (HA-HB’), H17-H11 (HA’-HB) and H17-H13 











Figure 4.6: a, Chemical structure of 4.5, with irradiated proton highlighted in blue. b, A schematic 1D 
NOE spectrum showing correlation between HA and HB. c and d, The four components which could 
contribute to the experimentally observed NOE correlation between HA and HB. 
Appropriate treatment of the contributions arising from the four components towards 
an experimentally observed NOE signal is crucial for accurate conformational analysis, 
especially in determining the ratio between M and P helices. For example, in the case of 4.5, 
the DFT computed interproton distances (discussed in more details in section 4.2.2.4.1) 
between H7 and H11 (HA-HB) in both the M and P helices are around 3.3 Å (Figure 4.7). If only 
this distance was considered in conformational analysis, one would expect both helical 
conformers contribute equally to the experimentally observed NOE correlation intensity. 
However, the interproton distance between H7 and H13 (HA-HB’), the latter being chemically 
equivalent to H11, is 2.13 Å in M helix and 4.47 Å in P helix. Therefore, if M helix populates 
to some extent (>3% population), it would contribute more to the NOE correlation intensity 






H Hx DFT computed ensemble-averaged distances/ Å 
H7 (HA) H11 (HB) 3.33 3.31 
H7 (HA) H13 (HB’) 2.13 4.47 
Figure 4.7: Diamond-lattice representation of both the M and P helices of 4.5, together with the 
respective interproton distances between H7-H11 and H7-H13 computed using B3LYP-D2 6-311G(d) 
optimised geometries with corresponding conformer energies corrected by the mean of single point 
energy calculations using a larger basis set (6-311G(d,p)) and implicit toluene (IEFPCM).  
Although the contribution of symmetry-breaking NOEs becomes more significant in 
the core of the molecule, the exact contributions of the individual components (HA-HB, HA’-
HB, HA’-HB’, HA-HB’) towards a given observable correlation is unknown apriori, and thus 
requires some knowledge of the conformational landscape of the molecule. Therefore, the 
experimentally observed NOE correlations, which consist of some combinations of all four 
individual components outlined above, were converted into ‘effective’ distances158 for 
quantitative comparison without averaging using equation 1.3 (Chapter 1, section 1.2.3). The 
reference distance (𝑟𝑟𝑒𝑓) was chosen to be the distance between H3 and H4, which is insensitive 
to change in molecular conformation. 
The experimental NOE signal intensities ( 𝜂𝑁𝑂𝐸 ) were derived from either 1D DPFGSE 
NOESY or CSSF-NOESY spectra. Values of PANIC corrections (discussed in Chapter 1, 
section 1.2.3) were chosen to account for the difference in the observed NOE intensities 
between a proton (for example, a CH group) and a methyl group when either the proton or the 
methyl group were irradiated. If a proton was irradiated and a correlation between this proton 
and a near-by methyl group was observed (CH→CH3), the three equivalent protons of the 




the same methyl group was irradiated and the above-mentioned correlation between this methyl 
group and the proton was observed (CH3→CH), the observed NOE signal intensity in this case 
would only arise from a single proton. Therefore, if the PANIC integration for both the proton 
(CH group) and the methyl group were set arbitrarily to the same value (e.g. 1000 for both), 
the resultant integrations for the same CH-methyl correlation would have different values, with 
the CH→CH3 correlation being three times stronger than the CH3→CH. The integration of the 
CH→CH3 correlation could be divided by three to match that of the CH3→CH correlation in 
order to weight average the three distances between the CH to each of the equivalent proton of 
the methyl group.8,159. To reduce confusion during the Boltzmann weighted averaging process 
in this study, rather than divide the resultant NOE correlation intensity by the number of 
equivalent spins which give rise to the signal, the PANIC integration was adjusted accordingly 
based on the total number of protons being irradiated in a NOE experiment.  
When two protons were irradiated, such as the equivalent CHs in 4.5, the PANIC 
integration of the irradiated peak was arbitrarily set to 2000. When six protons were irradiated, 
such as the equivalent methyl groups in 4.5, the PANIC integration of the irradiated peak was 
arbitrarily set to 6000. (Table 4.1) 
Table 4.1: A summary of PANIC integration values used in the study of C2 symmetric compound 4.5. 
Protons being irradiated are highlighted in blue.  
Protons being irradiated 
Number of protons  
being irradiated 










4.2.2.3 Computational modelling of 4.5 - generation of mirror image conformations for 
C2 symmetric molecules 
A Monte Carlo MM conformational search of 4.5 was performed using the MMFFs 
forcefield with CHCl3 as implicit solvent and found 45 conformers. All conformers found were 
subjected to DFT geometry optimization and free energy calculations using a combination of 
different exchange and correlation functionals and basis sets (discussed later in section 
4.2.2.4.1). 
Due to the symmetry of 4.5, the computed distances for pairs of equivalent protons 
should be the same. For example, the distance between H7 and H11 (rHA-HB) should be the same 
as the distance between H17 and H13 (rHA’-HB’). However, these two distances (rH7-H11 = 2.99 Å 
and rH17-H13 = 3.02 Å, Table 4.2) were initially found to be different after Boltzmann averaging 
regardless of which DFT calculation methods were used. Further examination of the distances 
of other equivalent pairs of protons revealed that indeed distances of equivalent pairs of protons 
were computed to be different (rHA-HB  rHA’-HB’).  
Table 4.2: Structure of 4.5 and the computed ensemble-averaged distances of selected pairs of 
equivalent protons prior to the generation of degenerate conformations. The computed distances listed 
were obtained using B3LYP-D2/6-311G(d) geometries with conformer energies corrected by single 
point energy calculations using B3LYP-D2/6-311G(d,p) functional and implicit toluene (IEFPCM).  
 
HA HB rHA-HB / Å HA’ HB’ rHA’-HB’ / Å 
H3 H5 2.76 H21 H19 2.82 
H3 H7 3.07 H21 H17 3.03 
H3 H9 2.63 H21 H15 2.69 
H5 H7 2.55 H19 H17 2.54 
H5 H9 2.97 H19 H15 3.01 
H5 H11 2.11 H19 H13 2.10 
H7 H9 2.80 H17 H15 2.82 
H7 H11 2.99 H17 H13 3.02 
 
Although the differences between rHA-HB and rHA’-HB’ are small (within 0.06 Å), this 
difference suggests that certain conformations might not have been captured in the initial MM 




enabled in the initial conformational search, it was unclear whether the mirror image 
conformers would actually be kept separately for C2 symmetric molecules, since both 
degenerate conformers would be superimposable and therefore could be treated as the same.  
To probe whether all conformations were captured for C2 symmetric molecules, 
conformational analysis of a truncated version of 4.5 (4.8, Table 4.3), which was 
desymmetrised in silico by the addition of a methyl group at one of the terminal alkynes, was 
performed using a MM conformational search under identical conditions (MMFFs force field, 
implicit CHCl3 as solvent, TNCG, MCMM, 500,000 iterations). If both conformational 
searches give the same results in terms of numbers of conformations found, this would confirm 
that mirror image conformers were being retained during conformational search of 4.9. On the 
other hand, if the conformational search of 4.8 gave more conformers than 4.9, then the initial 
conformational search of 4.9 did not capture the entire conformational space of the molecule 
and might have eliminated degenerate mirror image conformations.  
Table 4.3: Structure of 4.8 and 4.9, with the number of conformers and clusters found by MM 
conformational search. 
 
Compounds Total number of conformers Total number of clusters 
4.8 47 46 
4.9 29 28 
 
In the event, the conformational search of 4.8 found more unique conformations, which 
was reflected by nearly double the numbers of dihedral clusters, which was grouped by dihedral 
angle of the backbone as discussed previously (Figure 2.12, Chapter 2). To investigate which 
conformations of 4.9 were ‘missing’, the dihedral angle sequence of all clusters found in the 
conformational search of 4.8 were compared to those found in the conformational search of 
4.9.  
It then became apparent that the ‘missing’ conformations were, indeed, the mirror 
image conformers. For example, conformers with a backbone dihedral angle sequence of ap, 




However, the mirror image conformer with the backbone dihedral angle sequence of g+, +ac, 
ap, g+, ap was only found in the conformational search of 4.8 (conformer 4.8-9, Figure 4.8b). 
Although the backbone of conformers 6 and 9 could be superimposed in a ‘head-to-tail’ fashion 
(RMSD value of superimposition of backbone atoms < 0.02 Å, Figure 4.8c), they are not the 
same due to the presence of the terminal methyl group. Therefore, both conformers were treated 
as different conformers and stored separately in the conformational search output for 4.8. In 
the case of 4.9, when the terminal methyl group is absent the whole skeleton of both conformers 
would be superimposable and therefore even if both conformers were found, one would be 
eliminated as a redundant conformer and therefore not stored in the conformational search 








Overlay of 4.8-6 and 4.8-9 
Figure 4.8: Representative output conformers of the conformational search of 4.8. a, 3D structure of 
conformer 4.8-6 with computational atom labels. b, 3D structure of conformer 4.8-9 with computational 




The fact that two degenerate conformers could be overlaid in a ‘head to tail’ fashion 
suggests that the easiest way to generate the corresponding mirror image conformers would be 
to copy the geometry and swap the symmetry-equivalent atom labels. This was achieved by 
swapping the xyz coordinates of equivalent nuclei for all conformers using a python script 
written by Mr. William Gerrard. 
The generation of the ‘missing’ 45 mirror image conformers for 4.5 was performed and 
the ensemble-averaged interproton distances were recomputed after the inclusion of degenerate 
conformations. As table 4.4 shows, the distances between selected equivalent pairs of protons 
are now the same. In addition, there was a slight improvement in the fit to the experimentally 
derived 1H-1H distances, reflecting the decreased values of MAD and StDev. 
Table 4.4: Structure of 4.5 and the computed ensemble-averaged distances of selected pairs of 
equivalent protons after the generation of degenerate conformations. The computed distances listed 
were obtained using B3LYP-D2/6-311G(d) geometries with conformer energies corrected by single 
point energy calculations using B3LYP-D2/6-311G(d,p) functional and implicit toluene (IEFPCM). 
 
HA HB Computed Distances/ Å HA’ HB’ Computed Distances/ Å 
H3 H5 2.79 H21 H19 2.79 
H3 H7 3.05 H21 H17 3.05 
H3 H9 2.66 H21 H15 2.66 
H5 H7 2.55 H19 H17 2.55 
H5 H9 2.99 H19 H15 2.99 
H5 H11 2.11 H19 H13 2.11 
H7 H9 2.81 H17 H15 2.81 
H7 H11 3.00 H17 H13 3.00 
Comparison of the computed to the experimentally determined distances: 
 MAD StDev 2 (reduced) 
Without degenerate conformations 4.10% 4.97% 2.04 
With degenerate conformations 3.84% 4.92% 1.97 





4.2.2.4 QM/NMR analysis of 4.5.  
4.2.2.4.1 Comparison of computed ensemble-averaged 1H-1H distances to the 
experimentally determined NOE-distances: effect of MM and DFT calculations on 
conformer geometries and energies.  
MM calculations suggested that 4.5 preferentially adopts helical conformations (89.9% 
population) and both the M and P helices were found to be similar in energy (DE = 1.0 kJ 
mol1), thus have very similar conformer populations (Figure 4.9). The MM prediction 
contradicted with the expected helicity of 4.5 (ie. P helix) based on the minimisation of gauche 
interactions (section 4.2.1). 
However, the conformer energies were found to change substantially going from MM 
to DFT. For example, DFT geometry optimisation and frequency calculations using B3LYP-
D2 6-311G(d) level of theory predicted that 4.5 still preferentially adopts helical conformations 
(78.4% population) but with the P helix being the global minimum (68.3% population), and 
the energy difference between the M and P helices (with the same pitch) was calculated to be 
4.3 kJ mol–1 (Figure 4.9). Unlike the MM prediction, the DFT prediction agreed with the 
expected helicity of 4.5 (P helix). 
 
MM DFT  
  
Figure 4.9: Chemical structure of 4.5 with the conformer population predicted by MM and DFT 
calculations represented by bubble plots. Red dots represent P helix while blue dots represent M helix.  
To determine which predicted conformer population best describes the experimentally 
observed conformational behavior of 4.5, the ensemble-averaged 1H-1H distances computed 




distances. The goodness of fit was evaluated using 2 (reduced) values, where an acceptable 
model will have a value approaching 1. An expected standard deviation of 3.5% was chosen 
for the calculations of the 2 (reduced) values for 4.5.54 It was found that the MM predicted 
ensemble-averaged 1H-1H distances provided very poor fit to the experimental data with a 2 
(reduced) value of 11.57. Therefore, care must be taken when using the MM calculated 
conformer energies to predict the conformational landscape of molecules.  
The ensemble-averaged distances of 4.5 was also calculated using different DFT 
methods (Table 4.5). Compared to the MM calculated distances, all DFT-predicted distances 
provided better fit to the experimentally derived distances with 2 (reduced) values less than 6. 
In particularly, distances calculated using B3LYP-D2 6-311G(d) level of theory in gas phase 
provided a good fit to the experimentally derived distances with a 2 (reduced) value of 1.88. 
Therefore, on the basis of quantitative 1H-1H distance analysis, P helix is the major 
conformation of 4.5.  
The effect of different DFT calculation methods on conformer geometries and free 
energies was also investigated. Three different exchange and correlation functionals 
(mPW1PW91, B3LYP and M06-2X) and empirical dispersion correction (D2) in conjunction 
with the B3LYP functional were explored for geometry optimisation and frequency 
calculations. Selected combination of the four functionals with five different double- and triple-
ζ basis sets (6-31G(d), 6-311G(d), 6-311+G(d), 6-311G(d,p), 6-311+G(d,p)) gave rise to 11 
different sets of DFT methods. The ensemble-averaged 1H-1H distances predicted by these 11 
sets of calculations were compared to the experimentally derived NOE-distances. The 
goodness of fit of the comparison was again evaluated using 2 (reduced) values, which were 
summarised in table 4.5.  
The effect of basis set was first considered with the use of mPW1PW91 functional, 
which was the functional of use for NMR parameter calculations (entry 2 – 5, Table 4.5). The 
ensemble-averaged 1H-1H distances computed using the triple-ζ basis set (6-311G(d), 
2(reduced) = 3.20, entry 3) gave better fit to that using the double-ζ basis set (6-31G(d), 
2(reduced) = 5.08, entry 2), with an improvement of 1.88 in the 2 (reduced) value. The 
addition of polarisation function to the triple-ζ basis set was investigated and the ensemble-
averaged 1H-1H distances gave worse fit (6-311G(d,p), 2(reduced) = 4.41, entry 4). Manual 
inspection of the optimised geometry with and without the use of polarisation function 




conformer geometries imperceptibly in most conformers (RMSD < 0.1 Å). Therefore, the 
erosion of fit (D2(reduced) between entry 3 and 4 =−1.21) was presumably due to the change 
in conformer energies, which is within chemical accuracy (~ 4 kJ mol−1) for all major 
conformer (DG < 10 mol−1). Therefore, the inclusion of polarisation to the triple- ζ basis set, 
which required approximately 1.2 times more CPU time, is probably unnecessary for geometry 
optimisation and frequency calculations and the effect of polarisation function on conformer 
energies could be estimated using the less resource intensive single point energy calculations. 
Table 4.5: Comparison between the computed ensemble-averaged 1H-1H distances of 4.5 and the 
experimentally derived NOE-distances. 
Entry Force field  Solvation 2 (reduced) NOE 
1 MMFFs  Chloroform 
    
Entry DFT Functional Basis set Solvation 2 (reduced) NOE
2 mPW1PW91 6-31 G(d) Gas 5.08 
3  6-311 G(d) Gas 3.20 
4  6-311 G(d,p) Gas 4.41 
5  6-311+ G(d,p) Gas 3.47 
6 B3LYP 6-31 G(d) Gas NA 
7  6-311 G(d) Gas 5.12 
8  6-311 G(d) Toluene 5.22 
9 M06-2X 6-31 G(d) finegrid Gas 4.13 
10  6-311 G(d) finegrid Gas 3.81 
11 B3LYP-D2 6-31 G(d) Gas 2.08 
12  6-311 G(d) Gas 1.88 
 
The inclusion of diffuse functions (6-311+G(d,p), 2(reduced) = 3.47, entry 5) 
substantially improves the fit of the computed distances to the experimentally determined 
NOE-distances (D2(reduced) between entry 4 and 5 = 0.94). Although the use of the triple-ζ 
basis set with diffuse function and polarisation function (6-311+G(d,p), entry 5) provided a 
better fit, the inclusion of diffuse function requires approximately 3.5 times more CPU time. 
In addition, the goodness of fit is similar to that without the inclusion of polarisation and diffuse 




Therefore, the addition of diffuse function to the triple-ζ basis set for geometry optimisation 
and frequency calculations seems to be uneconomical.  
The effect of basis sets was also briefly explored using the other functionals (M06-2X 
and B3LYP-D2) and it was found that the ensemble-averaged 1H-1H distances computed using 
the triple-ζ basis set (6-311G(d), entry 10 and 12) gave a slightly better fit than that using the 
double-ζ basis set (6-31G(d), entry 9 and 11). Unfortunately, the same comparison could not 
be performed with the use of B3LYP functional because the geometry optimisation calculation 
for a major conformer did not converge to a stationary point when the double-ζ basis set was 
used. Manual inspection of the optimised conformer geometries with the use of double- and 
triple- ζ basis set suggested that the use of a bigger basis set sometimes gave slightly different 
conformer geometries (RMSD < 1.0 Å). Therefore, the improvement of fit when triple-ζ basis 
set was probably due to the better predicted conformer geometries and energies. Although the 
change is small and the use of triple-ζ basis set requires approximately 3 times more CPU time, 
the use of the larger triple- ζ basis set would be beneficial for geometry optimisation and 
frequency calculations.  
The effect of inclusion of a dielectric continuum corresponding to toluene was also 
investigated with B3LYP functional and 6-311 G(d) basis set (entry 8). It was found that the 
inclusion of implicit toluene (with the deuterated version being the choice of solvent for NMR 
experiments) have minimal effect on the fit between the computed and experimental 1H-1H 
distances (D2(reduced) between entry 7 and 8 = 0.1). Therefore, the inclusion of implicit 
toluene in geometry optimisation and frequency calculations are unnecessary and the effect of 
solvation on conformer energies, if there was any, could be included using the less resource 
intensive single point energy calculations 
Finally, the effect of dispersion correction was considered (entry 9 – 12). Two different 
types of dispersion corrections were investigated: one which is parameterised to account for 
some dispersion (M06-2X) and the other one with empirical dispersion corrections (D2) to the 
existing B3LYP functional. The computed ensemble-averaged 1H-1H distances using 
conformer geometries and energies computed by M06-2X functional also provided 
unreasonable fit to the experimentally determined NOE-distances (2(reduced) = 4.13 and 3.18 
for double- and triple-ζ basis sets respectively, entry 9 and 10). In addition, the keyword 
“finegrid” was required for smoother convergence of conformer geometries to a stationary 




distances using conformer geometries and energies computed using empirical dispersion 
correction (D2) in conjunction with B3LYP functional provided by far the best fit to the 
experimentally determined NOE-distances (2(reduced) = 2.08 and 1.88 for double- and triple-
ζ basis sets respectively, entry 9 and 10). The inclusion of D2 empirical dispersion correction 
had very little impact on the computational resource required and was found to affect both the 
optimised conformer geometries and the subsequently calculated free energies. Therefore, it is 
crucial to include dispersion correction in geometry and frequency calculations.  
Balancing accuracy and computational economy for DFT calculations, the optimal 
method for geometry optimisation and frequency calculations was considered to be the 
B3LYP-D2 6-311(G) level of theory (entry 12). The computed ensemble-averaged 1H-1H 
distances using this method provided a good fit to the experimentally determined NOE-
distances with reasonable time cost (~34 hours CPU time per calculations). The effect of a 
larger basis set (6-311G(d,p)) and implicit toluene (IEFPCM) on conformer energy was 
included by single point energy calculations and the fit of the computed 1H-1H distances to the 
experimental data was found to be very similar (2(reduced) = 1.97).  
4.2.2.4.2 Comparison between calculated and experimental nJHH. 
Having established the optimal DFT methods for calculating conformer geometries and 
energies, the scalar coupling constants of major conformers which were predicted to make up 
90% of the conformer population were subjected to DFT calculations using mPW1PW91 6-
311G(d,p) level of theory with implicit toluene (IEFPCM) to predict the ensemble-averaged 
scalar coupling constants. The DFT computed scalar coupling constants of equivalent pairs of 
protons were averaged with each other prior to Boltzmann averaging across all conformations. 
The long-range scalar coupling constants between H1 and H3 (
4JH1-H3, see Figure 4.10a for atom 
labels) was not included in the analysis because this coupling constant does not provide insights 
into the conformational behaviour of 4.5. In addition, the computed ensemble-averaged 4JH1-H3 
(4.18 Hz) was found to deviate substantially from the experimentally measured values (2.38 
Hz), presumably due to the poor description of the alkyne sp orbital even when keyword 
“mixed” was used in the NMR parameter calculations to incorporate explicit mixing of core 
orbitals in the calculation of the fermi contact term.160  
The computed NMR parameters are in good agreement with the experimentally 
measured values (1H-1H scalar coupling: MAD = 0.6 Hz, StDev = 0.7 Hz; 2(reduced) = 0.44. 




goodness of fit is in line with those observed for conformational analysis of compounds with 
similar structural complexity.8 Therefore, the dominant conformation of 4.5 in solution is the 
P helix (Figure 4.10c) as predicted (section 4.2.1). It was found that 4.5 also exists as a P helix 
in the solid state by X-ray crystallography (Figure 4.10d).  
a 
 
b c d 
   
Figure 4.10: a, Chemical structure of 4.5 with assignment labels. b, Comparison of the DFT computed 
ensemble-averaged 1H-1H scalar coupling constants and 1H-1H distances to the experimentally 
determined values. c, DFT-predicted lowest energy conformer (a P helix) of 4.5. d, X-ray crystal 
structure of 4.5. 
  















































4.2.2.5 Achieving helical switch by bidirectional chain extension (QM/NMR analysis of 
4.9and 4.10).  
Next, the conformational behaviour of the synthetic intermediates in the bidirectional 
homologation of 4.6 was also considered. If the minimisation of gauche interactions dictates 
the helical screw-sense of an all-syn methyl substituted hydrocarbon, the intermediates 4.9 and 
4.10 with different chain lengths (Figure 4.11) would preferentially fold into different helical 
conformers.  
At the start of the sequence, 4.9 folds into a P helix with backbone dihedral angles of 
g–, ap, g–, ap, g–, which has one less gauche interaction than the M helix (ap, g+, ap, g+, ap). If 
4.10 were to adopt the same helicity as 4.9, it would have backbone dihedral angles of ap, g–, 
ap, g–, ap, g–, ap which give rise to 18 gauche interactions. To minimize the number of gauche 
interactions 4.10 would therefore undergo a conformational switch from the P helix to the M 
helix, which has backbone dihedral angles of g+, ap, g+, ap, g+, ap, g+ giving rise to 17 gauche 
interactions. Consequently, the homologated products were expected to switch from P (4.9) to 
M (4.10) then back to P (4.5). One could view this as switching in helical screw-sense via 





Figure 4.11: Key intermediates in the bidirectional iterative homologation of boronic ester 4.6. 
Therefore, 4.9 and 4.10 were synthesised and computation was performed using a 
Monte Carlo MM conformational search followed by the generation of mirror image 
conformers as described previously (section 4.2.2.3). Subsequent DFT calculations were 




point energy calculations with a bigger basis set (6-311G(d,p)) and solvation (toluene, 
IEFPCM), section 4.2.2.4.1). It was found that both compounds have a strong conformational 
preference towards helical conformations (86% and 71% of the population adopting helical 
conformation for 4.9 and 4.10 respectively). The slight increase in helical population of 4.9 
(86% vs ~70% observed for both 4.10 and 4.5) could be the result of the decreasing entropic 
cost for adopting defined conformations associated with reducing the number of freely 
rotatable bonds. As predicted, the major conformers are the P helix for 4.9 and the M helix for 
4.10. The computed energy difference between M and P helices for both 4.9 and 4.10 
respectively were about 1 kcal mol–1, which is similar to that observed for 4.5. 
Comparing the computed Boltzmann averaged NMR parameters to the experimentally 
measured values gave good agreement for both 4.9 and 4.10 (Figure 4.12c and f, respectively. 
See figure title for MAD, StDev and 2(reduced) values), confirming the dominant 
conformations of each compound in solution, as well as the change in screw sense when 4.9 
was extended bidirectionally by two carbon units. 
 
Figure 4.12: Chemical structures of (a) 4.9 and (d) 4.10. DFT calculated conformer population of (b) 
4.9 and (e) 4.10 represented by bubble plots. Red dots represent the P helix while blue dots represent 
the M helix. Comparison between DFT calculated ensemble-averaged 1H-1H scalar coupling constants 
and 1H-1H distances of (c) 4.9 and (f) 4.10. Comparison for 4.9: 1H-1H scalar coupling: MAD = 0.5 Hz, 



































































































































StDev = 0.7 Hz; 2(reduced) = 0.8. NOE distances: MAD = 2.9%, StDev = 1.8%, 2(reduced) = 1.64. 
Comparison for 4.10: 1H-1H scalar coupling: MAD = 0.1 Hz, StDev = 0.1 Hz; 2(reduced) = 0.02. NOE 
distances: MAD = 4.3%, StDev = 5.4%, 2(reduced) = 2.6. 
In Summary, a theoretical model based on the minimisation of gauche interactions was 
proposed to rationalise the preferred helicity of 4.5 in solution-state. QM/NMR analysis of 4.5 
showed that indeed the P helix, which has one less gauche interaction than the M helix, was 
observed as predicted by the theoretical model.  
By exploiting the idea of minimising gauche interactions, switching between P and M 
helices was achieved going from 4.9 to 4.10 then to 4.5. QM/NMR analysis of 4.9 and 4.10 






4.2.3 QM/NMR analysis of compounds with odd numbers of contiguous methyl 
substituents (compounds 4.11, 4.12 and 4.13).  
4.2.3.1 QM/NMR analysis of 4.11.  
In section 4.2.2, QM/NMR analysis showed that compounds with even numbers of 
contiguous methyl substituents (4.9, 4.10 and 4.5) all adopt helical conformations with 
conformer population greater than 70%. Next, the conformational behaviour of compounds 
with odd numbers of contiguous methyl substituents, such as 4.11 (Figure 4.13a), was 
considered.  
Since 4.11 is a meso compound, it was expected that both M and P helices would have 
the same numbers of gauche interactions (Figure 4.13b). Therefore, they are energetically 
degenerate and should be present in a 1:1 ratio.   
 
Figure 4.13: a, Chemical structure of 4.11. b, M and P helical conformations of 4.11 represented on 
diamond lattices.  
Unlike 4.9, 4.10 and 4.5, in which the preferred helical conformations have both alkyne 
end groups adopting gauche conformations with respect to the helix (Figure 4.11), both the M 
and P helices of 4.11 have one of the alkyne end groups adopting a gauche conformation with 
respect to the helix, while the other alkyne end group adopting an antiperiplanar conformation 
with respect to the helix. Since the antiperiplanar conformation has one extra gauche 
interaction compared to each of the gauche conformations (Figure 4.4b), to minimise gauche 




favourable gauche conformations with the expense of breaking the helicity of the molecule. If 
the minimisation of gauche interactions indeed reduces the energy difference between the 
helical and non-helical conformers, one would expect to observe higher population of non-
helical conformers for 4.11 compared to 4.5, 4.9 and 4.10. (14–30%) 
To establish whether there is a break in helicity, conformational analysis of 4.11 using 
a Monte Carlo MM conformational search and DFT calculations was performed with 
procedures described previously (section 4.2.2.5). The ensemble-averaged scalar coupling 
constants of 4.11 were computed using DFT methods described previously (section 4.2.2.4.2). 
It was predicted that for 4.11, 63% of the conformers adopt helical conformations and the ratio 
between M and P helices is 1:1. The DFT computed ensemble-averaged 1H-1H coupling 
constants gave good fit to the experimentally observed values (both MAD and StDev < 0.25 
Hz, 2 (reduced) = 0.08).  
However, the ensemble-averaged 1H-1H coupling constants based on a 1:1 mixture of 
M and P helices with no non-helical conformations also gave good fit to the experimental data 
(both MAD and StDev < 0.36 Hz, 2 (reduced) = 0.24, Table 4.6). Therefore, the analysis of 
1H-1H coupling constants alone is insufficient to establish the presence, let alone the 
populations, of non-helical conformations in solution. 
Table 4.6: Comparison of the 1H-1H coupling constants computed based on the DFT-derived conformer 
energies and a 1:1 mixture of M and P helices to the experimentally measured values. 
 
DFT derived ensemble-
averaged J values 
M and P helices only                    
(50% : 50%) 
HA HB Exp. nJHH/Hz Calc. nJHH/Hz Dev./Hz Calc. nJHH /Hz Dev./Hz 
H3 H4 6.99 7.13 0.14 7.10 0.11 
H3 H5 6.90 6.54 −0.36 7.00 0.10 
H5 H6 6.80 7.00 0.20 6.96 0.16 
H5 H7 5.40 5.79 0.39 6.51 1.11 
H7 H8 6.80 6.99 0.19 6.95 0.15 
H7 H9 6.70 6.94 0.24 7.08 0.38 
H9 H10 6.80 7.04 0.24 6.97 0.17 
   MAD 0.25 MAD 0.31 
   StDev 0.24 StDev 0.36 





To investigate whether any NMR parameters (H, C, J values and NOE derived 1H-1H 
distances) could be used to detect the presence of non-helical conformations, two sets of 
ensemble-averaged NMR parameters were calculated and compared to the experimentally 
measured data. One set of calculated data was based on the DFT-derived conformer population, 
which consists of a mixture of equally populated M and P helices as well as non-helical 
conformations, while the other set was based on a 50%:50% mixture of M and P helices. The 
comparison of both sets of calculated data to the experimentally measured values showed very 
similar fit and both gave very similar 2 (reduced) values with the differences in 2 (reduced) 
values less than 0.3 for the comparison of H, C and 1H-1H coupling constants (Figure 4.14). 
Therefore, these NMR parameters are insensitive to the change in conformational space in the 




Figure 4.14 Comparison of two sets of ensemble-averaged H, C, 1H-1H couplings and 1H-1H distances 
to the experimentally measured values. The goodness of fit was evaluated by a statistical analysis using 
2 analysis.  
On the other hand, NOE derived 1H-1H distances are sensitive to the presence of non-
helical conformations (2 (reduced) = 6.08 for 50:50 M:P helices and 3.76 for DFT-derived 
population, Figure 4.14). Although the computed distances based on DFT-derived conformer 
population fits better to the experimentally measured distances (2 (reduced) value = 3.76, 







































therefore population refinement based on the experimentally derived NOE-distances 
(discussed in section 2.2.2, Chapter 2) was applied to correct for the DFT-approximate 
conformer population. Unlike the case of baulamycins, in which the entire conformational 
space was not computed by DFT due to the sheer number of conformations found by the initial 
MM conformational search (Chapter 2), population refinement should be more robust for 4.11 
since all conformations found by the initial MM conformational search were subjected to the 
subsequent DFT calculations. 
Constraints of 0, 100, 225 and 625 (Figure 4.15) were examined for Σ(DDG)2 and each 
represents a maximum change of 0, 10, 15 and 25 kJ mol1 in the DG of a particular dihedral 
cluster (out of 21 clusters). The ratio between the M and P helical conformers was enforced to 
1:1 during the refinement process. The ensemble-averaged 1H-1H coupling constants and 1H-
1H distances were recomputed after each refinement and compared to the experimentally 
measured values. After population refinement, the fit for the 1H-1H distances dramatically 
improved as the constraint increased from 0 to 100, with the 2 (reduced) values decreased 
from 3.76 to 1.42 (Figure 4.15). In addition, the excellent fit for the 1H-1H coupling constants 
was retained with essentially no change in 2 (reduced) values (0.08 and 0.07 for constraint = 
0 and 100 respectively, Figure 4.15). As the constraint of Sum(DDG)2 was increase further from 
100 to 225 then to 625, only a slight improvement in the fit for the 1H-1H distances was 
observed (2 (reduced) values = 1.42, 1.04 and 0.77 for Sum(DDG)2 = 100, 225 and 625 
respectively, Figure 4.15). However, slight erosion in the fit for 1H-1H coupling constants was 
also observed with the 2 (reduced) values increased gradually from 0.07 to 0.36 (Figure 4.15). 
The erosion of the fit for the 1H-1H coupling constants might be an indication of over-fitting as 
the DG (and thus populations) of the dihedral clusters were allowed to deviate substantially 
from the DFT computed values.  
In terms of population refinement, the optimal constraint for the refinement lies 
somewhere around 100 and 225 before overfitting takes place. A constraint of 100 was chosen 
as the optimal constraint for the refinement value because this value would give refined 





Figure 4.15: Comparison of ensemble-averaged 1H-1H couplings and 1H-1H distances based on 
conformer energies after population refinement using different constraints to the experimentally 
measured values. The goodness of fit was evaluated by 2 analysis.  
The change in the conformational landscape of 4.11 after population refinement using 
a constraint of 100 was considered in more detail. The combined population of helical 
conformations (M + P) dropped from 63.0% to 44.5% after refinement, while the population 
of two clusters, which shows a break in helicity (indicated by +ac/−ac dihedral angles) along 
the backbone have increased from nearly zero to 24.9% and 18.5% respectively. Helical 
conformers (M and P helices) remained to be the global minimum and the energy of four 
clusters changed for ~ 6 kJ mol–1, which is approaching chemical accuracies (~4 kJ mol−1). In 
the absence of strong intramolecular interactions (e.g. intramolecular hydrogen bonds in the 
case of baulamycins, Chapter 2), a very small change in the DG of the three clusters resulted in 
a dramatic improvement of the fit in 1H-1H distances (Figure 4.15) because DFT calculations 































Figure 4.16: Population of each cluster of conformations before and after NOE-based population 
refinement using a constraint (sum(DDG)2) of 100. 
Therefore, the presence and the conformer population of non-helical conformation was 
established by refining the DFT-computed ensemble-averaged 1H-1H distances based on the 
experimentally derived NOE distances. Although both helical conformations are still the lowest 
energy conformers after population refinement, the free energy difference between the helical 
and non-helical conformers is very small (1.4 kJmol−1), thus the minimisation of gauche 
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4.2.3.2 Investigation of the effect of entropy on conformational preference (QM/NMR 
analysis of 4.12 and 4.13).  
The meso compounds with odd numbers of contiguous methyl substituents provide the 
opportunity to directly explore the contribution of entropy on the conformational landscape of 
these systems. To examine this, compounds 4.12 and 4.13 (Scheme 4.2) with longer chain 
lengths were synthesised and their conformational behaviour was calculated using the MM 
conformational search and DFT calculation methods as described previously (section4.2.2.4.2).  
 
Scheme 4.2: Chemical structure of 4.12 and 4.13. 
The DFT-derived conformer energies were further refined based on the experimentally 
determined NOE-derived interproton distances using a constraint of 100 for Σ(DDG)2. A 
mixture of equally populated M and P helices, as well as non-helical conformations were 
observed for both 4.12 and 4.13. The combined population of helical conformers decreases 
with increasing chain length (from 44.6% to 29.6%, Figure 4.17), presumably because of the 
increasing entropic cost for adopting a regular helical conformation.  
 
Figure 4.17: Combined helical conformer population of 4.11, 4.12 and 4.13. 
In summary, the QM/NMR analysis of 4.11 found that neither chemical shifts nor scalar 
coupling constants were sensitive enough to establish the presence and the conformer 
population of non-helical conformers. Only NOE-distances, which are sensitive to conformer 
populations with short interproton distances (scaled with r−6), could establish the presence of 
non-helical conformers and ultimately determine their conformer populations. The QM/NMR 

































4.12 and 4.13) have poor conformational bias toward helical conformers because of the reduced 




4.2.4 Helical switch by altering end groups (QM/NMR analysis of 4.14). 
As discussed in section 4.2.2, the minimisation of gauche interactions dictates which 
helical conformation is preferred for compounds with even number of contiguous methyl 
substituents. To gain a deeper understanding of the actual energetic difference between the M 
and P helices, Mr. Johan A. Pradeilles re-visited the originally proposed model (Figure 4.4) 
and categorised the gauche interactions found in both helical screw-sense into five types (Table 
4.7): between two methyl substituents (Me-Me); between the end group and the methyl 
substituent (R-Me); between the methyl substituent and the helical backbone (Me-Helix), 
between the end group and the helical backbone (R-Helix); and between the helical backbones 
(Helix-Helix). Cancellations of the same types of gauche interactions found in both helical 
screw-sense revealed the actual difference in the gauche interactions. 
Table 4.7: A list of different types of gauche interactions observed in the M helix (4.4-1) and P helix 
(4.4-2) in compound 4.4.  
 
 
 M helix (4.4-1) P helix (4.4-2) 
Types of gauche 
interactions 
Numbers of gauche interactions 
Me-Me 9 9 
R-Me 2 0 
Me-Helix 8 8 
R-Helix 0 2 
Helix-Helix 4 3 
 
Interactions left after 
cancellations 





If the energy arises from two gauche interactions between the end group and the methyl 
substituent plus a gauche interaction between the helical backbones (2×(R-Me) + (Helix-Helix)) 
is larger than that which arises from the two gauche interactions between the end group and 
the helical backbone (2×(R-Helix)), the P helix will be lower in energy and dominate the 
conformer population.  
Although a P helix was observed for 4.5, the enthalpic costs of each type of gauche 
interactions (alkyne-Me, Helix-Helix and alkyne-Helix) which dictates the preference of 
helicity are currently unknown, thus hindering the quantitative assessment of the mathematical 
description of the model (Table 4.7). Nevertheless, the preference towards the M helix could 
be enhanced by increasing the enthalpic cost of the gauche interaction between the end group 
and the helical backbone (R-Helix).  
In addition to increasing the enthalpic penalty for adopting the P helical conformation, 
one could also reinforce the preference of the first backbone dihedral to adopt an antiperiplanar 
conformation to maximise the preference towards the M helical conformation. Therefore, using 
a tert-butyl group would not only substantially increase the enthalpic cost of the ‘R-Helix’ term, 
thus increasing the enthalpic penalty for adopting the P helical conformation, but would also 
reinforce the first backbone dihedral to adopt an antiperiplanar conformation due to the effect 
of a tert-butyl group on molecular conformation (Chapter 3). 
Therefore, the tert-butyl analogue 4.14 was studied computationally using a Monte 
Carlo MM conformational search as described previously (section 4.2.2.3). Compared to the 
MM calculation results of 4.5 (Figure 4.18a), which predicted that both M and P helices have 
equal conformer populations, the MM calculation results of 4.14 showed an enhanced bias 
towards the M helical conformation (75.7% of conformer population, ignoring end-group 
rotamers, Figure 4.18b). However, synthesis of 4.14 was challenging due to the lack of 
synthetic methods to directly introduce the terminal tert-butyl group. In addition, it would also 
be challenging to analyse the NMR spectra of 4.14 due to signal overlap. Therefore, an 
analogue 4.15 was designed and MM calculations predicted that the M helical conformation 
still dominated the conformer population of 4.15 with a conformer population of 69.9%.  
According to MM calculations, the introduction of a tert-butyl group indeed would 
enhance the preference to adopt the M helix as expected. However, MM predicted conformer 








Figure 4.18: a, Chemical structure of 4.14 and the MM predicted conformer population represented by 
a bubble plot. b, Chemical structure of 4.15 and the MM predicted conformer population represented 
by a bubble plot. Red dots represent P helix while blue dots represent M helix. 
Therefore, DFT calculations were also performed to obtain a better picture of the 
conformational behaviour of 4.15 using the procedures described previously (section 4.2.2.5). 
Again, the conformer energies were found to change substantially going from MM to DFT 
calculations. (section 4.2.2.4.1). Although the M helix was predicted to be the dominant 
conformation with a 69.9% of conformer population by MM calculations (Figure 4.18b), DFT 
calculations predicted that the M helix only has a 7.9% of conformer population with P helix 
representing 42.4% of the helical conformer population. In addition, the predicted combined 
population of helical conformers decreased from 86.2% (Figure 4.18b) to 50.3% (Figure 4.19c) 
going from MM to DFT calculations. The DFT-predicted conformer population was not in line 
with the expected conformational behaviour of 4.15 based on the mathematical description.  
To confirm the DFT-predicted conformational behavior of 4.15 in solution, the 
computed ensemble-averaged 1H-1H scalar coupling constants and 1H-1H distances were 
computed using DFT calculation methods described previously (sections 4.2.2.4.1 and 
4.2.2.4.2). The computed ensemble-averaged 1H-1H scalar coupling constants fit well to the 
experimentally determined values (MAD = 0.7 Hz, StDev = 0.9 Hz, 2 (reduced) = 0.9 Hz). 
However, the computed ensemble-averaged 1H-1H distances fits less well to the experimentally 
determined NOE-distances (MD = 5.7%, StDev = 7.5%) with a 2 (reduced) value of 4.6. The 
poor fit for NOE-distances arise from an outlier which corresponds to the distances between 
H3 and H9. (highlighted by a red circle, Figure 4.19b). The experimentally determined NOE 




ensemble-averaged distance (2.76 Å). This suggests that experimentally, one or more 
conformer populations with short H3-H9 distance are higher than what was predicted by DFT 
calculations. Since both the M helix and non-helical conformers of 4.15 show a short DFT-
computed H3-H9 distance, it likely the large deviation observed reflects either an inaccurately 
predicted ratio between the M and P helices, or an inaccurately predicted ratio between the 






Figure 4.19: a, Chemical structure of 4.15 with H3 and H9 labelled.  b, DFT-predicted conformer 
population of 4.15 represented by a bubble plot. Red dots represent P helix while blue dots represent M 
helix. c, Comparison of the DFT computed ensemble-averaged 1H-1H scalar coupling constants and 1H-
1H distances to the experimentally determined values, with an outlier in the comparison of the 1H-1H 
distances highlighted using a red circle.  
It seems that, experimentally, the major conformer of 4.15 is unlikely to be the M helical 
conformer as expected. Unfortunately, NOE-based population refinement was not performed 
on 4.15 to obtain a more accurate picture of the conformational landscape due to inadequate 
number of NOE-distances measured and time constraints. Only 17 NOE-distances could be 
measured from both 1D NOE and CSSF NOE spectra for 4.15 due to spectral overlap (c.t. 28 
NOE-distances measured for 4.5, which also has 10 contiguous methyl substituents), so the 
NOE-based population refinement would be less robust. Although other NOE techniques, such 
as pure shift NOESY161, would overcome the spectral overlap problem by collapsing multiplets 
to ‘pure shift’ single peaks, thus enabling more NOE-distances to be measured, the accuracy 




studies using rigid compounds such as strychnine is required to establish the accuracy of this 
method before application to structurally flexible compounds (such as 4.15). It is with regret 
that due to time constraints, the validation study was not performed to establish the accuracy 
of using pure shift NOESY for NOE-distance determination because at the time all the attention 
was focused on completing the synthetic work discussed in chapter 3. 
So, it was unclear at this stage whether the replacement of an alkyne end group by a 
tert-butyl group in 4.15 has enhanced the preference to adopt an M helical conformation, or 
has caused a break in helicity since it induces a different helicity to the alkyne end group at the 
other end of the chain. Therefore, 4.16 (Figure 4.20) was synthesised with tert-butyl groups at 
both ends of the chain to reinforce the same helicity (M) from both directions. Only the vicinal 
coupling constants between H3 and H5 were extracted for 4.16 due to spectral congestion. The 
value of JH3H5 is smaller than that of JH21H19 of 4.15 (Figure 4.20), therefore implying the 
change of both end groups to the tert-butoxy groups has decreased the conformer population 
of the P helix. However, the size of the observed JH3H5 was approaching that of averaged J 
values (~7 Hz), therefore it was unclear whether the rest of the conformer population of 4.16 
was occupied by non-helical conformers or the M helix. Unfortunately, due to spectral overlap 
in 1H NMR spectrum the measurement of experimental NOE distances was not possible, 
therefore population refinement based on NOE-distances could not be performed to study the 
detailed conformational behaviour of 4.16.  
 
Figure 4.20: a, Generic structure of a molecule with 10 contiguous methyl substituents, with protons at 
the peripheral positions (H3 and H21) highlighted. b, A summary of the observed 1H-1H scalar coupling 





4.3. Conclusions and Future work. 
4.3.1 Conclusions 
In conclusion, a theoretical model based on the minimisation of gauche interactions 
was proposed to account for the observed helicity of all-syn methyl-substituted hydrocarbons. 
Hydrocarbons with even numbers of methyl substituents were found to adopt regular helical 
conformations. Switching between the M and P helical forms was achieved by the bidirectional 
homologation of a C2 symmetric bis(boronic ester) 4.6 followed by the transformation of the 
pinacol boronic esters to the alkyne moieties. The preferred helical screw-sense of 4.5, and the 
change in screw-sense of hydrocarbons with six, eight and ten contiguous methyl substituents 
(4.9, 4.10 and 4.5) were confirmed and followed by QM/NMR analysis using 1H-1H scalar 
coupling constants and 1H-1H distances. Hydrocarbons with odd numbers of methyl 
substituents were found to have a more diluted conformer population because of the break in 
helicity. Only the quantitative analysis of 1H-1H distances could be used to confirm the 
presence and the conformer population of non-helical conformers in the case of 4.11. NOE-
based population refinement of hydrocarbons with seven, nine and eleven methyl substituents 
(4.11, 4.12 and 4.13) showed that the preference towards helical conformations decreased as 
chain length increased.  
Spectroscopic and computational methods were developed to aid the accurate 
conformational analysis of the all-syn methyl-substituted hydrocarbons. Care must be taken 
with the NOE-distance analysis of C2 symmetrical compounds (4.9, 4.10 and 4.5) due to the 
symmetry-breaking NOE correlations. The effect of different functionals and basis sets on the 
computed ensemble-averaged 1H-1H distances were explored. It was found that the use of 
triple- ζ basis sets consistently gave computed ensemble-averaged 1H-1H distances that fits 
better to the experimentally determined NOE-distances. The use of diffuse function, 
polarisation and solvation were found to have little impact on computed conformer free 
energies and the optimised geometries, and the three different functionals investigated (B3LYP, 
mPW1PW91 and M06-2X) all showed similar performance in terms of the fit of the computed 
ensemble-averaged 1H-1H distances to the experimentally determined NOE-distances. 
However, the inclusion of empirical dispersion correction (D2) in conjunction with the B3LYP 
functional was found to have a substantial impact on both the computed conformer geometries 
and free energies and gave the computed ensemble-averaged distances which fitted the 




Finally, a revised version of the theoretical model was proposed (section 4.2.4) and it 
formed the basis of achieving helical switch by altering the size of the end groups of molecules 
with 10 contiguous methyl substituents. While the use of tert-butyl groups was thought to 
increase the energetic penalty for adopting a P helical conformation and the additional 
conformational effect of a tert-butyl group would further enhance the bias towards an M helical 
conformation, DFT calculations predicted that replacing an alkyne end group in 4.5 by a tert-
butoxy moiety resulted in a break in helicity, rather than an enhanced preference towards the 
M helix. To remove the possibility of conflicts arising from different helicities being induced 
by different end groups, both alkyne end groups were replaced by tert-butoxy moieties to 
generate 4.16. Unfortunately, due to spectral overlap and the conformational behaviour of 4.16, 
it could not be studied in detail using QM/NMR approach. The magnitude of the only J value 
extracted (JH3H5 = 5.2 Hz) for 4.16 suggested that while the introduction of two sterically 
hindered tert-butoxy moieties decreases the preference toward the P helical conformation, the 
exact population of the M helical conformation could not be determined solely based on this 
value. The result obtained so far indicates the delicate balance between the preference towards 





4.3.2 Future work 
Having established the inherent preference of 4.5-type systems, a deeper understanding 
between the nature of the end group and the preferred helical screw-sense is required for the 
design and synthesis of switchable hydrocarbon-based helices. While the use of tert-butyl 
groups as end groups has indicated that a sterically demanding group has reduced the 
conformer population of helical conformations, it was unclear whether the steric hindrance, or 
the introduction of destabilising syn-pentane interactions caused the break in helicity. The 
analysis of end groups bearing different size by QM analysis (Scheme 4.3a) would hopefully 
offer insight into the relationship between the steric hindrance of the end group and the 
preferred helical screw-sense. It was also unclear whether the hybridisation of the end groups 
would have an impact on helicity, since most of the systems studied so far have an alkyne end 
group with an sp carbon attached to the helix. Therefore, investigation of molecules bearing 
end groups with sp2 carbons directly attached to the helix (Scheme 4.3b) was required. In 
addition, by introducing heteroatoms on the aryl rings or the use of triazole moieties would 
hopefully shed light on the effect of electronics on the preferred helical screw-sense.  
 
Scheme 4.3: Proposed target compounds to establish the relationship between the steric, hybridisation 
and electronic properties of the end group and the preferred helical screw-sense.  
In addition, spectral overlap has hindered the measurements of adequate number of 
accurate NOE-distances for the NOE-based population refinement in the case of 4.15. 
Therefore, one should investigate other NMR techniques (eg. pure shift NOESY161) which 




Chapter 5 Conclusions 
This thesis set out to use a quantitative QM/NMR approach together with synthesis as 
a tool to probe and predict flexible molecules’ solution state conformational behaviours.  
This tool was applied to investigate the complex dynamic conformational behaviour of 
baulamycin antibiotics which have long, flexible carbon chains. The comparison between the 
computed NMR parameters with the experimentally measured data enabled the elimination of 
112 out of 128 possible stereoisomers. The synthesis of an encoded mixture of the natural 
product finally enabled the correct configuration of baulamycins to be unambiguously 
identified.  
This tool was also applied to the design and conformational analysis of unnatural amino 
acids which project side chains in a predictable manner with tuneable distances based on the 
conformational control exerted by quaternary centres. Synthetic methodology utilising the 
stereoselective homologation of boronic ester was developed to install tert-butyl groups in a 
highly precise fashion. The predictable molecular conformation of these unnatural amino acid 
could, in principle, be utilised to generate novel chemical probes to interrogate other chemical 
or biological systems. 
Detailed conformational analysis using the quantitative QM/NMR approach offered 
insight into factors controlling the helical screw-sense of all-syn methylated hydrocarbons, 
which would allow the design and synthesis of a new system where the helical screw-sense can 
be switched between M and P forms. Although the minimisation of gauche interactions was 
found to be the major factor controlling the preference of the helical screw-sense of these 
molecules, further QM/NMR analysis of other all-syn methylated hydrocarbons with different 
end groups is required to establish the relationship between the nature of the end groups and 
the preferred helical screw-sense.  
The work outlined in this thesis demonstrated one’s ability to predict and probe 
complex dynamic conformational behaviours of flexible molecules using a combination of 
computational modelling, NMR spectroscopy and synthesis. Further developments in accurate 
conformational analysis by computation and NMR methods to extract hard-to-measure NMR 
parameters are required to enable us to confidently and reliably determine the structures of 
flexible open chain-molecules exclusively in silico, and to create molecules with bespoke 




Chapter 6 Experimental 
General Information 
Molecular mechanics calculations were performed using the MacroModel software package162 
(version 9.9) accessed through the Maestro108 (version 9.2) program. All geometry 
optimisations, frequency calculations and NMR calculations were performed using the 
Gaussian 09 Software package.158 All molecular mechanics calculations were performed using 
the Unix computational resource of the School of Chemistry, University of Bristol. All DFT 
calculations were performed using either the Unix computational resource or the computational 
facilities of the advanced computing research centre at the University of Bristol 
(http://www.bris.ac.uk/acrc). 
1H- and 13C- nuclear magnetic resonance (NMR) spectra were acquired at various field 
strengths as indicated using JEOL ECS 300MHz, JEOL ECS 400MHz, Varian 400 MR, Varian 
VNMRS 500MHz NMR spectrometers equipped with direct observe two-channel probes, a 
Bruker Avance III HDTM 700MHz NMR Spectrometer with a 1.7 mm inverse triple resonance 
micro-Cryo Probe or a Bruker AVANCE III HD 500 MHz NMR Spectrometer with 5 mm 
DCH 13C1H/D Cryo Probe. 1H chemical shifts (δH) are quoted in parts per million (ppm) and 
are referenced to the residual protio solvent resonance (CHCl3 = 7.26 ppm, MeOH = 3.31 ppm, 
toluene = 2.09 ppm). Data are reported as follows: chemical shift, integration, multiplicity (s = 
singlet, br. s = broad singlet, d = doublet, t = triplet, q = quartet, pent = pentet, sext = sextet, 
hept = heptet, m = multiplet, dd = doublet of doublet, etc.), coupling constant(s), and 
assignment. 13C chemical shifts (δC) are quoted in parts per million (ppm) and are referenced 
to the residual protio solvent resonance (CHCl3 = 77.0 ppm, MeOH = 49.0 ppm, toluene = 20.4 
ppm). 11B NMR spectra were measured using Norell S-200-QTZ quartz NMR tubes at 96 or 
128 MHz with complete proton decoupling.  
Analytical TLC was performed on aluminium backed silica plates (Merck, Silica Gel 60 F254, 
0.25 mm). Compounds were visualised by fluorescence quenching or by staining the plates 
with either 5% solution of phosphomolybdic acid (H3PMo12O40) in EtOH, KMnO4, ninhydrin, 
or anisaldehyde followed by heating. Flash column chromatography was performed on either 
silica gel (Merk, Silica Gel 60, 40‒63 µm) or Biotage SNAP prepacked columns. All mixed 
solvent eluents are reported as v/v solutions.  
GCMS was performed using an Agilent HP-5MS column (15 m × 0.250 mm), an Agilent 6890 




chromatogram and molecular ion analysis. Method 70-1X: Inlet temperature 250 °C; Flow rate: 
1.0 mL/min; hold at 70 °C for 0 min; ramp 20 °C/min to 200 °C; ramp 45.0 °C/min to 300 °C; 
hold at 300 °C for 2 min. 
Mass spectra were recorded by the University of Bristol, School of Chemistry departmental 
mass spectrometry service using electrospray ionisation (ESI) techniques for low- and high-
resolution mass spectra. HRMS ESI was performed on either a Bruker Daltonics Apex IV, 7-
Tesla FT-ICR or microTOF II. Samples were submitted in Et2O, pentane or CHCl3.  
All infrared spectra were recorded on the neat compounds using a PerkinElmer Spectrum One 
FT-IR spectrometer, irradiating between 4000 cm‒1 and 600 cm‒1. Only strong and selected 
absorbances (νmax) are reported.  
Optical rotations were obtained using a Bellingham + Stanley Ltd. ADP220 polarimeter at 589 
nm (Na D-line) in a cell with a path length of 1 dm. Specific rotation values are given in (deg 
mL)/(g dm). Melting points were measured with a Stuart SMP30 melting point apparatus and 
are uncorrected.  
Chiral high performance liquid chromatography (HPLC) separations were performed on an 
Agilent 1100 Series HPLC unit equipped with UV-vis diode-array detector monitored at 210.8 
nm, using Daicel Chiralpak IA, IB or IC columns (4.6 × 250 mm2, 5 µm) fitted with respective 
guards (4 × 10 mm2). Supercritical fluid chromatography (SFC) was performed on a Thar SFC 
investigator using a Daicel Chiralpak IA, IB, IC columns or a Whelk-O1 (4.6 × 250 mm2, 5 
µm). 
Single crystal X-ray diffraction experiments were carried out at 100(2) K on a Bruker APEX 
II CCD diffractometer using Mo-K α radiation (λ = 0.71073 Å). Intensities were integrated163 
and absorption corrections were based on equivalent reflections using SADABS.164 The 
structure was solved using Superflip165-166 and refined against F 2 in SHELXL167-168 using 
Olex2169.All of the non-hydrogen atoms were refined anisotropically. While all of the hydrogen 
atoms were located geometrically and refined using a riding model. Crystal structure and 





Chapter 2  
General computational procedures 
 
Figure 6.1: Compounds studied by NMR and computational modelling. All calculations were 
performed with terminal phenyl and methyl ketone end groups as shown in the figure. 
A Monte Carlo multiple minimum (MCMM)63 conformational search was used along 
with Merck Molecular Force Field (MMFFs)61,170 and structures were minimised using the 
truncated Newton Conjugate Gradients (TNCG) method with 500 iterations with a gradient 




found were stored. The searches were performed on all candidates outlined in Figure 6.1 with 
the conditions described above with a number of steps large enough that conformers below 10 
kJ mol−1 were found more than 10 times on average. Conformers which have the same 
backbone conformation but differ in Ph, OH and iPr rotations only were eliminated as 
redundant conformers based on maximum deviation for any pair of the corresponding atoms 
(NOT marked X in Figure 6.2) exceeding 0.5 Å, or energies differing by greater than 1 kJ mol−1. 
 
Figure 6.2: Atoms selected for redundant conformer elimination. 
Conformers with a molecular mechanics potential energy below 10 kJ mol−1, together 
with the same number of conformers between 10-21 kJ mol−1 in the remaining pool (see table 
6.2, 6.8, 6.14 and 6.18 for details), were subjected to Density Functional Theory (DFT) 
geometry optimisation and frequency calculations with the mPW1PW91 functional using the 
6-31 G (d) basis set (Basis set 1, BS1). Where the number of conformers below 10 kJ mol−1 
was less than 50, the first 50 conformers, together with a further randomly sampled 50 
conformers were subjected to the subsequent calculations.  
In order to obtain a more accurate description of conformer energies, additional single 
point calculations were performed using the BS1 optimised structures. The effect of a larger 
basis set on conformer energy was evaluated by performing single point calculations using 
mPW1PW91 functional and 6-311G (d,p) basis set (BS2). Solvation effects were also 
evaluated by performing single point calculations using mPW1PW91/BS1 with the Integral 
Equation Formalism Polarizable Continuum Model (IEF-PCM) continuum dielectric solvation 
model using methanol as solvent (=32.63).171-172 
At this stage, low energy conformers with a combined population of greater than 80%, 
based on their Gibbs free energies (see below), were subjected to further geometry optimisation 
by DFT using mPW1PW91 6-311 G (d, p) level of theory with methanol as solvent (IEF-PCM) 
and then NMR properties (magnetic shielding tensor and total nuclear spin-spin coupling 
constants) were computed with GIAO (gauge-independent atomic orbitals) method with 




PCM). Cartesian coordinates for conformers subjected to NMR calculations can be found at 





Calculation of estimated Gibbs free energies (𝑮𝒆𝒔𝒕
𝐁𝐒𝟐,𝐌𝐞𝐎𝐇
) and Boltzmann population 
Due to the size of the molecules (77 atoms) and large number of geometry optimisation 
and frequency calculations required to perform in this study (~100 for each diastereoisomer), 
the nature of the stationary point and the Gibbs free energy of each conformer were calculated 
using a lower basis set (BS1) and the effect of a higher basis set (BS2) and solvation (methanol) 
on energies were incorporated by single point calculations. Gibbs free energies (in kJ mol−1) 
of each conformer (𝐺𝑒𝑠𝑡
BS2,MeOH

















 is the Gibbs free energy of conformer i with basis set 1 in gas phase, 𝐸𝑖
BS1,gas
 
is the potential energy of conformer i with basis set 1 in gas phase, 𝐸𝑖
BS2,gas
 is single point 
energy of conformer i with basis set 2 in gas phase, 𝐸𝑖
BS1,MeOH
 is the single point energy of 
conformer i with basis set 1 in methanol. This approximation of Gibbs free energies is based 
on the assumption that the change in basis set and solvation has minimal impact on the change 




,   Equation 6.1). 
The estimated Gibbs free energies (𝐺BS2,MeOH) of each conformer were then used in 


















 is the estimated Gibbs free energy (relative to the global minimum, in kJ 
mol−1) of conformer i, R is the Boltzmann constant (8.314 × 10−3 kJ mol−1), T is temperature 
of the system (298K) and g is the degeneracy of conformer i (which is 1 for every conformer 
in this study). 
Calculation of Boltzmann averaged scaled chemical shifts. 









 Equation 6.3 
 
where 𝜎𝑖
𝑥 is the magnetic shielding tensor of nucleus x in conformer i, 𝑝𝑖 is the Boltzmann 
population of conformer i and ∑ 𝑝 is the combined population of conformers involved.  







 Equation 6.4 
where 𝜎𝑥  is the Boltzmann averaged magnetic shielding tensors for nucleus x, 𝜎𝑇𝑀𝑆  is the 
magnetic shielding tensor of either proton (31.92128) or carbon (189.5456) nuclei in 
tetramethylsilane (TMS) computed at the same level of theory (mPW1PW91, 6-311G(d,p), 
IEF-PCM (methanol)).  
In order to remove systematic errors, the calculated chemical shifts (𝛿𝑐𝑎𝑙𝑐
𝑥 ) were then 




 Equation 6.5 
where intercept and slope were obtained by plotting the calculated chemical shifts (𝛿𝑐𝑎𝑙𝑐) for 
each diastereoisomer (as y-axis) against the re-extracted experimental chemical shifts of 
baulamycin A95 (as x-axis) unless otherwise stated. Chemical shifts of nuclei at positions 1, 2’, 
3’, 4’, 5’, 16, 17, 18 and 3 were not used for either scaling the data or further comparison.  
These scaled chemical shifts were used for the Willoughby-type, DP4 and 2 analysis 




Calculation of Boltzmann averaged scalar coupling constants 
Total nuclear spin-spin coupling constants for each conformer were used to obtain the 




    Equation 6.6 
 
where 𝐽𝐻𝑋,𝑖 is the total calculated nuclear spin-spin coupling constant (in Hz) of interest in 
conformer i with a 6% linear scaling correction44,160, 𝑝𝑖  is the Boltzmann population of 
conformer i and ∑ 𝑝 is the combined population of conformers involved. 
 
Calculation of Boltzmann averaged 1H-1H distances 
Interproton distances were extracted from the BS1 optimised geometries for compound 
2.1, 2.7 – 2.10 to obtain the Boltzmann averaged 1H-1H distances. Because quantitative NOE-
distance analysis is very sensitive to conformer populations (interproton distances scale with 
r−6), all conformations sampled by DFT were subjected to the quantitative NOE-distance 
analysis and the subsequent NOE-distance based population refinement. (For more details see 
the NMR procedure section). Boltzmann averaged distances from one proton (H) to another 
proton (Hx) were calculated according to: 
𝑟𝐻−𝐻𝑥,𝑐𝑎𝑙𝑐 = (∑ (𝑟𝐻−𝐻𝑥,𝑖)
−6  × 𝑝𝑖)𝑖 
−
1
6 Equation 6.7 
 
where 𝑟𝐻−𝐻𝑥,𝑖 is the computed 
1H-1H distances (in Å) of interest in conformer i and 𝑝𝑖 is the 
Boltzmann population of conformer i. 
To Boltzmann average distances from a single proton (H) to a pair of methylene protons 
(Hab) which are overlapped e.g. H10 or H15, giving rise to a single NOE correlation, the 
following equation is used: 
𝑟𝐻−𝐻𝑎𝑏,𝑐𝑎𝑙𝑐 = (
∑ ((𝑟𝐻−𝐻𝑎,𝑖)
−6 ×𝑝𝑖 + (𝑟𝐻−𝐻𝑏,𝑖)









where 𝑟𝐻−𝐻𝑎,𝑖 is the computed 
1H-1H distances (in Å) from proton H to one of the methylene 
protons Ha, 𝑟𝐻−𝐻𝑏,𝑖  is the computed 
1H-1H distances (in Å) from the proton H to the other 
methylene proton Hb in conformer i and 𝑝𝑖 is the Boltzmann population of conformer i. 
χ2 Analysis 
Table 6.1: A summary of values of n and m used to calculate χ2(reduced) in fragment A and fragment 
B studies. 
Fragment A H C 
nJHH nJHC rnoe 
n 8 7 9 16 18 
m 1 
Fragment B H C 
nJHH nJHC rnoea 
n 10 9 13 10 0 
m 1 





Calculated data for fragment A studies starting from gas conformational search (2.6 and 
2.7 – 2.10) 
Conformational search was performed in gas phase using 500,000 iterations. Table 6.2 
gives the numbers of conformers found by molecular mechanics conformational search, 
numbers of non-redundant conformers derived from these, resulting numbers of conformers 
found below 10 kJ mol−1, numbers of conformers selected for DFT geometry optimisation and 
frequency calculations, and (from these last) the number of conformers selected for NMR 
calculations for compound 2.6 and 2.7 – 2.10. Total CPU time of ~ 18656 hours (~2.1 years) 
were spent on computing these compounds. 
Table 6.2: Summary of numbers of conformers found by molecular mechanics conformational search 







Conformers          














2.6 2086 1674 98 196 6 32 
2.7 650 444 18 100 8 8 
2.8 2215 1620 85 170 25 18 
2.9 2455 1730 82 164 9 10 




Calculated data for 2.6 (gas MM conformational search) 
 
Figure 6.3: 2D structure of 2.6 and 3D structure of its lowest energy conformer 2.6-1 obtained after population refinement using 1H-1H distances derived from 
the 2D-ROESY spectrum of the natural product. 
Table 6.3: Calculated energies (in kJ mol−1) and population for the major conformers of 2.6 before and after population refinement. All conformers listed were 










Dihedral cluster Population after refinement 
2.6-1 18.7 29.8 17.5 28.6 23.9 15.1 0.07% Cluster 26 12.17% 
2.6-2 8.9 13.2 15.3 13.4 11.2 18.3 0.02% Cluster 9 10.38% 
2.6-3 20.3 32.3 18.2 30.7 26.7 15.9 0.05% Cluster 26 8.97% 
2.6-4 2.9 11.9 18.9 10.8 11.7 22.5 0.00% Cluster 5 6.34% 
2.6-5a 19.9 17.7 5.6 16.3 8.6 0.0 30.11% Cluster 14 5.90% 
2.6-6 20.9 30.7 19.6 29.4 24.7 17.3 0.03% Cluster 26 5.09% 
2.6-7 20.9 33.3 20.3 29.4 27.4 15.4 0.06% Cluster 23 4.92% 
2.6-8a 16.4 17.9 6.9 16.4 8.5 0.7 22.29% Cluster 14 4.37% 
2.6-9 20.8 34.9 28.4 33.5 23.6 20.5 0.01% Cluster 9 4.27% 
2.6-10 11.8 11.4 15.1 9.4 12.1 18.7 0.02% Cluster 17 3.58% 




2.6-12 9.1 10.6 17.7 8.5 13.4 23.3 0.00% Cluster 3 3.40% 
2.6-13 9.1 17.0 21.1 15.4 16.8 24.1 0.00% Cluster 5 3.21% 
2.6-14 10.4 15.9 14.8 13.3 16.1 17.2 0.03% Cluster 23 2.30% 
2.6-15 9.5 15.0 15.1 12.7 15.3 17.9 0.02% Cluster 23 1.79% 
2.6-16 0.0 11.0 13.2 9.2 7.0 12.2 0.22% Cluster 20 1.52% 
2.6-17 8.0 12.1 20.0 12.6 9.9 23.1 0.00% Cluster 9 1.46% 
2.6-18a 18.6 19.9 9.9 17.3 11.4 3.6 7.08% Cluster 14 1.39% 
2.6-19 7.8 10.4 20.3 9.0 12.6 26.0 0.00% Cluster 3 1.14% 
2.6-20a 4.8 1.7 0.0 1.1 1.9 4.4 5.07% Cluster 14 0.99% 
2.6-21 2.6 1.0 0.0 0.8 1.1 4.7 4.58% Cluster 14 0.90% 
2.6-22 7.4 24.9 21.5 21.1 21.9 19.8 0.01% Cluster 15 0.87% 
2.6-23 4.0 1.7 0.3 1.1 2.0 4.8 4.27% Cluster 14 0.84% 
2.6-24 2.7 12.0 16.9 11.2 11.1 20.1 0.01% Cluster 7 0.76% 
2.6-25a 20.9 24.6 12.8 22.6 14.2 5.4 3.43% Cluster 14 0.67% 
2.6-26 20.7 37.0 27.1 33.0 29.2 20.3 0.01% Cluster 23 0.67% 
2.6-27 7.0 19.5 22.8 17.2 15.2 21.0 0.01% Cluster 15 0.52% 
2.6-28 15.7 15.0 22.1 15.9 13.1 26.1 0.00% Cluster 9 0.44% 
2.6-29b 16.3 22.1 21.1 19.2 20.5 21.5 0.01% Cluster 23 0.42% 
2.6-30 19.9 32.3 27.4 29.2 24.8 21.6 0.00% Cluster 23 0.39% 
2.6-31 9.2 15.1 20.2 13.6 13.4 21.8 0.00% Cluster 15 0.38% 
2.6-32 16.5 23.4 19.5 20.7 23.6 21.8 0.00% Cluster 7 0.38% 
aThese conformers were used to calculate the Boltzmann averaged NMR parameters before population refinement 







Calculated data for 2.7 (gas MM conformational search) 
 
Figure 6.4: 2D structure of 2.7 and 3D structure of its lowest energy conformer 2.7-1 obtained after population refinement using 1H-1H distances derived from 
the 2D-ROESY spectrum of the natural product. 
Table 6.4: Calculated energies (in kJ mol−1) and population for the major conformers of 2.7 before and after population refinement. The first 8 conformers with 
the combined population of 95.92% were used to calculate the NMR properties of 2.7 after population refinement. For the NOE-refined DDG (in kJ mol−1) for 
each dihedral group, see Table 6.32. 
Conformer ∆EMMFFs, 
gas 






Dihedral cluster Population after 
refinement 
2.7-1a 18.8 20.0 4.5 17.4 11.3 0.4 22.44% Cluster 4 35.61% 
2.7-2a 20.7 23.8 7.2 20.3 14.7 1.9 12.07% Cluster 4 19.15% 
2.7-3 9.3 27.5 23.9 25.2 21.3 22.8 0.00% Cluster 6 18.12% 
2.7-4a 19.8 27.9 8.2 24.9 19.5 4.3 4.73% Cluster 4 7.50% 
2.7-2.7a 20.8 24.0 9.6 21.1 15.2 5.3 3.11% Cluster 4 4.94% 
2.7-6a 12.6 3.6 0.0 2.4 2.8 5.4 2.93% Cluster 4 4.65% 
2.7-7a 18.1 23.3 3.0 21.6 14.7 0.0 26.32% Cluster 9 3.37% 
2.7-8a 12.3 21.1 2.3 19.5 13.8 0.7 20.17% Cluster 9 2.58% 
2.7-9a 0.0 0.0 0.4 0.0 0.0 7.7 1.18% Cluster 9 0.15% 
2.7-10a 18.5 24.4 10.5 22.3 16.8 8.2 0.96% Cluster 9 0.12% 
2.7-11a 9.5 3.2 2.0 3.1 3.2 9.1 0.66% Cluster 9 0.08% 




Calculated data for 2.8 (gas MM conformational search) 
  
Figure 6.5: 2D structure of 2.8 and 3D structure of its lowest energy conformer 2.8-1 obtained after population refinement using 1H-1H distances derived from 
the 2D-ROESY spectrum of the natural product. 
Table 6.5: Calculated energies (in kJ mol−1) and population for the major conformers of 2.8 before and after population refinement. The first 18 conformers 
with the combined population of 85.84% were used to calculate the NMR properties of 2.8 after population refinement. For the NOE-refined DDG (in kJ mol−1) 
for each dihedral group, see Table 6.32. 
Conformer ∆EMMFFs, 
gas 






Dihedral cluster Population after 
refinement 
2.8-1 8.3 27.9 9.8 26.8 16.8 8.3 20.98% Cluster 3 17.63% 
2.8-2 5.6 20.9 17.2 19.1 18.9 16.1 0.03% Cluster 5 15.00% 
2.8-3 9.8 24.5 20.0 21.9 21.8 17.4 0.02% Cluster 5 8.86% 
2.8-4a 12.1 22.7 11.0 20.9 13.1 2.2 8.53% Cluster 3 7.17% 
2.8-5a 8.5 0.0 0.0 0.0 0.0 2.6 7.24% Cluster 3 6.08% 
2.8-6 14.1 41.9 25.6 39.2 32.5 16.1 0.03% Cluster 1 4.71% 
2.8-7 7.0 38.8 25.8 35.6 30.1 16.7 0.02% Cluster 1 3.73% 
2.8-8a 3.9 8.9 2.6 7.5 8.9 4.0 4.23% Cluster 3 3.56% 
2.8-9a 9.1 23.9 10.6 22.2 16.5 4.1 3.99% Cluster 3 3.35% 
2.8-10a 18.0 28.3 14.5 25.9 18.3 4.7 3.10% Cluster 3 2.61% 




2.8-12a 19.9 25.8 11.7 26.0 16.5 5.1 2.66% Cluster 3 2.23% 
2.8-13 8.1 39.5 27.1 36.4 31.0 18.2 0.01% Cluster 1 2.04% 
2.8-14a 3.4 10.3 5.4 8.5 9.6 5.6 2.18% Cluster 3 1.83% 
2.8-15 6.4 20.2 12.6 18.6 13.0 6.4 1.60% Cluster 3 1.34% 
2.8-16 6.1 4.4 4.8 4.7 5.7 9.2 0.52% Cluster 10 1.24% 
2.8-17a 16.3 32.0 16.7 30.0 21.5 6.8 1.33% Cluster 3 1.12% 
2.8-18 20.4 25.1 23.9 23.5 22.7 22.5 0.00% Cluster 5 1.10% 
2.8-19a 7.3 4.8 2.4 6.8 1.4 3.6 4.92% Cluster 8 0.26% 
2.8-20a 9.6 28.6 10.9 28.3 19.8 4.3 3.75% Cluster 8 0.20% 
2.8-21a 9.8 25.3 11.4 24.7 16.8 4.9 2.91% Cluster 8 0.15% 
2.8-22a 9.4 28.4 15.2 28.9 15.1 5.1 2.64% Cluster 8 0.14% 
2.8-23a 5.7 24.8 12.2 25.2 15.0 5.3 2.44% Cluster 8 0.13% 
2.8-24a 18.2 28.2 13.1 27.4 18.7 5.5 2.26% Cluster 8 0.12% 
2.8-25a 9.4 15.4 14.1 12.5 7.4 5.8 2.00% Cluster 7 0.48% 
2.8-26a 2.3 14.5 12.8 11.6 8.2 6.2 1.69% Cluster 7 0.40% 
2.8-27a 10.4 20.2 14.0 17.0 13.3 6.5 1.50% Cluster 7 0.36% 
2.8-28a 17.6 32.1 17.0 30.4 21.2 7.0 1.23% Cluster 3 1.03% 
2.8-29a 20.4 30.8 14.0 28.7 23.4 7.1 1.22% Cluster 7 0.29% 
2.8-30a 19.9 28.1 14.5 26.9 19.5 7.4 1.06% Cluster 3 0.89% 
2.8-31a 17.7 28.0 14.4 28.2 18.1 7.4 1.05% Cluster 8 0.06% 
2.8-32a 2.5 13.3 7.7 13.7 10.2 7.7 0.95% Cluster 8 0.05% 
2.8-33a 14.0 19.3 13.1 16.1 14.6 7.8 0.89% Cluster 7 0.21% 




Calculated data for 2.9 (gas MM conformational search) 
  
Figure 6.6: 2D structure of 2.9 and 3D structure of its lowest energy conformer 2.9-1 obtained after population refinement using 1H-1H distances derived from 
the 2D-ROESY spectrum of the natural product. 
Table 6.6: Calculated energies (in kJ mol−1) and population for the major conformers of 2.9 before and after population refinement. The first 9 conformers with 
the combined population of 92.28% were used to calculate the NMR properties of 2.9 after population refinement. For the NOE-refined DDG (in kJ mol−1) for 










Dihedral cluster Population after 
refinement 
2.9-1 8.9 23.4 20.4 17.7 18.1 19.3 0.03% Cluster 7 22.18% 
2.9-2a 19.5 32.7 13.8 27.2 22.0 7.5 3.51% Cluster 15 15.89% 
2.9-3 7.1 21.9 21.0 15.5 17.5 20.2 0.02% Cluster 7 15.38% 
2.9-4a 16.2 19.4 3.2 15.9 9.7 0.0 73.79% Cluster 18 14.03% 
2.9-5a 0.0 13.6 9.8 7.4 9.6 9.8 1.43% Cluster 23 11.93% 
2.9-6a 20.1 25.0 9.4 21.3 16.1 6.9 4.61% Cluster 10 8.70% 
2.9-7 9.6 15.7 11.9 12.3 10.4 13.1 0.37% Cluster 15 1.67% 
2.9-8 16.6 20.6 12.7 17.3 15.0 13.6 0.30% Cluster 15 1.37% 




2.9-10a 18.6 25.3 10.4 22.5 14.0 6.3 5.67% Cluster 18 1.48% 
2.9-11a 4.6 0.0 0.0 0.0 0.2 10.2 1.20% Cluster 20 0.23% 
2.9-12a 16.2 19.2 8.2 13.7 16.8 10.3 1.16% Cluster 17 0.15% 
2.9-13a 9.2 19.0 10.1 15.5 13.3 11.0 0.86% Cluster 1 0.31% 




Calculated data for 2.10 (gas MM conformational search) 
  
Figure 6.7: 2D structure of 2.10 and 3D structure of its lowest energy conformer 2.10-1 obtained after population refinement using 1H-1H distances derived 
from the 2D-ROESY spectrum of the natural product. 
Table 6.7: Calculated energies (in kJ mol−1) and population for the major conformers of 2.10 before and after population refinement. All conformers with the 
combined population of 92.28% were used to calculate the NMR properties of 2.10 after population refinement. For the NOE-refined DDG (in kJ mol−1) for 











Dihedral cluster Population after 
refinement 
2.10-1a 17.0 26.6 4.7 21.2 13.7 0.00 38.14% Cluster 13 23.16% 
2.10-2 a 20.6 27.6 7.4 20.8 14.1 0.6 29.66% Cluster 4 12.68% 
2.10-3 9.2 21.1 15.9 14.8 11.8 13.9 0.14% Cluster 9 10.52% 
2.10-4a 17.6 15.2 0.7 12.3 7.2 3.4 9.79% Cluster 15 10.23% 
2.10-5 8.0 27.6 25.1 21.1 21.2 25.8 0.00% Cluster 6 4.42% 
2.10-6 20.9 50.3 33.8 43.2 35.8 25.9 0.00% Cluster 6 4.36% 
2.10-7 8.5 23.3 18.1 18.0 13.2 16.2 0.05% Cluster 9 4.16% 
2.10-8 20.4 29.0 21.8 24.0 14.9 16.3 0.05% Cluster 9 4.03% 
2.10-9 18.1 30.2 20.5 23.6 20.1 17.2 0.84% Cluster 9 2.77% 
2.10-10 8.3 3.6 1.8 0.7 0.5 17.3 0.04% Cluster 14 2.20% 




2.10-12a 8.4 11.1 1.9 7.3 4.6 5.1 4.79% Cluster 4 2.05% 
2.10-13 15.5 41.7 28.7 33.9 35.0 27.8 0.00% Cluster 6 2.02% 
2.10-14 16.9 43.2 29.7 37.0 34.0 27.9 0.00% Cluster 6 1.95% 
2.10-15a 8.9 10.5 2.9 6.2 4.5 6.2 3.10% Cluster 4 1.33% 
2.10-16 11.3 36.0 24.1 27.4 26.2 19.30 0.02% Cluster 9 1.21% 
2.10-17 9.4 23.8 14.3 17.3 14.1 11.77 0.33% Cluster 16 1.20% 
2.10-18 8.1 26.7 18.0 20.7 16.6 15.38 0.08% Cluster 2 1.18% 
2.10-19 11.5 25.1 14.5 18.6 17.6 14.25 0.12% Cluster 3 0.95% 
2.10-20 17.4 29.1 26.8 22.8 25.0 29.95 0.00% Cluster 6 0.84% 
2.10-21a 8.0 9.5 3.9 5.6 3.3 7.35 1.96% Cluster 4 0.84% 
2.10-22a 14.5 25.6 9.9 21.2 14.4 7.97 1.53% Cluster 4 0.65% 
2.10-23a 7.6 10.0 4.4 6.4 3.7 8.10 1.45% Cluster 4 0.62% 
2.10-24 20.4 36.0 24.2 29.5 25.7 21.07 0.008% Cluster 9 0.59% 
2.10-25 7.6 21.0 13.6 15.6 15.1 15.77 0.07% Cluster 10 0.52% 




Calculated data for fragment A studies starting from octanol conformational search (2.6 
and 2.7 – 2.10) 
Conformational search was performed with octanol as implicit solvent using 500,000 
iterations for 2.7, 2.8, and 2.9, 300,000 iterations for 2.6 and 2.10. Table 6.8 gives the numbers 
of conformers found by molecular mechanics conformational search, numbers of non-
redundant conformers derived from these, resulting numbers of conformers found below 10 kJ 
mol−1, numbers of conformers selected for DFT geometry optimisation and frequency 
calculations, and (from these last) the number of conformers selected for NMR calculations for 
compound 2.6 and 2.7 – 2.10. Total CPU time of ~ 24283 hours (~2.7 years) were spent on 
computing these compounds. 
Table 6.8: Summary of numbers of conformers found by molecular mechanics conformational search 







Conformers          














2.6 8698 5901 282 564 36 21 
2.7 2428 1114 44 100 12 8 
2.8 4272 1946 102 204 20 11 
2.9 5742 3280 62 124 5 10 
2.10 8794 3670 107 214 18 25* 






Calculated data for 2.6 (octanol MM conformational search) 
  
Figure 6.8: 2D structure of 2.6 and 3D structure of its lowest energy conformer 2.6-1 obtained after population refinement using 1H-1H distances derived from 
the 2D-ROESY spectrum of the natural product. 
Table 6.9: Calculated energies (in kJ mol−1) and population for the major conformers of 2.6 before and after population refinement. All conformers listed were 










Dihedral cluster Population after refinement 
2.6-1a 20.67 35.28 19.56 30.66 27.69 18.19 0.02% Cluster 6 15.57% 
2.6-2a 14.73 39.69 31.61 25.09 22.11 10.26 0.39% Cluster 13 11.84% 
2.6-3a 9.60 31.05 12.69 26.72 23.99 12.13 0.18% Cluster 21 9.60% 
2.6-4a 9.90 28.68 19.18 26.65 18.88 18.19 0.02% Cluster 19 8.69% 
2.6-5a 15.00 31.50 15.14 27.05 23.95 13.97 0.09% Cluster 21 4.56% 
2.6-6a 9.98 39.38 22.11 34.29 28.68 17.15 0.02% Cluster 5 4.42% 
2.6-7a 16.00 33.43 22.77 31.07 22.36 20.16 0.01% Cluster 19 3.93% 
2.6-8a 15.40 36.92 22.54 34.50 26.14 20.16 0.01% Cluster 19 3.92% 
2.6-9a 18.97 39.75 22.52 35.10 29.38 18.34 0.02% Cluster 5 2.74% 
2.6-10aa 3.25 17.62 0.00 15.32 9.09 0.00 24.71% Cluster 3 2.50% 




2.6-12a 16.68 32.91 17.00 28.52 25.78 16.31 0.03% Cluster 21 1.77% 
2.6-13a 8.89 33.30 17.33 29.07 26.07 16.71 0.03% Cluster 21 1.51% 
2.6-14a 11.69 17.37 18.60 15.78 13.79 24.27 0.00% Cluster 6 1.33% 
2.6-15a 17.64 38.25 21.07 33.66 28.65 17.72 0.02% Cluster 4 1.16% 
2.6-16a 8.45 31.03 24.00 28.70 21.87 23.33 0.00% Cluster 19 1.09% 
2.6-17a 8.84 43.22 26.81 38.07 31.96 21.22 0.00% Cluster 5 0.85% 
2.6-18aa 6.64 20.32 2.78 17.85 11.86 2.69 8.33% Cluster 3 0.84% 
2.6-19a 16.84 34.51 20.03 30.23 26.20 18.27 0.02% Cluster 21 0.81% 
2.6-20a 8.45 15.35 16.09 14.64 13.61 24.47 0.00% Cluster 19 0.69% 
2.6-21a 20.47 38.79 20.97 34.81 29.65 18.67 0.01% Cluster 21 0.69% 
2.6-22aa 6.83 19.43 4.57 17.13 9.91 3.58 5.82% Cluster 3 0.59% 
2.6-23aa 7.75 20.38 5.93 18.08 10.91 4.99 3.29% Cluster 3 0.33% 
2.6-24aa 9.41 20.28 5.55 17.78 11.67 5.28 2.93% Cluster 3 0.30% 
2.6-25aa 5.05 18.04 5.61 15.54 9.66 5.55 2.63% Cluster 3 0.27% 
2.6-26aa 8.83 20.10 6.74 17.46 10.83 5.65 2.53% Cluster 3 0.26% 
2.6-27aa 8.84 20.10 6.74 17.46 10.83 5.65 2.53% Cluster 3 0.26% 
2.6-28aa 7.58 22.96 7.51 20.51 12.85 5.78 2.40% Cluster 3 0.24% 
2.6-29aa 9.02 18.78 5.08 15.96 11.92 6.24 1.99% Cluster 3 0.20% 
2.6-30aa 8.54 20.77 6.78 18.54 11.91 6.52 1.77% Cluster 3 0.18% 
2.6-31aa 5.88 21.13 7.47 18.58 12.04 6.66 1.68% Cluster 3 0.17% 
2.6-32aa 9.46 20.86 7.91 18.28 11.51 6.80 1.58% Cluster 3 0.16% 
2.6-33aa 5.84 20.11 7.70 17.66 10.99 6.95 1.50% Cluster 3 0.15% 
2.6-34aa 16.65 43.97 35.02 27.69 21.63 7.23 1.33% Cluster 3 0.13% 
2.6-35aa 7.81 21.56 8.16 18.33 13.05 7.25 1.32% Cluster 3 0.13% 
2.6-36aa 7.16 21.54 7.31 18.86 13.59 7.51 1.19% Cluster 3 0.12% 
2.6-37aa 5.98 20.44 8.19 17.45 12.03 7.62 1.14% Cluster 3 0.12% 
2.6-38aa 5.70 22.30 9.50 20.10 12.00 7.84 1.04% Cluster 3 0.11% 
2.6-39aa 4.34 19.79 8.46 17.09 11.11 7.91 1.01% Cluster 3 0.10% 




2.6-41aa 4.75 20.49 8.14 17.87 12.27 8.12 0.93% Cluster 3 0.09% 
2.6-42aa 7.83 20.59 9.02 17.83 11.64 8.15 0.92% Cluster 3 0.09% 
2.6-43aa 4.39 18.41 8.29 16.16 9.80 8.26 0.88% Cluster 3 0.09% 
2.6-44aa 2.41 19.85 8.64 17.77 10.89 8.44 0.82% Cluster 3 0.08% 
2.6-45aa 6.64 21.23 8.67 18.29 13.13 8.47 0.81% Cluster 3 0.08% 
2.6-46aa 8.91 25.60 9.76 22.64 16.54 8.58 0.77% Cluster 3 0.08% 
2.6-47aa 8.87 24.14 10.84 21.18 14.09 8.67 0.75% Cluster 3 0.08% 
2.6-48aa 4.12 20.28 9.22 17.93 11.52 8.94 0.67% Cluster 3 0.07% 
2.6-49aa 3.85 20.61 9.49 18.38 11.56 9.05 0.64% Cluster 3 0.06% 
2.6-50aa 8.42 22.82 10.53 20.04 13.34 9.10 0.63% Cluster 3 0.06% 
2.6-51aa 6.31 18.84 9.38 16.34 10.26 9.14 0.62% Cluster 3 0.06% 






Calculated data for 2.7 (octanol MM conformational search) 
  
Figure 6.9: 2D structure of 2.7 and 3D structure of its lowest energy conformer 2.7 -1 obtained after population refinement using 1H-1H distances derived from 
the 2D-ROESY spectrum of the natural product. 
Table 6.10: Calculated energies (in kJ mol−1) and population for the major conformers of 2.7 before and after population refinement. All conformers listed were 










Dihedral cluster Population after refinement 
2.7-1aa 16.72 25.89 9.12 22.51 16.22 2.98 8.19% Cluster 4 40.01% 
2.7-2a 9.42 30.31 25.42 27.97 22.38 22.08 0.00% Cluster 3 8.89% 
2.7-3a 15.80 29.79 13.52 26.89 19.09 6.85 1.71% Cluster 4 8.37% 
2.7-4a 15.51 31.22 26.51 29.25 22.38 22.64 0.00% Cluster 3 7.08% 
2.7-5a 18.73 30.53 12.90 27.49 21.38 7.63 1.25% Cluster 4 6.12% 




2.7-7aa 6.65 27.91 6.93 26.75 15.22 0.00 27.26% Cluster 1 3.73% 
2.7-8a 18.95 47.30 20.95 41.61 35.65 10.53 0.39% Cluster 2 2.97% 
2.7-9aa 8.46 20.12 3.38 18.54 12.67 1.29 16.21% Cluster 1 2.22% 
2.7-10aa 9.42 29.27 10.83 27.11 17.27 3.58 6.42% Cluster 1 0.88% 
2.7-11aa 9.90 30.04 11.11 28.93 17.42 4.31 4.79% Cluster 1 0.66% 
2.7-12aa 7.09 25.98 11.20 24.84 13.93 4.93 3.72% Cluster 1 0.51% 
2.7-13aa 8.31 30.19 13.06 29.02 16.40 5.03 3.57% Cluster 1 0.49% 
2.7-14aa 8.50 28.91 13.07 27.13 16.15 5.45 3.02% Cluster 1 0.41% 
2.7-15aa 4.97 31.60 13.20 30.56 18.54 6.02 2.40% Cluster 1 0.33% 
2.7-16aa 15.41 22.71 6.94 20.82 16.76 6.04 2.38% Cluster 1 0.33% 
2.7-17aa 19.94 30.80 14.37 28.69 18.17 6.56 1.93% Cluster 1 0.26% 
2.7-18aa 8.89 32.14 13.80 31.01 19.10 6.57 1.92% Cluster 1 0.26% 





Calculated data for 2.8 (octanol MM conformational search) 
  
Figure 6.10: 2D structure of 2.8 and 3D structure of its lowest energy conformer 2.8 -1 obtained after population refinement using 1H-1H distances derived from 
the 2D-ROESY spectrum of the natural product. 
Table 6.11: Calculated energies (in kJ mol−1) and population for the major conformers of 2.8 before and after population refinement. All conformers listed were 










Dihedral cluster Population after refinement 
2.8-1a 19.96 33.26 18.99 29.96 22.87 13.43 0.09% Cluster 3 32.83% 
2.8-2aa 11.13 14.62 4.72 13.70 6.90 4.20 3.83% Cluster 6 7.51% 
2.8-3aa 13.02 16.49 6.18 16.14 7.18 4.65 3.20% Cluster 6 6.27% 
2.8-4aa 15.13 16.76 5.83 15.59 8.65 4.67 3.17% Cluster 6 6.22% 
2.8-5aa 9.04 17.81 6.72 17.45 8.28 4.96 2.82% Cluster 6 5.54% 
2.8-6aa 8.67 19.10 7.39 19.37 8.56 5.25 2.51% Cluster 6 4.93% 
2.8-7aa 3.64 12.62 5.36 13.09 4.52 5.86 1.96% Cluster 6 3.85% 




2.8-9a 19.05 38.11 25.91 36.07 23.83 17.72 0.02% Cluster 8 3.84% 
2.8-10aa 6.26 19.09 8.19 19.22 8.70 6.06 1.81% Cluster 6 3.55% 
2.8-11a 9.70 31.26 21.09 30.00 22.37 19.06 0.01% Cluster 8 2.23% 
2.8-12aa 5.63 20.75 2.70 21.63 9.04 0.00 20.92% Cluster 4 0.61% 
2.8-13aa 7.31 13.25 0.40 14.04 5.48 1.55 11.19% Cluster 4 0.33% 
2.8-14aa 8.40 21.56 6.92 22.42 8.99 3.34 5.43% Cluster 4 0.16% 
2.8-15aa 6.87 17.23 4.01 18.21 8.17 4.06 4.07% Cluster 4 0.12% 
2.8-16aa 7.22 23.16 7.34 23.57 11.49 4.20 3.84% Cluster 4 0.11% 
2.8-17aa 4.73 19.58 7.67 20.52 7.65 4.80 3.01% Cluster 4 0.09% 
2.8-18aa 20.65 13.43 3.69 14.27 5.58 4.81 3.00% Cluster 4 0.09% 
2.8-19aa 7.76 13.43 3.69 14.27 5.58 4.81 3.00% Cluster 4 0.09% 
2.8-20aa 3.07 21.08 9.11 22.64 8.21 5.92 1.92% Cluster 4 0.06% 
2.8-21aa 9.16 21.87 9.35 22.78 10.00 6.50 1.52% Cluster 4 0.04% 
2.8-22aa 9.28 22.43 10.70 23.16 9.72 6.84 1.32% Cluster 4 0.04% 






Calculated data for 2.9 (octanol MM conformational search) 
  
Figure 6.11: 2D structure of 2.9 and 3D structure of its lowest energy conformer 2.9-1 obtained after population refinement using 1H-1H distances derived from 
the 2D-ROESY spectrum of the natural product. 
Table 6.12: Calculated energies (in kJ mol−1) and population for the major conformers of 2.9 before and after population refinement. All conformers listed were 










Dihedral cluster Population after refinement 
2.9-1a 4.92 1.54 5.55 0.00 2.60 9.21 0.97% Cluster 11 25.03% 
2.9-2a 7.07 7.03 10.47 10.53 0.07 11.15 0.45% Cluster 5 15.97% 
2.9-3a 20.28 26.91 13.46 24.50 17.44 5.73 3.98% Cluster 17 8.96% 
2.9-4aa 17.76 9.78 2.02 11.19 4.29 2.07 17.43% Cluster 18 7.95% 
2.9-5a 20.00 25.45 18.06 23.46 18.37 13.13 0.20% Cluster 8 4.14% 
2.9-6a 19.68 25.57 17.38 24.78 19.81 14.98 0.09% Cluster 19 4.12% 
2.9-7a 15.02 11.98 10.72 15.40 6.21 12.51 0.26% Cluster 4 3.85% 
2.9-8a 18.80 25.88 17.10 24.42 19.46 13.36 0.18% Cluster 8 3.76% 




2.9-10aa 17.25 8.48 0.00 9.36 3.46 0.00 40.15% Cluster 6 3.00% 
2.9-11aa 17.38 10.34 4.03 11.42 4.17 3.09 11.52% Cluster 7 0.81% 
2.9-12aa 17.76 14.11 5.97 17.41 4.68 3.97 8.09% Cluster 7 0.57% 
2.9-13aa 17.51 17.02 8.25 18.96 8.20 5.51 4.33% Cluster 6 0.32% 






Calculated data for 2.10 (octanol MM conformational search) 
  
Figure 6.12: 2D structure of 2.10 and 3D structure of its lowest energy conformer 2.10-1 obtained after population refinement (constraint Σ(ΔΔG)2 =400) using 
1H-1H distances derived from the 2D-ROESY spectrum of the natural product. 
Table 6.13: Calculated energies (in kJ mol−1) and population for the major conformers of 2.10 before and after population refinement. All conformers listed 
were used to calculate the NMR properties of 2.10 after population refinement. For the NOE-refined DDG (in kJ mol−1) for each dihedral group, see Table 6.43. 












2.10-1aa – g  9.37 19.36 0.72 17.05 11.35 0.00 22.82% Cluster 15 17.62% 
2.10-2aa – g 8.75 16.88 2.11 14.72 8.69 1.35 13.24% Cluster 15 10.22% 
2.10-3aa – f 9.77 17.85 3.21 15.75 9.53 2.37 8.76% Cluster 15 6.76% 
2.10-4aa – e 8.20 19.04 2.86 16.62 12.37 3.34 5.92% Cluster 6 4.79% 
2.10-5aa – e 10.22 21.08 2.66 18.42 14.84 3.35 5.90% Cluster 6 4.77% 
2.10-6aa – i 19.73 23.28 5.93 22.04 12.90 3.89 4.74% Cluster 3 3.07% 




2.10-8aa – c 7.72 22.65 6.53 19.94 14.39 5.16 2.84% Cluster 15 2.19% 
2.10-9aa – c 6.07 17.68 5.41 15.69 10.42 5.75 2.24% Cluster 15 1.73% 
2.10-10aa – c 8.67 17.48 6.14 15.40 9.84 6.00 2.02% Cluster 15 1.56% 
2.10-11aa – c 9.66 18.89 6.37 16.53 11.44 6.14 1.91% Cluster 15 1.48% 
2.10-12aa – f 19.70 25.33 9.54 23.34 14.38 6.18 1.88% Cluster 10 0.84% 
2.10-13aa – f 9.36 39.67 16.31 33.54 26.40 6.51 1.65% Cluster 13 1.10% 
2.10-14aa – f 7.72 36.51 15.54 30.12 24.94 7.15 1.27% Cluster 13 0.85% 
2.10-15aa, d 16.78 25.68 8.36 23.17 17.54 7.29 1.20% Cluster 6 0.97% 
2.10-16ab – i  7.15 32.34 11.66 27.36 23.45 7.37 1.16% Cluster 8 6.14% 
2.10-17ab – i 6.44 31.56 12.19 26.61 22.97 8.24 0.82% Cluster 8 4.32% 
2.10-18ab – i 9.72 34.25 13.22 29.48 25.17 8.95 0.62% Cluster 8 3.25% 
2.10-19ab – i 8.75 34.58 14.31 29.62 25.81 10.18 0.37% Cluster 8 1.98% 
2.10-20ab – h 9.58 36.84 15.43 31.93 26.99 10.25 0.36% Cluster 8 1.92% 
2.10-21ab – g 9.42 33.70 14.90 28.44 24.85 10.38 0.34% Cluster 8 1.82% 
2.10-22ab – g 9.90 38.91 15.98 33.50 29.19 10.42 0.34% Cluster 8 1.79% 
2.10-23ab, e, f, g 8.40 35.48 16.71 30.85 25.10 11.28 0.24% Cluster 8 1.27% 
2.10-24ab, e, f, g 8.70 33.68 14.99 28.38 25.70 11.30 0.24% Cluster 8 1.26% 
2.10-25ac, f 14.84 40.05 17.10 35.00 30.71 12.29 0.16% Cluster 7 0.21% 
2.10-26da, e 8.98 34.25 14.29 28.07 24.94 8.39 0.77% Cluster 13 0.51% 
2.10-27ad, e 9.05 39.93 17.03 33.52 28.16 8.45 0.75% Cluster 13 0.50% 
2.10-28ad 12.90 40.60 18.75 34.40 27.26 8.79 0.66% Cluster 13 0.44% 
2.10-29ad 7.23 35.87 17.11 29.67 24.29 8.91 0.62% Cluster 13 0.42% 
2.10-30ad 9.03 36.42 16.06 29.66 26.66 9.11 0.58% Cluster 13 0.38% 
2.10-31ad 20.82 26.56 10.63 24.64 15.58 7.32 1.19% Cluster 10 0.53% 
2.10-32ad 16.57 32.51 10.42 27.24 25.54 7.76 0.99% Cluster 10 0.44% 
2.10-33ad 9.72 36.39 16.51 30.09 26.42 9.84 0.43% Cluster 13 0.29% 
2.10-34ad – f  19.01 48.48 29.44 43.00 38.14 23.19 0.00% Cluster 16 0.00% 
2.10-35ae, f 9.67 34.10 25.76 30.20 26.73 24.07 0.00% Cluster 16 0.00% 




2.10-37ae, f 20.83 36.15 16.43 31.54 26.79 12.05 0.18% Cluster 8 0.93% 
2.10-38af – i  17.18 43.58 24.39 39.30 33.20 19.30 0.01% Cluster 17 0.01% 
2.10-39af – i 9.99 40.57 23.43 36.84 31.08 19.79 0.01% Cluster 17 0.01% 
2.10-40af 7.71 36.15 16.44 31.54 26.79 12.05 0.18% Cluster 8 0.93% 
2.10-41ag – i  16.98 53.69 32.30 46.48 40.31 21.29 0.00% Cluster 14 0.00% 
2.10-42ag – i 17.76 44.83 27.96 40.41 34.46 22.77 0.00% Cluster 5 0.00% 
2.10-43ag 18.84 57.76 37.98 49.34 45.91 27.29 0.00% Cluster 14 0.00% 
2.10-44ah, i  18.58 43.18 24.14 38.12 31.76 17.24 0.02% Cluster 18 0.02% 
Conformer populations after population refinement (continues) 
conformer Σ(ΔΔG)2 =100 Σ(ΔΔG)
2 =225 Σ(ΔΔG)2 =400 Σ(ΔΔG)2 =625 Σ(ΔΔG)2 =900 Σ(ΔΔG)2 =1600 Σ(ΔΔG)2 =2500 
2.10-1a 15.15% 6.60% 4.00% 3.99% 2.19% 0.29% 0.03% 
2.10-2a 8.79% 3.83% 2.32% 2.32% 1.27% 0.17% 0.01% 
2.10-3a 5.81% 2.53% 1.53% 1.53% 0.84% 0.11% 0.01% 
2.10-4a 2.91% 5.27% 3.87% 0.77% 1.17% 0.06% 0.00% 
2.10-5a 2.90% 5.25% 3.85% 0.77% 1.16% 0.06% 0.00% 
2.10-6a 4.72% 6.29% 11.63% 14.44% 14.02% 17.55% 18.16% 
2.10-7a 1.92% 3.47% 2.55% 0.51% 0.77% 0.04% 0.00% 
2.10-8a 1.88% 0.82% 0.50% 0.50% 0.27% 0.04% 0.00% 
2.10-9a 1.49% 0.65% 0.39% 0.39% 0.21% 0.03% 0.00% 
2.10-10a 1.34% 0.58% 0.35% 0.35% 0.19% 0.03% 0.00% 
2.10-11a 1.27% 0.55% 0.34% 0.33% 0.18% 0.02% 0.00% 
2.10-12a 1.39% 2.71% 1.29% 1.36% 1.10% 0.10% 0.01% 
2.10-13a 1.63% 5.36% 2.69% 1.80% 0.52% 0.04% 0.00% 
2.10-14a 1.26% 4.13% 2.07% 1.38% 0.40% 0.03% 0.00% 
2.10-15a 0.59% 1.07% 0.79% 0.16% 0.24% 0.01% 0.00% 
2.10-16a 5.80% 4.85% 7.45% 7.40% 6.66% 6.91% 6.94% 
2.10-17a 4.08% 3.41% 5.24% 5.21% 4.69% 4.86% 4.89% 




2.10-19a 1.87% 1.56% 2.40% 2.38% 2.14% 2.23% 2.24% 
2.10-20a 1.81% 1.52% 2.33% 2.31% 2.08% 2.16% 2.17% 
2.10-21a 1.72% 1.44% 2.21% 2.19% 1.97% 2.05% 2.06% 
2.10-22a 1.69% 1.41% 2.17% 2.16% 1.94% 2.01% 2.02% 
2.10-23a 1.20% 1.00% 1.54% 1.53% 1.38% 1.43% 1.43% 
2.10-24a 1.19% 0.99% 1.53% 1.52% 1.37% 1.42% 1.42% 
2.10-25a 7.86% 0.62% 1.11% 2.00% 1.10% 0.10% 0.01% 
2.10-26a 0.76% 2.51% 1.26% 0.84% 0.24% 0.02% 0.00% 
2.10-27a 0.75% 2.45% 1.23% 0.82% 0.24% 0.02% 0.00% 
2.10-28a 0.65% 2.13% 1.07% 0.71% 0.21% 0.01% 0.00% 
2.10-29a 0.62% 2.03% 1.02% 0.68% 0.20% 0.01% 0.00% 
2.10-30a 0.57% 1.87% 0.94% 0.63% 0.18% 0.01% 0.00% 
2.10-31a 0.88% 1.71% 0.81% 0.86% 0.70% 0.06% 0.01% 
2.10-32a 0.73% 1.43% 0.68% 0.72% 0.58% 0.05% 0.00% 
2.10-33a 0.42% 1.39% 0.70% 0.47% 0.13% 0.01% 0.00% 
2.10-34a 0.00% 1.22% 6.20% 6.60% 0.02% 0.01% 0.00% 
2.10-35a 0.00% 0.85% 4.35% 4.63% 0.01% 0.00% 0.00% 
2.10-36a 0.94% 0.79% 1.21% 1.20% 1.08% 1.12% 1.13% 
2.10-37a 0.88% 0.73% 1.13% 1.12% 1.01% 1.04% 1.05% 
2.10-38a 0.02% 0.03% 0.07% 4.59% 3.43% 4.32% 4.39% 
2.10-39a 0.01% 0.03% 0.05% 3.78% 2.82% 3.56% 3.61% 
2.10-40a 0.88% 0.73% 1.12% 1.12% 1.01% 1.04% 1.05% 
2.10-41a 0.01% 0.01% 0.03% 0.10% 19.11% 20.94% 21.21% 
2.10-42a 0.01% 0.01% 0.02% 0.03% 10.03% 10.13% 10.14% 
2.10-43a 0.00% 0.00% 0.00% 0.01% 1.70% 1.86% 1.89% 
2.10-44a 0.04% 0.07% 0.15% 0.30% 0.25% 4.74% 4.89% 
aThese conformers were used to calculate the Boltzmann averaged NMR parameters before population refinement 
bThese conformers were used to calculate the Boltzmann averaged NMR parameters after population refinement using a constraint (Σ(ΔΔG)2) = 25 




dThese conformers were used to calculate the Boltzmann averaged NMR parameters after population refinement using a constraint (Σ(ΔΔG)2) = 225 
eThese conformers were used to calculate the Boltzmann averaged NMR parameters after population refinement using a constraint (Σ(ΔΔG)2) = 400 
fThese conformers were used to calculate the Boltzmann averaged NMR parameters after population refinement using a constraint (Σ(ΔΔG)2) = 625 
gThese conformers were used to calculate the Boltzmann averaged NMR parameters after population refinement using a constraint (Σ(ΔΔG)2) = 900 
hThese conformers were used to calculate the Boltzmann averaged NMR parameters after population refinement using a constraint (Σ(ΔΔG)2) = 1600 





Calculated data for fragment B studies (2.10 and 2.12 – 2.14, gas conformational search) 
The conformational searches for compounds 2.10 and 2.12 – 2.14 were conducted with 
octanol as solvent (500,000 iterations).  Total CPU time of ~ 11220 hours (~1.3 years) were 
spent on computing these compounds. 
Table 6.14: A summary of numbers of conformers found (starting from octanol conformational search) 






Conformers      










1353 1015 42 100 9 
2.12 466 347 23 100 15 
2.13 926 633 47 100 10 





Calculated data for 2.12 (gas MM conformational search) 
 
Figure 6.13: 2D structure of 2.12 and 3D structure of its lowest energy conformer 2.12-1. 
Table 6.15: Calculated energies (in kJ mol−1) for the major conformers of 2.12 with a combined 












2.12-1 15.99 1.81 0.01 1.65 0.98 0.00 23.75% 
2.12-2 5.33 0.00 0.00 0.00 0.00 0.98 16.00% 
2.12-3 4.86 0.55 0.33 0.96 0.28 1.45 13.23% 
2.12-4 9.50 3.85 2.08 3.97 2.39 1.72 11.85% 
2.12-5 11.97 4.65 1.54 6.02 2.87 2.10 10.17% 
2.12-6 11.50 8.07 4.35 8.95 5.03 3.18 6.58% 
2.12-7 18.27 4.81 0.85 4.57 7.65 4.44 3.96% 
2.12-8 6.93 3.74 4.04 3.01 6.06 6.60 1.65% 
2.12-9 9.37 16.83 9.51 13.51 16.62 6.97 1.43% 
2.12-10 17.55 6.13 3.77 5.42 9.08 6.99 1.41% 
2.12-11 6.59 4.44 3.02 4.01 7.91 7.04 1.39% 
2.12-12 12.57 13.73 8.81 10.97 14.40 7.70 1.06% 
2.12-13 8.84 19.71 12.22 16.82 17.41 8.00 0.94% 
2.12-14 11.69 20.00 13.84 16.96 16.34 8.13 0.89% 






Calculated data for 2.13 (gas MM conformational search) 
 
Figure 6.14: 2D structure of 2.13 and 3D structure of its lowest energy conformer 2.13-1. 
Table 6.16: Calculated energies (in kJ mol−1) for the major conformers of 2.13 with a combined 












2.13-1 0.00 0.00 0.00 0.79 0.26 0.00 60.64% 
2.13-2 7.11 0.82 5.09 1.10 0.44 3.93 12.39% 
2.13-3 7.77 3.36 4.42 5.46 2.58 4.68 9.17% 
2.13-4 0.37 0.16 5.89 1.24 0.48 6.23 4.90% 
2.13-5 7.61 0.13 7.63 0.00 0.00 6.32 4.73% 
2.13-6 6.68 3.26 9.34 4.26 2.37 8.40 2.04% 
2.13-7 20.27 20.03 17.92 18.93 14.53 10.26 0.96% 
2.13-8 5.43 7.28 13.21 6.61 6.65 10.86 0.75% 
2.13-9 14.20 2.71 10.73 2.68 3.96 10.91 0.74% 






Calculated data for 2.14 (gas MM conformational search) 
 
Figure 6.15: 2D structure of 2.14 and 3D structure of its lowest energy conformer 2.14-1. 
Table 6.17: Calculated energies (in kJ mol−1) for the major conformers of 2.14 with a combined 














8.6 0.00 0.00 0.09 0.00 0.00 40.30% 
2.14-2 
 
7.8 3.05 1.48 4.22 2.32 1.83 19.23% 
2.14-3 19.3 9.94 8.18 8.58 8.21 5.00 5.35% 
2.14-4 5.6 16.42 12.09 13.05 13.31 5.53 4.33% 
2.14-5 8.8 5.88 8.24 4.32 4.89 5.59 4.21% 
2.14-6 7.4 3.30 4.52 4.96 2.93 5.72 4.00% 
2.14-7 20.5 20.85 15.73 18.17 14.47 6.58 2.82% 
2.14-8 18.8 19.88 15.93 17.55 12.98 6.61 2.79% 
2.14-9 7.8 6.91 8.07 8.12 5.04 7.31 2.10% 
2.14-10 9.9 0.21 7.06 0.00 1.42 7.97 1.62% 
2.14-11 9.0 8.38 10.26 7.13 7.50 8.04 1.57% 
2.14-12 9.0 21.05 16.32 18.51 16.70 9.35 0.92% 






Calculated data for fragment B studies (2.10 and 2.12 – 2.14, octanol conformational 
search) 
The conformational searches for compounds 2.10 and 2.12 – 2.14 were conducted with 
octanol as solvent (100,000 iterations, except compound 2.10 which requires 300,000 iterations 
in order to find conformers below 10 kJ mol−1 more than 10 times on average).  Total CPU 
time of ~ 21456 hours (~2.5 years) were spent on computing these compounds. 
Table 6.18: A summary of numbers of conformers found (starting from octanol conformational search) 






Conformers      










8794 5350 107 214 18 
2.12 3060 1844 108 216 15 
2.13 3129 1871 117 234 18 





Calculated data of 2.12 (octanol MM conformational search) 
 
Figure 6.16: 2D structure of 2.12 and 3D structure of its lowest energy conformer 2.12-1. 
Table 6.19: Calculated energies (in kJ mol−1) for the major conformers of 2.12 with a combined 












2.12-1a 1.9 0.0 0.0 0.0 0.0 0.0 18.4% 
2.12-2a 1.2 0.6 0.3 1.0 0.3 0.5 15.2% 
2.12-3a 2.5 3.8 2.1 4.0 2.4 0.7 13.6% 
2.12-4a 5.7 4.7 1.5 6.0 2.9 1.1 11.7% 
2.12-5a 6.2 4.7 1.5 6.0 2.9 1.1 11.7% 
2.12-6a 3.9 8.1 4.4 9.0 5.0 2.2 7.5% 
2.12-7a 3.9 20.9 14.6 17.2 15.4 5.5 2.0% 
2.12-8a 5.2 3.7 4.0 3.0 6.1 5.6 1.9% 
2.12-9a 4.3 16.8 9.5 13.5 16.6 6.0 1.6% 
2.12-10a 5.9 4.4 3.0 4.0 7.9 6.1 1.6% 
2.12-11a 15.8 5.3 6.1 4.5 6.9 6.9 1.1% 
2.12-12a 1.8 19.7 12.2 16.8 17.4 7.0 1.1% 
2.12-13a 4.5 20.0 13.8 17.0 16.3 7.1 1.0% 
2.12-14a 18.9 28.4 16.4 28.3 19.3 7.2 1.0% 






Calculated data of 2.13 (octanol MM conformational search) 
 
Figure 6.17: 2D structure of 2.13 and 3D structure of its lowest energy conformer 2.13-1. 
Table 6.20: Calculated energies (in kJ mol−1) for the major conformers of 2.13 with a combined 












2.13-1a 0 1.6 0.0 1.8 1.9 0.0 19.9% 
2.13-2a 5.4 0.7 2.2 1.1 0.4 1.8 9.8% 
2.13-3a 6.5 3.2 1.5 5.5 2.6 2.5 7.2% 
2.13-4a 6.8 3.9 5.1 4.0 2.2 2.8 6.3% 
2.13-5a 11.8 22.8 13.3 20.9 15.7 3.7 4.5% 
2.13-6a 0.8 0.0 3.0 1.2 0.5 4.1 3.9% 
2.13-7a 5.7 0.0 4.7 0.0 0.0 4.1 3.7% 
2.13-8a 15.3 25.9 16.1 23.2 17.2 4.3 3.5% 
2.13-9a 7.2 21.2 13.6 19.2 14.9 4.6 3.1% 
2.13-10a 12.3 21.2 13.6 19.2 14.9 4.9 2.8% 
2.13-11a 16.2 27.4 13.7 26.0 20.6 5.1 2.5% 
2.13-12a 17.3 26.5 16.1 24.5 18.0 5.3 2.4% 
2.13-13a 4.3 26.7 15.1 25.9 18.3 5.4 2.3% 
2.13-14a 5.7 6.9 5.6 9.2 4.9 5.6 2.1% 
2.13-15a 15.5 26.7 17.7 24.0 18.0 5.7 2.0% 
2.13-16a 7.9 8.3 8.6 9.2 5.2 5.8 1.9% 
2.13-17a 2.3 3.1 6.4 4.3 2.4 6.2 1.6% 






Calculated data of 2.14 (octanol MM conformational search) 
  
Figure 6.18: 2D structure of 2.14 and 3D structure of its lowest energy conformer 2.14-1. 
Table 6.21: Calculated energies (in kJ mol−1) for the major conformers of 2.14 with a combined 














2.14-1a 8.3 0.4 0.0 0.9 0.3 0.0 13.5% 
2.14-2a 14.7 18.1 10.5 16.1 11.4 1.2 8.3% 
2.14-3a 13.4 3.4 1.5 5.1 2.7 1.8 6.5% 
2.14-4a 17.6 27.2 14.1 26.2 17.0 2.4 5.2% 
2.14-5a 13.5 20.2 12.1 18.2 13.3 2.7 4.6% 
2.14-6a 13.8 22.3 13.4 20.5 14.1 2.8 4.4% 
2.14-7a 18.6 24.5 15.7 22.2 14.8 3.2 3.7% 
2.14-8a 15.5 18.5 12.3 16.6 12.0 3.3 3.5% 
2.14-9a 13.1 16.5 11.9 12.4 12.8 3.5 3.3% 
2.14-10a 14.1 17.0 13.4 14.8 10.3 3.9 2.8% 
2.14-11a 13.8 38.8 20.1 34.3 27.7 3.9 2.8% 
2.14-12a 9.8 3.8 5.1 4.4 3.0 4.3 2.4% 
2.14-13a 14.8 26.8 15.3 25.3 18.0 4.4 2.3% 
2.14-14a 17.8 26.6 15.5 24.5 18.6 4.8 2.0% 
2.14-15a 12.2 6.2 8.2 5.2 5.2 5.6 1.4% 
2.14-16a 13.5 3.6 4.5 5.8 3.3 5.7 1.3% 
2.14-17a 18.6 26.0 17.4 23.7 17.3 5.7 1.3% 
2.14-18a 15.6 34.3 22.1 29.2 25.1 7.2 1.3% 
2.14-19a 17.5 41.8 24.2 35.9 30.5 6.3 1.1% 
2.14-20a 18.8 23.8 15.8 21.4 17.5 6.5 1.0% 
2.14-21a 20.1 29.9 17.4 28.6 20.8 6.5 1.0% 
2.14-22a 19.7 27.4 14.2 23.4 24.3 6.6 1.0% 
2.14-23a 12.8 18.0 15.8 15.7 11.5 6.6 1.0% 
2.14-24a 19.3 24.5 17.0 23.2 16.1 6.7 0.9% 
2.14-25a 13.3 10.3 10.7 9.6 7.4 6.7 0.9% 
2.14-26a 18.6 37.2 21.6 31.6 28.4 6.7 0.9% 
2.14-27a 13.8 24.4 16.3 22.2 17.8 6.8 0.9% 




2.14-29a 15.4 34.3 22.1 29.2 25.1 7.2 0.8% 
2.14-30a 19.7 25.2 18.2 23.2 16.9 7.2 0.7% 
2.14-31a 13.2 39.8 25.9 34.1 27.5 7.3 0.7% 
2.14-32a 13.7 25.2 18.3 24.2 15.9 7.4 0.7% 





General NMR procedures 
Determination of scalar coupling constants. 
1H-1H scalar coupling constants were measured manually from multiplets in 1H spectra 
and selective 1-dimensional TOCSY spectra. For the natural product these were also checked 
against the homonuclear 2DJ NMR spectrum provided by Sherman et al.95 To maximise the 
accuracy of the coupling constants (experimental error < 0.5 Hz), spin simulations were 
performed using the MestreNova (Version 11.0.2-18153) Spin Simulation module. Methylene 
protons (H12a/H12b, H10a/H10b, H7a/H7b and H5a/H5b) for each diastereomer computed were 
assigned based on the best fit to the experimental scalar coupling constants of the natural 
product. 
1H-13C scalar coupling constants of synthetic compounds 2.1 and 2.17 were measured 
from the Accordion In-Phase and Anti Phase (IPAP) HSQMBC NMR spectra174 (~19 mg in 
0.7 mL CD3OD, 12 scans, 1600 f1 increments and 8192 t2 data points, f1 spectra width 224.5 
ppm (28249Hz), f2 spectra width 7 ppm (3501Hz), matching JLR from 3Hz to 8 Hz) Both IP 
and AP spectra were recorded interleaved. The sum and difference spectra were created by 
adding/subtracting the AP and IP spectra. The offset between the sum (red, Figure 6.19) and 






Figure 6.19: Overlay of the sum (red) and difference (blue) HSQMBC traces for C-1’ (76.8 ppm) to H-
13 (3.98 ppm) of compound 2.17. The traces were taken at 76.8 ppm and the offset between the traces 
suggest 3JH13-C1’ = 4.2 Hz. 
Determination of 1H-1H distances. 
The interproton distances of baulamycin A were determined using  Equation 6.952 and 
the 2D ROESY spectrum provided by Sherman et al.95 (reprocessed using the following 
parameters: f1 phasing: PH0 = 178.97°, PH1 = 4.14°; f2 phasing: PH0 = -165.92° and PH1 = 
1.72°; Apodisation along t1: sine bell 90.00° and sine squre 90.00°; Apodisation along t2: sine 
bell 90.00°; t2 zero fill to 2K and t1 zero fill to 2K and forward linear predict from 128 to 384 






6 Equation 6.9 
Where 𝑟 is interproton distance and 𝜂 is NOE signal intensity derived from the 2D-
ROESY spectrum In order to compare ROE intensities across all traces taken from the 2D 
ROESY spectrum and correct for different rates of external relaxation for each proton in the 
molecule, peak amplitude normalisation for improved cross-relaxation (PANIC) 53,175-176 was 
employed by setting the irradiated peak in each slice of the 2D ROESY spectrum to a single 
value (arbitrarily 1000 intensity units in this analysis) as Figure 6.20 shows.  




Butts et al. have reported that by using a known distance between two protons as the 
reference distance in the same molecule, 𝑟𝑟𝑒𝑓 , the distance between other dipolar coupled 
protons for the rest of the molecule, 𝑟𝑁𝑂𝐸 , can be determined by comparing the relative 
intensity of the peak of interest (𝜂𝑁𝑂𝐸) and the relative intensity of the reference distance 
(𝜂𝑟𝑒𝑓).
51-52 For each diastereoisomer studied computationally (compound 2.6, 2.7 – 2.10, the 
reference distance (𝑟𝑟𝑒𝑓) was chosen to be the distance between methylene protons H12a and 
H12b. The reference distances for each diastereoisomer were optimised to give the best fit to the 
natural product data.  
Slices were taken for all resolved resonances in the processed 2D ROESY spectrum for 
baulamycin A. Figure 6.20 shows the slice of H12a of baulamycin A, showing a correlation to 
other protons within ~4 Å such as H1’ at 4.47 ppm. Taking H12a-H12b as the reference distance 
(𝑟𝑟𝑒𝑓, 1.76 Å), the corresponding H12a-H12b intensity (𝜂𝑟𝑒𝑓, 207.99), and the H12a-H1’ intensity 
(𝜂𝑁𝑂𝐸 , 23.31), one could calculate the H12a-H1’ distance using  Equation 6.9: 





6 = 2.53 Å  
This H12a-H1’ distance was subsequently averaged with the H1’-H12a distance (2.66 Å) 
determined from the slice of H1’ from the 2D-ROESY spectrum to give the final experimental 





Figure 6.20: 2D-ROESY f2 slice at f1 chemical shifts (700MHz, CD3OD) of H1’ of baulamycin A with 
blue integrals as the intensity units of each proton. 
To determine the distance from a given proton to pairs of methylene protons H15 and 
H10, the intensities of peaks corresponding to H15 (or Hx-H10) were divided by 2 to correct for 
the two protons contributing to the signals. Distances from any proton to H16, H17 and H18 were 
not used for comparison because conformations arising from the rotation of the iPr group were 
excluded were eliminated in redundant conformer elimination (see ‘general information’ in the 
computation section). 
In this study, only interproton distances in fragment A (C1’-C10 section) of baulamycin 
A were determined. Unfortunately, spectral overlap precluded the determination of interproton 
distances in fragment B (C8-C4 section).  
  
H12b 
207.99 intensity units 
H12a 
1000 intensity units 
H1’ 




Comparison of NMR of synthetic baulamycin diastereomers and that of the isolated 
natural product. 
Table 6.22: Comparison of the 1H and 13C NMR spectra of 2.1 and the isolated natural product. 
 
a. 1H and 13C chemical shifts were re-extracted from the spectra provided by Sherman et al.95 referenced to CD3OD 
(3.31 and 49.000 ppm respectively).  











1 1.02, t (7.3) 1.01, t (7.3)  8.1 8.1 
2 
2.57, dq (18.0, 7.4), 
2.49, dq (17.8, 7.3) 
2.56, dp (18.2, 7.3) 
2.51, dp (18.0, 7.2) 
 35.4 35.1 
3 - -  218.6 218.4 
4 2.76, dqd (9.1, 6.9, 5.3) 2.71, hept (6.9)  45.0 44.9 
5 
1.73, ddd (13.8, 9.1, 5.0) 
1.00, ddd (13.8, 8.8, 5.3) 
1.48, ddd (13.2, 8.1, 6.4) 
1.21, ddd (13.2, 7.6, 5.4) 
 42.0 42.3 
6 
1.43, ddqdd (8.8, 7.2, 7.0, 6.8, 
5.0) 
1.55-1.49, m  29.5 29.2 
7 
1.22, ddd (13.8, 6.8, 6.8) 
0.95,  dt (13.8, 7.2) 
1.14-1.08, m  46.6 46.2 




1.32-1.27, m  33.4 34.4 
10 1.43-1.38, m 1.49-1.44 m  35.7 35.9 
11 3.69, dddd (8.2, 8.0, 4.5, 4.3) 3.71, dddd (8.5, 7.1, 4.7, 4.1)  72.9 72.2 
12 
1.78, ddd (14.1, 4.5 3.2) 
1.54, ddd (14.1, 10.0, 8.2) 
1.68, dt (14.1, 9.1) 
1.63, dt (14.1, 4.4) 
 41.0 42.3 
13 4.00, dt (10.0, 3.3) 3.98, dt (9.1, 3.6)  73.7 74.9 
14 1.88, dddd (7.2, 6.8, 5.0, 3.5) 1.71-1.67, m  48.8 49.3 
15 1.21, m 1.43-1.37, m 
1.26-1.22, m 
 37.6 33.4 
16 1.38, m  . 7- . 3,   26.9 28.3 
17 0.77 d (6.5) 0.78, d (6.2)  23.6 23.4 
18 0.83, d (6.6) 0.64, d (6.3)  22.8 22.9 
19 0.86, d (6.6) 0.85, d (6.9) or 
0.84, d(6.9) 
 20.6 19.81/19.79 
20 0.88, d (6.6) 0.85, d (6.9) or 
0.84, d(6.9) 
 20.9 19.81/19.79 
21 1.06, d (6.9) 1.0 , (3. )  18.2 17.0 
1’ 4.47, d (6.8) 4.83, d (3.5)  76.9 76.8 
2’ - -  148.3 148.5 
3’ 6.33, d (2.1) 6.32, d (2.1)  106.3 105.7 
4’ - -  159.3 159.2 




As Figure 6.21, there are significant differences between the 13C chemical shift values of 
synthetic 2.1 and those of the isolated natural product. There were large differences (~1 ppm 
or more) for C-9, C-12, C-13, C-15, C-16, C-19, C-20, C-21, suggesting that both the relative 
configuration of the hydroxyl-rich region and methyl-rich region had been mis-assigned. 
 
Figure 6.21: Differences between 13C NMR spectra of 2.1 (CD3OD, 175MHz) and the natural product 
(CD3OD, 175 MHz). Natural product chemical shifts were re-extracted from the spectra provided by 


























Table 6.23: Comparison of the 1H and 13C NMR spectra of 2.11 and the natural product. 
 
a. 1H and 13C chemical shifts were re-extracted from the spectra provided by Sherman et al.95 referenced to 
CD3OD (3.31 and 49.000 ppm respectively).  
  











1 1.02, t (7.3) 1.02, t (7.2)  8.1 8.1 
2 
2.57, dq (18.0, 7.4), 
2.49, dq (17.8, 7.3) 
2.56, dq (18.0, 7.1) 
2.52, dq (18.0, 7.1) 
 35.4 35.1 
3 - -  218.6 218.5 
4 2.76, dqd (9.1, 6.9, 5.3) 2.72, hept (6.8)  45.0 44.9 
5 
1.73, ddd (13.8, 9.1, 5.0) 
1.00, ddd (13.8, 8.8, 5.3) 
1.51-1.46, m 
1.25-1.20, m 
 42.0 42.4 
6 1.43, ddqdd (8.8, 7.2, 7.0, 6.8, 5.0) 1.54-1.49, m  29.5 29.2 
7 
1.22, ddd (13.8, 6.8, 6.8) 
0.95,  dt (13.8, 7.2) 
1.15-1.07, m  46.6 46.2 




1.30-1.24, m  33.4 34.4 
10 1.43-1.38, m 1.45-1.39, m  35.7 35.9 
11 3.69, dddd (8.2, 8.0, 4.5, 4.3) 3.71-3.67, m  72.9 72.9 
12 
1.78, ddd (14.1, 4.5 3.2) 
1.54, ddd (14.1, 10.0, 8.2) 
1.78, dt (14.1, 4.2, 3.4) 
1.56-1.50, m 
 41.0 40.9 
13 4.00, dt (10.0, 3.3) 4.00, dt (10.0, 3.4)  73.7 73.7 
14 1.88, dddd (7.2, 6.8, 5.0, 3.5) 1.88, dddd  
(7.2, 6.8, 5.2, 3.5) 
 48.8 48.8 
15 1.21, m 1.26-1.18, m  37.6 37.6 
16 1.38, m  1.41-1.36, m  26.9 26.8 
17 0.77 d (6.5) 0.77, d (6.7)  23.6 23.6 
18 0.83, d (6.6) 0.83, d (6.5)  22.8 22.8 
19 0.86, d (6.6) 0.85, d (6.4) or 0.84 d (6.3)  20.6 19.83/19.81 
20 0.88, d (6.6) 0.85, d (6.4) or 0.84 d (6.3)  20.9 19.83/19.81 
21 1.06, d (6.9) 1.04, d (6.8)  18.2 17.0 
1’ 4.47, d (6.8) 4.47, d (6.8)  76.9 76.8 
2’ - -  148.3 148.3 
3’ 6.33, d (2.1) 6.33, d (2)  106.3 106.3 
4’ - -  159.3 159.3 




Table 6.24: Comparison of the 1H and 13C NMR spectra of 2.16 and the natural product. 
 
a. 1H and 13C chemical shifts were re-extracted from the spectra provided by Sherman et al.95 referenced to 
CD3OD (3.31 and 49.000 ppm respectively). 











1 1.02, t (7.3) 1.01, t (7.3)  8.1 8.1 
2 
2.57, dq (18.0, 7.4), 
2.49, dq (17.8, 7.3) 
2.58, dq (18.2, 7.4) 
2.48, dq (18.1, 7.3) 
 35.4 35.4 
3 - -  218.6 218.5 
4 2.76, dqd (9.1, 6.9, 5.3) 2.75, dqd (9.1, 6.9, 5.3)  45.0 44.9 
5 
1.73, ddd (13.8, 9.1, 5.0) 
1.00, ddd (13.8, 8.8, 5.3) 
1.72, ddd (13.8, 9.1, 4.9) 
1.00, ddd (13.8, 8.6, 5.3) 
 42.0 41.9 
6 
1.43, ddqdd (8.8, 7.2, 7.0, 6.8, 
5.0) 
1.44-1.40, m  29.5 29.5 
7 
1.22, ddd (13.8, 6.8, 6.8) 
0.95,  dt (13.8, 7.2) 
1.26-1.18, m 
0.94, dt (14.0, 7.2) 
 46.6 46.4 






 33.4 33.4 
10 1.43-1.38, m 1.51-1.47, m 
1.36-1.31, m 
 35.7 35.7 
11 3.69, dddd (8.2, 8.0, 4.5, 4.3) 3.71-3.65,   72.9 73.1 
12 
1.78, ddd (14.1, 4.5 3.2) 
1.54, ddd (14.1, 10.0, 8.2) 
1.78, ddd (14.1, 4.5, 3.0) 
1.56-1.51, m 
 41.0 40.9 
13 4.00, dt (10.0, 3.3) 4.00, dt (10.0, 3.5)  73.7 73.8 
14 1.88, dddd (7.2, 6.8, 5.0, 3.5) 1.88, dddd (7.0, 6.9, 5.3, 3.8)  48.8 48.8 
15 1.21, m 1.26-1.18, m  37.6 37.6 
16 1.38, m  1.41-1.36, m  26.9 26.9 
17 0.77 d (6.5) 0.77, d (6.5)  23.6 23.5 
18 0.83, d (6.6) 0.83, d (6.6)  22.8 22.8 
19 0.86, d (6.6) 0.87, d (6.6)  20.6 20.6 
20 0.88, d (6.6) 0.88, d (6.6)  20.9 20.9 
21 1.06, d (6.9) 1.06, d (6.9)  18.2 18.2 
1’ 4.47, d (6.8) 4.47, d (6.9)  76.9 76.8 
2’ - -  148.3 148.3 
3’ 6.33, d (2.1) 6.33, d (2.2)  106.3 106.3 
4’ - -  159.3 159.3 






Figure 6.22: Comparison of (a) 1H NMR (CD3OD, 500 MHz) and (b) 13C NMR (CD3OD, 176 MHz) spectrum of 2.16 (red) and baulamycin A (black). c.  Zoom 




Table 6.25: Comparison of the 1H and 13C NMR spectra of 2.17 and the natural product 
(CD3OD). 
 
a. 1H and 13C chemical shifts were re-extracted from the spectra provided by Sherman et al.95 referenced to CD3OD 
(3.31 and 49.000 ppm respectively). 
  











1 1.02, t (7.3) 1.02, t (7.3)  8.1 8.1 
2 
2.57, dq (18.0, 7.4), 
2.49, dq (17.8, 7.3) 
2.58, dq (17.9, 7.2), 
2.48, dq (18.0, 7.2) 
 35.4 35.4 
3 - -  218.6 218.6 
4 2.76, dqd (9.1, 6.9, 5.3) 2.76, dqd (9.1, 6.9, 5.3)  45.0 44.9 
5 
1.73, ddd (13.8, 9.1, 5.0) 
1.00, ddd (13.8, 8.8, 5.3) 
5a (pro-R):1.73, ddd (13.5, 9.1, 5.0) 
5b (pro-S):1.00, ddd (13.8, 8.8, 5.3) 
 42.0 42.0 
6 
1.43, ddqdd (8.8, 7.2, 7.0, 
6.8, 5.0) 
1.42, ddqdd (8.8, 7.2, 7.0, 6.8, 5.0)  29.5 29.5 
7 
1.22, ddd (13.8, 6.8, 6.8) 
0.95,  dt (13.8, 7.2) 
7a (pro-R):1.22, ddd (13.8, 6.6, 6.8) 
7b: (pro-S):0.95, dt (13.8, 7.2) 
 46.6 46.6 
8 1.53,  m 1.52, dddqd (8.5, 7.2, 6.8, 6.6, 4.8)  31.2 31.2 
9 1.32, m 
1.19, m 
1.35-1.30, m, 1H 
1.22-1.17, m, 1H 
 33.4 33.4 
10 1.43-1.38, m 1.42- .39, m  35.7 35.7 
11 3.69, dddd (8.2, 8.0, 4.5, 
4.3) 
3.68, dddd (8.2, 8.0, 4.5, 4.3)  72.9 72.9 
12 
1.78, ddd (14.1, 4.5 3.2) 
1.54, ddd (14.1, 10.0, 8.2) 
12a (pro-R):1.78, ddd (14.1, 4.5 3.2) 
12b: (pro-S):1.54, ddd (14.1, 10.0, 
8.2) 
 41.0 41.0 
13 4.00, dt (10.0, 3.3) 4.00, dt (9.9, 3.3)  73.7 73.7 
14 1.88, dddd (7.2, 6.8, 5.0, 
3.5) 
1.88, dddd (7.2, 6.8, 5.0, 3.5)  48.8 48.8 
15 1.21, m 1.23-1.2, m  37.6 37.6 
16 1.38, m  1.40.1.35, m  26.9 26.9 
17 0.77 d (6.5) 0.77, d (6.5)  23.6 23.6 
18 0.83, d (6.6) 0.83, d (6.6)  22.8 22.8 
19 0.86, d (6.6) 0.86, d (6.6)  20.6 20.6 
20 0.88, d (6.6) 0.89, d (6.6)  20.9 20.9 
21 1.06, d (6.9) 1.06, d (6.9)  18.2 18.2 
1’ 4.47, d (6.8) 4.47, d (6.8)  76.9 76.8 
2’ - -  148.3 148.3 
3’ 6.33, d (2.1) 6.32, d (2.1)  106.3 106.3 
4’ - -  159.3 159.3 




NMR data computed vs experimental values of baulamycin A  
NMR data used for validation study  
Table 6.26: Calculated Boltzman averaged 1H chemical shifts (H) for 2.6 and experimental 1H 
chemical shifts of C1’-C10 region for both synthetic 2.1 and baulamycin A with Mean Absolute 
Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 (reduced) values (2 (red.)). 
 Cal. 2.6a Exp. H of 2.1 Deviation Exp.  H of Baulamycin A Deviation 
H1' 4.78 4.83 0.05 4.47 0.31 
H14 1.48 1.69 0.21 1.88 0.4 
H13 4.14 3.98 0.16 4.00 0.14 
H12a 1.42 1.63 0.21 1.78 0.36 
H12b 1.69 1.68 0.01 1.54 0.15 
H11 3.73 3.71 0.02 3.69 0.04 
H10a 1.32 1.46 0.14 1.41 0.09 
H10b 1.55 1.46 0.09 1.39 0.16 
  MAD 0.11 MAD 0.21 
  StDev 0.14 StDev 0.26 
  χ2(red.) 2.06 χ2(red.) 6.62 
a Experimental chemical shifts of compound 3 were used to scale the calculated chemical shift of 3a using 
 Equation 6.5. 
 
Table 6.27: Calculated Boltzman averaged 13C chemical shifts (C) for 2.6 and experimental 1H 
chemical shifts of C1’-C10 region for both synthetic 2.1 and baulamycin A with Mean Absolute 
Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 (reduced) values (2 (red.)). 
 Cal. 2.6a Exp. C of 2.1 Deviation Exp. C of Baulamycin A Deviation 
C1' 82.89 76.78 0.47 76.85 6.04 
C14 52.18 49.26 0.37 48.82 3.36 
C15 31.50 33.39 2.98 37.63 6.13 
C10 37.97 35.87 0.32 35.72 2.25 
C11 79.03 72.18 0.69 72.87 6.16 
C12 43.76 42.27 0.90 40.99 2.77 
C13 83.77 74.97 2.14 76.38 7.39 
  MAD 1.12 MAD 4.87 
  StDev 1.57 StDev 4.52 
  χ2(red.) 0.97 χ2(red.) 12.10 
a Experimental chemical shifts of compound 2.1 were used to scale the calculated chemical shift of 2.6 using 




Table 6.28: Calculated Boltzman averaged nJHC for 2.6 and experimental 1H-13C scalar coupling 
constants of C1’-C10 region for both 2.1 and baulamycin A with Mean Absolute Deviations (MAD, in 
Hz), Standard Deviations (StDev, in Hz) and 2 (reduced) values (2 (red.)). For details on 
determination of scalar coupling constants see general information in NMR procedure section. 
H C Calc. 
nJHC             
of 2.6/Hz 
Exp. nJHC 




Exp. nJHC of 
Baulamycin Ab/Hz 
Deviation from 
Baulamycin A /Hz 
H1' C15 4.4 4.5 0.1 2.3 2.1 
C13 4.0 2.9 1.2 4.3 0.3 
H13 C14 2.2 2.5 0.2 3.5 1.3 
C1' 3.8 4.2 0.5 2.8 1.0 
H14a 
C12 2.0 - - 3.8 1.8 
C13 2.2 - - 5.0 2.7 
C1' 2.9 - - 4.9 2.0 
H12a 
C14 2.3 2.6 0.3 1.8 0.4 
C13 1.8 2.9 1.1 2.3 0.5 
C10 1.2 3.2 1.9 2.5 1.3 
C11 1.5 3.0 1.5 3.3 1.7 
H12b 
C14 0.9 2.6 1.7 2.5 1.6 
C13 6.0 6.6 0.6 6.2 0.2 
C10 2.7 2.4 0.3 3.3 0.6 
C11 6.3 6.0 0.4 6.0 0.3 
H11 C13 2.7 2.7 0.1 3.1 0.4 
   MAD 0.7 MAD 1.1 
   StDev 0.9 StDev 1.2 
   χ2(red.) 1 χ2(red.) 2.0 
 
a Due to spectral overlap in the f2 dimention, it is not viable to extract nJHC of H14 in compound 1. 
b Experimental nJCH values reported here were extracted from NMR spectra measured on the synthetic 




Assignments of all diastereomers computed.  
Table 6.29 – 32 show the assignments of all diastereomers computed in this study. Methylene protons (H12a/H12b, H10a/H10b, H7a/H7b and 
H5a/H5b) were assigned based on the best fit to the natural product NMR data.  
Table 6.29: Assignments of fragment A of compounds 2.6 and 2.7 – 2.10 (gas conformational searches) 
a) Before population refinement 
 Bmc A dH, Mult. (J /Hz) 2.6 dH, Mult. (J /Hz)* 2.7 dH, Mult. (J /Hz) 2.8 dH, Mult. (J /Hz) 2.9 dH, Mult. (J /Hz) 2.10 dH, Mult. (J /Hz) 
H1' 4.47, d (6.8) 4.71, d (1.8) 4.72, d (6.8) 4.68, d (4.7) 4.33, d (8.9) 4.65 d (6.1) 
H14 
1.88, dddd (7.2, 6.8, 5.0, 
3.5) 
1.49, dddd (1.8, 2.2, 
4.6, 3.3) 
1.87, dddd  (6.8, 2.6, 6.9, 
8.4) 
1.65, dddd (4.7, 2.2, 8.4, 
5.6) 
1.78, dddd (8.9, 6.6, 7.6, 
1.4) 
1.81, dddd (6.1, 3.5, 6.7, 
5.7) 
H13 4.00, dt (10.0, 3.3) 4.08, ddd (2.2, 1.1, 9.0) 3.81, ddd (2.6, 9.7, 1.5) 3.97, ddd (2.2, 10.4, 2.0) 4.17, ddd (6.6, 2.9, 10.1) 4.03, ddd (3.5, 1.6, 9.9) 
H12a 1.78, ddd (14.1, 4.5 3.2) 1.44, ddd(14.6, 1.1, 2.2) 1.19, ddd (14.5, 1.5, 1.7) 1.18, ddd (15.0, 2.0, 3.3) 1.65, ddd (14.4, 2.9, 4.6) 1.16, ddd (14.7, 1.6, 1.7) 
H12b 1.54, ddd (14.1, 10.0, 8.2) 
1.69, ddd (14.6, 9.0, 
9.6) 
1.74, ddd (14.5, 9.7, 9.0) 1.98, ddd (15.0, 10.4, 4.3) 1.90, ddd (14.4, 10.1, 3.1) 1.20, ddd (14.7, 9.9, 9.1) 
H11 
3.69, dddd (8.2, 8.0, 4.5, 
4.3) 
3.68, dddd (2.2, 9.6, 
2.1, 9.1) 
3.71, dddd (9.0, 1.7, 8.8, 
2.2) 
3.65, dddd (4.3, 3.3, 7.0, 
6.5) 
3.54, dddd (4.6, 3.1, 8.9, 
2.8) 
3.70, dddd (1.7, 9.1, 2.4, 
9.1) 
H10a 1.41, m 1.33, m 1.38, m 1.43, m 1.32, m 1.15, m 
H10b 1.39, m 1.55, m 1.39, m 1.45, m 1.89, m 1.25, m 
b) After population refinement 
 Bmc A dH, Mult. (J /Hz) 2.6  dH, Mult. (J /Hz)* 2.7 dH, Mult. (J /Hz) 2.8 dH, Mult. (J /Hz) 2.9 dH, Mult. (J /Hz) 2.10 dH, Mult. (J /Hz) 
H1' 4.47, d (6.8) 4.69, d (5.3) 4.66, d (4.8) 4.83, d(4.7) 4.57, d (5.4) 4.51, d (6.7) 
H14 
1.88, dddd (7.2, 6.8, 5.0, 
3.5) 
1.89, dddd (5.3, 3.2, 
8.4, 4.2) 
1.94, dddd (4.8, 2.4, 9.5, 
6.0) 
1.64, dddd (4.7, 2.1, 8.6, 
5.7) 
1.97, dddd (5.4, 4.5, 7.4, 
5.7) 





H13 4.00, dt (10.0, 3.3) 4.01, ddd (9.3, 3.2, 2.4) 3.86, ddd (2.4, 8.1,2.9) 3.83, ddd (2.1, 9.2, 2.9) 4.00, ddd (4.5, 3.0, 8.8) 4.19, ddd (3.7, 3.6, 8.9) 
H12a 1.78, ddd (14.1, 4.5 3.2) 
1.25, ddd (14.8, 2.4, 
1.8) 
1.40, ddd (14.7, 2.9, 2.3) 1.28, ddd (14.8, 2.9, 3.1) 1.16, ddd (14.8, 3.0, 7.1) 1.44, ddd (14.6, 3.6, 1.7) 
H12b 1.54, ddd (14.1, 10.0, 8.2) 
1.41, ddd (14.8, 9.3, 
9.0) 
1.74, ddd (14.7, 8.1, 9.8) 1.87, ddd (14.8, 9.2, 6.8) 1.77, ddd (14.8, 8.8, 2.2) 1.33, ddd (14.6, 8.9, 9.0) 
H11 
3.69, dddd (8.2, 8.0, 4.5, 
4.3) 
3.71, dddd (1.8, 9.0, 
3.4, 8.4) 
3.81, dddd (9.8, 2.3, 6.5, 
4.2) 
3.67, dddd (6.8, 3.1, 5.3, 
5.9) 
3.73, dddd (7.1, 2.2, 5.3, 
8.0) 
3.65, dddd (1.7, 9.0, 4.5, 
6.8) 
H10a 1.41, m 1.25, m 1.49, m 1.34, m 1.54, m 1.19, m 





Table 6.30: Assignments of fragment A of compounds 2.6 and 2.7 – 2.10 (octanol conformational search) 
a) Before population refinement 
 Bmc A dH, Mult. (J /Hz) 2.6 dH, Mult. (J /Hz)* 2.7 dH, Mult. (J /Hz) 2.8 dH, Mult. (J /Hz) 2.9 dH, Mult. (J /Hz) 2.10 dH, Mult. (J /Hz) 
H1' 4.47, d (6.8) 4.68, d (1.78) 4.43, d (8.38) 4.46, d (7.34) 4.49, d (7.31) 4.61, d (4.15) 
H14 
1.88, dddd (7.2, 6.8, 5.0, 
3.5) 
1.49, dddd (1.78, 2.15, 
4.94, 2.82) 
1.86, dddd (8.38, 2.91, 
4.71, 10.60) 
1.78, dddd (7.34, 2.81, 
5.78, 9.41) 
1.81, dddd (7.31, 6.52, 
7.45, 2.18) 
1.96, dddd (4.15, 3.10, 4.12, 
9.64) 
H13 4.00, dt (10.0, 3.3) 
4.05, ddd (2.15, 1.15, 
9.14) 
3.98, ddd (2.91, 1.21, 9.47) 
4.08, ddd (2.81, 1.53, 
10.39) 
4.19, ddd (6.52, 2.94, 
8.53) 
4.08, ddd (3.10, 1.44, 9.66) 
H12a 1.78, ddd (14.1, 4.5 3.2) 
1.45, ddd (14.62, 2.07, 
1.08) 
1.59, ddd (14.79, 1.94, 
1.14) 
1.43, ddd (15.16, 2.63, 
1.44) 
1.42, ddd (14.91, 4.96, 
2.78) 
1.15, ddd (14.98, 1.70, 1.36) 
H12b 1.54, ddd (14.1, 10.0, 8.2) 
1.69, ddd (14.62, 9.49, 
9.14) 
1.70, ddd (14.79, 9.53, 
9.47) 
2.12, ddd (15.16, 4.69, 
10.39) 
1.85, ddd (14.91, 3.28, 
8.53) 
1.34, ddd (14.98, 9.23, 9.66) 
H11 
3.69, dddd (8.2, 8.0, 4.5, 
4.3) 
3.65, dddd (14.62, 2.07, 
2.74, 8.46) 
3.80, dddd (14.79, 1.94, 
5.19, 5.74) 
3.72, dddd (15.16, 2.63, 
3.60, 8.44) 
3.64, dddd (14.91, 4.96, 
2.32, 9.22) 
3.61, dddd (14.98, 1.70, 5.41, 
6.35) 
H10a 1.41, m 1.37, m 1.45, m 1.43, m 1.51, m 1.20, m 
H10b 1.39, m 1.60, m 1.58, m 1.61, m 1.46, m 1.45, m 
b) After population refinement (using a constraint of 400) 
 Bmc A dH, Mult. (J /Hz) 2.6  dH, Mult. (J /Hz)* 2.7 dH, Mult. (J /Hz) 2.8  dH, Mult. (J /Hz) 2.9 dH, Mult. (J /Hz) 2.10 dH, Mult. (J /Hz) 
H1' 4.47, d (6.8) 4.71, d (4.72) 4.85, d (4.72) 4.84, d (5.51) 4.57, d (6.53) 4.37, d (6.93) 
H14 
1.88, dddd (7.2, 6.8, 5.0, 
3.5) 
1.88, dddd (4.72, 4.20, 
5.11, 5.46) 
1.73, dddd (4.72, 2.25, 
9.28, 4.87) 
1.77, dddd (5.51, 2.30, 
8.14, 6.17) 
1.91, dddd (6.53, 4.13, 
8.40, 4.16) 
1.90, dddd (6.93, 2.63, 4.24, 
9.36) 
H13 4.00, dt (10.0, 3.3) 
3.97, ddd (4.20, 2.37, 
9.41) 
3.82, ddd (2.25, 3.09, 8.20) 3.84, ddd (2.30, 2.10, 9.40) 
4.03, ddd (4.13, 5.01, 
8.24) 




H12a 1.78, ddd (14.1, 4.5 3.2) 
1.36, ddd (14.71, 1.70, 
1.08) 
1.27, ddd (14.57, 2.36, 
1.14) 
1.51, ddd (14.59, 2.57, 
1.44) 
1.54, ddd (14.88, 7.19, 
2.78) 
1.47, ddd (14.75, 1.75, 1.36) 
H12b 1.54, ddd (14.1, 10.0, 8.2) 
1.41, ddd (14.71, 8.96, 
9.41) 
1.67, ddd (14.57, 9.59, 
8.20) 
1.83, ddd (14.59, 6.94, 
9.40) 
1.75, ddd (14.88, 2.73, 
8.24) 
1.51, ddd (14.75, 9.04, 9.17) 
H11 
3.69, dddd (8.2, 8.0, 4.5, 
4.3) 
3.61, dddd (14.71, 1.70, 
3.34, 8.19) 
3.80, dddd (14.57, 2.36, 
3.52, 6.22) 
3.52, dddd (14.59, 2.57, 
4.66, 7.77) 
3.70, dddd (14.88, 7.19, 
7.11, 5.40) 
3.62, dddd (14.75, 1.75, 4.13, 
7.35) 
H10a 1.41, m 1.26, m 1.57, m 1.98, m 1.38, m 1.35, m 





Table 6.31: Assignments of fragment B of compounds 2.10 and 2.12 – 2.14. 
a) NMR parameters calculated using gas phase conformational search candidates 
 Bmc A dH, multi (J /Hz) 2.10 H, multi (J /Hz) 2.12 H, multi (J /Hz) 2.13 H, multi (J /Hz) 2.14 H, multi (J /Hz) 
H8 1.53, m 1.74 1.84, ddddq (2.7, 10.1, 9.9, 2.0, 
6.2) 
1.73, ddddq (4.3, 4.3, 9.1, 3.6, 
6.5) 
1.67, ddddq (3.4, 5.1, 10.4, 3.8, 
6.5) 
H7a 1.22, ddd (13.8, 7.5) 1.24, ddd (14.5, 6.3, 6.5) 1.11, ddd (14.5, 2.0, 10.3) 1.40, ddd (14.7, 3.6, 8.7) 1.08, ddd (14.6, 10.4, 1.7) 
H7b 0.95, dt (13.8, 7.2) 1.03, ddd (14.5, 7.7, 5.7) 0.99, ddd (14.5, 9.9, 1.9) 0.54, ddd (14.7, 9.1, 3.5) 0.97, ddd (14.6, 3.8, 9.5) 
H6 1.43, ddqdd (8.8, 7.5, 7.2, 6.6, 
5.0) 
1.43, ddddq (5.7, 6.5, 5.4, 7.4, 6.2) 1.12, ddddq (1.9, 10.3, 9.0, 0.8, 
6.2) 
1.19, ddddq (3.5, 8.7, 9.8, 2.9, 
6.1) 
1.11, ddddq (1.7, 9.5, 1.9, 9.8, 
6.2) 
H5a 1.73, ddd (13.8, 9.1, 5.0) 1.53, ddd (14.2, 5.4, 7.8) 2.03, ddd (14.3, 0.8, 10.8) 1.75, ddd (14.8, 2.9, 10.8) 1.63, ddd (14.3, 1.9, 10.8) 
H5b 1.00, ddd (13.8, 8.8, 5.3) 1.18, ddd (14.2, 7.4, 5.7) 0.77, ddd (14.3, 9.0, 2.1) 1.31, ddd (14.8, 9.8, 4.2) 1.01, ddd (14.3, 9.8, 2.5) 
H4 2.76, dqd (9.1, 6.9, 5.3) 2.76, ddq (7.8, 5.7, 6.4) 2.82, ddq (2.1, 10.8, 6.8) 2.64, ddq (4.2, 10.8, 6.5) 2.88, ddq (10.8, 2.5, 6.8) 
H19 0.86, d (6.6) 0.85, d (6.2) 0.89, d (6.2) 0.78, d (6.5) 0.82, d (6.5) 
H20 0.88, d (6.6) 0.94, d (6.2) 0.95, d (6.2) 0.87, d (6.1) 0.78, d (6.2) 
H21 1.06, d (6.9) 1.10, d (6.4) 1.19, d (6.8) 1.21, d (6.5) 1.14, d (6.8) 
b) NMR parameters calculated using octanol conformational search candidates 
 Bmc A dH, multi (J /Hz) 2.10 H, multi (J /Hz) 2.12 H, multi (J /Hz) 2.13 H, multi (J /Hz) 2.14 H, multi (J /Hz) 
H8 1.53, m 1.43, ddddq (4.9, 7.4, 3.4, 10.1, 
6.1) 
1.87, ddddq (2.8, 10.1, 9.8, 2.1, 
6.2) 
1.67, ddddq (3.7, 6.8, 7.9, 4.8, 
6.3) 
1.52, ddddq (3.6, 7.2, 8.3, 5.8, 
6.2) 
H7a 1.22, ddd (13.8, 7.5) 1.20, ddd (13.9, 10.1, 3.3) 1.11, ddd (14.5, 2.1, 10.2) 1.26, ddd (14.6, 7.9, 4.8) 1.19, ddd (14.3, 8.3, 5.0) 
H7b 0.95, dt (13.8, 7.2) 0.93, ddd(13.9, 3.4, 10.2) 1.00, ddd (14.5, 9.8, 1.9) 0.70, ddd (14.6, 4.8, 7.8) 0.98, ddd (14.3, 5.8, 7.6) 
H6 1.43, ddqdd (8.8, 7.5, 7.2, 6.6, 
5.0) 
1.39, ddddq (10.2, 3.3, 9.2, 3.3, 
6.2) 
1.13, ddddq (1.9, 10.2, 9.1, 0.9, 
6.2) 
1.35, ddddq (4.8, 7.8, 8.1, 3.8, 
6.2) 
1.41, ddddq (5.0, 7.8, 3.0, 9.4, 
6.1) 
H5a 1.73, ddd (13.8, 9.1, 5.0) 1.79, ddd (14.2, 3.3, 9.8) 2.02, ddd (14.3, 0.9, 10.8) 1.88, ddd (14.7, 3.8, 9.7) 1.81, ddd (14.1, 3.0, 10.0) 
H5b 1.00, ddd (13.8, 8.8, 5.3) 0.97, ddd (14.2, 9.2, 3.3) 0.77, ddd (14.3, 9.1,2.1) 1.24, ddd (14.7, 8.1, 4.1) 0.90, ddd (14.1, 9.4, 3.2) 
H4 2.76, dqd (9.1, 6.9, 5.3) 2.83, ddq (3.3, 9.8, 6.6) 2.82, ddq (2.1, 10.8, 6.8) 2.69, ddq (4.1, 9.7, 6.5) 2.82, ddq (10.0, 3.2, 6.7) 
H19 0.86, d (6.6) 0.81, d (6.1) 0.91, d (6.2) 0.82, d (6.3) 0.92, d (6.2) 








NMR data of fragment A (compounds 2.6 and 2.7 – 2.10, gas conformational search) 
Table 6.32: Conformation clusters of compounds 2.6 and 2.7 – 2.10 with initial DFT energy derived 
population, NOE-refined DDG (in kJ mol−1) and NOE-refined population for each cluster. 







2.6 1 g+ g+ g+ ap 0.00% 0.09 0.01% 
 2 g+ g+ ap ap 0.00% 0.23 0.01% 
 3 g+ ap g ap 0.00% 6.72 4.54% 
 4 g+ +ac ap g+ 0.00% 0.00 0.00% 
 5 g+ +ac ap ap 0.01% 7.45 9.54% 
 6 g+ ap ap g+ 0.00% 0.03 0.00% 
 7 g+ ap ap ap 0.01% 0.19 1.14% 
 8 g+ ap g ap 0.00% 0.06 0.02% 
 9 g+ g ap ap 0.03% 4.48 17.63% 
 10 +ac g ap ap 0.00% 0.00 0.00% 
 11 ap g+ g+ ac 0.00% 0.01 0.00% 
 12 ap g+ g+ ap 0.00% 0.17 0.00% 
 13 ap ap ap g+ 0.00% 0.03 0.00% 
 14 ap ap ap ap 99.11% 15.18 19.44% 
 15 ap ap g ap 0.04% 0.15 3.00% 
 16 ap ap g g 0.00% 0.34 0.07% 
 17 ac g g+ ap 0.02% 2.28 3.58% 
 18 ap g +ac ap 0.00% 0.00 0.00% 
 19 ap g ap g+ 0.00% 0.00 0.00% 
 20 ap g ap ap 0.50% 6.34 3.45% 
 21 g g+ ap ap 0.00% 0.00 0.00% 
 22 g ap ap g+ 0.00% 0.13 0.01% 
 23 g ap ap ap 0.14% 0.28 11.32% 
 24 g ap g ap 0.00% 0.02 0.00% 
 25 g ap g g 0.00% 0.02 0.00% 
 26 g g ap ap 0.15% 1.72 26.23% 
         
         
2.7 1 g+ g+ ap ap 0.00% 0.00 0.00% 
 2 g+ ap g+ ap 0.00% 0.13 0.01% 
 3 g+ ap g+ g+ 0.00% 0.00 0.00% 
 4 g+ ap ap ap 47.28% 4.87 75.05% 
 5 g+ ap ap g 0.00% 0.00 0.00% 




 7 ap g+ ap g+ 0.00% 0.03 0.03% 
 8 ap g+ ap +ac 0.00% 0.01 0.00% 
 9 ap g+ ap ap 52.71% 11.11 6.75% 
 10 ap g+ ap g 0.00% 0.04 0.02% 
 11 ap g ap ap 0.00% 0.00 0.00% 
 12 g ac ap ap 0.00% 0.02 0.00% 
 13 g g ap ap 0.00% 0.00 0.00% 
         
         
2.8         
 1 g+ ap g+ g+ 0.08% 9.26 11.54% 
 2 g+ ap ap ap 0.01% 0.10 0.05% 
 3 g+ ap ap g 65.48% 3.59 55.02% 
 4 +ac ap ap g 0.00% 0.00 0.00% 
 5 ap g+ ap g+ 0.06% 12.08 28.49% 
 6 ap g+ ap +ac 0.00% 0.07 0.01% 
 7 ap g+ ap ap 9.54% 6.72 2.27% 
 8 ap g+ ap g 24.28% 10.44 1.28% 
 9 ap g+ ac ap 0.01% 0.14 0.04% 
 10 ap g+ g ap 0.52% 1.00 1.25% 
 11 ap ap ap g 0.01% 0.54 0.05% 
 12 ap ac ap g 0.00% 0.00 0.00% 
 13 ap g g ap 0.00% 0.00 0.00% 
 14 g g+ ap g 0.00% 0.00 0.00% 
 15 g ac ap g 0.00% 0.01 0.00% 
 16 g g ap g 0.00% 0.03 0.00% 
         
         
2.9         
 1 g+ g+ g+ ap 1.09% 2.66 0.39% 
 2 g+ g+ ap g+ 0.38% 0.60 0.31% 
 3 g+ g+ ap ap 0.04% 0.00 0.05% 
 4 g+ +ac ap g+ 0.00% 0.00 0.00% 
 5 g+ ap ap g+ 0.00% 0.01 0.00% 
 6 g+ g ap g+ 1.66% 2.54 0.62% 
 7 g+ g ap ap 0.05% 16.22 37.55% 
 8 g+ g g ap 1.17% 0.37 1.41% 
 9 g+ g g g 0.03% 0.60 0.04% 
 10 +ac ap g+ ap 4.61% 1.48 8.70% 
 11 +ac ap ap g+ 0.09% 0.82 0.07% 




 13 +ac g ap g+ 0.08% 0.59 0.06% 
 14 ap g+ g+ ap 0.62% 4.92 0.09% 
 15 ap g+ ap g+ 4.95% 3.65 22.40% 
 16 ap ap g+ ap 0.04% 0.01 0.04% 
 17 ap g ap g+ 2.04% 4.54 0.34% 
 18 ap ap ap g+ 80.14% 4.20 15.24% 
 19 ap ap ap ap 0.03% 0.18 0.03% 
 20 ap ac ap ap 1.24% 3.58 0.30% 
 21 ap g ap ap 0.20% 1.92 0.10% 
 22 ap ap ap g 0.00% 0.00 0.00% 
 23 ap g g ap 1.46% 5.17 12.21% 
 24 ap g g g 0.00% 0.05 0.00% 
 25 g ap g+ ap 0.01% 0.10 0.02% 
 26 g ap ap g+ 0.02% 0.11 0.02% 
 27 g ap ap ap 0.01% 0.11 0.01% 
 28 g g ap ap 0.00% 0.07 0.00% 
 29 g g ap g+ 0.01% 0.56 0.00% 
         
         
2.10 1 g+ g+ ap g+ 0.00% 0.00 0.00% 
 2 g+ g+ ap ap 0.13% 1.70 1.99% 
 3 g+ +ac g ap 0.12% 0.03 0.95% 
 4 g+ g ap ap 49.87% 7.19 21.32% 
 5 +ac g ap ap 0.00% 0.00 0.00% 
 6 g+ g g ap 0.00% 15.42 13.59% 
 7 g+ g g g 0.00% 0.02 0.01% 
 8 ap g+ ap g+ 0.00% 0.02 0.00% 
 9 ap g+ ap ap 0.31% 5.67 23.54% 
 10 ap g+ g ap 0.17% 0.03 1.34% 
 11 g g ap ap 0.00% 0.00 0.00% 
 12 g ap ap ap 0.01% 0.04 0.11% 
 13 ap ap ap ap 38.23% 6.32 23.21% 
 14 ap ac ap ap 0.86% 2.69 2.26% 
 15 ap ac ap ap 9.96% 4.98 10.41% 
 16 ap g ap ap 0.33% 1.87 1.20% 




Table 6.33: Comparison of experimental 1H chemical shifts re-extracted from the 1H spectrum provided 
by Sherman et al.95 with the calculated scaled 1H chemical shifts before population refinement for 
compound 2.6, 2.7 – 2.10 with Deviations (Dev., in ppm), Mean Absolute Deviations (MAD, in ppm), 
Standard Deviations (StDev, in ppm) and 2 (reduced) values (2 (red.)). 
 Lit. H 2.6 Dev. 2.7 Dev. 2.8 Dev. 2.9 Dev. 2.10 Dev. 
H1' 4.47 4.70 0.23 4.72 0.25 4.68 0.21 4.33 0.14 4.65 0.18 
H14 1.88 1.49 0.39 1.87 0.01 1.65 0.23 1.78 0.10 1.81 0.07 
H13 4.00 4.08 0.08 3.81 0.19 3.97 0.03 4.17 0.17 4.03 0.03 
H12a 1.78 1.43 0.35 1.19 0.59 1.18 0.60 1.64 0.14 1.16 0.62 
H12b 1.54 1.69 0.15 1.74 0.20 1.98 0.44 1.90 0.36 1.20 0.34 
H11 3.69 3.68 0.01 3.71 0.02 3.65 0.04 3.54 0.15 3.70 0.01 
H10a 1.41 1.33 0.08 1.38 0.03 1.43 0.02 1.32 0.09 1.15 0.26 
H10b 1.39 1.55 0.16 1.39 0.00 1.45 0.06 1.89 0.50 1.24 0.15 
  MAD 0.18 MAD 0.16 MAD 0.20 MAD 0.20 MAD 0.21 
  StDev 0.24 StDev 0.26 StDev 0.31 StDev 0.26 StDev 0.25 
  χ2(red.) 2.51 χ2(red.) 3.10 χ2(red.) 4.17 χ2(red.) 3.07 χ2(red.) 3.95 
 
Table 6.34: Comparison of experimental 13C chemical shifts re-extracted from the 13C spectrum 
provided by Sherman et al.95 with the calculated scaled 13C chemical shifts before population refinement 
for compound 2.6 and 2.7 – 2.10 with Deviations (Dev., in ppm), Mean Absolute Deviations (MAD, in 
ppm), Standard Deviations (StDev, in ppm) and 2 (reduced) values (2 (red.)). 
 Lit. C 2.6 Dev. 2.7 Dev. 2.8 Dev. 2.9 Dev. 2.10 Dev. 
C1' 76.85 76.14 0.7 76.60 0.2 79.32 2.5 81.23 4.4 75.43 1.4 
C14 48.82 48.95 0.1 48.43 0.4 49.51 0.7 48.29 0.5 47.14 1.7 
C15 37.63 30.63 7.0 36.01 1.6 36.41 1.2 36.90 0.7 39.47 1.8 
C10 35.72 36.37 0.6 37.19 1.5 34.71 1.0 34.71 1.0 35.25 0.5 
C11 72.87 72.73 0.1 74.74 1.9 74.21 1.3 70.86 2.0 71.85 1.0 
C12 40.99 41.49 0.5 38.87 2.1 37.22 3.8 39.98 1.0 42.60 1.6 
C13 73.68 76.92 3.2 74.43 0.8 71.13 2.6 74.25 0.6 77.71 4.0 
  MAD 1.77 MAD 1.21 MAD 1.86 MAD 1.46 MAD 1.72 
  StDev 3.01 StDev 1.50 StDev 2.22 StDev 2.10 StDev 2.02 





Table 6.35: Experimental nJHH values (in Hz) of Balamycin A and Boltzmann averaged calculated nJHH of C1’-C10 region (fragment A, in Hz) before population 
refinement for 2.6 and 2.7 – 2.10 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, in Hz) and 2 (reduced) 
values (2 (red.)). 
H Coupled H Exp. nJHH Calc. 2.6 Dev. Calc. 2.7 Dev. Calc. 2.8 Dev. Calc. 2.9 Dev. Calc. 2.10 Dev. 
H1' H14 6.8 1.8 5.0 6.8 0.0 4.7 2.1 8.9 2.1 6.1 0.7 
H14 H13 3.5 2.2 1.3 2.6 0.9 2.2 1.3 6.6 3.1 3.5 0.0 
H13 
H12a 3.2 1.1 2.1 1.5 1.7 2.0 1.2 2.9 0.3 1.6 1.6 
H12b 10.0 9.0 1.0 9.7 0.3 10.4 0.4 10.1 0.1 9.9 0.1 
H12a 
H12b 14.1 14.6 0.5 14.5 0.4 15.0 0.9 14.4 0.3 14.7 0.6 
H11 4.5 2.2 2.3 1.7 2.8 3.3 1.2 4.6 0.1 1.7 2.8 
H12b H11 8.2 9.6 1.4 9.0 0.8 4.3 3.9 3.1 5.1 9.1 0.9 
H11 
H10a 4.3 2.1 2.2 2.2 2.1 6.5 2.2 2.8 1.5 2.4 1.9 
H10b 8.0 9.2 1.2 8.8 0.8 7.0 1.0 8.9 0.9 9.1 1.1 
   MAD 1.9 MAD 1.1 MAD 1.6 MAD 1.5 MAD 1.1 
   StDev 2.0 StDev 1.3 StDev 1.8 StDev 2.3 StDev 1.3 













Table 6.36: Experimental nJHC values of synthetic baulamycin A (compound 2.17, in Hz) and Boltzmann averaged calculated nJHC of C1’-C10 region (fragment 
A, in Hz) before population refinement for 2.6 and 2.7 – 2.10 with Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, in Hz) and 2 
(reduced) values (2 (red.)). 
H C Exp. nJHCa Calc. 2.6 Dev. Calc. 2.7 Dev. Calc. 2.8 Dev. Calc. 2.9 Dev. Calc. 2.10 Dev. 
H1' 
C15 2.3 4.4 2.1 1.9 0.4 2.1 0.2 2.5 0.2 2.5 0.2 
C13 4.3 4.0 0.3 3.6 0.7 4.9 0.6 2.3 2.0 4.6 0.3 
H13 
C14 3.5 2.2 1.3 2.9 0.6 2.5 1.0 1.5 2.0 2.2 1.3 
C1' 2.8 3.8 1.0 5.0 2.2 4.2 1.4 4.3 1.5 5.0 2.3 
H14 
C12 3.8 2.0 1.8 3.2 0.6 2.8 1.0 1.7 2.0 2.4 1.4 
C13 5.0 2.2 2.7 4.6 0.3 3.8 1.1 5.5 0.5 3.6 1.3 
C1' 4.9 2.9 2.0 4.8 0.1 3.4 1.5 6.0 1.1 4.0 0.9 
H12a 
C14 1.8 2.3 0.4 1.6 0.2 1.6 0.2 0.9 0.9 1.6 0.2 
C13 2.3 1.8 0.5 1.7 0.7 1.3 1.0 1.7 0.7 1.8 0.5 
C10 2.5 1.2 1.3 1.8 0.7 0.9 1.6 0.6 1.9 1.8 0.7 
C11 3.3 1.5 1.7 2.1 1.2 2.1 1.2 2.5 0.7 1.9 1.4 
H12b 
C14 2.5 0.9 1.6 1.1 1.4 1.7 0.8 2.6 0.1 1.3 1.2 
C13 6.2 6.0 0.2 6.0 0.2 6.3 0.1 5.9 0.3 6.0 0.2 
C10 3.3 2.7 0.6 2.3 1.0 5.5 2.2 5.4 2.1 2.3 0.9 
C11 6.0 6.3 0.3 6.1 0.1 5.2 0.8 5.3 0.7 6.1 0.1 
H11 C13 3.1 2.7 0.4 3.3 0.2 6.4 3.3 6.8 3.7 3.4 0.3 
   MAD 1.1 MAD 0.7 MAD 1.1 MAD 1.3 MAD 0.8 
   StDev 1.2 StDev 0.8 StDev 1.4 StDev 1.6 StDev 1.0 















Table 6.37: Experimental 1H-1H distances derived from 2D-ROESY spectrum provided by Sherman et al.95 and the Boltzmann averaged computed 1H-1H 
distances of C1’-C10 region (fragment A, in Å) before population refinement for 2.6 and 2.7 – 2.10 with Mean Absolute Deviations (MAD),  Standard 
Deviations (StDev) and 2 (reduced) values (2 (red.)). 
H Hx Exp r /Å Calc.2.6 / Å % errora Exp r /Å Calc.2.7 / Å % errora Exp r /Å Calc.2.8 / Å % errora 
H1' 
H13 3.09 2.27 −30% 2.99 3.72 22% 3.04 3.70 20% 
H14 2.75 2.46 −11% 2.66 2.64 −1% 2.71 2.56 −6% 
H12a 2.72 4.22 43% 2.64 3.05 15% 2.68 3.24 19% 
H12b 4.15 4.54 9% 4.02 2.58 −43% 4.08 2.77 −38% 
H15 3.02 3.77 22% 2.92 2.87 −2% 2.97 2.96 −1% 
H13 
H11 2.71 2.45 −10% 2.62 2.43 −8% 2.66 3.54 28% 
H14 2.55 2.41 −6% 2.47 2.45 −1% 2.51 2.44 −3% 
H12a 2.68 2.53 −6% 2.60 2.53 −3% 2.64 2.51 −5% 
H12b 3.09 3.05 −1% 2.99 3.05 2% 3.04 3.04 0% 
H15 3.26 3.82 16% 3.16 3.40 7% 3.21 3.47 8% 
H11 
H14 3.31 4.16 23% 3.20 4.39 31% 3.25 4.82 39% 
H12a 2.79 2.47 −12% 2.70 2.49 −8% 2.74 2.47 −10% 
H12b 2.90 3.05 5% 2.81 3.05 8% 2.86 2.42 −17% 
H10 2.95 2.66 −10% 2.85 2.61 −9% 2.90 2.65 −9% 
H9a 3.03 2.58 −16% 2.93 2.59 −12% 2.98 2.65 −12% 
H9b 3.10 3.26 5% 3.00 3.10 3% 3.05 2.92 −4% 
H12a H14 2.86 2.48 −14% 2.76 2.76 0% 2.81 2.65 −6% 
H12b 1.85 1.77 −5% 1.79 1.77 −1% 1.82 1.76 −3% 
   MAD/% 13.57%  MAD/% 9.78%  MAD/% 12.60% 
   StDev/% 17.48%  StDev/% 15.44%  StDev/% 17.68% 
   χ2(red.) 12.23  χ2(red.) 9.54  χ2(red.) 12.50 





(Table 6.37 continued) 
H Hx Exp r /Å Calc.2.9 / Å % errora Exp r /Å Calc.2.10 / Å % errora    
H1' 
H13 3.02 2.57 −16% 3.04 2.91 −4%    
H14 2.69 2.98 10% 2.71 2.65 −2%    
H12a 2.66 3.51 27% 2.68 4.20 44%    
H12b 4.06 4.10 1% 4.08 4.22 3%    
H15 2.96 2.63 −12% 2.97 2.76 −7%    
H13 
H11 2.65 3.59 30% 2.66 2.44 −9%    
H14 2.50 2.87 14% 2.51 2.62 4%    
H12a 2.62 2.47 −6% 2.64 2.50 −5%    
H12b 3.02 2.93 −3% 3.04 3.03 0%    
H15 3.19 2.83 −12% 3.21 2.61 −21%    
H11 
H14 3.23 3.64 12% 3.25 4.35 29%    
H12a 2.73 2.42 −12% 2.74 2.50 −9%    
H12b 2.84 2.46 −14% 2.86 3.05 7%    
H10 2.88 2.69 −7% 2.90 2.66 −9%    
H9a 2.96 2.54 −16% 2.98 2.66 −11%    
H9b 3.03 2.94 −3% 3.05 3.10 2%    
H12a H14 2.79 3.23 14% 2.81 2.59 −8%    
H12b 1.81 1.77 −2% 1.82 1.76 −3%    
   MAD/% 11.81%  MAD/% 9.91%    
   StDev/% 14.47%  StDev/% 15.05%    
   χ2(red.) 8.38  χ2(red.) 9.06    




Table 6.38: Comparison of experimental 1H chemical shifts re-extracted from the 1H spectrum provided 
by Sherman et al.95 with the calculated scaled 1H chemical shifts after population refinement for 
compound 2.6 and 2.7 – 2.10 with Deviations (Dev, in ppm) Mean Absolute Deviations (MAD, in ppm), 
Standard Deviations (StDev, in ppm) and 2 (reduced) values (2 (red.)). 
 Lit. H 2.6 Dev. 2.7 Dev. 2.8 Dev. 2.9 Dev. 2.10 Dev. 
H1' 4.47 4.69 0.22 4.66 0.19 4.83 0.36 4.57 0.10 4.51 0.04 
H14 1.88 1.89 0.01 1.94 0.06 1.64 0.24 1.97 0.09 1.88 0.00 
H13 4.00 4.01 0.01 3.86 0.14 3.83 0.17 4.00 0.00 4.19 0.19 
H12a 1.78 1.25 0.53 1.40 0.38 1.28 0.50 1.16 0.62 1.44 0.34 
H12b 1.54 1.41 0.13 1.74 0.20 1.87 0.33 1.77 0.23 1.33 0.21 
H11 3.69 3.71 0.02 3.81 0.12 3.67 0.02 3.73 0.04 3.65 0.04 
H10a 1.41 1.25 0.16 1.49 0.08 1.34 0.07 1.54 0.13 1.19 0.22 
H10b 1.39 1.40 0.01 1.33 0.06 1.48 0.09 1.34 0.05 1.40 0.01 
  MAD 0.14 MAD 0.15 MAD 0.22 MAD 0.16 MAD 0.13 
  StDev 0.22 StDev 0.19 StDev 0.29 StDev 0.26 StDev 0.17 
  χ2(red.) 2.33 χ2(red.) 1.67 χ2(red.) 3.75 χ2(red.) 3.05 χ2(red.) 1.58 
 
Table 6.39: Comparison of experimental 13C chemical shifts re-extracted from the 13C spectrum 
provided by Sherman et al.95 with the calculated scaled 13C chemical shifts after population refinement 
for compound 2.6 and 2.7 – 2.10 with Deviations (Dev., in ppm) Mean Absolute Deviations (MAD, in 
ppm), Standard Deviations (StDev, in ppm) and 2 (reduced) values (2 (red.)). 
 Lit. C 2.6 Dev. 2.7 Dev. 2.8 Dev. 2.9 Dev. 2.10 Dev. 
C1' 76.85 76.94 0.1 77.17 0.3 78.64 1.8 79.99 3.1 76.96 0.1 
C14 48.82 49.33 0.5 49.34 0.5 49.20 0.4 48.92 0.1 47.75 -1.1 
C15 37.63 36.57 -1.1 37.00 -0.6 36.25 -1.4 41.29 3.7 39.01 1.4 
C10 35.72 36.03 0.3 37.29 1.6 35.11 -0.6 36.75 1.0 36.48 0.8 
C11 72.87 72.76 -0.1 72.97 0.1 74.45 1.6 69.75 -3.1 71.38 -1.5 
C12 40.99 39.84 -1.2 39.37 -1.6 38.27 -2.7 40.17 -0.8 41.56 0.6 
C13 73.68 74.53 0.8 73.62 -0.1 70.80 -2.9 72.57 -1.1 75.47 1.8 
  MAD 0.58 MAD 0.69 MAD 1.62 MAD 1.85 MAD 1.02 
  StDev 0.76 StDev 0.99 StDev 1.90 StDev 2.41 StDev 1.21 




Table 6.40: Experimental nJHH values (in Hz) of balamycin A and population refined Boltzmann averaged calculated nJHH of C1’-C10 region (fragment A, in 
Hz) for 2.6 and 2.7 – 2.10 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, in Hz) and 2 (reduced) values 
(2 (red.)). 
H Coupled H Exp. nJHH Calc. 2.6 Dev Calc. 2.7 Dev. Calc. 2.8 Dev. Calc. 2.9 Dev. Calc. 2.10 Dev. 
H1' H14 6.8 5.3 1.5 4.8 2.0 4.7 2.1 5.4 1.4 6.7 0.1 
H14 H13 3.5 3.2 0.3 2.4 1.1 2.1 1.4 4.5 1.0 3.7 0.2 
H13 
H12a 3.2 2.4 0.8 2.9 0.3 2.9 0.3 3.0 0.2 3.6 0.4 
H12b 10.0 9.3 0.7 8.1 1.9 9.2 0.8 8.8 1.2 8.9 1.1 
H12a 
H12b 14.1 14.8 0.7 14.7 0.6 14.8 0.7 14.8 0.7 14.6 0.5 
H11 4.5 1.8 2.7 2.3 2.2 3.1 1.4 7.1 2.6 1.7 2.8 
H12b H11 8.2 9.0 0.8 9.8 1.6 6.8 1.4 2.2 6.0 9.0 0.8 
H11 
H10a 4.3 3.4 0.9 4.2 0.1 5.3 1.0 5.3 1.0 4.5 0.2 
H10b 8.0 8.3 0.3 6.5 1.5 5.9 2.1 7.9 0.1 6.8 1.2 
   MAD 1.0 MAD 1.3 MAD 1.2 MAD 1.6 MAD 0.8 
   StDev 1.1 StDev 1.3 StDev 1.1 StDev 2.4 StDev 1.1 















Table 6.41: Experimental nJHC values of synthetic baulamycin A (compound 2.17, in Hz) and the population refined Boltzmann averaged calculated nJHC of 
C1’-C10 region (fragment A, in Hz) for 2.6 and 2.7 – 2.10 with Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, in Hz) and 2 (reduced) 
values (2 (red.)). 
H C Exp. nJHCa Calc. 2.6 Dev Calc. 2.7 Dev. Calc. 2.8 Dev. Calc. 2.9 Dev. Calc. 2.10 Dev. 
H1' 
C15 2.3 3.1 0.8 1.8 0.5 2.0 0.3 3.2 0.9 2.7 0.4 
C13 4.3 3.6 0.7 5.4 1.1 4.7 0.4 3.1 1.2 3.7 0.6 
H13 
C14 3.5 2.7 0.8 2.5 1.0 2.2 1.3 2.6 0.9 2.1 1.4 
C1' 2.8 5.7 3.0 3.6 0.8 4.0 1.2 5.1 2.3 3.9 1.1 
H14 
C12 3.8 4.1 0.3 2.3 1.5 2.4 1.3 1.8 2.0 3.2 0.6 
C13 5.0 4.5 0.5 3.6 1.4 3.6 1.4 4.1 0.9 3.9 1.1 
C1' 4.9 5.9 1.0 3.4 1.5 3.2 1.7 4.5 0.4 4.9 0.0 
H12a 
C14 1.8 1.9 0.1 2.4 0.5 1.9 0.1 1.7 0.1 1.6 0.2 
C13 2.3 2.1 0.2 2.8 0.5 2.3 0.0 1.8 0.5 2.5 0.2 
C10 2.5 1.7 0.8 1.2 1.3 3.1 0.6 1.3 1.2 1.8 0.7 
C11 3.3 1.9 1.3 1.5 1.8 3.6 0.3 4.8 1.5 1.9 1.3 
H12b 
C14 2.5 1.5 1.1 1.7 0.8 2.0 0.6 1.9 0.6 2.4 0.1 
C13 6.2 5.6 0.6 6.1 0.1 5.9 0.3 6.1 0.1 5.8 0.4 
C10 3.3 2.4 0.9 2.8 0.5 4.6 1.3 3.3 0.0 2.4 0.9 
C11 6.0 6.1 0.1 6.3 0.3 5.4 0.6 2.7 3.3 6.3 0.3 
H11 C13 3.1 3.2 0.1 2.6 0.5 4.5 1.4 4.8 1.7 3.2 0.1 
   MAD 0.8 MAD 0.9 MAD 0.8 MAD 1.1 MAD 0.6 
   StDev 1.1 StDev 1.3 StDev 1.0 StDev 1.4 StDev 0.7 















Table 6.42: Experimental 1H-1H distances derived from 2D-ROESY spectrum provided by Sherman et al.95 and the population refined Boltzmann averaged 
computed 1H-1H distances of C1’-C10 region (fragment A, in Å) for 2.6 and 2.7 – 2.10 with Mean Absolute Deviations (MAD), Standard Deviations (StDev) 
and 2 (reduced) values (2 (red.)). 
H Hx Exp r /Å Calc.2.6 / Å % errora Exp r/Å Calc.2.7 / Å % errora Exp r /Å Calc.2.8 / Å % errora 
H1' 
H13 2.95 2.82 −5% 3.04 3.69 19% 2.95 3.70 23% 
H14 2.62 2.67 2% 2.71 2.52 −7% 2.63 2.56 −3% 
H12a 2.60 3.40 27% 2.68 3.03 12% 2.60 3.05 16% 
H12b 3.96 2.92 −30% 4.08 3.51 −15% 3.96 2.86 −32% 
H15 2.88 2.81 −2% 2.97 3.10 4% 2.88 2.98 3% 
H13 
H11 2.58 2.47 −4% 2.66 2.49 −7% 2.58 2.86 10% 
H14 2.43 2.42 0% 2.51 2.43 −3% 2.43 2.45 1% 
H12a 2.56 2.53 −1% 2.64 2.60 −2% 2.56 2.55 0% 
H12b 2.94 2.91 −1% 3.04 2.85 −6% 2.95 2.89 −2% 
H15 3.11 3.52 12% 3.21 3.58 11% 3.11 3.54 13% 
H11 
H14 3.15 3.16 0% 3.25 4.17 25% 3.15 3.13 −1% 
H12a 2.66 2.48 −7% 2.74 2.48 −10% 2.66 2.46 −8% 
H12b 2.77 3.04 9% 2.86 3.05 6% 2.77 2.56 −8% 
H10 2.81 2.65 −6% 2.90 2.60 −11% 2.81 2.56 −9% 
H9a 2.89 2.71 −7% 2.98 2.75 −8% 2.89 2.81 −3% 
H9b 2.96 3.36 13% 3.05 3.11 2% 2.96 2.99 1% 
H12a H14 2.72 2.72 0% 2.81 2.58 −8% 2.72 2.71 −1% 
H12b 1.763 1.76 0% 1.82 1.77 −3% 1.76 1.76 0% 
   MAD/% 7.02%  MAD/% 8.90%  MAD/% 7.39% 
   StDev/% 11.37%  StDev/% 11.00%  StDev/% 11.66% 
   χ2(red.) 5.14  χ2(red.) 4.8  χ2(red.) 5.44 





(Table 6.42 continued) 
H Hx Exp r /Å Calc.2.9 / Å % errora Exp r/Å Calc.2.10 / Å % errora    
H1' 
H13 2.95 3.10 5% 2.91 3.04 5%    
H14 2.63 2.79 6% 2.59 2.72 5%    
H12a 2.60 2.83 9% 2.56 2.87 11%    
H12b 3.96 3.76 −5% 3.91 3.45 −12%    
H15 2.88 2.62 −10% 2.84 2.64 −7%    
H13 
H11 2.59 2.82 9% 2.55 2.53 −1%    
H14 2.44 2.48 2% 2.40 2.53 5%    
H12a 2.56 2.55 0% 2.52 2.51 −1%    
H12b 2.95 2.79 −5% 2.91 2.85 −2%    
H15 3.12 2.93 −6% 3.07 2.83 −8%    
H11 
H14 3.16 3.25 3% 3.11 3.21 3%    
H12a 2.66 2.66 0% 2.62 2.51 −5%    
H12b 2.77 2.51 −10% 2.73 3.04 11%    
H10 2.81 2.67 −5% 2.77 2.66 −4%    
H9a 2.89 3.00 4% 2.85 2.70 −6%    
H9b 2.96 2.92 −1% 2.92 2.96 1%    
H12a H14 2.73 2.90 6% 2.69 2.78 3%    
H12b 1.77 1.76 0% 1.741 1.76 1%    
   MAD/% 4.83%  MAD/% 5.10%    
   StDev/% 5.91%  StDev/% 6.37%    
   χ2(red.) 1.40  χ2(red.) 1.62    





The fit of all calculated NMR parameters for Fragment A of 2.6 and 2.7 – 2.10, to those of the 
experimental parameters derived from the natural product is shown in Figure 6.23. 
 
Figure 6.23: a. Generic structure of isomers studied for fragment A analysis using conformers obtained 
from gas MM conformational search. b. Relative stereochemistry of isomers studied for fragment A 
analysis. Results of comparison of NMR properties (1H and 13C chemical shifts, 1H-1H and 1H-13C scalar 
































































































NMR data of fragment A (compounds 2.6, 2.7 – 2.10, octanol conformational search) 
Table 6.43: Conformation clusters of compounds 2.10 with initial DFT energy derived population, NOE-refined DDG (in kJ mol−1) using different constraints 
and NOE-refined population for each cluster. 
      Σ(ΔΔG)2 =25 Σ(ΔΔG)2 =100 Σ(ΔΔG)2 =225 
















1 +ac ap ap ap 0.01% −0.01 0.01% 0.01 0.01% 0.02 0.02% 
2 −ac g− ap ap 0.00% 0.00 0.00% 0.04 0.01% 0.01 0.01% 
3 ap −ac ap ap 4.77% 1.15 3.09% 1.59 4.75% 1.93 7.52% 
4 ap −ac ap g+ 0.00% 0.00 0.00% 0.00 0.00% 0.00 0.00% 
5 ap −ac g− ap 0.00% −0.44 0.00% −0.46 0.01% −0.05 0.01% 
6 ap ap ap ap 17.68% 0.60 14.32% 3.34 8.70% 3.15 17.01% 
7 ap ap ap g+ 0.16% −0.66 0.22% −8.08 7.92% 0.00 0.55% 
8 ap g+ ap ap 5.51% −4.05 29.13% −2.40 27.54% −0.85 26.68% 
9 ap g+ g− ap 0.01% −0.02 0.01% −0.01 0.01% 0.01 0.02% 
10 ap g− ap ap 4.56% 2.08 2.03% 2.33 3.36% 2.01 6.97% 
11 ap g− g− ap 0.00% −0.01 0.00% −0.01 0.00% −0.03 0.00% 
12 ap g− g− g− 0.00% 0.00 0.00% −0.01 0.00% −0.03 0.01% 
13 g+ g+ ap ap 8.61% 1.07 5.76% 1.60 8.55% 1.82 14.18% 
14 g+ g+ ap g+ 0.00% 0.00 0.00% −0.01 0.01% −0.03 0.02% 
15 g+ g− ap ap 58.61% 0.71 45.35% 2.59 38.99% 5.26 24.03% 




17 g− +ac ap ap 0.02% 0.01 0.02% −0.01 0.04% −0.02 0.06% 
18 g− ap ap ap 0.03% 0.02 0.03% 0.01 0.05% 0.02 0.09% 
19 g− g+ ap ap 0.01% 0.01 0.01% −0.01 0.02% 0.01 0.04% 
20 g− g− ap ap 0.01% 0.01 0.01% 0.10 0.02% 0.05 0.03% 


















1 0.41 0.07% 0.21 0.05% 1.16 0.01% 2.68 0.00% 
2 1.15 0.03% 0.78 0.02% 2.40 0.00% 3.95 0.00% 
3 3.51 14.54% 2.54 14.11% −0.67 17.68% −4.76 18.29% 
4 0.00 0.01% −0.06 0.01% −0.03 0.00% −0.03 0.00% 
5 −0.19 0.03% −15.51 10.06% −18.19 10.16% −22.20 10.17% 
6 11.32 2.31% 9.24 3.49% 13.74 0.19% 16.22 0.01% 
7 0.00 2.02% 0.44 1.11% 3.73 0.10% 5.65 0.01% 
8 1.68 35.15% 0.90 31.62% −1.85 32.82% −5.86 32.97% 
9 0.03 0.08% 0.21 0.05% 0.04 0.02% 0.05 0.00% 
10 7.08 3.29% 6.54 2.67% 9.82 0.24% 12.05 0.02% 
11 −0.03 0.00% −0.10 0.00% −0.05 0.00% −0.05 0.00% 
12 −0.54 0.02% −0.03 0.01% −0.15 0.00% −0.16 0.00% 
13 6.05 9.41% 8.09 2.71% 12.09 0.18% 14.47 0.01% 
14 −1.61 0.11% −15.64 21.11% −18.51 23.15% −22.55 23.44% 
15 10.58 10.28% 11.03 5.63% 13.40 0.74% 15.44 0.06% 
16 −13.86 12.84% −0.17 0.03% 0.05 0.01% 0.05 0.00% 
17 −9.07 9.20% −9.39 6.86% −12.62 8.65% −16.66 8.79% 




19 −0.11 0.16% 0.02 0.10% 0.72 0.03% 1.25 0.00% 





Table 6.44: Conformation clusters of compounds 2.6 and 2.7 – 2.10 with initial DFT energy derived 
population, NOE-refined DDG (in kJ mol−1) using a constraint of 400 and NOE-refined population for 
each cluster. 








2.6 1 −ac g− ap ap 0.00% 0.34 0.08% 
 2 −ac g− g+ ap 0.00% −0.04 0.04% 
 3 ap ap ap ap 97.94% 14.30 9.89% 
 4 ap ap ap g+ 0.02% −1.53 1.39% 
 5 ap ap g− ap 0.06% −4.27 11.80% 
 6 ap g+ ap ap 0.02% −8.42 16.90% 
 7 ap g+ ap g+ 0.00% 0.00 0.00% 
 8 ap g+ g+ −ac 0.00% 0.00 0.00% 
 9 ap g− ap ap 1.04% 7.33 1.76% 
 10 ap g− ap g+ 0.00% 0.00 0.00% 
 11 ap sp ap ap 0.00% 0.03 0.07% 
 12 g+ +ac ap ap 0.00% 0.00 0.01% 
 13 g+ ap ap ap 0.43% 0.18 13.14% 
 14 g+ ap ap g+ 0.00% 0.00 0.00% 
 15 g+ g+ ap ap 0.00% −0.01 0.01% 
 16 g+ g+ ap g+ 0.00% 0.00 0.00% 
 17 g+ g+ g+ +ac 0.00% 0.00 0.00% 
 18 g+ g+ g+ ap 0.00% −0.01 0.01% 
 19 g+ g− ap ap 0.04% −6.98 22.78% 
 20 g− +ac ap ap 0.00% 0.00 0.01% 
 21 g− ap ap ap 0.42% −1.17 22.03% 
 22 g− ap g− ap 0.00% 0.00 0.00% 
 23 g− g− ap ap 0.00% 0.37 0.05% 
 24 sp ap ap ap 0.00% 0.00 0.03% 
         
         
2.7 1 ap g+ ap ap 86.44% 13.00 12.03% 
 2 ap g+ ap g− 0.50% 3.04 3.82% 
 3 ap g+ g+ ap 0.01% −11.22 15.93% 
 4 g+ ap ap ap 13.04% 4.15 63.58% 
 5 g+ ap ap g− 0.02% −0.15 0.45% 
 6 g+ ap g+ ap 0.00% −8.86 4.19% 




 8 g− −ac ap ap 0.00% −0.03 0.01% 
 9 g− g− ap ap 0.00% 0.00 0.00% 
         
         
2.8 1 +ac ap ap g− 0.00% 0.00 0.00% 
 2 ap g+ ap ap 2.16% 5.55 1.35% 
 3 ap g+ ap g+ 0.09% −10.16 32.84% 
 4 ap g+ ap g− 71.82% 13.13 2.10% 
 5 g+ ap ap ap 0.06% −1.54 0.65% 
 6 g+ ap ap g− 25.80% 2.72 50.58% 
 7 g+ ap g+ ap 0.02% −0.58 0.16% 
 8 g+ ap g+ g+ 0.05% −9.13 12.32% 
         
         
2.9 1 +ac ap g+ ap 0.11% 1.30 0.12% 
 2 −ac g− ap g+ 0.00% 0.24 0.00% 
 3 ap −ac ap ap 0.04% −0.14 0.08% 
 4 ap −ac ap g+ 0.33% −5.07 4.96% 
 5 ap ap ap ap 0.45% −7.23 16.03% 
 6 ap ap ap g+ 47.58% 8.06 3.56% 
 7 ap ap g+ ap 20.59% 8.20 1.45% 
 8 ap g+ ap g+ 0.81% −5.86 16.82% 
 9 ap g+ g+ ap 0.23% 4.31 0.08% 
 10 ap g− ap g+ 0.37% 3.12 0.20% 
 11 ap g− g− ap 0.97% −6.40 25.03% 
 12 ap g− g− g− 0.01% 0.00 0.01% 
 13 g+ g+ ap −ac 0.00% 0.00 0.00% 
 14 g+ g+ ap ap 0.02% 0.16 0.03% 
 15 g+ g+ ap g+ 4.44% −0.07 8.85% 
 16 g+ g+ g+ ap 0.05% 0.25 0.09% 
 17 g+ g− ap ap 3.98% −0.37 8.96% 
 18 g+ g− ap g+ 17.73% 3.58 8.09% 
 19 g+ g− g− g− 0.11% −7.70 4.59% 
 20 g− ap ap ap 0.00% 0.01 0.00% 
 21 g− ap g+ ap 2.19% 3.47 1.04% 
         
         
2.10 1 +ac ap ap ap 0.01% 0.02 0.05% 
 2 −ac g− ap ap 0.00% 0.01 0.03% 
 3 ap −ac ap ap 4.77% 2.58 11.71% 




 5 ap −ac g− ap 0.00% −0.05 0.02% 
 6 ap ap ap ap 17.68% 5.86 11.58% 
 7 ap ap ap g+ 0.16% 0.00 1.12% 
 8 ap g+ ap ap 5.51% 0.20 35.38% 
 9 ap g+ g− ap 0.01% 0.01 0.04% 
 10 ap g− ap ap 4.56% 5.75 3.12% 
 11 ap g− g− ap 0.00% −0.03 0.00% 
 12 ap g− g− g− 0.00% −0.03 0.01% 
 13 g+ g+ ap ap 8.61% 3.59 14.08% 
 14 g+ g+ ap g+ 0.00% −0.03 0.03% 
 15 g+ g− ap ap 58.61% 9.12 10.30% 
 16 g+ g− g− ap 0.00% −15.16 12.07% 
 17 g− +ac ap ap 0.02% −0.02 0.13% 
 18 g− ap ap ap 0.03% 0.02 0.19% 
 19 g− g+ ap ap 0.01% 0.01 0.08% 





Table 6.45: Experimental nJHH values (in Hz) of Balamycin A and Boltzmann averaged calculated nJHH of C1’-C10 region (fragment A, in Hz) before population 
refinement for 2.6 and 2.7 – 2.10 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, in Hz) and 2 (reduced) 
values (2 (red.)). 
H Coupled H Exp. nJHH Calc. 2.6 Dev. Calc. 2.7 Dev. Calc. 2.8 Dev. Calc. 2.9 Dev. Calc. 2.10 Dev. 
H1' H14 6.8 1.78 −5.02 8.38 1.58 7.34 0.54 7.31 0.51 4.15 −2.65 
H14 H13 3.5 2.15 −1.35 2.91 −0.59 2.81 −0.69 6.52 3.02 3.10 −0.40 
H13 
H12a 3.2 1.15 −2.05 1.21 −1.99 1.53 −1.67 2.94 −0.26 1.44 −1.76 
H12b 10.0 9.14 −0.86 9.47 −0.53 10.39 0.39 8.53 −1.47 9.66 −0.34 
H12a 
H12b 14.1 14.62 0.52 14.79 0.69 15.16 1.06 14.91 0.81 14.98 0.88 
H11 4.5 2.07 −2.43 1.94 −2.56 2.63 −1.87 4.96 0.46 1.70 −2.80 
H12b H11 8.2 9.49 1.29 9.53 1.33 4.69 −3.51 3.28 −4.92 9.23 1.03 
H11 
H10a 4.3 2.74 −1.56 5.19 0.89 3.60 −0.70 2.32 −1.98 5.41 1.11 
H10b 8.0 8.46 0.46 5.74 −2.26 8.44 0.44 9.22 1.22 6.35 −1.65 
   MAD 1.73 MAD 1.38 MAD 1.21 MAD 1.63 MAD 1.40 
   StDev 1.90 StDev 1.60 StDev 1.47 StDev 2.27 StDev 1.55 
   χ2(red.) 5.31 
 
χ2(red.) 1.56 χ2(red.) 2.66 
 





Table 6.46: Experimental 1H-1H distances derived from 2D-ROESY spectrum provided by Sherman et al.95 and the Boltzmann averaged computed 1H-1H 
distances of C1’-C10 region (fragment A, in Å) before population refinement for 2.6 and 2.7 – 2.10 with Mean Absolute Deviations (MAD), Standard Deviations 
(StDev) and 2 (reduced) values (2 (red.)). 
H Hx Exp r /Å Calc.2.6 / Å % errora Exp r /Å Calc.2.7 / Å % errora Exp r /Å Calc.2.8 / Å % errora 
H1' 
H13 3.09 2.28 −30% 3.00 3.77 23% 3.03 3.75 21% 
H14 2.75 2.46 −11% 2.67 2.89 8% 2.70 2.78 3% 
H12a 2.72 4.21 43% 2.64 2.73 3% 2.67 2.83 6% 
H12b 4.15 4.50 8% 4.03 2.43 −50% 4.07 2.46 −49% 
H15 3.02 3.75 22% 2.93 2.70 −8% 2.96 2.75 −7% 
H13 
H11 2.71 2.44 −10% 2.63 2.44 −7% 2.66 3.70 33% 
H14 2.55 2.41 −6% 2.48 2.49 0% 2.50 2.47 −2% 
H12a 2.68 2.52 −6% 2.60 2.54 −3% 2.63 2.54 −4% 
H12b 3.09 3.00 −3% 3.00 3.05 2% 3.03 3.05 1% 
H15 3.26 3.82 16% 3.17 3.26 3% 3.20 3.35 5% 
H11 
H14 3.31 4.17 23% 3.21 4.65 37% 3.24 5.16 46% 
H12a 2.79 2.47 −12% 2.71 2.48 −9% 2.74 2.45 −11% 
H12b 2.90 3.05 5% 2.82 3.04 8% 2.85 2.40 −17% 
H10 2.95 2.64 −11% 2.86 2.59 −10% 2.89 2.65 −9% 
H9a 3.03 2.62 −14% 2.94 2.76 −6% 2.97 2.64 −12% 
H9b 3.10 3.01 −3% 3.01 2.95 −2% 3.04 2.82 −8% 
H12a H14 2.86 2.48 −14% 2.77 3.23 15% 2.80 3.01 7% 
H12b 1.85 1.77 −5% 1.80 1.77 −2% 1.82 1.76 −3% 
   MAD/% 13.43%  MAD/% 10.81%  MAD/% 13.42% 
   StDev/% 17.30%  StDev/% 17.25%  StDev/% 20.20% 
   χ2(red.) 11.98  χ2(red.) 11.90  χ2(red.) 16.32 





(Table 6.46 continued) 
H Hx Exp r /Å Calc.2.9 / Å % errora Exp r /Å Calc.2.10 / Å % errora    
H1' 
H13 2.99 2.66 −12% 3.01 3.19 6%    
H14 2.66 2.79 5% 2.68 2.58 −4%    
H12a 2.64 4.07 43% 2.65 3.48 27%    
H12b 4.02 4.26 6% 4.04 4.01 −1%    
H15 2.92 2.64 −10% 2.94 2.55 −14%    
H13 
H11 2.62 3.59 31% 2.63 2.42 −8%    
H14 2.47 2.73 10% 2.48 2.50 1%    
H12a 2.60 2.46 −5% 2.61 2.51 −4%    
H12b 2.99 2.81 −6% 3.00 3.05 1%    
H15 3.16 2.78 −13% 3.18 3.05 −4%    
H11 
H14 3.20 2.89 −10% 3.22 4.31 29%    
H12a 2.70 2.50 −8% 2.71 2.50 −8%    
H12b 2.81 2.46 −13% 2.83 3.05 8%    
H10 2.85 2.66 −7% 2.87 2.64 −8%    
H9a 2.93 2.62 −11% 2.95 2.78 −6%    
H9b 3.00 2.89 −4% 3.02 2.81 −7%    
H12a H14 2.76 2.99 8% 2.78 2.59 −7%    
H12b 1.79 1.76 −2% 1.80 1.76 −2%    
   MAD/% 11.30%  MAD/% 8.07%    
   StDev/% 15.38%  StDev/% 11.54%    
   χ2(red.) 9.47  χ2(red.) 5.32    




Table 6.47: Experimental nJHH values (in Hz) of balamycin A and population refined (using different constraints) Boltzmann averaged calculated nJHH of C1’-
C10 region (fragment A, in Hz) for 2.10 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, in Hz) and 2 
(reduced) values (2 (red.)) 
   Σ(ΔΔG)2 =25 Σ(ΔΔG)2 =100 Σ(ΔΔG)2 =225 Σ(ΔΔG)2 =625 Σ(ΔΔG)2 =900 
H Coupled H Exp. nJHH Calc.  Dev. Calc.  Dev. Calc.  Dev. Calc.  Dev. Calc. Dev. 
H1' H14 6.8 5.44 −1.36 5.71 −1.09 6.17 −0.63 6.73 −0.07 6.75 −0.05 
H14 H13 3.5 2.94 −0.56 3.06 −0.44 3.24 −0.26 1.85 −1.65 1.87 −1.63 
H13 
H12a 3.2 1.50 −1.70 1.57 −1.63 1.80 −1.40 2.79 −0.41 2.79 −0.41 
H12b 10.0 9.74 −0.26 9.80 −0.20 9.74 −0.26 9.03 −0.97 9.21 −0.79 
H12a 
H12b 14.1 14.92 0.82 14.78 0.68 14.87 0.77 14.83 0.73 14.71 0.61 
H11 4.5 1.60 −2.90 2.37 −2.13 1.54 −2.96 2.12 −2.38 4.03 −0.47 
H12b H11 8.2 9.07 0.87 8.62 0.42 8.96 0.76 9.12 0.92 7.58 −0.62 
H11 
H10a 4.3 4.95 0.65 4.58 0.28 4.34 0.04 4.24 −0.06 3.87 −0.43 
H10b 8.0 6.78 −1.22 6.97 −1.03 6.99 −1.01 7.21 −0.79 7.63 −0.37 
   MAD 1.15 MAD 0.88 MAD 0.90 MAD 0.89 MAD 0.60 
   StDev 1.29 StDev 0.97 StDev 1.16 StDev 1.06 StDev 0.59 








(Table 6.47 continued) 
   Σ(ΔΔG)2 =1600 Σ(ΔΔG)2 =2500    
H Coupled H Exp. nJHH Calc.  Dev. Calc.  Dev.       
H1' H14 6.8 6.69 −0.11 6.62 −0.18       
H14 H13 3.5 2.16 −1.34 2.16 −1.34       
H13 
H12a 3.2 2.71 −0.49 2.73 −0.47       
H12b 10.0 9.07 −0.93 9.08 −0.92       
H12a 
H12b 14.1 14.73 0.63 14.74 0.64       
H11 4.5 4.12 −0.38 4.18 −0.32       
H12b H11 8.2 7.66 −0.54 7.62 −0.58       
H11 
H10a 4.3 3.81 −0.49 3.65 −0.65       
H10b 8.0 7.79 −0.21 7.92 −0.08       
   MAD 0.57 MAD 0.57       
   StDev 0.54 StDev 0.56       






Table 6.48: Experimental nJHH values (in Hz) of balamycin A and population refined (Σ(ΔΔG)2 =400) Boltzmann averaged calculated nJHH of C1’-C10 region 
(fragment A, in Hz) for 2.6 and 2.7 – 2.10 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, in Hz) and 2 
(reduced) values (2 (red.)) 
H Coupled H Exp. nJHH Calc. 2.6 Dev Calc. 2.7 Dev. Calc. 2.8 Dev. Calc. 2.9 Dev. Calc. 2.10 Dev. 
H1' H14 6.8 4.72 −2.08 4.72 −2.08 5.51 −1.29 6.53 −0.27 6.93 0.13 
H14 H13 3.5 4.20 0.70 2.25 −1.25 2.30 −1.20 4.13 0.63 2.63 −0.87 
H13 
H12a 3.2 2.37 −0.83 3.09 −0.11 2.10 −1.10 5.01 1.81 2.83 −0.37 
H12b 10.0 9.41 −0.59 8.20 −1.80 9.40 −0.60 8.24 −1.76 9.17 −0.83 
H12a 
H12b 14.1 14.71 0.61 14.57 0.47 14.59 0.49 14.88 0.78 14.75 0.65 
H11 4.5 1.70 −2.80 2.36 −2.14 2.57 −1.93 7.19 2.69 1.75 −2.75 
H12b H11 8.2 8.96 0.76 9.59 1.39 6.94 −1.26 2.73 −5.47 9.04 0.84 
H11 
H10a 4.3 3.34 −0.96 3.52 −0.78 4.66 0.36 7.11 2.81 4.13 −0.17 
H10b 8.0 8.19 0.19 6.22 −1.78 7.77 −0.23 5.40 −2.60 7.35 −0.65 
   MAD 1.06 MAD 1.31 MAD 0.94 MAD 2.09 MAD 0.81 
   StDev 1.27 StDev 1.25 StDev 0.82 StDev 2.72 StDev 1.06 
   χ2(red.) 1.96 
 
χ2(red.) 2.46 χ2(red.) 1.30 
 







Table 6.49: Experimental 1H-1H distances derived from 2D-ROESY spectrum provided by Sherman et al.95 and the population refined (using different 
constraints) Boltzmann averaged computed 1H-1H distances of C1’-C10 region (fragment A, in Å) for 2.10 with Mean Absolute Deviations (MAD), Standard 
Deviations (StDev) and 2 (reduced) values (2 (red.)). 
  Σ(ΔΔG)2 =25 Σ(ΔΔG)2 =100 Σ(ΔΔG)2 =225 
H Hx Exp r /Å Calc./ Å % errora Exp r/Å Calc./ Å % errora Exp r /Å Calc./ Å % errora 
H1' 
H13 2.98 3.10 4% 2.98 3.06 3% 2.96 3.05 3% 
H14 2.65 2.65 0% 2.65 2.66 0% 2.64 2.68 2% 
H12a 2.62 2.77 6% 2.62 2.80 6% 2.61 2.81 7% 
H12b 4.00 3.84 −4% 4.00 3.84 −4% 3.98 3.83 −4% 
H15 2.91 2.58 −12% 2.91 2.59 −12% 2.90 2.64 −9% 
H13 
H11 2.61 2.42 −7% 2.61 2.45 −6% 2.60 2.44 −6% 
H14 2.46 2.50 2% 2.46 2.51 2% 2.44 2.53 4% 
H12a 2.58 2.51 −3% 2.58 2.51 −3% 2.57 2.51 −2% 
H12b 2.97 3.05 2% 2.97 3.05 2% 2.96 3.01 2% 
H15 3.14 3.16 1% 3.14 3.14 0% 3.13 3.10 −1% 
H11 
H14 3.18 4.39 32% 3.18 4.39 32% 3.17 3.82 19% 
H12a 2.69 2.50 −7% 2.69 2.52 −6% 2.67 2.50 −7% 
H12b 2.80 3.05 8% 2.80 2.96 6% 2.78 3.04 9% 
H10 2.84 2.64 −7% 2.84 2.64 −7% 2.82 2.63 −7% 
H9a 2.92 2.76 −5% 2.92 2.73 −7% 2.90 2.76 −5% 
H9b 2.99 2.83 −5% 2.99 2.85 −5% 2.97 2.86 −4% 
H12a H14 2.75 2.71 −1% 2.75 2.73 −1% 2.74 2.76 1% 
H12b 1.78 1.76 −1% 1.78 1.76 −1% 1.77 1.76 −1% 
   MAD/% 6.05%  MAD/% 5.76%  MAD/% 5.07% 
   StDev/% 9.51%  StDev/% 9.27%  StDev/% 6.84% 
   χ2(red.) 3.65  χ2(red.) 3.44  χ2(red.) 1.87 





(Table 6.49 continued) 
  Σ(ΔΔG)2 =625 Σ(ΔΔG)2 =900 Σ(ΔΔG)2 =1600 
H Hx Exp r /Å Calc./ Å % errora Exp r/Å Calc./ Å % errora Exp r /Å Calc./ Å % errora 
H1' 
H13 2.92 2.94 1% 2.94 2.99 2% 2.94 2.99 2% 
H14 2.60 2.65 2% 2.62 2.65 1% 2.62 2.63 0% 
H12a 2.57 2.69 5% 2.59 2.73 5% 2.59 2.72 5% 
H12b 3.92 3.81 −3% 3.95 3.86 −2% 3.95 3.88 −2% 
H15 2.85 2.70 −6% 2.87 2.75 −4% 2.88 2.80 −3% 
H13 
H11 2.55 2.48 −3% 2.57 2.54 −1% 2.58 2.55 −1% 
H14 2.41 2.52 5% 2.43 2.52 4% 2.43 2.53 4% 
H12a 2.53 2.55 1% 2.55 2.54 0% 2.55 2.55 0% 
H12b 2.91 2.89 −1% 2.94 2.96 1% 2.94 2.96 1% 
H15 3.08 3.08 0% 3.10 3.19 3% 3.11 3.15 2% 
H11 
H14 3.12 3.15 1% 3.14 3.14 0% 3.15 3.14 0% 
H12a 2.63 2.49 −5% 2.65 2.57 −3% 2.65 2.57 −3% 
H12b 2.74 3.02 10% 2.76 2.85 3% 2.76 2.84 3% 
H10 2.78 2.63 −5% 2.80 2.64 −6% 2.81 2.65 −6% 
H9a 2.86 2.72 −5% 2.88 2.72 −6% 2.88 2.73 −6% 
H9b 2.92 2.87 −2% 2.95 2.95 0% 2.95 2.98 1% 
H12a H14 2.69 2.82 5% 2.72 2.84 4% 2.72 2.84 4% 
H12b 1.74 1.76 1% 1.76 1.76 0% 1.76 1.76 0% 
   MAD/% 3.30%  MAD/% 2.59%  MAD/% 2.33% 
   StDev/% 4.21%  StDev/% 3.32%  StDev/% 3.06% 
   χ2(red.) 0.71  χ2(red.) 0.44  χ2(red.) 0.38 






(Table 6.49 continued) 
  Σ(ΔΔG)2 =2500   
H Hx Exp r /Å Calc./ Å % errora       
H1' 
H13 2.94 2.99 1%       
H14 2.62 2.63 0%       
H12a 2.59 2.72 5%       
H12b 3.95 3.88 −2%       
H15 2.88 2.81 −3%       
H13 
H11 2.58 2.55 −1%       
H14 2.43 2.53 4%       
H12a 2.55 2.55 0%       
H12b 2.94 2.96 1%       
H15 3.11 3.15 1%       
H11 
H14 3.15 3.14 0%       
H12a 2.65 2.57 −3%       
H12b 2.76 2.84 3%       
H10 2.81 2.65 −6%       
H9a 2.88 2.73 −6%       
H9b 2.95 2.98 1%       
H12a H14 2.72 2.84 4%       
H12b 1.76 1.76 0%       
   MAD/% 2.32%       
   StDev/% 3.05%       
   χ2(red.) 0.37       






Table 6.50: Experimental 1H-1H distances derived from 2D-ROESY spectrum provided by Sherman et al.95 and the population refined (Σ(ΔΔG)2 =400) 
Boltzmann averaged computed 1H-1H distances of C1’-C10 region (fragment A, in Å) for 2.6 and 2.7 – 2.10 with Mean Absolute Deviations (MAD), Standard 
Deviations (StDev) and 2 (reduced) values (2 (red.)). 
H Hx Exp r /Å Calc.2.6 / Å % errora Exp r/Å Calc.2.7 / Å % errora Exp r /Å Calc.2.8 / Å % errora 
H1' 
H13 2.89 2.76 −5% 3.00 3.70 21% 2.94 3.70 23% 
H14 2.57 2.49 −3% 2.67 2.55 −5% 2.62 2.57 −2% 
H12a 2.55 2.85 11% 2.64 2.99 12% 2.59 3.02 15% 
H12b 3.88 3.35 −15% 4.03 3.17 −24% 3.95 2.87 −32% 
H15 2.83 2.86 1% 2.93 3.01 3% 2.87 2.96 3% 
H13 
H11 2.53 2.48 −2% 2.63 2.50 −5% 2.58 2.81 9% 
H14 2.39 2.47 3% 2.48 2.44 −1% 2.43 2.45 1% 
H12a 2.51 2.52 0% 2.60 2.59 0% 2.55 2.57 1% 
H12b 2.89 2.93 1% 3.00 2.82 −6% 2.94 2.89 −1% 
H15 3.05 3.22 5% 3.17 3.34 5% 3.11 3.52 12% 
H11 
H14 3.09 3.17 2% 3.21 3.61 12% 3.14 3.14 0% 
H12a 2.61 2.50 −4% 2.71 2.49 −8% 2.65 2.47 −7% 
H12b 2.72 3.03 11% 2.82 3.00 6% 2.76 2.58 −7% 
H10 2.76 2.65 −4% 2.86 2.54 −12% 2.80 2.66 −5% 
H9a 2.83 2.62 −8% 2.94 3.07 4% 2.88 2.72 −6% 
H9b 2.90 2.92 1% 3.01 3.17 5% 2.95 2.75 −7% 
H12a H14 2.67 2.69 1% 2.77 2.63 −5% 2.72 2.73 0% 
H12b 1.73 1.77 2% 1.80 1.77 −2% 1.76 1.76 0% 
   MAD/% 4.46%  MAD/% 7.63%  MAD/% 7.33% 
   StDev/% 6.17%  StDev/% 10.14%  StDev/% 11.43% 
   χ2(red.) 1.52  χ2(red.) 4.11  χ2(red.) 5.23 





(Table 6.50 continued) 
H Hx Exp r /Å Calc.2.9 / Å % errora Exp r/Å Calc.2.10 / Å % errora    
H1' 
H13 2.96 3.07 4% 2.94 3.07 4%    
H14 2.63 2.76 5% 2.62 2.69 3%    
H12a 2.61 2.89 10% 2.59 2.69 4%    
H12b 3.97 3.69 −7% 3.95 3.82 −3%    
H15 2.89 2.69 −7% 2.88 2.67 −7%    
H13 
H11 2.59 2.85 10% 2.58 2.47 −4%    
H14 2.44 2.51 3% 2.43 2.53 4%    
H12a 2.57 2.59 1% 2.55 2.54 −1%    
H12b 2.95 2.73 −8% 2.94 2.90 −2%    
H15 3.12 3.03 −3% 3.11 3.06 −2%    
H11 
H14 3.16 3.19 1% 3.15 3.18 1%    
H12a 2.67 2.64 −1% 2.65 2.50 −6%    
H12b 2.78 2.50 −11% 2.76 3.03 9%    
H10 2.82 2.64 −7% 2.81 2.63 −6%    
H9a 2.90 3.01 4% 2.88 2.74 −5%    
H9b 2.97 3.00 1% 2.95 2.87 −3%    
H12a H14 2.73 2.93 7% 2.72 2.86 5%    
H12b 1.77 1.76 −1% 1.76 1.77 0%    
   MAD/% 4.97%  MAD/% 3.87%    
   StDev/% 6.18%  StDev/% 4.64%    
   χ2(red.) 1.53  χ2(red.) 0.87    





The fit of all calculated NMR parameters for fragment A of 2.6 and 2.7 – 2.10, to those of the 
experimental parameters derived from the natural product is shown in Figure 6.24. 
 
Figure 6.24: a. Generic structure of isomers studied for fragment A analysis using conformers obtained 
from octanol MM conformational search. b. Relative stereochemistry of isomers studied for fragment 
A analysis. Results of comparison of NMR properties (1H and 13C chemical shifts, 1H-1H and 1H-13C 




































































































NMR data of fragment B (compounds 2.10 and 2.12 – 2.14, gas MM conformational 
search) 
Table 6.51: Comparison of experimental 1H chemical shifts re-extracted from the 1H spectrum provided 
by Sherman et al.95 with the calculated scaled 1H chemical shifts for compound 2.10 and 2.12 – 2.14 
obtained from conformers generated by gas conformational search with Deviations (Dev., in ppm), 
Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 (reduced) 
values (2 (red.)). 
H δH/ppm 2.10 Dev. 2.12 Dev. 2.13 2.14 Q Dev. 
H8 1.53 1.74 0.21 1.84 0.31 1.73 0.20 1.67 0.14 
H7a 1.22 1.24 0.02 1.11 0.11 1.40 0.18 1.08 0.14 
H7b 0.95 1.03 0.08 0.99 0.04 0.54 0.41 0.97 0.02 
H6 1.43 1.43 0.00 1.12 0.31 1.19 0.24 1.10 0.33 
H5a 1.73 1.53 0.20 2.03 0.30 1.75 0.02 1.63 0.10 
H5b 1.00 1.18 0.18 0.77 0.23 1.31 0.31 1.01 0.01 
H4 2.76 2.76 0.00 2.82 0.06 2.64 0.12 2.88 0.12 
H19 0.86 0.85 0.01 0.89 0.03 0.78 0.08 0.82 0.04 
H20 0.88 0.94 0.06 0.95 0.07 0.87 0.01 0.78 0.10 
H21 1.06 1.10 0.04 1.19 0.13 1.21 0.15 1.14 0.08 
  MAD 0.08 MAD 0.16 MAD 0.17 MAD 0.11 
  StDev 0.11 StDev 0.20 StDev 0.22 StDev 0.14 
  χ2(red.) 0.62 χ2(red.) 1.85 χ2(red.) 2.17 χ2(red.) 0.90 
 
Table 6.52: Comparison of experimental 13C chemical shifts re-extracted from the 13C spectrum 
provided by Sherman et al.95 with the calculated scaled 13C chemical shifts for compound 2.10 and 2.12 
– 2.14 obtained from conformers generated by gas conformational search with Deviations (Dev., in 
ppm), Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and and 2 
(reduced) values (2 (red.)). 
C δC/ppm 2.10 Dev. 2.12 Dev. 2.13 2.14 Q Dev. 
C9 33.38 32.47 0.91 29.78 3.60 29.24 4.14 29.82 3.56 
C8 31.23 30.95 0.28 27.90 3.33 29.84 1.39 30.71 0.52 
C7 46.61 44.24 2.37 46.94 0.33 38.83 7.78 43.87 2.74 
C6 29.47 29.08 0.39 30.57 1.10 30.84 1.37 29.85 0.38 
C5 42.00 41.38 0.62 38.35 3.65 43.08 1.08 42.42 0.42 
C4 44.96 44.74 0.22 46.48 1.52 47.99 3.03 46.21 1.25 
C19 20.55 19.87 0.68 20.78 0.23 21.03 0.48 22.08 1.53 
C20 20.85 22.17 1.32 21.98 1.13 21.78 0.93 18.99 1.86 
C21 18.17 18.42 0.25 20.06 1.89 19.90 1.73 20.91 2.74 
  MAD 0.78 MAD 1.86 MAD 2.44 MAD 1.67 












Table 6.53: Experimental nJHH values (in Hz) of balamycin A and Boltzmann averaged calculated nJHH of C4-C8 region (fragment B, in Hz) for 2.10 and 2.12 – 
2.14 obtained from conformers generated by gas conformational search with Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, in Hz) and 
2 (reduced) values (2 (red.)). 
H Coupled H Exp. nJHH Calc. 2.10 Deviation Calc. 2.12 Deviation Calc. 2.13 Deviation Calc. 2.14 Deviation 
H8 
H7a 7.5 6.3 1.2 2.0 5.5 3.6 3.9 10.4 2.9 
H7b 7.2 7.7 0.5 9.9 2.7 9.1 1.9 3.8 3.4 
H19 6.6 6.2 0.4 6.2 0.4 6.5 0.1 6.5 0.1 
H7a 
H7b 13.8 14.5 0.7 14.5 0.7 14.7 0.9 14.6 0.8 
H6 7.5 6.5 1.0 10.3 2.8 8.7 1.2 1.7 5.8 
H7b H6 7.2 5.7 1.5 1.9 5.3 3.5 3.7 9.5 2.3 
H6 
H5a 5 5.4 0.4 0.8 4.2 2.9 2.1 1.9 3.1 
H5b 8.8 7.4 1.4 9.0 0.2 9.8 1.0 9.8 1.0 
H20 7 6.2 0.8 6.2 0.8 6.1 0.9 6.2 0.8 
H5a 
H5b 14 14.2 0.2 14.3 0.3 14.8 0.8 14.3 0.3 
H4 9.1 7.8 1.3 10.8 1.7 10.8 1.7 10.8 1.7 
H5b H4 5.3 5.7 0.4 2.1 3.2 4.2 1.1 2.5 2.8 
H4 H21 6.9 6.4 0.5 6.8 0.1 6.5 0.4 6.8 0.1 
   MAD/Hz 0.8 MAD/Hz 2.1 MAD/Hz 1.5 MAD/Hz 1.9 
   StDev/Hz 0.8 StDev/Hz 2.8 StDev/Hz 1.9 StDev/Hz 2.5 













Table 6.54: Experimental nJHC values of synthetic baulamycin A(2.17, in Hz) and Boltzmann averaged calculated nJHC of C4-C8 region (fragment B) for 2.10 
and 2.12 – 2.14  obtained from conformers generated by gas conformational search with Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, 
in Hz) and 2 (reduced) values (2 (red.)). 
Proton Coupled 
Carbon 
Exp. nJHCa Calc. 2.10 Deviation Calc. 2.12 Deviation Calc. 2.13 Deviation Calc. 2.14 Deviation 
H7a C9 5.1 
 
5.4 0.3 3.9 1.2 5.8 0.7 2.3 2.8 
H7b C9 4.8 
 
2.7 2.1 7.2 2.4 3.3 1.5 6.2 1.4 
H6 C4 4.3 2.2 2.1 4.3 0.0 3.2 1.1 3.6 0.7 
H5a 
C7 3.3 5.4 2.1 4.3 1.0 6.1 2.8 4.6 1.3 
C20 6.2 3.5 2.7 1.8 4.4 3.2 3.0 6.8 0.6 
C21 3.7 4.1 0.4 7.1 3.4 4.3 0.6 2.3 1.4 
H5b 
C7 3.3 2.8 0.5 0.4 2.9 3.6 0.3 0.9 2.4 
C21 3.7 3.6 0.1 5.8 2.1 1.9 1.8 3.1 0.6 
C20 5.0 3.9 1.1 3.4 1.6 2.8 2.2 4.4 0.7 
H4 C6 2.6 2.1 0.5 2.2 0.4 1.3 1.3 1.7 0.9 
   MAD/Hz 1.2 MAD/Hz 1.9 MAD/Hz 1.5 MAD/Hz 1.3 
   StDev/Hz 1.4 StDev/Hz 2.5 StDev/Hz 1.7 StDev/Hz 1.5 












NMR data of fragment B (compounds 2.10 and 2.12 – 2.14, octanol MM conformational 
search) 
Table 6.55: Comparison of experimental 1H chemical shifts re-extracted from the 1H spectrum provided 
by Sherman et al.95 with the calculated scaled 1H chemical shifts for compound 2.10 and 2.12 – 2.14 
obtained from conformers generated by octanol conformational search with Deviations (Dev., in ppm), 
Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 (reduced) 
values (2 (red.)). 
H δH/ppm 2.10 Dev. 2.12 Dev. 2.13 2.14 Q Dev. 
H8 1.53 1.43 0.10 1.87 0.34 1.67 0.14 1.52 0.01 
H7a 1.22 1.20 0.02 1.11 0.11 1.26 0.04 1.19 0.03 
H7b 0.95 0.93 0.02 1.00 0.05 0.70 0.25 0.98 0.03 
H6 1.43 1.39 0.04 1.13 0.30 1.35 0.08 1.41 0.02 
H5a 1.73 1.79 0.06 2.02 0.29 1.88 0.15 1.81 0.08 
H5b 1.00 0.97 0.03 0.77 0.23 1.24 0.24 0.90 0.10 
H4 2.76 2.83 0.07 2.82 0.06 2.69 0.07 2.82 0.06 
H19 0.86 0.81 0.05 0.91 0.05 0.82 0.04 0.92 0.06 
H20 0.88 0.89 0.01 0.94 0.06 0.90 0.02 0.92 0.04 
H21 1.06 1.11 0.05 1.18 0.12 1.18 0.12 1.13 0.07 
  MAD 0.05 MAD 0.16 MAD 0.11 MAD 0.05 
  StDev 0.05 StDev 0.20 StDev 0.14 StDev 0.06 
  χ2(red.) 0.14 χ2(red.) 1.88 χ2(red.) 0.94 χ2(red.) 0.16 
 
Table 6.56: Comparison of experimental 13C chemical shifts re-extracted from the 13C spectrum 
provided by Sherman et al.95 with the calculated scaled 13C chemical shifts for compound 2.10 and 2.12 
– 2.14 obtained from conformers generated by octanol conformational search with Deviations (Dev., in 
ppm), Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 analysis. 
C δC/ppm 2.10 Dev. 2.12 Dev. 2.13 2.14 Q Dev. 
C9 33.38 35.21 1.83 30.12 3.26 30.23 3.15 32.34 1.04 
C8 31.23 31.76 0.53 27.75 3.48 29.83 1.40 32.14 0.91 
C7 46.61 42.98 3.63 47.08 0.47 40.87 5.74 44.76 1.85 
C6 29.47 29.22 0.25 30.55 1.08 30.53 1.06 29.44 0.03 
C5 42.00 41.58 0.42 38.54 3.46 41.90 0.10 40.23 1.77 
C4 44.96 43.38 1.58 46.50 1.54 46.13 1.17 44.52 0.44 
C19 20.55 18.41 2.14 20.71 0.16 20.59 0.04 20.29 0.26 
C20 20.85 20.44 0.41 21.92 1.07 21.47 0.62 20.46 0.39 
C21 18.17 20.26 2.09 20.11 1.94 20.26 2.09 19.73 1.56 
  MAD 1.43 MAD 1.83 MAD 1.71 MAD 0.92 
  StDev 1.83 StDev 2.28 StDev 2.47 StDev 1.12 





Table 6.57: Experimental nJHH values (in Hz) of balamycin A and Boltzmann averaged calculated nJHH of C4-C8 region (fragment B, in Hz) for 2.10 and 2.12 – 
2.14 obtained from conformers generated by octanol conformational search with Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, in Hz) 
and 2 analysis. 
H Coupled H Exp. nJHH Calc. 2.10 Deviation Calc. 2.12 Deviation Calc. 2.13 Deviation Calc. 2.14 Deviation 
H8 
H7a 7.5 10.1 2.6 2.1 5.4 7.9 0.4 8.3 0.8 
H7b 7.2 3.4 3.8 9.8 2.6 4.8 2.4 5.8 1.4 
H19 6.6 6.1 0.5 6.2 0.4 6.3 0.3 6.2 0.4 
H7a 
H7b 13.8 13.9 0.1 14.5 0.7 14.7 0.9 14.3 0.5 
H6 7.5 3.3 4.2 10.2 2.7 4.9 2.6 5.0 2.5 
H7b H6 7.2 10.2 3.0 1.9 5.3 7.8 0.6 7.6 0.4 
H6 
H5a 5 3.3 1.7 0.9 4.1 3.8 1.2 3.0 2.0 
H5b 8.8 9.2 0.4 9.0 0.2 8.2 0.6 9.4 0.6 
H20 7 6.2 0.8 6.2 0.8 6.2 0.8 6.1 0.9 
H5a 
H5b 14 14.2 0.2 14.3 0.3 14.7 0.7 14.2 0.2 
H4 9.1 9.8 0.7 10.8 1.7 9.7 0.6 10.0 0.9 
H5b H4 5.3 3.3 2.0 2.1 3.2 4.1 1.2 3.2 2.1 
H4 H21 6.9 6.6 0.3 6.8 0.1 6.5 0.4 6.7 0.2 
   MAD 1.6 MAD 2.1 MAD 1.0 MAD 1.0 
   StDev 2.1 StDev 2.8 StDev 1.1 StDev 1.2 













Table 6.58: Experimental nJHC values of synthetic baulamycin A(compound 2.17, in Hz) and Boltzmann averaged calculated nJHC of C4-C8 region (fragment B) 
for 2.10 and 2.12 – 2.14 obtained from conformers generated by octanol conformational search with Mean Absolute Deviations (MAD, in Hz), Standard 
Deviations (StDev, in Hz) and 2 analysis. 
Proton Coupled Carbon Exp. nJHCa Calc. 2.10 Deviation Calc. 2.12 Deviation Calc. 2.13 Deviation Calc. 2.14 Deviation 
H7a C9 5.1 2.5 2.6 7.2 2.1 5.8 0.7 2.3 2.8 
H7b C9 4.8 2.8 2.0 3.8 1.0 3.3 1.5 5.7 0.9 
H6 C4 4.3 2.4 1.9 4.2 0.1 3.5 0.8 2.7 1.6 
H5a 
C7 3.3 6.6 3.3 4.2 0.9 5.1 1.8 3.4 0.1 
C20 6.2 2.8 3.4 1.8 4.4 3.1 3.1 7.0 0.8 
C21 3.7 3.7 0.0 7.1 3.4 4.7 1.0 2.7 1.0 
H5b 
C7 3.3 3.4 0.1 0.5 2.8 4.0 0.7 2.0 1.3 
C21 3.7 2.4 1.3 5.7 2.0 2.7 1.0 3.3 0.4 
C20 5.0 3.4 1.5 3.4 1.6 3.5 1.5 3.7 1.2 
H4 C6 2.6 1.8 0.8 2.2 0.4 1.8 0.8 1.8 0.8 
   MAD 1.7 MAD 1.9 MAD 1.3 MAD 1.1 
   StDev 1.8 StDev 2.4 StDev 1.5 StDev 1.1 












The fit of all calculated NMR parameters for fragment B of 2.10 – 2.14 to those of the 
experimental parameters derived from the natural product is shown in Figure 6.25.  
 
Figure 6.25: a. Generic structure of isomers studied for fragment B analysis. b. Relative 
stereochemistry of the isomers studied for fragment B analysis. c. Comparison of the calculated 
Boltzmann averaged chemical shifts (1H and 13C) and scalar coupling constants (1H-1H and 1H-13C) 
obtained from c gas conformational search candidates and (d) octanol conformational search versus the 















































































Materials and Reagents 
Reaction mixtures were stirred magnetically. Air- and moisture-sensitive reactions were 
carried out in flame-dried glassware under a N2 atmosphere using standard Schlenk manifold 
technique. All required fine chemicals were purchased from Acros Organics, Alfa Aesar, 
Inochem-Frontier Scientific or Sigma-Aldrich and used as received unless otherwise 
mentioned. n-Butyllithium (nBuLi) was received from Acros Organics as a 1.6 M solution in 
n-hexane and the molarity was verified by titration with N-benzylbenzamide.177 Solutions of 
nBuLi where precipitate had formed were discarded as these were found to not be effective in 
Sn-Li exchange reactions. (+)-Sparteine was obtained as the free base (Ark Pharm), distilled 
over CaH2 and stored in a Young’s tube under N2. (−)-Sparteine was obtained as the free base 
(Spartax Chemicals), distilled over CaH2 and stored in a Young’s tube under N2. The sparteine 
free base readily absorbs atmospheric carbon dioxide (CO2) and should be stored in a Young’s 
tube under argon/N2 at −20 °C. Petrol refers to the fraction of petroleum ether boiling at 40 – 
60 °C. Anhydrous THF, CH2Cl2, toluene, n-hexane, acetonitrile and Et2O were dried by passing 
through a modified Grubbs system of alumina columns, manufactured by Anhydrous 
Engineering, stored over 3Å molecular sieves (25% of total volume) and were transferred under 




Synthetic General Procedures  
General Procedure 1 (GP1): Lithiationborylation  
Stannane 3.29 (R or S enantiomers, respectively 1.30 – 2.30 eq.) was transferred to a flame 
dried schlenk tube via syringe and stirred under vacuum for 10 min to remove any air 
introduced during the weighing process. The stannane was dissolved in anhydrous Et2O (0.30 
M) and cooled to 78 °C (colourless solution). nBuLi (1.60 M in n-hexane, 1.3 – 2.25 eq.) was 
added dropwise and the reaction mixture was stirred at this temperature for 1 – 2 h (when Sn-
Li exchange takes place the reaction mixture will be bright yellow). Boronic ester (1 M in 
anhydrous Et2O, 1.00 eq.) was added dropwise (4 mL/hr) to the reaction mixture at 78 °C and 
the reaction was stirred at this temperature for 10 min – 1 h. The cooling bath was removed 
and the reaction was stirred at the desired solvent, time and temperature for 1,2 migration (see 
below for time and temperature guide for 1,2-migration). The reaction was filtered through a 
plug of wetted (Et2O) silica (~ 2 cm depth) to give a pale-yellow solution. The silica was 
washed with Et2O, which was removed in vacuo to give crude boronic ester. The crude boronic 
ester could be re-dissolved in anhydrous Et2O for further homologations or purified by flash 
column chromatography.  
 
1,2-Migration Time Guide 
 
General Procedure 2 (GP2): Matteson Homologation  
Small scale (~0.2 mmol of boronic ester) procedure94  
A solution of boronic ester (0.2 M in anhydrous Et2O, 1.00 eq.) and bromochloromethane (3.00 
eq.) was cooled to 78 °C. nBuLi (1.6 M in n-hexane, 2.50 eq.) was slowly added (1.2 mL/hr) 
to the reaction mixture and the mixture was stirred at 78 °C for 20 min. After 20 min the 




mixture was filtered through a plug of wetted (Et2O) silica (~ 1.5 cm depth) to give a colourless 
solution. The silica was washed with Et2O and solvent was removed in vacuo to give crude 
boronic ester. The crude boronic ester could be re-dissolved in anhydrous Et2O for further 
homologations or purified by flash column chromatography. 
Large scale (> 0.5 mmol of boronic ester) procedure 
A solution of boronic ester (0.15 – 0.20 M in anhydrous Et2O, 1.00 eq.) and 
bromochloromethane (3.00 eq.) was cooled to 95 °C (MeOH/liquid N2). nBuLi (1.6 M in n-
hexane, 2.50 eq.) was added (2.00 mL/hr) to the reaction mixture and the mixture was stirred 
at 95 °C for 1.5 h. After 1.5 h the reaction was warmed to ambient temperature and was stirred 
for a further 1 h. The reaction mixture was filtered through a plug of wetted (Et2O) silica (~ 1.5 
cm depth) to give a colourless solution. The silica was washed with Et2O and solvent was 
removed in vacuo to give crude boronic ester. The crude boronic ester could be re-dissolved in 
anhydrous Et2O for further homologations or purified by flash column chromatography. 
 
General Procedure 3 (GP3): Amination of boronic esters using a modified literature 
procedure116 
Potassium tert butoxide (5.00 eq.) was added to a flame-dried sample vial containing boronic 
ester (1.00 eq.) followed by the addition of anhydrous toluene (0.15 M) and MeONH2 (5.00 
eq.). The vial was sealed and heated at 100 °C with stirring overnight. (The reaction turned 
from colourless to a milky suspension). A solution of aqueous NaOH (3.00 M) was added to 
the reaction and stirred for 10 min. The layers were separated, and the aqueous layer was extract 
by EtOAc (5 mL × 3). The organic layers were combined, dried over MgSO4 and solvent was 
removed in vacuo. The crude mixture was dissolved in anhydrous THF followed by the 
addition of Boc2O (1.5 eq.) and reaction was stirred at ambient temperature for 5 h. Purification 
of the crude material by flash column chromatography gave pure products. 
 
General Procedure 4 (GP4): Boc-protection of carbamates using a modified literature 
procedure.143  
A solution of carbamate (1.00 eq.) in anhydrous THF (0.30 M) was cooled to −78 °C followed 




0 °C followed by the addition of Boc2O (1.50 eq.) and a solution of DMAP (.001 eq.) in 
anhydrous THF (0.50 M). After 20 min the reaction was warmed to ambient temperature and 
stirred overnight. The reaction was quenched by the addition of water and Et2O. The phases 
were separated and the aqueous layer was extracted with EtOAc (3 mL × 3). The organic 
extracts were combined, dried over MgSO4 and solvent was removed in vacuo. Purification of 
the crude material by flash column chromatography gave pure products. 
 
General Procedure 5 (GP5): Deprotection of benzyl protecting group. 
Carbamate (1 eq.) was dissolved in ethanol (0.25 M) followed by the addition of Pd/C (10% wt, 
10 mol%). The reaction was stirred under H2 atmosphere overnight. The crude residue was 
filtered through a short pad of wetted celite (EtOH) and solvent was removed in vaco. 
Purification of the crude material gave the corresponding alcohols.  
 
General Procedure 6 (GP6): Stahl oxidation of alcohols.139  
Solid Cu(MeCN)4OTf (5 – 10 mol%), 4,4’-dimethoxy-2,2’-bipyridine (
MeObpy, 5 mol%), 
ABNO (1 mol%), and NMI (10 mol%) were added to a solution of alcohol (1 eq.) in MeCN 
(0.5 M) in a sample vial. The addition of each catalytic component was followed by a rinse of 
MeCN (0.1 mL). The dark red solution was stirred at 950 RPM open to air at ambient 
temperature until all the alcohol was consumed, as indicated by TLC or LCMS analysis. 
Reaction completion was accompanied by a change in colour to blue/green. The reaction was 
filtered through a pad of wetted SiO2 (MeCN) and solvent was removed in vacuo. Purification 
of the crude material gave the corresponding aldehydes.  
 
General Procedure 7 (GP7): Pinnick oxidation of aldehydes.178  
A solution of aldehyde (1.00 eq.) was stirred in tert-BuOH (0.05 M) at room temperature 
followed by the addition of 2-methyl-2-butene (50.00 eq.). The reaction was stirred at ambient 
temperature for 5 min followed by the dropwise addition of a solution of sodium chlorite (9.00 
eq.), sodium phosphate monobasic (7.00 eq.) in water (500.00 eq.). The reaction mixture was 
stirred at room temperature for 4.5 h and tert-BuOH was removed in vacuo. The crude residue 




The crude reaction mixture was extracted using EtOAc (5 mL × 4) and the organic phases were 
combined and dried over MgSO4. Solvent was removed in vacuo to yield crude carboxylic 
acids, which were subjected to the subsequent transformations without purification.  
 
General Procedure 8 (GP8): Methylation of carboxylic acids.179  
(Trimethylsilyl)diazomethane (2.0 M in Et2O, 1.00 eq.) was added to a solution of carboxylic 
acid (1.00 eq.) in 3:2 mixture of anhydrous methanol and toluene (0.10 M) at ambient 
temperature for 30 min. The reaction was quenched by the addition of water (0.5 mL) and ethyl 
acetate (1 mL). Two layers were separated and the aqueous layer was extracted by EtOAc (5 
mL × 3). The organic layers were combined, washes with brine (5 mL), dried over MgSO4 and 
solvent were removed in vacuo. Purification of the crude material by column chromatography 
gave the corresponding methyl esters. 
 
General Procedure 9 (GP9): – Mono Boc deprotection.180  
TFA (2.00 eq.) was added to a solution of bis-Boc carbamate (1.00 eq.) in DCM (0.15 M) at 
room temperature and the reaction was stirred for 4.5 h. Solvent was removed in vacuo and the 





Neopentyl 2,4,6-triisopropylbenzoate, 3.26 
 
Diisopropyl azodicarboxylate (15.8 mL, 80.0 mmol) was added dropwise to a solution of 2,4,6-
triisopropylbenzoic acid (19.8 g, 80.0 mmol), triphenyl phosphine (20.0 g, 76.0 mmol) and 
neopentyl alcohol (7.1 g, 80.0 mmol) in anhydrous THF (152 mL) at 0 °C. The reaction mixture 
was stirred at this temperature for 20 min before warming to room temperature and allowed to 
stir overnight. The reaction was quenched by the addition of saturated aqueous NaHCO3 (120 
mL) and H2O (120 mL). The layers were separated and the aqueous layer was extracted with 
Et2O (3 × 60 mL). The combined organic phase was dried over MgSO4, filtered and 
concentrated in vacuo to give a pale yellow oil, which was then dried under high vacuum to 
yield a yellow solid. Pentane (300 mL) was added to the solid and the resulting suspension was 
passed through a short plug of SiO2. The filtrate was concentrated in vacuo to give a pale oil. 
Purification by flash column chromatography (2:98, Et2O:n-pentane) gave benzoate 3.26 (22.5 
g, 70.0 mmol, 93%) as a colourless oil. 
Rf (2 : 98 Et2O : pentane) 0.29. 
1H NMR (CDCl3, 500 MHz) 7.01 (2H, s, H7), 3.98 (2H, s, H3), 2.94-2.81 (3H, m, H9 and 
H11), 1.25 (6H, d, J = 7.0 Hz, H10), 1.25 (12H, d, J = 6.8 Hz, H12), 0.99 (9H, s, H1). 
13C NMR (CDCl3, 125 MHz) δ 171.5 (C4), 150.0 (C5), 144.8 (C6), 131.0 (C8), 120.9 (C7), 74.9 
(C3), 34.5 (C11 or C9), 31.7 (C11 or C9), 31.2 (C2), 26.7 (C1), 24.3 (C12), 24.1 (C10). 
IR (νmax/cm
-1, neat): 2959, 2870, 1725, 1606. 
HRMS (ESI+): calc. for C21H34O2Na [M+Na]





2,2-Dimethyl-1-(trimethylstannyl)propyl 2,4,6-triisopropylbenzoate, rac-3.29 
 
A solution of benzoate 3.26 (1.26 g, 3.97 mmol) and TMEDA (0.77 mL, 7.94 mmol) in 
anhydrous Et2O (14.0 mL) was cooled to78 °C, followed by the dropwise addition of sec-
BuLi (1.30 M in cyclohexane/ n-hexane (92/8), 6.1 mL. 7.94 mmol). The reaction was stirred 
at 78 °C for 5 h followed by the dropwise addition of Me3SnCl (1.00 M in n-hexane, 7.94 mL, 
7.94 mmol). The reaction was stirred at this temperature for 10 min before warming up to room 
temperature. After 1 hour the reaction was quenched by aqueous HCl (2.00 M, 14 mL) and left 
to stir for 20 min. The layers were separated and the organic layer was washed with HCl (2.00 
M, 3 × 15 mL). The combined aqueous phases were extracted with Et2O (3 × 15 mL). The 
combined organic phase was dried over MgSO4 and concentrated in vacuo to give crude 
stannane as a clear oil. Purification by flash column chromatography (0.5:95.5, Et2O:pentane) 
gave racemic stannane rac-3.29 (1.58 g, 3.28 mmol, 83%) as a colourless oil. For 
















(R)-2,2-Dimethyl-1-(trimethylstannyl)propyl 2,4,6-triisopropylbenzoate, (R)-3.29 
 
sBuLi (1.3 M in cyclohexane/ n-hexane (92/8), 33.80 mL, 43.90 mmol) was added to a solution 
of benzoate 3.26 (8.70 g, 27.50 mmol) and (+)-sparteine (10.10 mL, 43.90 mmol) in anhydrous 
Et2O (137.00 mL) at 78 °C. The reaction was stirred at78 °C for 20 h followed by the 
dropwise addition of Me3SnCl (1.00 M in n-hexane, 46.70 mL, 46.70 mmol). The reaction was 
stirred at this temperature for 30 min before warming up to room temperature. After 1 hour the 
reaction was quenched by slow addition of 2 M HCl aqueous solution (150.00 mL) and left to 
stir for 20 min. The layers were separated and the organic layer was washed with 2M aqueous 
HCl (3 × 50 mL). The combined aqueous phases were extracted with Et2O (3 × 100 mL). The 
combined organic phase was dried over MgSO4 and concentrated in vacuo to give crude 
stannane as a clear oil. Purification by column chromatography (Biotage SNAP ultra 100g 
column, using a gradient elution of 2% toluene/pentane to 15% toluene/pentane) gave the R 
enantiomer of stannane 3.29 (11.9 g, 24.8 mmol, 92%, er 97:3) as a colourless oil. 
The opposite enantiomer ((S)-3.29) was synthesised by using ()-sparteine instead pf (+)-
sparteine in identical yield and similar er (98:2). Stannanes used in this project were dried under 
high vacuum (1 mbar) at 40 °C with stirring overnight.  
Note: it is essential to achieve a good conversion for desirable separation by column 
chromatography.  
Rf (15 : 85 toluene : pentane) 0.35.  
1H NMR (CDCl3, 500 MHz) 7.00 (2H, s, H11), 5.03 (1H, s, J (1H-117/119Sn) = 14.5 Hz, H3), 
2.89 (3H, m, H8 and H13), 1.25 (12H, d, J = 6.9 Hz, H9 and H10), 1.22 (6H, d, J = 6.9 Hz, H14), 
1.02 (9H, s, H1), 0.24 (9H, s, J(
1H-117Sn) = 50.74 Hz, J(1H-119Sn) = 53.11 Hz, H4). 
13C NMR (CDCl3, 125 MHz) δ 171.1 (C5), 149.9 (C6), 145.3 (C7), 130.8 (C12), 121.1 (C11), 
84.1 (C3, J(





13C -117/119Sn = 21.5 Hz), 24.7 (C9, C10 or C14), 24.5 (C9, C10 or C14), 24.1 (C9, C10 
or C14), 6.4 (C4, J(
13C-119Sn) = 324.6 Hz, J(13C -117Sn) = 309.8 Hz). 
IR (νmax/cm
-1, neat): 2959, 2929, 2868, 1708, 1607, 1250, 1075, 767, 525. 
HRMS (ESI+): calc. for C24H42O2
119SnNa [M+Na]+: 505.2107; found 505.2106. 
[𝜶]𝑫
𝟐𝟎 35 (c 1, CHCl3) for (R)-isomer, 30 (c 1, CHCl3) for (S)-isomer. 
Chiral HPLC IB column with guard, 100% n-hexane, flow rate 0.9 mL/min, 210 nm, room 
temperature; tR = 4.30 min (R enantiomer), 5.29 (S enantiomer). 










Sparteine recovery 85 
The combined aqueous layers were made basic (brought to about pH 11) with NaOH (20%aq). 
The aqueous phase was extracted with Et2O (3 × 100 mL). The combined aqueous layers were 
dried (MgSO4), filtered and concentrated in vacuo to give crude (–)-sparteine. Distillation over 
CaH2 (1.5 mbar, sparteine bp: 173 – 178 °C, oil bath: 150 °C) of the residual oil gave (–)-









(R)-stannane 3.29 (206.60 mg, 0.43 mmol) was transferred to a flame dried Schlenk tube via 
syringe and stirred under vacuum for 5 min to remove any air introduced during the weighing 
process. The stannane was dissolved in anhydrous Et2O (2.15 mL) and cooled to 78 °C 
(colourless solution). nBuLi (1.60 M in n-hexane, 0.26 mL, 0.42 mmol) was added dropwise 
and the reaction mixture was stirred at this temperature for 2 h. Diborylmethane (50.00 mg, 
0.19 mmol) was dissolved in anhydrous Et2O (0.60 mL) and the resulting solution was added 
dropwise (4.80 mL/hr) to the reaction mixture at 78 °C. The reaction was stirred at this 
temperature for 3 h then warmed 65 °C. After 40 min the reaction was warmed to room 
temperature and sttireed overnight. The reaction mixture was filtered through a plug of wetted 
(Et2O) silica (~ 1.5 cm depth) to give a pale yellow solution. The silica was washed with Et2O 
and solvent was removed in vacuo to give crude boronic esters. Purification by column 
chromatography (6:94, Et2O: n-hexane) gave homologated boronic ester 3.42 (21.4 mg, .0.06 








Rf (6 : 94 Et2O : n-hexane) 0.19. 
1H NMR (CDCl3, 500 MHz), 1.25 (12H, s, H1 and H2 or H9 and H10), 1.22 (6H, s, 
H1/H2/H9/H10), 1.21 (6H, s, H1/H2/H9/H10), 0.990.93 (1H, m, H4), 0.91 (9H, s, H6), 0.860.78 
(2H, m, H7). 
13C NMR (CDCl3, 125 MHz) δ 82.9 (C3 or C8), 82.8 (C3 or C8), 32.5 (C5), 29.2 (C6), 25.4 
(C1/C2/C9/C10), 25.2(C1/C2/C9/C10), 25.0(C1/C2/C9/C10), 24.8(C1/C2/C9/C10), carbons attached 
to boron (C4 & C7) were not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ 33.41. 
IR (νmax/cm
-1, neat): 2977, 2867, 1466, 1388, 1369, 1311, 1142, 969. 
[𝜶]𝑫
𝟐𝟎 2 (c 1, CHCl3). 
HRMS (ESI+): calc. for C18H36B2NaO4 [M+Na]








Rf (6 : 94 Et2O : n-hexane) 0.3. 
1H NMR (CDCl3, 500 MHz), 6.99 (2H, s, H13), 3.83 (1H, s, H4), 3.06 (2H, hept, J = 6.8 Hz, 
H10), 2.89 (1H, hept, J = 7.1 Hz, H15), 1.31 (6H, s, H1 or H2), 1.28 (6H, s, H1 or H2), 1.25 (6H, 
d, J = 6.9 Hz, H11/H12/H16), 1.24 (6H, d, J = 6.6 Hz, H11/H12/H16),  1.22 (6H, d, J = 6.8 Hz, 
H11/H12/H16), 1.03 (9H, s, H6). 
13C NMR (CDCl3, 125 MHz) δ 172.6 (C7), 149.9 (C14), 145.4 (C9), 130.6 (C8), 120.9 (C13), 
83.9 (C3), 75.9 (br, C4), 34.5 (C15), 32.8 (C5), 30.9 (C10), 27.5 (C6), 25.08 (C1/C2), 25.08 (C1/C2), 
24.6 (C16), 24.3 (C11/C12), 24.1 (C11/C12). 
11B NMR (CDCl3, 128 MHz) δ 30.88. 
IR (νmax/cm
-1, neat): 2952, 2927, 2868, 1705, 1372, 1338, 1143. 
[𝜶]𝑫
𝟐𝟎 12 (c 1, CHCl3). 
M.P. 97.5 – 98 °C (pentane). 
HRMS (ESI+): calc. for C27H45BNaO4 [M+Na]







A solution of (4-methoxyphenyl)boronic acid (3.79 g, 25.00 mmol) and pinacol (2.95 g, 25.00 
mmol) in anhydrous Et2O (50.00 mL) was stirred at room temperature overnight. Flame dried 
MgSO4 (3.00 g, 25.00 mmol) was added and stirring continued at room temperature for 2 h. 
The reaction mixture was filtered through celite and the filtrate was concentrated in vacuo.  
Purification by column chromatography (10:90, EtOAc:pentane) gave the product pinacol 
boronic ester 3.20 (5.57 g, 23.80 mmol, 95%) as a colourless oil.  
Note: After cooling in the freezer overnight the product became an amorphous solid.  
Rf (10 : 90 EtOAc : pentane) 0.7. 
1H NMR (CDCl3, 400 MHz), , apparent d, J = 8.5 Hz, H4/H5), 6.90 (2H, apparent 
d, J = 8.5 Hz, H4/H5), 3.83 (3H, s, H7), 1.33 (12H, s, H1). 
13C NMR (CDCl3, 101 MHz) δ 162.2 (C6), 136.6 (C4/C5), 113.4 (C4/C5), 86.6 (C2), 55.2 (C7), 
24.9(C1), C3 was not observed due to quadrupolar relaxation.  








Prepared according to GP1 using boronic ester 3.20 (48.00 mg, 0.20 mmol), R enantiomer of 
stannane (R)-3.29 (148.00 mg, 0.31 mmol) and nBuLi (1.59 M in n-hexane, 0.19 mL, 0.29 
mmol) in anhydrous Et2O (1.00 mL, 0.30 M). The crude material was purified by flash column 
chromatography (2:98, Et2O:n-hexane) to give homologated boronic ester 3.47 (61.00 mg, 0.20 
mmol, 99%, er 98.7:1.3) as a colourless oil. 
Rf (5 : 95 Et2O : n-hexane): 0.25. 
1H NMR (CDCl3, 400 MHz) 7.17 (2H, apparent d, J = 8.7 Hz, H8/H9), 6.79 (2H, apparent d, 
J = 8.7 Hz, H8/H9), 3.78 (3H, s, H11), 2.15 (1H, s, H4), 1.24 (6H, s, H1/H2), 1.21 (6H, s, H1/H2), 
0.93 (9H, s, H6). 
13C NMR (CDCl3, 101 MHz) δ 157.6 (C10), 132.5 (C7), 132.1 (C8/C9), 113.0 (C8/C9), 83.0 (C3), 
55.2 (C11), 33.3(C5), 29.4 (C6), 24.9, (C1/C2)24.8 (C1/C2), carbon attached to boron not 
observed due to quadrupolar relaxation. 
IR (νmax/cm
-1, neat): 2975, 2949, 2905, 2868, 1607, 1508, 1350, 1315, 1245, 1138. 
[𝜶]𝑫
𝟐𝟎 12 (c 1, CHCl3). 
HRMS (ESI+): calc’d for C18H30BO3 [M+H]
+ 305.2286; found 305.2295. 
Boronic ester 3.47 was oxidised to the corresponding alcohol for chiral SFC analysis.  
Chiral SFC IC column, iso 5%, 4 mL/min, 125 bar, co-solvent: MeOH; tR (R-enantiomer) = 














Small scale: performed according to GP2 using boronic ester 3.47 (37.800 mg, 0.12 0mmol), 
bromochloromethane (0.025 mL, 0.370 mmol) and nBuLi (1.59 M in n-hexane, 0.200 mL, 
0.310 mmol) in anhydrous Et2O (0.500 mL) at  °C. Purification of the crude material by 
flash column chromatography (4:96, Et2O : n-hexane) gave product 3.48 (35.000 mg, 0.110 
mmol, 92%) as a colourless oil. 
Large scale: performed according to GP2 using boronic ester 3.47 (258.4 mg, 0.85 mmol), 
bromochloromethane (0.19 mL, 2.82 mmol) and nBuLi (1.6 M in n-hexane, 1.46 mL, 2.35 
mmol) in anhydrous Et2O (6.5 mL) at  °C. Purification of the crude material by flash 
column chromatography (4:96, Et2O:n-hexane) gave product 3.48 (261.8 mg, 0.82 mmol, 88%) 
as a colourless oil. 
Rf (5 : 95 Et2O : n-hexane) 0.23. 
1H NMR (CDCl3, 500 MHz) 7.08 (2H, apparent d, J = 8.7 Hz, H9/H10), 6.79 (2H, apparent 
d, J = 8.7 Hz, H9/H10), 3.77 (3H, s, H12), 2.66 (1H, dd, J = 10.3, 7.1 Hz, H5), 1.24-1.18 (2H, m, 
H4), 0.98 (6H, s, H1/H2), 0.91 (6H, s, H1/H2), 0.84 (9H, s, H7). 
13C NMR (CDCl3, 125 MHz) δ 157.8 (C11), 136.7 (C8), 130.6 (C9/C10), 112.6 (C9/C10), 82.8 
(C3), 55.3 (C12), 50.9 (C5), 34.2 (C6), 27.8 (C7), 24.7 (C1/C2), 24.3 (C1/C2), 12.5 (C4). 
[𝜶]𝑫
𝟐𝟎 −26 (c 1, CHCl3). 
IR (νmax/cm
-1, neat): 2965, 2834, 1610, 1511, 1365, 1244, 1144, 831. 
HRMS (ESI+): calc. for C19H31BO3Na [M+Na]








Prepared according to GP1 using boronic ester 3.48 (48.0 mg, 0.20 mmol), (R)enantiomer of 
stannane (R)-3.29 (67.8 mg, 0.14 mmol) and nBuLi (1.59  in n-hexane, 0.09 mL, 0.13 mmol) 
in anhydrous Et2O (0.65 mL). MgBr2/MeOH (1 M, 0.19 mL, 0.19 mmol) was added before 
warming the reaction mixture to room temperature. The crude material was purified by flash 
column chromatography (2:98 → 3:97, Et2O:n-hexane) to give homologated boronic ester 3.19 
(27.7 mg, 0.07 mmol, 76%, dr 95:5) as a colourless oil. 
Rf (4 : 94 Et2O : n-hexane) 0.22. 
1H NMR (CDCl3, 500 MHz) 7.04 (2H, apparent d, J = 8.1 Hz, H12 or H13), 6.76 (2H, apparent 
d, J = 8.5 Hz, H12 or H13), 3.76 (3H, s, H15), 2.15 (1H, dd, J= 10.2, 3.1 Hz, H8), 1.89 (1H, dt, 
J= 14 Hz, 3.2 Hz, H7a or H7b), 1.8 (1H, ddd, J= 14, 10.2, 7.3 Hz, H7a or H7b), 1.08 (6H, s, H1 
or H2), 1.02 (6H, s, H1 or H2), 0.94 (9H, s, H6 or H10), 0.83 (9H, s, H6 or H10), 0.58 (1H, dd,
 J= 
7.2, 3.3 Hz, H4). 
13C NMR (CDCl3, 125 MHz) δ 157.9 (C14), 135.9 (C11), 130.7 (C12 or C13), 113.0 (C12 or C13), 
82.79(C3), 58.6 (C8), 55.3 (C15), 34.9(C9), 33.5 (C5), 30.4 (C4), 29.6 (C6 or C10), 28.5 (C6 or 
C10), 27.5 (C7), 25.4 (C1 or C2), 24.9 (C1 or C2). 
[𝜶]𝑫
𝟐𝟎 13 (c 0.98, CHCl3). 
IR (νmax/cm
-1, neat): 2950, 2902, 2867, 1610, 1511, 1362, 1246, 1140, 831, 734, 561. 
M.P.  66.2 – 66.8 °C (pentane). 
HRMS (ESI+) calc. for C24H41BO3Na










Prepared according to GP1 using boronic ester 3.48 (30 mg, 0.13 mmol), (S)enantiomer of 
stannane (S)-3.29 (67.8 mg, 0.14 mmol) and nBuLi (1.59 M in n-hexane, 0.09 mL, 0.13 mmol) 
in anhydrous Et2O (0.42 mL). The crude material was purified by flash column 
chromatography (2:98 → 3:97, Et2O : n-hexane) to give the homologated boronic ester 3.44 
(31.7 mg, 0.82 mmol, 87%, dr  95:5) as a colourless oil. 
Rf (4:96, Et2O : n-hexane): 0.22. 
1H NMR (CDCl3, 500 MHz) 6.99 (2H, m, H12 or H13), 6.77 (2H, apparent d, J = 8.8 Hz, H12 
or H13), 3.78 (3H, s, H15), 2.10 (1H, dd, , J= 12.6, 2.5 Hz, H8), 1.87 (1H, td, J= 12.6, 2.5 Hz, 
H7a or H7b), 1,70 (1H, td, J= 12.6, 2.6 Hz, H7a or H7b), 1.29 (6H, s, H1 or H2), 1.27 (6H, s, H1 
or H2), 0.85 (9H, s, H6 or H10), 0.84 (9H, s, H6 or H10), 0.48 (1H, dd, J= 12.6, 2.6 Hz, H4). 
13C NMR (CDCl3, 125 MHz) δ 157.7 (C14), 135.0 (C11), 113.0 (C12 and C13), 82.8 (C3), 56.0 
(C15), 55.1 (C8), 34.2 (C9), 32.0 (C5), 29.6(C6 or C10), 28.5(C6 or C10), 26.8 (C7), 25.3 (C1 or 
C2), 25.1 (C1 or C2), C4 was not observed due to quadrupolar relaxation. 
IR (νmax/cm
-1, neat): 2952, 1511, 1246, 1141, 830. 
[𝜶]𝑫
𝟐𝟎 −35 (c 1, CHCl3). 
HRMS (ESI+): calc’d for C24H42BO3 [M+Na]






DIPEA (18.90 mL, 108.00 mmol) was added to a solution of methoxyamine hydrochloride 
(7.52 g, 90.00 mmol) in glycerol (40.00 mL). The reaction mixture was heated at 50 °C for 2 
h. Methoxyamine (bp: 48–50 °C) was distilled from the reaction mixture (oil bath: 110 °C; 
distillation temperature: 40 °C) to give pure methoxyamine (2.6 g, 90 mmol, 61%) as a 
colourless liquid. Methoxyamine was stored at 4 °C under an atmosphere of nitrogen. 
 
tert-butyl ((3R,5S)-5-(4-methoxyphenyl)-2,2,6,6-tetramethylheptan-3-yl)carbamate, 3.43 
 
Prepared according to GP3 using boronic ester 3.19 (50.0 mg, 0.13 mmol), MeONH2 (30.5 mg, 
0.65 mmol), KOtBu (72.9 mg, 0.65 mmol) in anhydrous toluene (0.89 mL). The reaction 
mixture was then subjected to basic work up followed by Boc-protection using Boc2O (33.7 
mg, 0.15 mmol) in THF (0.65 mL). The crude material was purified by flash column 
chromatography (6:94, EtOAc:n-hexane) to give the carbamate 3.43 (22.5 mg, 0.068 mmol, 
85%) as a colourless oil.  
Note: After two days at room temperature the product became a white solid.  
Rf (10:90, EtOAc:n-hexane, TLC visualised by ninhydrin stain): 0.25. 
1H NMR (CDCl3, 500 MHz) 7.04 (2H, apparent d, J = 8.3 Hz, H12 or H13), 6.78 (2H, apparent 
d, J = 8.3 Hz, H12 or H13), 3.78 (3H, s, H15), 3.68 (1H, d, J = 10 Hz, NH), 3.38 (1H, td, J = 10.8, 
2.9 Hz, H4), 2.31 (1H, dd, J = 8.1, 2.5 Hz, H8), 2.14 (2H, dt, J = 14 Hz, 2.8 Hz, H7a or H7b), 
1.48-1.41 (1H, m, H7a or H7b), 1.32 (9H, s, H1), 0.85 (9H, s, H6 or H10), 0.83(9H, s, H6 or H10). 
13C NMR (CDCl3, 125 MHz) δ 157.6 (C14), 153.8 (C3), 137.3 (C11), 125.6 (C12 or C13), 113.1 
(C12 or C13), 78.2 (C2), 61.2 (C4), 55.2 (C15), 54.6 (C8), 35.7 (C5 or C9), 34.9 (4 C5 or C9), 31.6 
(C7), 28.1 (C6 or C10), 26.41 (C6 or C10). 
IR (νmax/cm
-1, neat): 3665, 3453, 3372, 2960, 2870, 1698, 1510, 1364, 733. 
[𝛂]𝐃




M.P. 64.5 – 65 °C (pentane). 
HRMS (ESI+): calc. for C23H39NNaO3 [M+Na]







Sodium hydride 60% wt. (1.99 g, 49.80 mmol) was washed with anhydrous n-hexane three 
times under nitrogen atmosphere and dried under vacuum for 10 min. Anhydrous DMSO 
(90.50 mL, 0.50 M) was added followed by the addition of distilled benzyl alcohol (4.68 mL, 
45.30 mmol, 1.00 eq) at room temperature and the reaction mixture was stirred overnight. 2-
(Bromomethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (10.00 g, 45.30 mmol) was added to 
the reaction mixture at 0 °C and the reaction was stirred at room temperature overnight. The 
reaction was quenched with saturated aqueous NH4Cl (200 mL) followed by the addition of 
Et2O (100 mL). The layers were separated and the aqueous layer was extracted with Et2O (3 × 
100 mL) and the combined organic layer was washed with brine (100 mL), dried over MgSO4 
and the solvent was removed in vacuo. The crude product was purified by distillation (1.10 
mbar, 102 – 110 °C, oil bath 175 °C), re-dissolved in n-pentane and washed with H2O three 
times to yield boronic ester 3.59 (8.22 g, 33.12 mmol, 73%) as a colourless oil.  
1H NMR (CDCl3, 400 MHz), 7.38-7.27 (5H, m, H7, H8, H9), 4.52 (2H, s, H5), 3.28 (2H, s, 
H4), 1.27 (12H, s, H1, H2). 
13C NMR (CDCl3, 101 MHz) δ138.2 (C6), 128.4 (C7 and C8), 127.7 (C9), 84.0 (C3), 75.9 (C5), 
57.3(br, C4), 24.9 (C1,C2). 
11B NMR (CDCl3, 128 MHz) 31.49. 
IR (νmax/cm
-1, neat): 2978, 2847, 1338, 1143, 1031, 957, 845, 735, 697. 
HRMS (ESI+): calc. for C21H34O2Na [M+H]








Prepared according to GP1 using boronic ester 3.59 (1.00 g, 4.00 mmol), (R)enantiomer of 
stannane (R)-3.29 (2.90 g, 6.00 mmol) and nBuLi (1.60 M in n-hexane, 3.65 mL, 5.87 mmol) 
in anhydrous Et2O (20.15 mL). The crude material was purified by flash column 
chromatography (3:97, Et2O:n-hexane) to give the homologated boronic ester 3.62 (940.5 mg, 
2.96 mmol, 73%) as a colourless oil. 
Rf (4:96, Et2O:n-hexane) 0.24. 
1H NMR (CDCl3, 400 MHz), 7.35-7.28 (4H, m, H10, H11), 7.25-7.22 (1H, m, H12), 4.49 (2H, 
s, H8), 3.64 (1H, app. s, H7a or H7b), 3.63 (1H, app. d, J = 2.3 Hz, H7a or H7b), 1.37 (1H, dd, J = 
9.1, 7.1 Hz H4), 1.23 (12H, s, H1, H2), 0.97 (9H, s, H6). 
13C NMR (CDCl3, 101 MHz) δ139.1 (C9), 128.2 (C11), 127.5 (C10), 127.2 (C12), 83.0 (C3), 73.1 
(C8), 70.4 (C7), 37.34 (br, C4), 31.3 (C5), 30.1 (C6), 25.0 (C1 or C2), 24.9(9) (C1 or C2). 
11B NMR (CDCl3, 96 MHz): 33.07. 
IR (νmax/cm
-1, neat): 2955, 2867, 1454, 1370, 1142. 
[𝜶]𝑫
𝟐𝟑  (c 1, CHCl3). 
HRMS (ESI+): calc. for C19H31BO3Na [M+Na]





Boronic ester 3.62 was oxidised to the corresponding alcohol for chiral SFC analysis.  
(S)-1-(Benzyloxy)-3,3-dimethylbutan-2-ol 
 
A mixture of boronic ester 3.62 containing an unknown impurity (combined weight 100 mg, < 
0.31 mmol of the boronic ester) was dissolved in THF (1.5 mL) and cooled to 0 °C. A 2:1 
mixture of NaOH (0.86 mL, 3 M in water) and hydrogen peroxide (0.43 mL, 30% aqueous 
solution v/v) was added to the reaction mixture. The mixture was warmed to room temperature 
and left to stir vigorously overnight. The reaction mixture was diluted with water (2 mL) and 
Et2O (2 mL). The phases were separated and the aqueous later was extracted with Et2O (3 × 10 
mL) and the combined organic phase were washed with brine (5 mL), dried over MgSO4 and 
concentrated in vacuo. Purification by flash column chromatography (10:90, Et2O:n-hexane) 
gave the corresponding alcohol (39 mg, 0.19 mmol, > 62%) as a colourless oil. 
Rf (10 : 90 Et2O : n-hexane) 0.15. 
1H NMR (CDCl3, 500 MHz), 7.35-7.28 (4H, m, H7, H8, H9), 4.56 (2H, s, H5), 3.63 (1H, dd, 
J = 9.2, 2.6 Hz, H4a or H4b), 3.52 (1H, dd, J = 9.1, 2.4 Hz, H3), 3.39 (1H, t, J = 9.2 Hz, H4a or 
H4b), 2.46 (1H, s, OH), 0.92 (9H, s, H1). 
13C NMR (CDCl3, 125 MHz) δ 138.1 (C6), 128.6 (C9), 127.9 (C7/C8), 127.8 (C7/C8), 77.6 (C3), 
73.5 (C5), 71.6 (C4), 33.5 (C2), 26.1 (C1). 
IR (νmax/cm
-1, neat): 3482, 3030, 2954, 2869, 1453, 1364, 1074. 
[𝜶]𝑫
𝟐𝟐 22 (c 1, CHCl3). 
HRMS (ESI+): calc. for C19H20NaO2 [M+Na]
+: 231.1356; found: 231.1350. 
Chiral SFC Whelk-01 column, iso 10%, 4 mL/min, 125 bar, co-solvent: 50% IPA/Hex; tR (S-











A side product 3.63 (28.00 mg, 0.08 mmol) was also isolated.   
2-hydroxy-3,3-dimethyl-1-(2,4,6-triisopropylphenyl)butan-1-one, 3.63 
 
Rf (3:97, Et2O:n-hexane) 0.11. 
1H NMR (CDCl3, 400 MHz), 7.02 (2H, s, H11), 4.24 (1H, d, J = 7.0 Hz, H3), 3.57 (1H, d, J 
= 7.2 Hz, H4), 2.88 (1H, hept, J = 6.9 Hz, H13), 2.81 (2H, hept, J = 6.9 Hz, H8), 1.28 – 1.20 (18 
H, m, H9, H10 and H14), 0.89 (9H, s, H1). 
13C NMR (CDCl3, 100 MHz) 221.9 (C5), 151.1 (C12), 146.1 (C6), 135.4 (C7), 121.9 (C11), 
86.1 (C3), 36.9 (C2), 34.4 (C13), 31.2 (C8), 26.5 (C1), 24.1 (C9, C10 or C14), 24.0 (C9, C10 or C14), 
23.9 (C9, C10 or C14). 
IR (νmax/cm
-1, neat): 3481, 2961, 2870, 1707, 1677, 1461, 1364, 1264, 1080. 
M.P.: 92 – 93 °C (pentane). 
HRMS (ESI+): calc. for C21H34NaO2 [M+Na]








Small scale: performed according to GP2 using boronic ester 3.62 (30.00 mg, 0.09 mmol), 
bromochloromethane (0.02 mL, 0.28 mmol) and nBuLi (1.55 M in n-hexane, 0.15 mL, 0.24 
mmol) in anhydrous Et2O (0.38 mL) at  °C. Purification of the crude material by flash 
column chromatography (5:95, Et2O:n-hexane) gave product 3.65 (25.70 mg, 0.08 mmol, 89%) 
as a colourless oil. 
Large scale: performed according to GP2 using boronic ester 3.62 (398.40 mg, 1.25 mmol), 
bromochloromethane (0.24 mL, 3.75 mmol) and nBuLi (1.6 M in n-hexane, 1.96 mL, 3.13 
mmol) in anhydrous Et2O (5.09 mL) at  °C. Purification of the crude material by flash 
column chromatography (5:95, Et2O:n-hexane) gave product 3.65 (358.80 mg, 1.07 mmol, 
86%) as a colourless oil. 
Rf (5:95, Et2O:n-hexane) 0.24. 
1H NMR (CDCl3, 500 MHz), 7.39-7.29 (4H, m, H11 and H12), 7.28-7.23 (1H, m, H13), 4.50 
(2H, m, H9), 3.58 (1H, dd, J = 8.9, 4.5 Hz, H8a or H8b), 3.18 (1H, t, J = 8.8 Hz, H8a or H8b), 1.80 
(1H, ddt, J = 10, 8.6, 4.4 Hz, H5), 1.21 (6H, s, H1 or H2), 1.20 (6H, s, H1 or H2), 0.90-0.82 (1H, 
m, H4a or H4b), 0.85 (9H, s, H7), 0.71 (1H, dd, J = 15.3, 10 Hz, H4a or H4b). 
13C NMR (CDCl3, 125 MHz) δ 139.1 (C10), 128.4 (C12), 127.7 (C11), 127.4 (C13) 82.8 (C3), 
72.99 (C8 or C9), 72.97 (C8 or C9), 44.7 (C5), 32.8 (C6), 27.9 (C7), 25.1 (C1 or C2), 24.9 (C1 or 
C2), 11.1 (C4). 
IR (νmax/cm
-1, neat): 2962, 2867, 1368, 1810, 1145, 1094, 733. 
[𝜶]𝑫
𝟐𝟎 2 (c 1, CHCl3). 
HRMS (ESI+): calc. for C20H34BO3 [M+H]








Prepared according to GP1 using boronic ester 3.65 (748.20 mg, 2.25 mmol), R enantiomer of 
stannane (R)-3.29 (1.63 g, 3.40 mmol) and nBuLi (1.53  in n-hexane, 2.13 mL, 3.26 mmol) 
in anhydrous Et2O (11.30 mL). MgBr2/MeOH (1.00 M, 3.38 mL, 3.38 mmol) was added before 
warming the reaction mixture to room temperature. The crude material was purified by flash 
column chromatography (2:98 → 4:96, Et2O:n-hexane) to give the homologated boronic ester 
3.57 (624.00 mg, 1.55 mmol, 69%, dr 95:5) as a colourless oil. 
Rf (4 : 96 Et2O : n-hexane) 0.26. 
1H NMR (CDCl3, 500 MHz), 7.36-7.29 (4H, m, H14 and H15), 7.27-7.21 (1H, m, H16), 4.45 
(2H, s, H12a and H12b), 3.48 (1H, dd, J = 9.6, 5.9 Hz, H11a or H11b), 3.42 (1H, dd, J = 9.6, 3.9 Hz, 
H11a or H11b), 1.52 (1H, dt, J = 13.7, 4.1 Hz, H7a or H7b), 1.32-1.26 (1H, m, J = Hz, H7a or H7b), 
1.20 (6H, s, H1 or H2), 1.22 (6H, s, H1 or H2), 1.21-1.17 (1H, m, H8), 0.95 (9H, s, H6 or H10), 
0.93 (9H, s, H6 or H10), 0.92-0.99 (m, 1H, H4). 
13C NMR (CDCl3, 125 MHz) δ 139.3 (C13), 128.3 (C14 or C15), 127.6 (C14 or C15), 127.3 (C16), 
82.3 (C3), 72.9 (C12), 72.7 (C11), 49.9 (C8), 34.0 (C5 or C9) 33.12 (C5 or C9), 9.6 (C6 or C10), 
28.6 (C6 or C10), 25.4 (C1 or C2), 24.9 (C1 or C2). 
11B NMR (CDCl3, 128 MHz): 33.60. 
IR (νmax/cm
-1, neat): 2955, 2867, 1475, 1364, 1314, 1141, 1111, 695. 
[𝜶]𝑫
𝟐𝟏 14 (c 1, CHCl3). 
HRMS (ESI+): calc. for C25H43BNaO3 [M+Na]








Prepared according to GP3 using boronic ester 3.57 (557.7 mg, 1.39 mmol), MeONH2 (0.36 
mL, 6.95 mmol), KOtBu (777.50 mg, 6.95 mmol) in anhydrous toluene (9.00 mL). The reaction 
mixture was subjected to basic work up followed by Boc-protection using Boc2O (362.90 mg, 
1.66 mmol) in THF (6.95 mL). The crude material was purified by flash column 
chromatography (5:95, Et2O:n-hexane) to give carbamate 3.77 (468.10 mg, 1.20 mmol, 85%) 
as a white solid. 
Rf (5 : 95 Et2O : n-hexane) 0.25. 
1H NMR (CDCl3, 500 MHz), 7.37-7.27 (4H, m, H14 and H15), 7.31-7.27 (1H, m, H16), 4.77 
(1H, d, J = 9.2 Hz, NH), 4.54 (1H, d, J = 12.1 Hz, H12a and H12b), 4.44 (1H, d, J = 12.1 Hz, 
H12a and H12b), 3.59 (1H, dd, J = 9.0, 3.9 Hz, H11a/b), 3.28 (1H, ddd, J = 12.1, 9.2, 3.0 Hz, H4), 
3.21 (1H, t, J = 9.1 Hz, H11a/b), 1.71 (1H, ddd, J = 14.6, 5.0, 3.1 Hz, H7a or H7b), 1.42 (9H, s, 
H1), 1.37 (1H, dq, J = 8.7, 3.9 Hz, H8), 1.20 (1H, ddd, J = 14.6, 12.0, 3.4 Hz, H7a or H7b), 0.90 
(9H, s, H6), 0.87 (9H, s, H10). 
13C NMR (CDCl3, 125 MHz), δ 156.9 (C3), 138.9 (C13), 128.4 (C16), 127.5 (C15), 127.4 (C14), 
78.4 (C2), 73.1 (C12), 72.4 (C11), 60.1 (C4), 45.6 (C8), 35.7 (C5), 33.3 (C9), 28.6 (C1), 28.5 (C7), 
28.1 (C10), 26.5 (C6). 
IR (νmax/cm
-1, neat): 3395, 2951, 2869, 1715, 1503, 1363, 1169, 1049, 732, 697. 
[𝜶]𝑫
𝟐𝟎 17 (c 1, CHCl3). 
M.P. 44.4 – 45.4 °C (pentane). 
HRMS (ESI+): calc. for C24H41NNaO3 [M+Na]




tert-Butyl ((3R,5S)-5-(hydroxymethyl)-2,2,6,6-tetramethylheptan-3-yl)carbamate, 3.66 
 
Prepared according to GP5 using carbamate 3.77 (389.00 mg, 0.99 mmol), Pd/C (10% wt, 
105.70 mg, 0.099 mmol) in EtOH (3.97 mL). Purification of the crude material by flash column 
chromatography (13:87, EtOAc:n-hexane) gave the syn alcohol 3.66 (244.7 mg, 0.81 mmol, 
82%) as a white solid. 
Rotamers were observed in both 1H and 13C NMR. 
Rf (15 : 85 EtOAc : n-hexane) 0.23. 
1H NMR (CDCl3, 400 MHz), 4.67 (1H, broad s, NH), 3.83 (1H, dd, J = 10.6, 3.7 Hz, H11a or 
H11b), 3.35 (1.5H, m, H11a or H11b, H4 rotamer), 3.23 (0.5H, m, H4 rotamer), 1.90 (broad s, OH), 
1.76 (1H, m, H7a or H7b), 1.48-1.40 (9H, m, H1), 1.22 (1H, m, H8), 1.20 (1H, m, H7a or H7b), 
0.91 (9H, s, H10), 0.90 (9H, s, H6). 
13C NMR (CDCl3, 101 MHz) δ 156.9 (C3), 78.9 (C2), 64.3 (C11), 61.7 (C4 rotamer), 60.0 (C4 
rotamer), 48.9 (C8 rotamer), 48.3 (C8 rotamer), 35.6 (C5), 33.5 (C9), 29.1 (C7), 28.6 (C1), 28.2 
(C10), 26.6 (C6). 
IR (νmax/cm
-1, neat): 3361, 2961, 2871, 1715, 1691, 1365, 1172, 1049. 
[𝜶]𝑫
𝟐𝟎  (c 1, CHCl3). 
M.P. 81.5 – 82.5 °C (pentane). 
HRMS (ESI+): calc. for C17H35NNaO3 [M+Na]





tert-Butyl (R)-2,4-di-tert-butyl-2,3-dihydro-1H-pyrrole-1-carboxylate, 3.66 
 
NaHCO3 (83.60 mg, 1.00 mmol) was added to a solution of alcohol 3.66 (30.00 mg, 0.10 mmol) 
in anhydrous DCM (0.50 mL) at 0 °C. DMP (84.40 mg, 0.20 mmol) was added and the reaction 
was stirred at 0 °C for 3 h. The reaction mixture was diluted with EtOAc (2 mL) and quenched 
by the addition of saturated aqueous Na2S2O3 (2 mL). The layers were separated and the 
aqueous layer was extracted with EtOAc (2 × 2 mL), dried over MgSO4 and concentrated in 
vacuo. The crude material was purified by flash column chromatography (10:90, Et2O:n-
hexane) to give 3.68 (15.30 mg, 0.065 mmol, 65%) as a white solid.  
Rf (10:90, Et2O:n-hexane) 0.48. 
1H NMR (CDCl3, 500 MHz), 6.34-5.98 (1H, m, H1), 4.10-3.80 (1H, n, H4), 2.71-2.56 (1H, 
m H3a or H3b), 2.30-2.16 (1H, d, J = 16.1 Hz, H3a or H3b), 1.48 (9H, s, H11), 1.06 (9H, s, H6), 
0.85 (9H, s, H8). 
13C NMR (CDCl3, 125 MHz) δ 132.4 (C2), 123.2 (C1), 79.7 (C10), 65.5 (C4), 36.7 (C7), 31.60 
(C3 and C5), 29.1 (C6), 28.6 (C11), 26.1 (C8), C9 was not observed. 
IR (νmax/cm
-1, neat): 2953, 1705, 1382, 1125. 
[𝜶]𝑫
𝟐𝟑 190 (c 0.18, CHCl3). 
M.P.  69.9 – 70.9 °C (pentane). 
HRMS (ESI+): calc. for C17H31NNaO2 [M+Na]





tert-butyl ((3R,5S)-5-formyl-2,2,6,6-tetramethylheptan-3-yl) carbamate, 3.67 and tert-
butyl (3S,5R)-3,5-di-tert-butyl-2-hydroxypyrrolidine-1-carboxylate, 3.70 
 
Prepared according to GP6 using alcohol 3.66(5.00 mg, 0.02 mmol), Cu(MeCN)4OTf (0.31 
mg, 0.001 mmol), 4,4’-dimethoxy-2,2’-bipyridine (MeObpy, 0.18 mg, 0.001 mmol), ABNO 
(0.02 mg, 0.2 µmmol), and NMI (1.5 µL, 0.002 mmol) in MeCN (0.01 mL). The crude material 
was purified by flash column chromatography (5:95, EtOAc:n-hexane) to give product (4 mg, 
0.013 mmol, 81%) as a 1 : 4 mixture of aldehyde 3.67 and hemiaminal 3.70 in CDCl3. 
Rf (5 : 95 EtOAc : n-hexane) 0.3. 
1H NMR (CDCl3, 500 MHz),  9.89 (1H, d, J = 2.6 Hz, H1), 5.57 (1H, m, H13), 4.15 (1H, J = 
10.8 Hz, NH), 3.79 (1H, t, J = 8.6 Hz, H16), 3.31 (1H, td, J = 11.3, 3.1 Hz, H7), 2.28 (1H, dt, J 
= 8.8, 2.4 Hz, H3), 1.96 (1H, broad s, OH), 1.87 (2H, dd, J = 10.2, 8.3 Hz, H15), 1.81 (1H, m, 
H6a/H6b), 1.68 (1H, m, H6a or H6b), 1.54 (1H, tdd, J = 10.4, 4.7 Hz, H14), 1.49 (9H, s, H19), 1.43 
(9H, s, H12), 1.04 (9H, s, H23), 1.02 (9H, s, H5), 0.94 (9H, s, H20), 0.92 (9H, s, H9). 
13C NMR (CDCl3, 125 MHz) δ 206.5 (C2), 156.5 (C17 and C10), 86.5 (C13), 80.2 (C18), 79.2 
(C11), 65.8 (C16), 60.1(9) (C3 or C7), 60.1(6) (C3 or C7), 53.4 (C14), 35.5(C21), 35.2(C8), 34.8(C4), 
31.4(C22), 28.9(C23), 28.5(C12 and C19), 28.1(C5), 27.7(C20), 26.5(C9), 26.2(C15), 25.4 (C6). 
IR (νmax/cm
-1, neat): 3420, 2959, 1669, 1365, 1113. 
HRMS (ESI+): calc. for C17H32NO2 [M+H−H2O]
+: 282.2428; found: 282.2426.  
Notes:  
1. Due to the limited availability of the products, [𝜶]𝑫
𝟐𝟎 was not measured.  
2. Extra signals observed in the NMR spectra (not included in the above assignments) were 
thought to be the diastereomer of the hemiaminal 3.70, which arises from the epimer of the 
stereogenic centre at position 13. Although the intensities associated with these signals in the 




oxidation of the products only gave the lactam, thus implying these minor signals corresponds 




tert-Butyl (3S,5R)-3,5-di-tert-butyl-2-oxopyrrolidine-1-carboxylate, 3.71 
 
Solid Cu(MeCN)4OTf (4.39 mg, 0.012 mmol), 4,4’-dimethoxy-2,2’-bipyridine (
MeObpy, 2.52 
mg, 0.010 mmol), ABNO (0.33 mg, 0.002 mmol), and NMI (1.9 µL, 0.020 mmol) were added 
to a solution of alcohol 3.66 (70.20 mg, 0.230 mmol) in MeCN (2.33 mL) in a sample vial. The 
addition of each catalytic component was followed by a rinse of MeCN (0.15 mL). The dark 
red solution was purged with O2 balloon and stirred at 950 RPM at 70°C for two h. All the 
catalytic components (Cu(MeCN)4OTf, 
MeObpy, ABNO and NMI) were reloaded every two h 
the reaction was stirred at 70°C with O2 balloon for further 6 h until full conversion to the 
product was observed (monitored by LCMS analysis). The reaction was filtered through a pad 
of SiO2 with MeCN wash and solvent was removed in vacuo. The crude material was purified 
by flash column chromatography (5:95, EtOAc:n-hexane) to give product 3.71 (44.8 mg, 0.15 
mmol, 65%) as a white solid. 
Rf (5:95, EtOAc:n-hexane) 0.32; 
1H NMR (CDCl3, 500 MHz),  3.85 (1H, app. t, J = 8.5 Hz, H4), 2.30 (1H, t, J = 11.3 Hz, H2), 
2.02 (1H, ddd, J = 13.2, 10.6, 8.2 Hz, H3a or H3b), 1.58 (1H, ddd, J = 13.2, 11.3, 8.9 Hz, H3a or 
H3b), 1.53 (9H, s, H7), 1.05 (9H, s, H11), 0.91 (9H, s, H8). 
13C NMR (CDCl3, 125 MHz) δ 176.2 (C1), 153.1 (C5), 83.2 (C6), 62.0 (C4), 51.7 (C2), 36.1 
(C9), 32.7 (C10), 28.0 (C7), 27.6 (C11), 26.7 (C8), 22.8 (C3).  
IR (νmax/cm
-1, neat): 2964, 1724, 1477, 1367, 1280, 1147. 
[𝜶]𝑫
𝟐𝟏 20 (c 1, CHCl3). 
M.P. 88.8 – 89.1 °C (pentane). 
HRMS (ESI+): calc. for C17H31NNaO3 [M+Na]







A solution of ethanethiol (4 µL, 0.06 mmol) in anhydrous THF (0.08 mL) was stirred at −78 °C 
followed by the dropwise addition of nBuLi (1.6 M in n-hexane, 0.03 mL) and stirred for 5 min. 
The reaction mixture was warming to 0°C and stirred for 15 min. A solution of lactam 3.71 
(5.0 mg, 0.06 mmol) in anhydrous THF (0.1 mL) was cooled to −78 °C and added to the 
reaction mixture via syringe at 0 °C. The reaction was stirred at 0 °C overnight and quenched 
by the addition of 0.5 mL aqueous NaOH solution (1M) and 0.5 mL Et2O. The reaction was 
stirred for 5 min and two phases were separated. The aqueous phase was extracted by Et2O (1 
mL × 3) and the organic phases were combined, dried over MgSO4 and solvent was removed 
in vacuo. The crude material was purified by flash column chromatography (20:80, EtOAc:n-
hexane) to give product 3.76 (1.9 mg, 0.01 mmol, 51%) as a white solid. 
Note: Due to the limited amount of product, which was also being contaminated by BHT (from 
Et2O), IR, [𝛼]𝐷  and melting point were not measured.  
Rf (20:80, EtOAc:n-hexane) 0.15. 
1H NMR (CDCl3, 500 MHz),  5.16 (1H, broad s, NH), 3.20 (1H, dd, J = 8.5, 4.8 Hz, H4), 
2.21 (1H, dd, J = 9.9, 7.2 Hz, H2), 2.02-1.87 (2H, m, H3), 1.03 (9H, s, H8), 0.87 (9H, s, H6). 
13C NMR (CDCl3, 125 MHz) δ 178.85 (C1), 61.0 (C4), 50.2 (C2), 34.5 (C5), 33.2 (C7), 27.5 
(C8), 25.6 (C3), 25.4 (C6). 
HRMS (ESI+): calc. for C12H23NNaO [M+Na]





tert-Butyl ((3R,5S)-5-(hydroxymethyl)-2,2,6,6-tetramethylheptan-3-yl) bis-carbamate, 
3.78 
 
Prepared according to GP4 using carbamate 3.77 (40.00 mg, 0.10 mmol), nBuLi (1.60 M, 0.06 
mL, 0.10 mmol), DMAP (12.50 mg, 0.10 mmol), Boc2O (33.70 mg, 0.15 mmol) in anhydrous 
THF (0.33 mL). Purification of the crude material by flash column chromatography (3:97, 
Et2O:n-hexane) gave product 3.78 (39.00 mg, 0.08 mmol, 79%) as a colourless oil.  
Rf (5:95, Et2O:n-hexane) 0.48. 
1H NMR (CDCl3, 500 MHz), 7.34-7.28 (4H, m, H17, H18), 7.26-7.22 (1H, m, H19), 4.43 (2H, 
s, H15), 4.02 (1H, dd, J = 9.6, 3.6 Hz, H7), 3.55 (1H, dd, J = 10.1, 3.1 Hz, H14a or H14b), 3.50 
(1H, dd, J = 10.1, 5.9 Hz, H14a or H14b), 1.98 (1H, ddd, J = 15.1, 9.6, 6.5 Hz, H10a or H10b), 1.69 
(1H, dt, J = 15.2, 4.0 Hz, H10a or H10b), 1.48 (9H, s, H1 or H6), 1.47 (9H, s, H1 or H6), 1.37-1.31 
(1H, m, H11), 0.98 (9H, s, H9), 0.96 (9H, s, H13). 
13C NMR (CDCl3, 125 MHz),155.7 (C4 or C3), 153.9 (C4 or C3), 139.4 (C16), 128.3 (C18), 
127.5 (C17), 127.2 (C19), 81.7 (C2 or C5), 81.6 (C2 or C5), 73.0 (C15), 72.2 (C14), 67.0 (C7), 47.2 
(C11), 37.3 (C8), 34.0 (C12), 28.6 (C13), 28.2 (C1 or C6), 28.1 (C9), 28.0 (C1 or C6), 26.1 (C10). 
IR (νmax/cm
-1, neat): 2960, 1870, 1744, 1700, 1366, 1334, 1147, 1113. 
[𝜶]𝑫
𝟐𝟎 4 (c 1, CHCl3). 
HRMS (ESI+): calc. for C29H49NNaO5 [M+Na]





tert-Butyl ((3R,5S)-5-(hydroxymethyl)-2,2,6,6-tetramethylheptan-3-yl) bis-carbamate, 
3.79 
 
Prepared using GP5 using Carbamate 3.78 (39.00 mg, 0.08 mmol), Pd/C (10% wt, 8.40 mg, 
0.008 mmol) in ethanol (0.32 mL). Purification of the crude material by flash column 
chromatography (5:95, EtOAc:n-hexane) gave alcohol 3.79 (26.80 mg, 0.06 mmol, 84%) as a 
colourless oil. 
Rf (5:95, EtOAc:n-hexane) 0.17. 
1H NMR (CDCl3, 500 MHz), 4.07 (1H, dd, J = 12.4, 3.2 Hz, H7), 3.70 (1H, d, J = 8.5 Hz, 
H14a or H14b), 3.45 (1H, dd, J = 10.9, 8.0 Hz, H14a or H14b), 3.30 (1H, s, OH), 2.09 (1H, ddd, J 
= 15.4, 12.4, 3.1 Hz, H10a or H10b), 1.74 (1H, ddd, J = 15.3, 6.6, 3.3 Hz, H10a or H10b), 1.49(5) 
(9H, s, H1 or H4) 1.49(3) (9H, s, H1 or H4), 1.24-1.18 (1H, m, H11), 0.98 (9H, s, H9), 0.92 (9H, 
s, H13). 
13C NMR (CDCl3, 125 MHz) δ 156.0 (C3 or C6), 155.0 (C3 or C6), 83.0 (C2 or C5), 81.9 (C2 or 
C5), 66.5 (C7), 64.8 (C14), 48.2 (C11), 36.9 (C8), 33.5 (C12), 28.1 (C13), 28.1 (C1 or C4), 27.7 (C1 
or C4), 27.6 (C9), 26.5 (C10). 
IR (νmax/cm
-1, neat): 3512, 2964, 2872, 1736, 1695, 1367, 1338, 1173, 1145, 1114. 
[𝜶]𝑫
𝟐𝟎  (c 1, CHCl3). 
HRMS (ESI+): calc. for C22H43NNaO5 [M+Na]





tert-Butyl ((3R,5S)-5-formyl-2,2,6,6-tetramethylheptan-3-yl) bis-carbamate, 3.80 
 
Prepared according to GP6 using alcohol 3.79 (21 mg, 0.05 mmol), Cu(MeCN)4OTf (1.00 mg, 
0.003 mmol), 4,4’-dimethoxy-2,2’-bipyridine (MeObpy, 0.57 mg, 0.003 mmol), ABNO (0.07 
mg, 0.001 mmol), and NMI (0.4 µL, 0.01 mmol) in MeCN (0.1 mL). The crude material was 
purified by flash column chromatography (2:98, EtOAc:n-hexane) to give aldehyde 3.80 (15.60 
mg, 0.04 mmol, 78%) as a colourless oil. 
Rf (2:98, EtOAc:n-hexane) 0.19. 
1H NMR (CDCl3, 500 MHz), 9.66 (1H, d, J = 4.8 Hz, H14), 3.88 (1H, dd, J = 11.7, 3.0 Hz, 
H7), 2.65 (ddd, J = 14.8, 11.8, 8.0 Hz, H10a or H10b), 1.90 (1H, ddd, J = 8.0, 4.9, 3.2 Hz, H11), 
1.74 (1H, dt, J = 14.8, 3.1, 3.1 Hz, H10a or H10b), 1.49 (9H, s, H1 or H6), 1.47 (9H, s, H1 or H6), 
0.99 (9H, s, H13), 0.98 (9H, s, H9). 
13C NMR (CDCl3, 125 MHz) δ 206.2 (C14), 155.1 (C3 or C6), 154.1 (C3 or C6), 82.3 (C2 or C5), 
82.0 (C2 or C5), 66.2 (C7), 60.8 (C11), 36.8 (C8), 34.1 (C12), 28.2 (C1/C4/C9/C13), 
28.1(C1/C4/C9/C13), 27.9(C1/C4/C9/C13), 27.8(C1/C4/C9/C13), 23.7 (C10). 
IR (νmax/cm
-1, neat): 2957, 2934, 2872, 1745, 1724, 1699, 1363, 1335, 1175, 1147, 1116. 
[𝜶]𝑫
𝟐𝟎  (c 0.62, CHCl3). 
HRMS (ESI+): calc. for C22H41NNaO5 [M+Na]








Prepared according to GP7 using a solution of aldehyde 3.80 (15.60 mg, 0.04 mmol) in tBuOH 
(0.78 mL), 2-methyl-2-butene (0.21 mL, 1.95 mmol) and a solution of sodium chlorite (39.72 
mg, 0.35 mmol) and sodium phosphate monobasic (32.80 mg, 0.27 mmol) in water (0.35 mL, 





Prepared according to GP8 using a solution of acid 3.81 (16.2 mg, 0.04 mmol) in anhydrous 
methanol (0.23 mL), toluene (0.16 mL) and (Trimethylsilyl)diazomethane (2.0 M in Et2O, 0.02 
mL, 0.04 mmol). Purification of the crude material by column chromatography (2:98, 
EtOAc:n-hexane) gave methyl ester 3.82 (13.4 mg, 0.03 mmol, 77%) as a colourless oil. 
Rf (5:95, EtOAc:n-hexane) 0.37. 
1H NMR (CDCl3, 500 MHz), 3.90 (1H, dd, J = 10.4, 3.2 Hz, H7), 3.60 (3H, s, H15), 2.44 (1H, 
ddd, J = 14.8, 10.4, 8.8 Hz, H10a or H10b), 2.12 (1H, dd, J = 8.9, 2.5 Hz, H11), 1.78 (1H, dt, J = 
14.8, 3.0 Hz, H10a or H10b), 1.49 (9H, s, H1 or H4), 1.48 (9H, s, H1 or H4),0.96 (9H, s, H9 or 
H13), 0.95 (9H, s, H9 or H13). 
13C NMR (CDCl3, 125 MHz) δ 175.7 (C14), 155.4 (C6 or C3), 153.5 (C6 or C3), 81.9 (C2 or C5), 
51.4 (C2 or C5), 66.8 (C7), 55.3 (C11), 51.1 (C15), 36.9 (C8), 33.9 (C12), 28.2 (C1/C4/C9/C13), 
28.0 (C1/C4/C9/C13), 27.9 (C1/C4/C9/C13), 27.7 (C1/C4/C9/C13), 26.7 (C10). 
IR (νmax/cm





𝟐𝟎  (c 0.38, CHCl3). 
HRMS (ESI+): calc. for C22H43NNaO6 [M+Na]








Prepared according to GP9 using a solution of bis Boc 3.82 (35.30 mg, 0.08 mmol) in DCM 
(0.55 mL) and TFA (10 µL, 0.16 mmol) was added to a solution of in DCM (0.55 mL, 0.15 M). 
The crude material was purified by flash column chromatography (5:95, EtOAc:n-hexane) to 
give carbamate 3.11 (22.50 mg, 0.07 mmol, 85%) as a white solid. 
Rotamers were observed in both 1H and 13C NMR. 
Rf (5 : 95 EtOAc : n-hexane) 0.22. 
1H NMR (CDCl3, 500 MHz), 4.11 (0.84H, d, J = 10.5 Hz, NH rotamer), 3.79 (0.15H, d, J = 
10.5 Hz, NH rotamer), 3.65 (2.45H, H12 rotamer) 3.63 (0.51H, H12 rotamer), 3.34 (0.88H, ddd, 
J = 11.4, 11.2, 3.5 Hz, H4 rotamer), 3.17 (0.12H, ddd, J = 12.0, 11.9, 2.92 Hz, H4 rotamer), 
2.14 (0.85H, dd, J = 10.3, 1.6 Hz, H8 rotamer), 2.05 (0.15H dd, J = 10.7, 1.7 Hz, H8 rotamer), 
1.79-1.74 (0.96H, ddd, J = 14.0, 3.6, 1.7 Hz, H7a rotamer), 1.75-1.71 (1H, m, H7a rotamer), 
1.66 (1.42H, ddd, J = 14.0. 11.8, 10.3 Hz, H7b rotamer), 1.62-1.55 (0.51H, m, H7b rotamer), 
1.46 (1.30H, s, H1 rotamer), 1.42 (7.80H, s, H1 rotamer), 0.93 (1.59H, s, H10 rotamer), 0.92 
(7.41H, s, H10 rotamer), 0.89-0.85 (9H, m, H6). 
13C NMR (CDCl3, 125 MHz) δ 177.7 (C11 rotamer), 176.9 (C11 rotamer), 156.0 (C3 rotamer), 
155.7 (C3 rotamer), 79.5 (C2 rotamer), 78.9 (C2 rotamer), 62.1 (C4 rotamer), 60.1 (C4 rotamer), 
54.9 (C8 rotamer), 54.2 (C8 rotamer), 51.5 (C12 rotamer), 51.4 (C12 rotamer), 35.4(9) (C5 
rotamer), 35.4(6) (C5 rotamer), 33.6 (C9 rotamer), 33.5 (C9 rotamer), 28.7 (C7 rotamer), 28.6 
(C1 rotamer), 28.5 (C1 rotamer), 28.3 (C7 rotamer), 27.8(1) (C10 rotamer), 27.7(9) (C10 rotamer), 
26.4(2) (C6 rotamer), 26.4(0) (C6 rotamer). 
IR (νmax/cm
-1, neat): 3371, 2984, 2950, 1730, 1713, 1519, 1363, 1170, 1157, 1048. 
[𝜶]𝑫
𝟐𝟎  (c 0.2, CHCl3). 
M.P. 104.9 – 105.6 °C (pentane). 
HRMS (ESI+): calc. for C18H35NNaO4 [M+Na]







Boronic ester 3.62 (150 mg, 0.47 mmol) was subjected to two iterative homologations. After 
each homologation the crude mixture was filtered through a pad of wetted SiO2 (Et2O) and 
solvent was removed under reduced pressure to give the crude boronic ester for the subsequent 
reaction.  
1st homologation (GP2): Performed using bromochloromethane (0.09 mL, 1.40 mmol) and 
nBuLi (1.65 M in n-hexane, 0.71 mL, 1.17 mmol) in anhydrous Et2O (2.36 mL). 
2nd homologation (GP1): Performed using (S)-3.29 (340.3 mg, 0.71 mmol), nBuLi (1.65M in 
n-hexane, 0.42 mL, 0.68 mmol) in anhydrous Et2O (1.6 mL). 
The crude reaction mixture was purified by column chromatography (2:98, Et2O:n-hexane) to 
yield the corresponding homologated boronic ester 3.83 (124.20 mg, 0.31 mmol, 66%, dr 96 : 
4) as a waxy oil.  
Rf (3 : 97 Et2O : n-hexane) 0.22. 
1H NMR (CDCl3, 500 MHz), 7.36-7.29 (2H, m, H14 and H15), 7.27-7.22 (1H, m, H16), 4.47-
4.40 (2H, m, H12), 3.50 (1H, dd, J = 10.1, 4.9 Hz, H11a or H11b), 3.42 (1H, dd, J = 10.1, 2.4 Hz, 
H11a or H11b), 1.54 (1H, td, J = 12.6, 1.9 Hz, H7a or H7b), 1.31 (1H, td, J = 12.3, 2.7 Hz, H7a or 
H7b), 1.24 (12H, s, H1 and H2), 1.04 (1H, ddt, J = 11.7, 4.5, 2.1 Hz, H8), 0.96-0.93 (1H, m, H4), 
0.93(4) (9H, s, H10), 0.93(0) (9H, s, H6). 
13C NMR (CDCl3, 125 MHz) δ 139.4 (C13), 128.3 (C15), 127.6 (C14), 127.2 (C16), 82.9 (C3), 
73.0 (C12), 70.3 (C11), 48.5 (C8), 33.5 (C5), 32.4 (C9), 29.7 (C10), 28.6 (C6), 25.48(C1 or C2), 
25.16 (C1 or C2), 24.5 (C7), C4 was not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz): 33.43. 
IR (νmax/cm
-1, neat): 2957, 2858, 1454, 1370, 1313, 1142, 695. 
[𝜶]𝑫




HRMS (ESI+): calc. for C25H44BO3 [M+H]








Prepared according to GP3 using boronic ester 3.83 (124.20 mg, 0.31 mmol), MeONH2 (0.01 
mL, 1.85 mmol) and KOtBu (207.80 mg, 1.85 mmol) in anhydrous toluene (3.10 mL). The 
reaction mixture was subjected to basic work up followed by Boc-protection using Boc2O 
(101.00 mg, 0.46 mmol) in THF (1.55 mL). The crude material was purified by flash column 
chromatography (5:95, Et2O:n-hexane) to give carbamate 3.108 (90.00 mg,0.23 mmol, 73%) 
as a viscous oil.  
Rf (5:95, Et2O:n-hexane) 0.23. 
Rotamers were observed in both 1H and 13C NMR. 
1H NMR (CDCl3, 500 MHz), 7.36-7.28 (4H, m, H14 and H15), 7.27-7.22 (1H, m, H16), 4.51-
4.40 (2H, m, H12a and H12b), 4.19 (0.83H, d, J = 10.6 Hz, NH rotamer), 3.96 (0.17H, d, J = 10.8 
Hz, NH rotamer), 3.62-3.54 (1.91H, m, H11a and H11b rotamer), 3.53-3.49 (0.20H, app. dd, J 
= 9.8, 3.7 Hz H11a and H11b rotamer), 3.49-3.38 (0.90H, td, J = 11.1, 1.8 Hz, H4 rotamer), 3.44-
3.34 (0.14H, m, H4 rotamer), 1.75-1.68 (0.90H, ddd, J = 13.9, 10.6, 1.8 Hz, H7a rotamer or H7b 
rotamer), 1.68-1.62 (0.21H, m, H7a/H7b rotamer), 1.42 (9H, broad s, H1), 1.38-1.32 (0.41H, m, 
H8 rotamer), 1.31-1.23 (0.64H, m, H8 rotamer), 1.12-1.02 (1H, m, H7a rotamer or H7b rotamer), 
0.91(9H, broad s, H10), 0.87 (9H, broad s, H6). 
13C NMR (CDCl3, 125 MHz), δ 156.7 (C3 rotamer), 156.5 (C3 rotamer), 139.3 (C13 rotamer), 
139.1 (C13 rotamer), 128.3 (C15 rotamer), 128.3 (C15 rotamer), 127.6 (C14 rotamer), 127.4 (C14 
rotamer), 127.3 (C16), 75.6 (C2 rotamer), 78.8 (C2 rotamer), 73.3 (C12 rotamer), 73.2 (C12 
rotamer), 70.5 (C11 rotamer), 70.2 (C11 rotamer), 58.9 (C4 rotamer), 57.6 (C4 rotamer), 45.1 (C8 
rotamer), 44.93 (C8 rotamer), 35.3 (C5 rotamer), 35.1 (C5 rotamer), 33.0 (C9), 28.6(4) (C10), 
28.6(2) (C1), 28.6 (C10 rotamer or C1 rotamer), 28.5 (C10 rotamer or C1 rotamer), 28.3 (C7 
rotamer), 28.2 (C7 rotamer), 26.5 (C6). 
IR (νmax/cm
-1, neat): 3260, 2961, 1698, 1364, 1170, 1106, 733, 697. 
[𝜶]𝑫




HRMS (ESI+): calc. for C24H41NNaO3 [M+Na]




tert-Butyl ((3S,5S)-5-((benzyloxy)methyl)-2,2,6,6-tetramethylheptan-3-yl) bis-carbamate, 
3.109 
 
Prepared according to GP4 using carbamate 3.108 (81.00 mg, 0.21 mmol) nBuLi (1.65 M in 
n-hexane, 0.13 mL, 0.21 mmol), Boc2O (67.70 mg, 0.31 mmol), DMAP (25.30 mg, 0.21 mmol) 
in anhydrous THF (0.69 mL). Purification of the crude material by flash column 
chromatography (3:97, Et2O:n-hexane) gave product 3.109 (56.6 mg, 0.12 mmol, 55 %, 97% 
yield BRSM) as a colourless liquid.  
Rf (5:95, Et2O:n-hexane) 0.47. 
1H NMR (CDCl3, 500 MHz), 7.35-7.29 (4H, m, H17, H18), 7.26-7.22 (1H, m, H19), 4.49 (1H, 
d, J = 12.1 Hz, H15a or H15b), 4.44 (1H, d, J = 12.0 Hz, H15a or H15b), 4.02 (1H, dd, J = 12.1, 
2.5 Hz, H7), 3.59 (2H, d, J = 3.4 Hz, H14a and H14b), 2.19 (1H, ddd, J = 14.3, 12.2, 2.2 Hz, H10a 
or H10b), 1.60 (1H, ddd, J = 14.2, 11.5, 2.6 Hz, H10a or H10b), 1.48 (9H, s, H1 or H6), 1.47 (9H, 
s, H1 or H6), 1.19 (1H, dtd, J = 11.6, 3.4, 2.1 Hz, H11), 0.97 (9H, s, H9), 0.94 (9H, s, H13). 
13C NMR (CDCl3, 125 MHz),156.2 (C4 or C3), 153.5 (C4 or C3), 139.4 (C16), 128.3 (C18), 
127.5 (C17), 127.2 (C19), 81.6 (C5 or C2), 81.5 (C5 or C2), 73.18 (C15), 69.6 (C14), 64.5 (C7), 
45.1 (C11), 36.5 (C8), 33.3 (C12), 28.9 (C13), 28.2 (C1/C9/C6), 28.1(4) (C1/C9/C6), 28.1(0) 
(C1/C9/C6), 23.6 (C10). 
IR (νmax/cm
-1, neat): 2964, 1744, 1701, 1367, 1335, 1115, 905, 732, 649. 
[𝜶]𝑫
𝟐𝟎  (c 0.28, CHCl3). 
HRMS (ESI+): calc. for C29H49NNaO5 [M+Na]





tert-Butyl ((3S,5S)-5-(hydroxymethyl)-2,2,6,6-tetramethylheptan-3-yl) bis-carbamate, 
3.84 
 
Prepared using GP5 using 3.109 (56.60 mg, 0.12 mmol), Pd/C (12.30 mg, 10% wt, 10 mol%) 
in ethanol (0.46 mL). Purification of the crude material by flash column chromatography (5:95, 
EtOAc:n-hexane) gave alcohol 3.84 (32.00 mg, 0.08 mmol, 69%) as a colourless oil. 
Rf (5:95, EtOAc:n-hexane) 0.20. 
1H NMR (CDCl3, 500 MHz), 4.01 (1H, dd, J = 12.4, 2.5 Hz, H7), 3.77 (1H, dd, J = 11.9, 3.8 
Hz, H14a or H14b), 3.56 (1H, dd, J = 11.9, 3.2 Hz, H14a or H14b), 2.23 (1H, ddd, J = 14.3, 12.4, 
2.0 Hz, H10a or H10b), 2.24-2.13 (1H, br s, OH), 1.48 (9H, s, H1 or H4), 1.47 (9H, s, H1 or H4), 
1.27 (1H, ddd, J = 14.3, 12.0, 2.6 Hz, H10a or H10b), 1.07 (1H, dtd, J = 12.0, 3.6, 2.0, H11), 0.99 
(9H, s, H9), 0.92 (9H, s, H13). 
13C NMR (CDCl3, 125 MHz) δ 157.2 (C3 or C6), 153.0 (C3 or C6),82.4 (C2 or C5), 81.8 (C2 or 
C5), 65.0 (C7), 63.9 (C14), 48.9 (C11), 36.5 (C8), 33.2 (C12), 28.3 (C13), 28.2 (C9), 28.1 (C1 and 
C4), 25.1 (C10). 
IR (νmax/cm
-1, neat): 3503, 2959, 1744, 1699, 1366, 1333, 1172, 1147, 1132, 943. 
[𝜶]𝑫
𝟐𝟓  (c 1, CHCl3). 
HRMS (ESI+): calc. for C17H36NO3 [M+H]





tert-Butyl ((3S,5S)-5-formyl-2,2,6,6-tetramethylheptan-3-yl) bis-carbamate, 3.110 
 
Prepared according to GP6 using alcohol 3.84 (32.0 mg, 0.08 mmol), Cu(MeCN)4OTf (1.5 mg, 
0.004 mmol), 4,4’-dimethoxy-2,2’-bipyridine (MeObpy, 0.9 mg, 0.004 mmol), ABNO (0.1 mg, 
0.0008 mmol), and NMI (0.6 µL, 0.008 mmol) in MeCN (0.8 mL). The crude material was 
purified by flash column chromatography (5:95, EtOAc:n-hexane) to give aldehyde 3.110 
(22.60 mg, 0.06 mmol, 71%) as a colourless oil.  
Rf (5:95, EtOAc:n-hexane) 0.31. 
1H NMR (CDCl3, 500 MHz), 9.82 (1H, d, J = 3.0 Hz, H14), 3.65 (1H, dd, J =12.3, 2.9 Hz, 
H7), 2.27-2.16 (2H, m, H10a or H10b and H11), 1.91 (1H, ddd, J = 13.7, 11.3, 2.8, H10a or H10b), 
1.48-1.46 (18H, m, H1 and H4), 1.00 (9H, s, H9), 0.97 (9H, s, H13). 
13C NMR (CDCl3, 125 MHz) δ 206.4 (C14), 155.5 (C3 or C6),153.4 (C3 or C6), 82.0 (C2 or C5), 
81.8 (C2 or C5), 64.5 (C7), 58.4 (C11), 36.5 (C8), 34.2 (C12), 28.4 (C1/C4/C9/C13), 
28.1(C1/C4/C9/C13), 28.0(7) (C1/C4/C9/C13), 27.9(8) (C1/C4/C9/C13), 21.90 (C10). 
IR (νmax/cm
-1, neat): 2954, 1744, 1720, 1703, 1367, 1334, 1173, 1148, 1115. 
[𝜶]𝑫
𝟐𝟎  (c 1, CHCl3). 
HRMS (ESI+): calc. for C22H41NNaO5 [M+Na]








Prepared according to GP7 using a solution of aldehyde 3.110 (22.60 mg, 0.06 mmol) in 
tBuOH (1.13 mL), 2-methyl-2-butene (0.30 mL, 2.83 mmol) and a solution of sodium chlorite 
(57.55 mg, 0.51 mmol) and sodium phosphate monobasic (47.50 mg, 0.40 mmol) in water (0.51 





Prepared according to GP8 using a solution of crude acid 3.111 in anhydrous methanol (0.35 
mL), toluene (0.24 mL) and (Trimethylsilyl)diazomethane (2.0 M in Et2O, 0.03 mL, 0.06 








Prepared according to GP9 using a solution of bis carbamate 3.112 (13.40 mg, 0.03 mmol) in 
DCM (0.21 mL) and TFA (5 µL, 0.06 mmol). The crude material was purified by flash column 
chromatography (5:95, EtOAc:n-hexane) to give carbamate 3.12 (7.40 mg, 0.002 mmol, 75%) 
as a colourless oil. 
Rotamers were observed in both 1H and 13C NMR. 
Rf (5:95, EtOAc:n-hexane) 0.2. 
1H NMR (CDCl3, 500 MHz), 4.15 (0.75H, d, J = 10.6 Hz, NH rotamer), 4.00 (0.25H, m, NH 
rotamer), 3.18 (0.73H, td, J = 11.6, 2.4 Hz, H4 rotamer), 2.99 (0.30H, t, J = 11.2 Hz, H4 rotamer), 
2.34 (0.30H, dd, J = 12.2, 2.2 Hz, H8 rotamer), 2.28 (0.74H, dd, J = 12.1, 2.5 Hz, H8 rotamer), 
1.97 (1H, ddd, J = 14.4, 12.1, 2.6 Hz, H7a or H7b), 1.46-1.43 (9H, m, H1), 1.19 (1.10H, ddd, J 
= 13.9, 11.8, 2.6 Hz, H7a rotamer or H7b rotamer), 1.12 (0.66H, ddd, J = 13.7, 11.7, 2.3 Hz, H7a 
rotamer or H7b rotamer), 0.94-0.92 (9H, m, H10), 0.88-0.86 (9H, m, H6). 
13C NMR (CDCl3, 125 MHz) δ 175.6 (C11 rotamer), 175.5 (C11 rotamer), 156.6 (C3 rotamer), 
156.0 (C3 rotamer), 79.8 (C2 rotamer), 78.9 (C2 rotamer), 59.2 (C4 rotamer), 57.3 (C4 rotamer), 
52.9 (C8 rotamer), 52.8 (C8 rotamer), 51.2 (C12 rotamer), 51.1 (C12 rotamer), 35.3 (C5 rotamer), 
35.2 (C5 rotamer), 33.1 (C9 rotamer), 33.0 (C9 rotamer), 29.0 (C7 rotamer), 28.6 (C7 rotamer), 
28.6 (C1 rotamer), 28.4 (C1 rotamer), 28.1 (C10), 26.4 (C6). 
IR (νmax/cm
-1, neat): 3256, 2955, 1732, 1699, 1385, 1355, 1174, 1049. 
[𝜶]𝑫
𝟐𝟎  (c 0.26, CHCl3). 
HRMS (ESI+): calc. for C18H35NNaO4 [M+Na]








Boronic ester 3.62 (102.20 mg, 0.32 mmol) was subjected to three iterative homologations. 
After each homologation the crude mixture was filtered through a pad of wetted SiO2 (Et2O) 
and solvent was removed under reduced pressure to give the crude boronic ester for the 
subsequent reaction.  
1st homologation (GP2): Performed using bromochloromethane (0.06 mL, 0.96 mmol) and 
nBuLi (1.65 M in n-hexane, 0.48 mL, 0.80 mmol) in anhydrous Et2O (1.61 mL). 
2nd homologation (GP2): Performed using bromochloromethane (0.06 mL, 0.96 mmol) and 
nBuLi (1.65 M in n-hexane, 0.48 mL, 0.80 mmol) in anhydrous Et2O (1.61 mL). 
3rd homologation (GP1): Performed using (R)-stannane 3.29 (215.10 mg, 0.46 mmol), nBuLi 
(1.65 M in n-hexane, 0.27 mL, 0.45 mmol) in anhydrous Et2O (1.49 mL) 
The crude reaction mixture was purified by column chromatography (3:97, Et2O:n-hexane) to 
yield the corresponding homologated boronic ester 3.91 (37.00 mg, 0.09 mmol, 26%, dr 94:4) 
as a colourless oil.  
Rf (3:97, Et2O:n-hexane) 0.19. 
1H NMR (CDCl3, 500 MHz), 7.35-7.29 (4H, m, H15 and H16), 7.23-7.27 (1H, m, H17), 4.49-
4.42 (2H, m, H13), 3.54 (1H, dd, J = 9.6, 4.7 Hz, H12a or H12b), 3.36 (1H, dd, J = 9.5, 4.8 Hz, 
H12a or H12b), 1.59 (1H, tt, J = 12.4, 4.0 Hz, H7a or H7b), 1.40 (1H, tdd, J = 12.6, 4.6, 2.9 Hz, 
H8a or H8b), 1.30 (1H, qd, J = 12.1, 4.6 Hz, H7a or H7b), 1.28-1.21 (1H, m, H9), 1.25 (12H, s, 
H1 and H2), 1.13-1.01 (1H, dddd, J = 12.6, 12.0, 9.2, 4.0 Hz, H8a or H8b), 0.92 (9H, s, H6), 0.90 
(9H, s, H11), 0.75 (1H, dd, J = 12.2, 3.4 Hz, H4). 
13C NMR (CDCl3, 125 MHz), δ 139.1 (C14), 128.4 (C16), 127.5 (C15), 127.4 (C17), 82.9 (C3), 
73.1 (C13), 71.9 (C12), 49.7 (C9), 33.21 (C10), 32.2 (C5), 29.76 (C6), 29.59 (C8), 28.4 (C11), 27.3 




11B NMR (CDCl3, 128 MHz): 34.17. 
IR (νmax/cm
-1, neat): 2957, 2867, 1366, 1313, 1142, 696. 
[𝜶]𝑫
𝟐𝟒 3 (c 1, CHCl3). 
HRMS (ESI+): calc. for C26H46BO3 [M+H]





tert-Butyl ((3R,6S)-6-((benzyloxy)methyl)-2,2,7,7-tetramethyloctan-3-yl)carbamate, 3.92 
 
Prepared according to GP3 using boronic ester 3.91 (43.60 mg, 0.10 mmol), KOtBu (70.50 mg, 
0.63 mmol) and MeONH2 (0.03 mL, 0.63 mmol) in anhydrous toluene (0.70 mL). The reaction 
mixture was subjected to basic work up followed by Boc-protection using Boc2O (27.40 mg, 
0.13 mmol) in THF (0.70 mL). The crude material was purified by flash column 
chromatography (10:90, Et2O:n-hexane) to give carbamate 3.92 (33.00 mg, 0.08 mmol, 77%) 
as a colourless oil.  
Rf (10 : 90 Et2O : n-hexane) 0.32; 
Rotamers were observed in both 1H and 13C NMR. 
1H NMR (CDCl3, 500 MHz), 7.35-7.29 (4H, m, H15, H16), 7.29-7.23 (1H, m, H17), 4.46 (2H, 
m, H13a and H13b), 4.26 (0.80H, d, J = 10.4 Hz, NH rotamer), 4.01 (0.13H, d, J = 10.5 Hz, NH 
rotamer), 3.56 (1H, dd, J = 9.5, 4.0 Hz, H12a or H12b), 3.40-3.36 (0.15H, m, H12a rotamer or H12b 
rotamer), 3.34 (0.86H, dd, J = 9.5, 5.1 Hz, H12a rotamer or H12b rotamer), 3.25 (0.81H, td, J = 
11.0, 2.3 Hz, H4 rotamer), 3.16-3.07 (0.14H, m, H4 rotamer), 1.88-1.79 (0.85H, m, H7a rotamer 
or H7b rotamer), 1.79-1.75 (0.11H, m, H7a rotamer or H7b rotamer), 1.62-1.54 (1H, m, H8a or 
H8b), 1.46 (1.4H, s, H1 rotamer), 1.43 (7.5H, s, H1 rotamer), 1.27-1.15 (2H, m, H9 and H8a or 
H8b), 1.04-0.94 (1H, m, H7a or H7b), 0.92-0.88 (9H, m, H11), 0.86-0.84 (9H, br. s, H6). 
13C NMR (CDCl3, 125 MHz), δ 156.8 (C3 rotamer), 156.5 (C3 rotamer), 138.9 (C14), 128.4 
(C16), 127.6 (C15), 127.5 (C17), 79.5 (C2 rotamer), 78.7 (C2 rotamer), 73.2 (C13), 72.3 (C12 
rotamer), 72.0 (C12 rotamer), 62.0 (C4 rotamer), 60.2 (C4 rotamer), 49.3 (C9 rotamer), 49.1 (C9 
rotamer), 34.9 (C5 rotamer), 34.9 (C5 rotamer), 33.2 (C10), 30.8 (C7 rotamer), 30.6 (C7 rotamer), 
28.6 (C1), 28.3 (C11 rotamer), 28.2 (C11 rotamer), 26.53 (C8 or C6), 26.5 (C8 or C6). 
IR (νmax/cm
-1, neat): 3451, 3360, 3265,2961, 2868, 1716, 1700, 1498, 1364, 1171, 734, 697. 
[𝜶]𝑫
𝟐𝟎 11 (c 1, CHCl3). 
HRMS (ESI+): calc. for C25H43NNaO3 [M+Na]




tert-Butyl ((3R,6S)-6-(hydroxymethyl)-2,2,7,7-tetramethyloctan-3-yl)carbamate, 3.93 
 
Prepared using GP5 using 3.92 (34.30 mg, 0.08 mmol), Pd/C (8.70 mg, 10% wt, 10 mol%) in 
ethanol (0.30 mL). Purification of the crude material by flash column chromatography (10:90, 
EtOAc:n-hexane) gave alcohol 3.93 (21.00 mg, 0.07 mmol, 85%) as a colourless oil. 
Note: After two days at room temperature the product became a white solid.  
Rf (10:90, EtOAc:n-hexane) 0.18. 
Rotamers were observed in both 1H and 13C NMR. 
1H NMR (CDCl3, 500 MHz), 4.31 (0.87H, d, J = 10.5 Hz, NH rotamer), 4.14-4.08 (0.13H, 
m, NH rotamer), 3.83 (0.03H, dd, J = 10.5, 3.7 Hz, H12a rotamer or H12b rotamer), 3.76 (0.98H, 
dd, J = 11.2, 4.0 Hz, H12a rotamer or H12b rotamer), 3.57 (0.12H, dd, J = 11.2, 5.3 Hz, H12a 
rotamer or H12b rotamer), 3.48 (0.87H, dd, J = 11.2, 6.1 Hz, H12a rotamer or H12b rotamer), 3.31 
(0.88H, td, J = 11.0, 2.2 Hz, H4 rotamer), 3.14 (0.12, m, H4 rotamer), 1.75 (1H, dddd, J = 13.8, 
9.2, 7.2, 2.2 Hz, H7a or H7b), 1.67-1.61 (0.15H, m, H8a rotamer or H8b rotamer), 1.61-1.52 (1H, 
m, H8a rotamer or H8b rotamer), 1.46 (1.21H, s, H1 rotamer), 1.43 (7.81H, s, H1 rotamer), 1.28-
1.19 (1.28H, m, H8a rotamer or H8b rotamer), 1.21-1.09 (0.12H, m, H8a rotamer or H8b rotamer), 
1.16-0.98 (2H, m, H9 and H7a or H7b), 0.91-0.89 (9H, br. s, H11), 0.89-0.85 (9H, br. s, H6). 
13C NMR (CDCl3, 125 MHz) δ 156.9(5) (C3 rotamer), 156.8(3) (C3 rotamer), 76.7 (C2 rotamer), 
79.2 (C2 rotamer), 64.2 (C12 rotamer), 63.9 (C12 rotamer), 61.7 (C4 rotamer), 59.4 (C4 rotamer), 
51.5 (C9 rotamer), 51.4 (C9 rotamer), 35.0 (C5 rotamer), 34.8 (C5 rotamer), 33.4 (C10 rotamer), 
33.2 (C10 rotamer), 30.9 (C7 rotamer), 30.8 (C7 rotamer), 28.6 (C1), 28.3 (C11), 26.5 (C6); 25.6 
(C8 rotamer), 24.9 (C8 rotamer). 
IR (νmax/cm
-1, neat): 3347, 2952, 1686, 1355, 1170, 1054. 
[𝜶]𝑫
𝟐𝟒  (c 0.84, CHCl3). 
M.P. 77.9 – 78.9 °C (pentane). 
HRMS (ESI+): calc. for C18H37NNaO3 [M+Na]




tert-Butyl ((3R,6S)-6-formyl-2,2,7,7-tetramethyloctan-3-yl)carbamate, 3.94 
 
Prepared according to GP6 using alcohol 3.93 (15.00 mg, 0.04 mmol), Cu(MeCN)4OTf (0.68 
mg, 0.002 mmol), 4,4’-dimethoxy-2,2’-bipyridine (MeObpy, 0.39 mg, 0.002 mmol), ABNO 
(0.05 mg, 0.0004 mmol), and NMI (0.3 µL, 0.004 mmol) in MeCN (0.4 mL). The crude 
material was subjected to subsequent transformations without purification.  
(2S,5R)-5-((Tert-butoxycarbonyl)amino)-2-(tert-butyl)-6,6-dimethylheptanoic acid, 3.113 
 
Prepared according to GP7 using a solution of crude aldehyde 3.94 in tBuOH (0.72 mL), 2-
methyl-2-butene (0.19 mL, 1.80 mmol) and a solution of sodium chlorite (36.64 mg, 0.32 mmol) 
and sodium phosphate monobasic (30.25 mg, 0.25 mmol) in water (0.32 mL, 28.30 mmol) The 








Prepared according to GP8 using a solution of crude acid 3.113 in anhydrous methanol (0.20 
mL), toluene (0.14 mL) and (trimethylsilyl)diazomethane (2.0 M in Et2O, 0.02 mL, 0.04 mmol). 
Purification of the crude material by column chromatography (5:95, EtOAc:n-hexane) gave 
methyl ester 3.88 (12.40 mg, 0.036 mmol, 90%) as a white solid. 
Rf (5:95, EtOAc:n-hexane) 0.24. 
Rotamers were observed in both 1H and 13C NMR. 
1H NMR (CDCl3, 500 MHz), 4.23 (0.77H, d, J = 10.6 Hz, NH rotamer), 4.05, (0.17H, d, J = 
10.6 Hz, NH rotamer), 3.65 (3H, s, H13), 3.27 (0.79H, td, J = 10.9, 2.1 Hz, H4 rotamer), 3.15 
(0.19H, m, H4 rotamer), 2.07 (1H, dd, J = 11.7, 2.9 Hz, H9), 1.70-1.50 (2H, m, H8a and H8b), 
1.58-1.74 (1H, m, H7a/H7b), 1.47 (1.68H, s, H1 rotamer), 1.44 (7.27H, s, H1 rotamer), 0.93 (9H, 
s, H11), 0.94-0.94 (1H, m, H7a/H7b), 0.85 (9H, s, H6). 
13C NMR (CDCl3, 125 MHz) δ 176.1 (C12 rotamer), 175.9 (C12 rotamer), 79.8 (C2 rotamer), 
78.9 (C2 rotamer), 61.5 (C4 rotamer), 59.7 (C4 rotamer), 57.1 (C9 rotamer), 56.7 (C9 rotamer), 
51.1 (C13), 34.9 (C5), 33.1 (C10), 29.7 (C7), 28.6 (C1), 28.0 (C11), 26.5 (C6), 25.7 (C8 rotamer), 
25.4 (C8 rotamer). 
IR (νmax/cm
-1, neat): 3391, 2957, 1707, 1517, 1152. 
[𝜶]𝑫
𝟐𝟑 − (c 0.5, CHCl3). 
M.P. 99 – 100 °C (Et2O). 
HRMS (ESI+): calc. for C19H37NNaO4 [M+Na]





General computational procedures 
 
Figure 6.26: Compounds studied by NMR and computational modelling. 
A Monte Carlo multiple minimum (MCMM)63 conformational search was performed 
in implicit CHCl3 using 500,000 iterations along with Merck Molecular Force Field 
(MMFFs)61,170. Structures were minimised using the truncated Newton Conjugate Gradients 
(TNCG) method with 500 iterations with a gradient convergence criteria of 0.05. Conformers 
within 21.0 kJ mol−1 of the lowest energy conformer found were stored.  
All conformers found were subjected to DFT geometry optimisation and frequency 
calculations with the mPW1PW91 functional using the 6-311 G (d,p) basis set in implicit 
chloroform (IEFPCM, =4.71). The Boltzmann averaged chemical shifts, total spin-spin 
coupling constants and interproton distances were computed using the same DFT method using 
GIAO method. A keyword ‘mixed’ was also used to incorporate explicit mixing of core orbitals 
in the calculation of the fermi contact term.160 
Conformer population and Boltzmann averaged NMR parameters were calculated 





Calculated data of 3.85 
 
Table 6.59: DFT calculated energies (in kJ mol−1) of 3.85 conformers. 
Conformer DG (kJ mol−1) Population (298 K, %) 
3.85-1 0.00 78.93% 
3.85-2 3.96 15.97% 
3.85-3 9.82 1.50% 
3.85-4 10.11 1.33% 
3.85-5 10.92 0.96% 
3.85-6 12.02 0.61% 
3.85-7 12.67 0.47% 
3.85-8 14.48 0.23% 
 
Calculated data of 3.88 
 
Table 6.60: DFT calculated energies (in kJ mol−1) of 3.88 conformers. 
Conformer DG (kJ mol−1) Population (298 K, %) 
3.88-1 0.00 55.42% 
3.88-2 2.51 20.09% 
3.88-3 3.67 12.61% 
3.88-4 5.55 5.90% 
3.88-5 8.36 1.90% 
3.88-6 10.01 0.97% 
3.88-7 10.40 0.83% 
3.88-8 11.00 0.65% 
3.88-9 12.27 0.39% 
3.88-10 13.53 0.23% 
3.88-11 14.48 0.16% 
3.88-12 14.72 0.15% 
3.88-13 14.78 0.14% 
3.88-14 15.24 0.12% 
3.88-15 15.33 0.11% 





Calculated data of 3.89 
 
Table 6.61: DFT calculated energies (in kJ mol−1) of 3.89 conformers. 
Conformer DG (kJ mol−1) Population (298 K, %) 
3.89-1 0.00 61.46% 
3.89-2 2.13 26.04% 
3.89-3 5.99 5.48% 
3.89-4 7.58 2.88% 
3.89-5 8.38 2.08% 
3.89-6 11.33 0.63% 
3.89-7 11.50 0.59% 
3.89-8 12.60 0.38% 
3.89-9 14.63 0.17% 
3.89-10 16.62 0.07% 
3.89-11 16.87 0.07% 
3.89-12 17.34 0.06% 
3.89-13 18.08 0.04% 
3.89-14 18.64 0.03% 
3.89-15 21.10 0.01% 
3.89-16 23.24 0.01% 
 
Calculated data of 3.98 
 
Table 6.62: DFT calculated energies (in kJ mol−1) of 3.98 conformers. 
Conformer DG (kJ mol−1) Population (298 K, %) 
3.98-1 0.00 91.64% 
3.98-2 7.19 5.03% 
3.98-3 9.61 1.89% 
3.98-4 14.32 0.28% 
3.98-5 14.52 0.26% 
3.98-6 15.05 0.21% 
3.98-7 15.22 0.20% 
3.98-8 16.90 0.10% 
3.98-9 17.69 0.07% 




3.98-11 17.80 0.07% 
3.98-12 18.07 0.06% 
 
Calculated data of 3.103 
 
Table 6.63: DFT calculated energies (in kJ mol−1) of 3.103 conformers. 
Conformer DG (kJ mol−1) Population (298 K, %) 
3.103-1 0.00 54.77% 
3.103-2 2.06 23.88% 
3.103-3 3.14 15.43% 
3.103-4 8.27 1.94% 
3.103-5 10.48 0.80% 
3.103-6 10.70 0.73% 
3.103-7 11.61 0.50% 
3.103-8 11.68 0.49% 
3.103-9 11.70 0.49% 
3.103-10 12.15 0.41% 
3.103-11 12.94 0.29% 
3.103-12 13.16 0.27% 
 
Calculated data of 3.105 
 
Table 6.64: DFT calculated energies (in kJ mol−1) of 3.105 conformers. 
Conformer DG (kJ mol−1) Population (298 K, %) 
3.105-1 0.00 30.34% 
3.105-2 0.78 22.17% 
3.105-3 1.93 13.93% 
3.105-4 1.93 13.92% 
3.105-5 4.36 5.22% 
3.105-6 6.62 2.10% 
3.105-7 7.25 1.62% 
3.105-8 7.27 1.61% 
3.105-9 7.43 1.51% 
3.105-10 7.57 1.43% 




3.105-12 8.63 0.93% 
3.105-13 8.63 0.93% 
3.105-14 9.60 0.63% 
3.105-15 10.11 0.51% 
3.105-16 11.10 0.34% 
3.105-17 11.11 0.34% 
3.105-18 11.49 0.29% 
3.105-19 12.38 0.20% 
3.105-20 13.49 0.13% 
3.105-21 13.68 0.12% 






General NMR procedures 
All NMR spectra were recorded in CDCl3. 
1H-1H scalar coupling constants were 
measured manually from multiplets in 1H spectra. 1H-13C scalar coupling constants of both U-
shaped and L-shaped molecules (3.11 and 3.12, respectively) were measured from the 
Accordion In-Phase and Anti Phase (IPAP) HSQMBC NMR spectra (12 scans, 1600 f1 
increments and 8192 t2 data points, f1 spectra width 190.2 ppm (23923Hz), f2 spectra width 
10 ppm (5005Hz), matching JLR from 3Hz to 8 Hz.)
174 The spectra were processed using 
methods as discussed in the experimental section of Chapter 2.  
NMR data of U-shaped molecule (3.11) 
Table 6.65: Experimental nJHH values (in Hz) and Boltzmann averaged calculated nJHH (in Hz) before 
for 3.11 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations 
(StDev, in Hz) and 2 (reduced) values (2 (red.)). 
HA HB Exp. nJHH/ Hz Calc. nJHH/Hz Deviation/Hz 
NH H4 10.80 11.86 1.06 
H4 H7a 3.30 4.00 0.70 
H4 H7b 11.40 13.10 1.70 
H8 H7a 1.54 0.99 −0.55 
H8 H7b 10.47 11.14 0.67 
   MAD 0.94 
   StDev 0.82 
   2 (red.) 1.31 
 
Table 6.66: Experimental nJCH values (in Hz) and Boltzmann averaged calculated nJCH (in Hz) before 
for 3.11 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations 
(StDev, in Hz) and 2 (reduced) values (2 (red.)). 
H C Exp. nJHH/ Hz Calc. nJHH/Hz Deviation/Hz 
H12 C11 3.83 4.10 0.27 
H8 C11 7.48 8.02 0.54 
H7a C11 8.97 9.38 0.40 
H7b C11 4.66 5.19 0.52 
H4 C3 3.39 3.89 0.50 
H7a C3 1.59 1.09 −0.50 
NH C4 2.95 2.97 0.02 
H8 C4 4.38 4.58 0.20 
H7b C4 5.54 5.77 0.23 
H12 C8 1.61 0.39 −1.22 
H4 C8 2.90 2.58 −0.31 
H7a C8 4.19 4.20 0.01 




H10 C8 3.94 3.96 0.02 
H4 C5 3.62 3.85 0.23 
H6 C5 3.96 3.60 −0.36 
H8 C9 4.93 5.06 0.13 
H7a C9 3.66 4.24 0.58 
H10 C9 3.92 3.66 −0.26 
H4 C7 4.43 4.95 0.52 
H8 C7 3.82 3.82 0.00 
H8 C10 3.35 3.45 0.10 
H4 C6 2.98 3.10 0.12 
   MAD 0.32 
   StDev 0.41 
   2 (red.) 0.18 
 
NMR data of L-shaped molecule (3.12) 
Table 6.67: Experimental nJHH values (in Hz) and Boltzmann averaged calculated nJHH (in Hz) before 
for 3.12 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations 
(StDev, in Hz) and 2 (reduced) values (2 (red.)). 
HA HB Exp. nJHH/ Hz Calc. nJHH/Hz Deviation/Hz 
NH H4 10.64 11.69 1.05 
H4 H7a 11.56 13.03 1.47 
H4 H7b 2.40 3.03 0.63 
H8 H7a 2.55 2.31 −0.24 
H8 H7b 12.10 12.82 0.72 
   MAD 0.82 
   StDev 0.63 
   2 (red.) 1.06 
 
Table 6.68: Experimental nJCH values (in Hz) and Boltzmann averaged calculated nJCH (in Hz) before 
for 3.12 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations 
(StDev, in Hz) and 2 (reduced) values (2 (red.)). 
H C Exp. nJHH/ Hz Calc. nJHH/Hz Deviation/Hz 
H12 C11 3.81 4.12 0.31 
H8 C11 7.33 7.92 0.59 
H7b C11 3.14 3.48 0.34 
H7a C11 9.88 10.63 0.75 
H4 C3 3.49 3.99 0.50 
H7b C3 1.44 1.21 −0.22 
NH C4 2.78 2.96 0.18 
H8 C4 2.94 2.91 −0.02 
H7b C4 1.81 1.74 −0.07 




H12 C8 1.29 0.39 −0.90 
H4 C8 3.08 2.73 −0.35 
H7b C8 5.18 5.61 0.44 
H7a C8 3.39 3.19 −0.21 
H10 C8 3.70 4.00 0.30 
H4 C5 3.98 4.11 0.13 
H7b C5 1.42 1.02 -0.40 
H7a C5 1.60 1.61 0.01 
H6 C5 3.78 3.60 −0.18 
H8 C9 4.90 4.87 −0.03 
H7b C9 1.69 1.17 −0.52 
H7b C9 2.33 1.17 −1.16 
H10 C9 3.91 3.67 −0.24 
H4 C7 4.28 4.47 0.19 
H8 C7 3.78 4.17 0.39 
H8 C10 3.48 3.35 −0.13 
H4 C6 3.22 3.15 −0.07 
   MAD 0.33 
   StDev 0.43 






X-ray structure of U-shaped molecule 3.11 
 
Table 6.69: Crystal data and structure refinement for 3.11 
Identification code 3.11 
Empirical formula C18H35NO4 
Formula weight 329.47 
Temperature/K 100(2) 
Crystal system orthorhombic 












Crystal size/mm3 0.435 × 0.378 × 0.282 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.116 to 55.776 
Index ranges -13 ≤ h ≤ 13, -25 ≤ k ≤ 22, -26 ≤ l ≤ 26 
Reflections collected 18725 
Independent reflections 4819 [Rint = 0.0437, Rsigma = 0.0394] 
Data/restraints/parameters 4819/0/222 




Final R indexes [I>=2σ (I)] R1 = 0.0363, wR2 = 0.0801 
Final R indexes [all data] R1 = 0.0454, wR2 = 0.0844 




Table 6.70: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters (Å2×103) 
for 3.11. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O1 4266.5(12) 5679.0(7) 6395.2(6) 19.9(3) 
O2 5539.7(12) 5647.1(7) 5487.2(6) 19.8(3) 
O3 2729.0(11) 4017.6(7) 5717.1(6) 17.9(3) 
O4 3341.4(12) 3888.5(8) 6817.3(6) 22.1(3) 
N1 4765.4(14) 4040.7(8) 5967.7(8) 15.1(3) 
C1 3315(2) 5977.9(12) 5961.3(10) 28.5(5) 
C2 5359.2(17) 5525.9(9) 6080.1(9) 15.5(4) 
C3 6316.8(16) 5215.5(9) 6559.4(8) 13.6(3) 
C4 6818.1(17) 4522.7(9) 6274.9(9) 15.6(4) 
C5 5892.5(16) 3919.1(9) 6378.9(9) 14.3(4) 
C6 3590.8(16) 3972.4(9) 6222.7(8) 15.6(4) 
C7 1404.0(17) 3834.6(10) 5855.2(9) 17.5(4) 
C8 800.9(18) 3890.2(11) 5160.2(10) 23.8(4) 
C9 1318.4(19) 3088.6(10) 6114.0(10) 23.1(4) 
C10 816.9(18) 4353.5(11) 6339.0(10) 24.5(4) 
C11 7366.2(17) 5763.7(10) 6724.6(9) 16.7(4) 
C12 8215.5(19) 5909.4(11) 6116.4(9) 23.3(4) 
C13 8164.7(19) 5485.4(10) 7309.2(9) 21.4(4) 
C14 6744(2) 6445.2(10) 6957.5(10) 24.9(4) 
C15 6460.1(17) 3182.2(9) 6255.7(9) 16.2(4) 
C16 5429(2) 2631.0(10) 6363.0(11) 25.5(4) 
C17 7516.6(19) 3045.1(10) 6769.7(10) 22.4(4) 





Table 6.71: Anisotropic Displacement Parameters (Å2×103) for 3.11. The Anisotropic displacement factor 
exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O1 16.9(6) 24.7(7) 18.1(7) 1.3(6) 0.2(5) 7.8(6) 
O2 21.3(7) 23.4(7) 14.6(6) 2.7(5) -1.5(5) 0.5(6) 
O3 10.3(6) 26.4(7) 17.0(6) 3.4(5) 0.1(5) -2.4(5) 
O4 16.3(6) 33.6(8) 16.5(6) 3.3(6) 0.9(5) -1.2(6) 
N1 13.8(7) 20.7(8) 10.8(7) 2.9(6) -0.5(6) -0.9(6) 
C1 21.4(10) 38.0(13) 26.1(10) 6.5(9) -3.2(8) 12.8(9) 
C2 17.0(9) 11.8(8) 17.5(8) -1.2(7) -0.3(7) -0.6(7) 
C3 13.7(8) 14.7(9) 12.5(8) 1.7(7) 0.7(7) 0.6(7) 
C4 14.6(9) 14.7(9) 17.6(9) 0.3(7) 0.9(7) 0.9(7) 
C5 13.5(8) 15.9(9) 13.5(8) 1.1(7) 0.7(6) 0.5(7) 
C6 15.4(9) 15.5(9) 15.9(9) 1.7(7) -0.4(7) -1.0(7) 
C7 10.4(8) 21.3(10) 20.8(9) -0.1(7) 3.0(7) -1.4(7) 
C8 15.9(9) 31.2(11) 24.2(10) 1.2(9) -2.9(8) -2.9(8) 
C9 21.9(10) 20.7(10) 26.6(10) -0.9(8) 1.6(9) -2.7(8) 
C10 15.8(9) 25.6(11) 32.1(11) -6.5(9) 2.4(8) -1.1(8) 
C11 17.5(9) 15.1(9) 17.5(9) 1.5(7) -1.6(7) -2.8(7) 
C12 23.1(10) 24.7(10) 22.1(9) 3.4(8) -0.8(8) -7.3(8) 
C13 21.6(10) 22.6(10) 20.0(9) -0.6(8) -3.6(8) -1.3(8) 
C14 29.0(11) 15.7(10) 30.0(11) -2.9(8) -5.5(9) -1.4(8) 
C15 18.7(9) 14.9(9) 15.1(8) 0.1(7) 0.3(7) -0.1(7) 
C16 27.6(11) 15.6(10) 33.1(11) 1.3(8) 5.2(9) -3.2(8) 
C17 26.8(10) 18.5(10) 21.7(9) 0.6(8) -4.5(9) 6.9(8) 
C18 29.8(11) 18.8(10) 18.5(9) -2.3(8) 2.1(8) 4.2(8) 
 
Table 6.72: Bond Lengths for 3.11. 
Atom Atom Length/Å  Atom Atom Length/Å 
O1 C1 1.444(2)  C4 C5 1.532(3) 
O1 C2 1.349(2)  C5 C15 1.556(2) 
O2 C2 1.211(2)  C7 C8 1.521(3) 
O3 C6 1.358(2)  C7 C9 1.522(3) 




O4 C6 1.217(2)  C11 C12 1.529(3) 
N1 C5 1.465(2)  C11 C13 1.530(3) 
N1 C6 1.351(2)  C11 C14 1.535(3) 
C2 C3 1.512(2)  C15 C16 1.536(3) 
C3 C4 1.538(2)  C15 C17 1.536(3) 
C3 C11 1.566(2)  C15 C18 1.533(2) 
 
Table 6.73: Bond Angles for 3.11. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C2 O1 C1 114.37(14)  O3 C7 C9 110.06(15) 
C6 O3 C7 119.35(13)  O3 C7 C10 110.66(15) 
C6 N1 C5 122.02(14)  C8 C7 C9 110.19(16) 
O1 C2 C3 111.92(14)  C10 C7 C8 110.63(16) 
O2 C2 O1 122.81(16)  C10 C7 C9 112.35(16) 
O2 C2 C3 125.23(17)  C12 C11 C3 112.18(15) 
C2 C3 C4 110.05(14)  C12 C11 C13 109.42(15) 
C2 C3 C11 110.14(14)  C12 C11 C14 109.53(16) 
C4 C3 C11 114.24(14)  C13 C11 C3 108.50(15) 
C5 C4 C3 112.45(14)  C13 C11 C14 107.95(15) 
N1 C5 C4 109.17(14)  C14 C11 C3 109.18(15) 
N1 C5 C15 111.94(14)  C16 C15 C5 109.15(15) 
C4 C5 C15 114.66(14)  C16 C15 C17 108.06(15) 
O4 C6 O3 125.06(16)  C17 C15 C5 109.53(14) 
O4 C6 N1 125.08(16)  C18 C15 C5 111.70(14) 
N1 C6 O3 109.86(14)  C18 C15 C16 108.96(16) 
O3 C7 C8 102.53(14)  C18 C15 C17 109.37(16) 
 
Table 6.74: Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) for 3.11. 
Atom x y z U(eq) 
H1A 3131.15 5654.85 5590.5 43 
H1B 3622.21 6420.16 5776.09 43 
H1C 2545.41 6061.42 6223.01 43 




H4A 6985.51 4578.07 5785.69 19 
H4B 7626.22 4408.14 6499.02 19 
H5 5619.97 3935.39 6862.37 17 
H8A 911.45 4364.5 4985.73 36 
H8B -100.43 3784.51 5194.57 36 
H8C 1203 3557.53 4852.29 36 
H9A 1793.38 2779.49 5812.98 35 
H9B 433.6 2942.54 6125.13 35 
H9C 1673.18 3063.55 6570.65 35 
H10A 1184.78 4293.09 6789.43 37 
H10B -94.66 4274.6 6361.59 37 
H10C 980.73 4828.39 6178.82 37 
H12A 8601.35 5472.84 5963.34 35 
H12B 8877.61 6239.23 6246.7 35 
H12C 7711.69 6109.39 5749.36 35 
H13A 7610.7 5333 7676.93 32 
H13B 8724.12 5855.1 7473.19 32 
H13C 8670.62 5089.92 7152.04 32 
H14A 6246.87 6641.61 6585.98 37 
H14B 7396.78 6778.83 7092.09 37 
H14C 6190.39 6350.3 7343.19 37 
H16A 5053.01 2691.99 6811.39 38 
H16B 5800.57 2164.38 6329.91 38 
H16C 4777.21 2684.96 6016.35 38 
H17A 8215.33 3368.19 6687.1 34 
H17B 7816.14 2564.37 6721.55 34 
H17C 7192.13 3115.36 7228.35 34 
H18A 6315.13 3198.39 5209.37 34 
H18B 7313.18 2635.55 5473.97 34 
H18C 7669.73 3446.27 5471.53 34 







General computational procedures 
 
Figure 6.27: Compounds studied by computational modelling and NMR spectroscopy.  
 
Figure 6.28: Computational workflow used in chapter 4. 
a. Molecular Mechanics:  
Conformational Search 
b. DFT: Geometry optimisation  
and frequency calculations 
B3LYP-D2, 6-311G (d), gas 
c. Python: Generation of  
degenerate conformations 
e. DFT:  
Calculation of  and J 
h. Comparison of calculated data and experimentally measured data 
d. DFT: Single point energy 
calculations (BS2, solvation) 














Here is a description of the computational procedures for each stage (a to f, Figure 6.28) 
of the workflow. 
Stage a, Molecular mechanics (MM) conformational search. 
A Monte Carlo multiple minimum (MCMM)63 conformational search was performed 
in implicit CHCl3 using 500,000 iterations along with Merck Molecular Force Field 
(MMFFs)61,170. Structures were minimised using the truncated Newton Conjugate Gradients 
(TNCG) method with 500 iterations with a gradient convergence criteria of 0.05. Conformers 
within 21.0 kJ mol−1 of the lowest energy conformer found were stored.  
Stage b, Density Functional Theory (DFT) geometry optimisation and frequency 
calculations. 
All conformers found were subjected to DFT geometry optimisation and frequency 
calculations using the B3LYP-D2 functional and the 6-311 G (d) basis set (Basis set 1, BS1) 
in gas phase unless stated otherwise. 
Stage c, Generation of degenerate conformations (for C2 symmetric molecules only) 
 Degenerate conformations were generated using a python script which swap the xyz 
coordinates of equivalent nuclei.  
# Atom_swapper.sh 
# Will Gerrard  (wg12385@bristol.ac.uk) 
# 
# Script for swapping atom coordinates in gaussian .com files 
# Usage: python atom_swapper.py File1 File2 
# Where File1 is a list of atom numbers to be swapped in two column, comma 
separated format 




from __future__ import print_function 
import sys 
import numpy as np 
 
def isnum(s): 
    try: 
        float(s) 
    except: 
        return(False) 
    else: 




    swapfile = sys.argv[1] 
except: 
    print("Usage: python atom_swapper.py < file1: list of atoms to swap >  






    comfile = sys.argv[2] 
except: 
    print("Usage: python atom_swapper.py < file1: list of atoms to swap >  
< file2: gaussian .com file >") 
 
swap_pairs = [] 
 
pairs = 0 
 
with open(swapfile, "r") as f: 
  for line in f: 
    items = line.split(",") 
    if len(items) >= 2: 
        if isnum(items[0]) and isnum(items[1]): 
            swap_pairs.append(line) 
            pairs += 1 
 
swap_array = np.zeros((pairs, 2), dtype=np.int64) 
 
 
for k in range(0, pairs): 
    pair = swap_pairs[k].split(',') 
    a = pair[0] 
    b = pair[1].split("\\") 
    b = b[0] 
 
    swap_array[k][0] = int(a)-1 
    swap_array[k][1] = int(b)-1 
 
ln = 0 
 
com_lines = [] 
atoms = 0 
 
 
with open(comfile, "r") as f: 
    for line in f: 
        com_lines.append(line) 
        ln += 1 
        items = line.split() 
        if len(items) > 2: 
            if not isnum(items[0]) and ( isnum(items[1]) and 
isnum(items[2]) and isnum(items[3])): 
                if atoms == 0: 
                    start_line = ln - 1 
                else: 
                    end_line = ln - 1 
                atoms += 1 
 
swap_array = swap_array + start_line 
 
line_order = np.zeros((ln), dtype=np.int64) 
 
for i in range(0, ln): 
    line_order[i] = i 
 
for p in range(pairs): 
    line_order[swap_array[p][0]] = swap_array[p][1] 
    line_order[swap_array[p][1]] = swap_array[p][0] 
 
outfile = "swapped_" + comfile 
 
with open(outfile, "w") as f: 
    for i in range(0, ln): 






Stage d, DFT single point energy calculations. 
In order to obtain a more accurate description of conformer energies, additional single 
point calculations were performed using the BS1 optimised geometries. The effect of a larger 
basis set on conformer energy was evaluated by performing single point calculations using 
B3LYP-D2 functional and 6-311G (d,p) basis set (BS2) in gas phase. Solvation effects were 
also evaluated by performing single point calculations using B3LYP-D2 with the Integral 
Equation Formalism Polarizable Continuum Model (IEF-PCM) continuum dielectric solvation 
model using toluene as solvent ( = 2.3741).   
Stage e and f, Calculation of NMR properties (, J and interproton NOE-distances) 
The magnetic shielding tensor and total nuclear spin-spin coupling constants of low 
energy conformers with a combined population of greater than 90%, based on their free 
energies (see below), were computed with GIAO (gauge-independent atomic orbitals) with 
mPW1PW91 functional using the 6-311G (d, p) basis set173 with toluene as solvent (IEF-PCM). 
In order to maximise the accuracy of scalar coupling constant prediction, in particular for 1H-
13C couplings, the Gaussian keyword “mixed” was used to incorporate more explicit mixing of 
core orbitals as described by Bally T. and Rablen P160. Interproton distances were extracted 
from the BS1 optimised geometries for all conformers (100% population) to obtain the 
Boltzmann averaged 1H-1H distances. Cartesian coordinates for all conformers subjected to 
NMR calculations can be found at the CD attached to this thesis 
Calculation of estimated Gibbs free energies (∆𝑮𝒆𝒔𝒕
𝐁𝐒𝟐,𝐭𝐨𝐥𝐮𝐞𝐧𝐞
) and Boltzmann population 
The nature of the stationary point and the Gibbs free energy of each conformer were 
calculated using a lower basis set (BS1) and the effect of a higher basis set (BS2) and solvation 
(toluene) on energies were incorporated by single point calculations. Gibbs free energies (in kJ 
mol−1) of each conformer (𝐺𝑒𝑠𝑡
BS2,toluene













) Equation 6.10 
where 𝐺𝑖
BS1,gas
 is the Gibbs free energy of conformer i with basis set 1 in gas phase, 𝐸𝑖
BS1,gas
 
is the potential energy of conformer i with basis set 1 in gas phase, 𝐸𝑖
BS2,gas
 is single point 
energy of conformer i with basis set 2 in gas phase, 𝐸𝑖
BS1,toluene
 is the single point energy of 




the assumption that the change in basis set and solvation has minimal impact on the change in 




,  Equation 6.10). 
The estimated Gibbs free energies (𝐺BS2,toluene) of each conformer were then used in 


















 is the estimated Gibbs free energy (relative to the global minimum, in kJ 
mol−1) of conformer i, R is the Boltzmann constant (8.314 × 10−3 kJ mol−1), T is temperature 
of the system (298K) and g is the degeneracy of conformer i. g equals to 2 for all C2 symmetric 
compounds (4.9, 4.10 and 4.5) and equals to 1 for all meso compounds (4.11, 4.12 and 4.13). 
χ2 Analysis 
Table 6.75: A summary of estimated standard deviations for comparison between computed and 
experimental chemical shifts, scalar coupling constants and 1H-1H distances 
NMR properties Typical standard deviations 
H 0.15 ppm77,79 
C 1.5 ppm79 
nJHX (X=H or C) 1 Hz 44 
rnoe 3.5%54 
 





4.9 7 8 5 6 
4.11 9 10 7 22 
4.10 9 10 7 21 
4.12 - - - 19 
4.5 11 12 9 28 
4.13 - - - 12 
m 1 
 
Calculation of Boltzmann averaged 1H-1H effective distances 
Boltzmann averaged distances from one proton (HA) to another proton (HB) were 




𝑟𝑒𝑓𝑓(𝐻𝐴−𝐻𝐵,𝑐𝑎𝑙𝑐) = (∑ ((𝑟𝐻𝐴,𝑖−𝐻𝐵,𝑖)
−6 +  (𝑟𝐻𝐴,𝑖−𝐻𝐵′,𝑖)
−6 + (𝑟𝐻𝐴′,𝑖−𝐻𝐵,𝑖)





6 Equation 6.12 
where 𝑟𝐻𝐴,𝑖−𝐻𝐵,𝑖, 𝑟𝐻𝐴,𝑖−𝐻𝐵′,𝑖, 𝑟𝐻𝐴′,𝑖−𝐻𝐵,𝑖 and 𝑟𝐻𝐴′,𝑖−𝐻𝐵′,𝑖 are the computed 
1H-1H distances (in Å) 
of equivalent pairs of protons in conformer i, and 𝑝𝑖 is the Boltzmann population of conformer 
i.  
To Boltzmann average the effective distances from a single proton (HA) to a methyl 
group (HC, CH3), the following equation is used:  






−6 +  (𝑟𝐻𝐴,𝑖−𝐻𝐶3′,𝑖)
−6 + (𝑟𝐻𝐴′,𝑖−𝐻𝐶1,𝑖)
−6 +  (𝑟𝐻𝐴′,𝑖−𝐻𝐶2,𝑖)
−6 +  (𝑟𝐻𝐴′,𝑖−𝐻𝐶3,𝑖)
−6 +
 (𝑟𝐻𝐴′,𝑖−𝐻𝐶1−𝑒𝑞,𝑖)
−6 +  (𝑟𝐻𝐴′,𝑖−𝐻𝐶2′,𝑖)
−6 +  (𝑟𝐻𝐴′,𝑖−𝐻𝐶3′,𝑖)
−6 ) × 𝑝𝑖)
−
1
6 Equation 6.13 
 
where 𝑟𝐻𝐴,𝑖−𝐻𝐶1,𝑖  is the computed 
1H-1H distances from proton H to one of the equivalent 
protons of the methyl group, 𝑟𝐻𝐴,𝑖−𝐻𝐶2,𝑖 and 𝑟𝐻𝐴,𝑖−𝐻𝐶3,𝑖is the computed 
1H-1H distances from 
proton H the other two of the equivalent protons of the methyl group. The dash (eg. HA’) 
represents the corresponding chemically equivalent protons of either the single proton, or the 
equivalent protons of the methyl group.  
To Boltzmann average the effective distances from one methyl group (HC, CH3) to 
another methyl group (HD, CH3), the following equation is used: 
𝑟𝑒𝑓𝑓(𝐻𝐵−𝐻𝑐,𝑐𝑎𝑙𝑐) = (∑ ((𝑟𝐻𝐶1,𝑖−𝐻𝐷1,𝑖)
−6 + (𝑟𝐻𝐶1,𝑖−𝐻𝐷2,𝑖)








−6 +  (𝑟𝐻𝐶3,𝑖−𝐻𝐷3,𝑖)










−6 +  (𝑟𝐻𝐶3,𝑖−𝐻𝐷3′,𝑖)














−6 +  (𝑟𝐻𝐶1′,𝑖−𝐻𝐷3′,𝑖)











−6  ) × 𝑝𝑖)
−
1
6 Equation 6.14 
where HC1, HC2 and HC3 represent the three equivalent protons of one methyl group, and 
HD1, HD2 and HD3 represent the three equivalent protons of the other methyl group. The dash 





Calculated data for 4.9-4.13. 
 
Table 6.77: Calculated energies (in kJ mol−1) and DFT calculated population for all conformers of 4.9.  





4.9-1 0.00 0.94 5.04 0.82 0.35 4.33 5.49% 
4.9-2 1.51 0.00 0.00 0.00 0.00 0.00 31.53% 
4.9-3 5.85 4.90 3.55 5.57 4.79 4.12 5.98% 
4.9-4 8.22 5.92 7.51 5.81 5.72 7.21 1.72% 
4.9-5 10.88 12.31 14.54 12.29 11.78 13.99 0.11% 
4.9-6 10.90 6.85 10.96 6.59 6.55 10.41 0.47% 
4.9-7 11.86 8.49 7.58 9.10 8.32 8.03 1.23% 
4.9-8 12.64 7.87 11.46 8.16 7.56 11.44 0.31% 
4.9-9 13.27 10.90 15.02 10.72 10.06 14.01 0.11% 
4.9-10 13.50 8.49 7.58 9.10 8.32 8.03 1.23% 
4.9-11 14.19 10.12 10.62 10.45 9.96 10.78 0.41% 
4.9-12 14.26 12.92 13.87 13.65 12.30 13.98 0.11% 
4.9-13 14.71 10.76 14.61 10.72 10.54 14.34 0.10% 
4.9-14 14.84 12.76 11.71 13.25 12.35 11.79 0.27% 
4.9-15 15.27 7.44 14.66 7.47 7.30 14.56 0.09% 
4.9-16 16.56 16.35 18.12 16.86 15.72 17.99 0.02% 
4.9-17 16.63 14.93 18.09 15.30 14.70 18.22 0.02% 
4.9-18 17.34 13.97 13.87 14.25 13.76 13.94 0.11% 
4.9-19 17.43 17.76 21.97 17.73 17.10 21.29 0.01% 
4.9-20 18.35 12.92 13.87 13.65 12.30 13.98 0.11% 




4.9-22 18.91 21.78 22.87 22.52 20.73 22.56 0.00% 
4.9-23 19.75 14.26 16.15 14.35 14.17 16.15 0.05% 
4.9-24 19.94 17.37 21.20 17.65 17.06 21.18 0.01% 
4.9-25 20.32 19.78 22.17 20.33 19.14 22.07 0.00% 
4.9-26 20.35 16.04 16.31 16.62 15.64 16.49 0.04% 
4.9-27 20.37 15.15 14.49 15.71 15.00 14.90 0.08% 
4.9-28 20.48 25.08 28.57 25.04 24.04 27.48 0.00% 








Table 6.78: Calculated energies (in kJ mol−1), DFT calculated population and conformer population after NOE-refinement for all conformers of 4.11. 












4.11-1 0.00 0.00 0.00 0.00 0.00 0.00 31.47% Cluster 1 22.31% 
4.11-2 0.01 0.00 0.00 0.00 0.00 0.00 31.47% Cluster 1 22.31% 
4.11-3 7.11 5.86 8.74 5.91 5.79 8.73 0.93% Cluster 2 0.14% 
4.11-4 7.14 5.86 8.74 5.91 5.79 8.73 0.93% Cluster 2 0.14% 
4.11-5 10.00 12.84 17.20 12.93 12.35 16.79 0.04% Cluster 12 0.03% 
4.11-6 10.01 12.84 17.20 12.93 12.35 16.79 0.04% Cluster 12 0.03% 
4.11-7 11.25 6.74 5.58 6.64 7.02 5.76 3.08% Cluster 3 1.22% 
4.11-8 11.26 6.74 5.58 6.64 7.02 5.76 3.08% Cluster 3 1.22% 
4.11-9 12.02 10.22 3.40 10.32 10.12 3.38 8.03% Cluster 2 1.20% 
4.11-10 12.03 10.22 3.39 10.32 10.12 3.37 8.06% Cluster 2 1.20% 
4.11-11 12.81 10.33 10.22 10.48 10.13 10.17 0.52% Cluster 8 0.49% 
4.11-12 12.82 10.33 10.22 10.48 10.13 10.17 0.52% Cluster 8 0.49% 
4.11-13 13.21 10.33 10.68 10.33 10.12 10.48 0.46% Cluster 9 0.34% 
4.11-14 13.21 10.33 10.68 10.33 10.12 10.48 0.46% Cluster 9 0.34% 
4.11-15 13.53 8.19 6.93 8.53 8.57 7.65 1.43% Cluster 4 12.43% 
4.11-16 13.54 8.19 6.93 8.53 8.57 7.65 1.43% Cluster 4 12.43% 




4.11-18 13.67 11.75 8.47 12.47 11.56 8.99 0.83% Cluster 7 9.25% 
4.11-19 13.83 12.63 13.21 12.96 12.16 13.07 0.16% Cluster 15 0.31% 
4.11-20 13.83 12.63 13.21 12.96 12.16 13.07 0.16% Cluster 15 0.31% 
4.11-21 14.02 13.94 14.24 14.21 13.44 14.01 0.11% Cluster 12 0.09% 
4.11-22 14.02 13.94 14.24 14.21 13.44 14.01 0.11% Cluster 12 0.09% 
4.11-23 14.03 13.94 14.24 14.21 13.44 14.01 0.11% Cluster 12 0.09% 
4.11-24 15.83 15.18 11.95 15.95 14.72 12.26 0.22% Cluster 11 0.23% 
4.11-25 15.84 15.18 11.95 15.95 14.72 12.26 0.22% Cluster 11 0.23% 
4.11-26 16.10 6.90 7.81 7.14 7.55 8.69 0.94% Cluster 6 0.57% 
4.11-27 16.11 6.90 7.81 7.14 7.55 8.69 0.94% Cluster 6 0.57% 
4.11-28 16.31 14.05 15.71 14.14 13.84 15.58 0.06% Cluster 17 0.05% 
4.11-29 16.32 14.05 15.71 14.14 13.84 15.58 0.06% Cluster 17 0.05% 
4.11-30 16.55 10.98 7.38 11.94 11.29 8.66 0.95% Cluster 5 0.74% 
4.11-31 16.56 10.98 7.38 11.94 11.29 8.66 0.95% Cluster 5 0.74% 
4.11-32 16.65 14.76 12.94 15.39 15.12 13.93 0.11% Cluster 14 0.14% 
4.11-33 16.66 14.76 12.94 15.39 15.12 13.93 0.11% Cluster 14 0.14% 
4.11-34 16.78 13.99 12.74 15.00 14.13 13.89 0.12% Cluster 13 0.10% 
4.11-35 16.79 13.99 12.74 15.00 14.13 13.89 0.12% Cluster 13 0.10% 
4.11-36 17.92 11.92 11.13 11.78 12.17 11.25 0.33% Cluster 10 0.20% 
4.11-37 17.93 11.92 11.13 11.78 12.17 11.25 0.33% Cluster 10 0.20% 
4.11-38 18.85 19.80 21.15 20.98 19.54 22.07 0.00% Cluster 20 0.00% 
4.11-39 18.85 19.80 21.15 20.98 19.54 22.07 0.00% Cluster 20 0.00% 
4.11-40 18.89 19.70 22.38 20.03 19.04 22.05 0.00% Cluster 21 0.00% 
4.11-41 18.89 19.70 22.38 20.03 19.04 22.05 0.00% Cluster 21 0.00% 
4.11-42 19.61 15.81 17.62 15.79 15.53 17.34 0.03% Cluster 19 0.03% 
4.11-43 19.61 15.81 17.62 15.79 15.53 17.34 0.03% Cluster 19 0.03% 
4.11-44 20.47 13.46 14.53 13.94 13.66 15.21 0.07% Cluster 16 0.06% 
4.11-45 20.48 13.46 14.53 13.94 13.66 15.21 0.07% Cluster 16 0.06% 
4.11-46 20.60 16.33 16.87 17.03 16.01 17.25 0.03% Cluster 18 0.03% 
4.11-47 20.60 16.33 16.87 17.03 16.01 17.25 0.03% Cluster 18 0.03% 













Conformer Σ(ΔΔG)2 =225 Σ(ΔΔG)2 =625   
4.11-1 11.57% 9.06% 4.11-27 0.63% 0.55%   
4.11-2 11.57% 9.06% 4.11-28 0.05% 0.04%   
4.11-3 0.09% 0.05% 4.11-29 0.05% 0.04%   
4.11-4 0.09% 0.05% 4.11-30 0.47% 0.92%   
4.11-5 0.02% 0.01% 4.11-31 0.47% 0.92%   
4.11-6 0.02% 0.01% 4.11-32 0.19% 14.40%   
4.11-7 1.32% 1.06% 4.11-33 0.19% 14.40%   
4.11-8 1.32% 1.06% 4.11-34 0.08% 0.07%   
4.11-9 0.76% 0.42% 4.11-35 0.08% 0.07%   
4.11-10 0.77% 0.42% 4.11-36 0.17% 0.10%   
4.11-11 0.27% 0.26% 4.11-37 0.17% 0.10%   
4.11-12 0.27% 0.26% 4.11-38 0.00% 0.00%   
4.11-13 0.23% 0.11% 4.11-39 0.00% 0.00%   
4.11-14 0.23% 0.11% 4.11-40 0.00% 0.00%   
4.11-15 19.63% 7.38% 4.11-41 0.00% 0.00%   
4.11-16 19.63% 7.38% 4.11-42 0.02% 0.02%   
4.11-17 3.67% 5.35% 4.11-43 0.02% 0.02%   
4.11-18 3.67% 5.35% 4.11-44 0.06% 0.04%   
4.11-19 10.47% 9.99% 4.11-45 0.06% 0.04%   
4.11-20 10.47% 9.99% 4.11-46 0.03% 0.02%   
4.11-21 0.06% 0.04% 4.11-47 0.03% 0.02%   
4.11-22 0.06% 0.04%      
4.11-23 0.06% 0.04%      
4.11-24 0.16% 0.09%      
4.11-25 0.16% 0.09%      





Table 6.79: Calculated energies (in kJ mol−1) and DFT calculated population for all conformers of 4.10. 





4.10-1 0.00 2.10 5.63 2.10 1.49 5.02 4.13% 
4.10-2 1.07 0.00 0.00 0.00 0.00 0.00 31.41% 
4.10-3 8.24 5.38 8.49 5.40 5.32 8.43 1.04% 
4.10-4 8.38 6.48 3.76 7.68 6.34 4.83 4.46% 
4.10-5 10.54 6.55 11.99 6.42 6.30 11.62 0.29% 
4.10-6 11.17 12.56 14.56 12.66 12.06 14.16 0.10% 
4.10-7 12.36 10.89 13.26 10.84 10.12 12.44 0.21% 
4.10-8 12.42 9.91 16.62 9.72 9.10 15.60 0.06% 
4.10-9 12.51 10.06 9.69 10.21 9.88 9.67 0.63% 
4.10-10 13.60 9.01 10.44 9.39 8.78 10.60 0.43% 
4.10-11 13.72 10.50 8.72 10.63 10.31 8.66 0.95% 
4.10-12 14.07 7.88 7.88 8.65 7.96 8.73 0.92% 
4.10-13 14.38 10.67 7.67 11.68 10.43 8.44 1.04% 
4.10-14 14.42 10.67 7.67 11.68 10.43 8.45 1.04% 
4.10-15 14.59 12.26 13.67 12.53 11.81 13.49 0.14% 
4.10-16 14.60 13.87 13.04 14.20 13.39 12.88 0.17% 
4.10-17 15.37 13.68 20.08 14.05 13.54 20.32 0.01% 
4.10-18 15.98 11.67 11.52 11.69 11.59 11.46 0.31% 
4.10-19 16.06 10.91 7.40 11.32 10.71 7.61 1.45% 
4.10-20 16.19 8.79 11.95 8.92 8.72 12.02 0.25% 
4.10-21 16.75 13.81 11.72 14.92 13.41 12.43 0.21% 




4.10-23 17.22 14.44 13.30 14.48 14.24 13.13 0.16% 
4.10-24 18.48 16.10 18.68 16.95 15.47 18.91 0.02% 
4.10-25 18.77 14.98 13.75 15.10 14.78 13.66 0.13% 
4.10-26 18.96 18.58 13.75 18.63 18.04 13.26 0.15% 
4.10-27 19.55 22.01 23.57 22.60 21.02 23.16 0.00% 
4.10-28 19.84 19.79 21.31 20.06 19.18 20.96 0.01% 
4.10-29 20.01 15.55 17.22 15.69 15.27 17.07 0.03% 
4.10-30 20.18 11.80 16.35 12.46 11.48 16.68 0.04% 







Table 6.80: Calculated energies (in kJ mol−1), DFT calculated population and conformer population after NOE-refinement for all conformers of 4.12. 










4.12-1 0.00 0.00 0.00 0.00 0.00 0.00 20.63% Cluster 1 16.82% 
4.12-2 0.03 0.00 0.00 0.00 0.00 0.00 20.63% Cluster 1 16.82% 
4.12-3 7.82 6.12 6.71 6.08 6.05 6.60 1.44% Cluster 8 1.35% 
4.12-4 7.82 6.12 6.71 6.08 6.05 6.60 1.44% Cluster 8 1.35% 
4.12-5 9.18 7.29 3.42 8.34 7.13 4.32 3.61% Cluster 1 2.94% 
4.12-6 9.21 7.29 3.42 8.34 7.13 4.32 3.61% Cluster 1 2.94% 
4.12-7 10.02 7.67 7.02 7.58 7.52 6.78 1.34% Cluster 8 1.25% 
4.12-8 10.03 7.67 7.02 7.58 7.52 6.78 1.34% Cluster 8 1.25% 
4.12-9 10.74 5.32 3.68 5.17 5.67 3.87 4.32% Cluster 3 0.69% 
4.12-10 10.75 5.32 3.68 5.17 5.67 3.87 4.32% Cluster 3 0.69% 
4.12-11 10.75 13.39 16.07 13.44 12.83 15.57 0.04% Cluster 23 0.02% 
4.12-12 10.76 13.39 16.07 13.44 12.83 15.57 0.04% Cluster 23 0.02% 
4.12-13 11.74 9.09 8.56 9.22 8.88 8.48 0.67% Cluster 12 0.33% 
4.12-14 11.77 9.09 8.56 9.22 8.88 8.48 0.67% Cluster 12 0.33% 
4.12-15 12.15 8.92 6.65 8.72 8.69 6.22 1.67% Cluster 7 0.24% 
4.12-16 12.15 8.92 6.65 8.72 8.69 6.22 1.67% Cluster 7 0.24% 
4.12-17 12.20 4.13 4.83 4.04 5.03 5.65 2.11% Cluster 5 12.33% 
4.12-18 12.22 4.13 4.83 4.04 5.03 5.65 2.11% Cluster 5 12.33% 
4.12-19 12.32 11.64 13.21 11.74 11.16 12.81 0.12% Cluster 23 0.07% 




4.12-21 12.46 9.15 9.20 9.14 9.01 9.05 0.53% Cluster 15 0.29% 
4.12-22 12.46 9.15 9.20 9.14 9.01 9.05 0.53% Cluster 15 0.29% 
4.12-23 13.12 10.84 10.17 10.41 10.55 9.45 0.45% Cluster 17 0.17% 
4.12-24 13.12 10.84 10.17 10.41 10.55 9.45 0.45% Cluster 17 0.17% 
4.12-25 13.36 10.33 14.82 10.27 9.89 14.31 0.06% Cluster 28 0.03% 
4.12-26 13.36 10.33 14.81 10.27 9.89 14.30 0.06% Cluster 28 0.03% 
4.12-27 13.58 8.72 9.02 8.80 8.24 8.63 0.63% Cluster 14 0.13% 
4.12-28 13.60 8.72 9.02 8.80 8.24 8.64 0.63% Cluster 14 0.13% 
4.12-29 13.67 11.51 13.40 11.74 11.01 13.12 0.10% Cluster 24 0.05% 
4.12-30 13.69 11.51 13.40 11.74 11.01 13.12 0.10% Cluster 24 0.05% 
4.12-31 13.83 4.18 8.09 4.24 4.14 8.11 0.78% Cluster 10 0.18% 
4.12-32 13.83 4.18 8.09 4.24 4.14 8.11 0.78% Cluster 10 0.18% 
4.12-33 13.96 7.54 6.26 8.00 7.87 7.04 1.20% Cluster 6 0.57% 
4.12-34 13.97 7.54 6.26 8.00 7.87 7.04 1.20% Cluster 6 0.57% 
4.12-35 14.50 3.57 10.92 3.85 3.07 10.70 0.27% Cluster 18 0.09% 
4.12-36 14.50 3.57 10.92 3.85 3.07 10.70 0.27% Cluster 18 0.09% 
4.12-37 14.64 6.19 3.07 6.93 6.84 4.45 3.42% Cluster 2 1.50% 
4.12-38 14.66 6.19 3.07 6.93 6.84 4.45 3.42% Cluster 2 1.50% 
4.12-39 14.80 10.23 7.95 10.02 10.00 7.51 1.00% Cluster 9 0.22% 
4.12-40 14.82 10.23 7.95 10.02 10.00 7.51 1.00% Cluster 9 0.22% 
4.12-41 15.21 3.57 10.92 3.85 3.07 10.70 0.27% Cluster 18 0.09% 
4.12-42 15.21 3.57 10.92 3.85 3.07 10.70 0.27% Cluster 18 0.09% 
4.12-43 15.28 10.87 10.76 11.74 10.66 11.42 0.20% Cluster 8 0.19% 
4.12-44 15.29 10.87 10.76 11.74 10.66 11.42 0.20% Cluster 8 0.19% 
4.12-45 15.45 12.41 13.11 12.80 12.82 13.92 0.07% Cluster 22 0.04% 
4.12-46 15.45 12.41 13.11 12.80 12.82 13.92 0.07% Cluster 22 0.04% 
4.12-47 15.48 3.57 10.92 3.85 3.07 10.70 0.27% Cluster 18 0.09% 
4.12-48 15.50 12.83 15.79 12.85 12.64 15.61 0.04% Cluster 30 0.02% 
4.12-49 15.50 3.57 10.92 3.85 3.07 10.70 0.27% Cluster 18 0.09% 
4.12-50 15.51 12.83 15.79 12.85 12.64 15.61 0.04% Cluster 30 0.02% 




4.12-52 16.05 9.81 4.70 10.21 10.14 5.43 2.30% Cluster 4 8.20% 
4.12-53 16.20 11.60 13.89 11.97 11.55 14.22 0.07% Cluster 25 0.03% 
4.12-54 16.21 11.60 13.89 11.97 11.55 14.22 0.07% Cluster 25 0.03% 
4.12-55 16.41 6.89 8.83 7.02 7.41 9.48 0.45% Cluster 13 0.12% 
4.12-56 16.42 6.89 8.83 7.02 7.41 9.48 0.45% Cluster 13 0.12% 
4.12-57 16.72 13.99 9.99 14.41 14.07 10.50 0.30% Cluster 16 0.12% 
4.12-58 16.73 13.99 9.99 14.41 14.07 10.50 0.30% Cluster 16 0.12% 
4.12-59 17.45 18.74 17.57 18.84 17.97 16.89 0.02% Cluster 36 0.01% 
4.12-60 17.47 18.74 17.57 18.84 17.97 16.89 0.02% Cluster 36 0.01% 
4.12-61 17.70 14.62 12.82 15.57 14.10 13.24 0.10% Cluster 21 0.06% 
4.12-62 17.72 14.62 12.82 15.57 14.10 13.24 0.10% Cluster 21 0.06% 
4.12-63 18.07 12.64 11.95 13.84 12.62 13.13 0.10% Cluster 16 0.04% 
4.12-64 18.08 12.64 11.95 13.84 12.62 13.13 0.10% Cluster 16 0.04% 
4.12-65 18.17 18.80 21.72 19.06 18.16 21.34 0.00% Cluster 39 0.00% 
4.12-66 18.17 18.80 21.72 19.06 18.16 21.34 0.00% Cluster 39 0.00% 
4.12-67 18.37 14.17 13.91 13.95 13.87 13.39 0.09% Cluster 26 0.04% 
4.12-68 18.37 14.17 13.91 13.95 13.87 13.39 0.09% Cluster 26 0.04% 
4.12-69 18.50 11.23 12.04 11.10 11.52 12.21 0.15% Cluster 19 0.06% 
4.12-70 18.51 11.23 12.04 11.10 11.52 12.21 0.15% Cluster 19 0.06% 
4.12-71 18.58 12.35 15.34 12.20 12.20 15.04 0.05% Cluster 29 0.02% 
4.12-72 18.59 12.35 15.34 12.20 12.20 15.04 0.05% Cluster 29 0.02% 
4.12-73 18.72 12.64 11.95 13.84 12.62 13.13 0.10% Cluster 16 0.04% 
4.12-74 18.76 11.63 14.49 12.06 11.61 14.90 0.05% Cluster 27 0.02% 
4.12-75 18.77 11.63 14.49 12.06 11.61 14.90 0.05% Cluster 27 0.02% 
4.12-76 18.85 15.77 16.83 15.34 15.44 16.06 0.03% Cluster 34 0.01% 
4.12-77 18.87 15.77 16.83 15.34 15.44 16.06 0.03% Cluster 34 0.01% 
4.12-78 19.17 20.15 19.45 20.74 19.77 19.66 0.01% Cluster 31 0.00% 
4.12-79 19.17 20.15 19.45 20.74 19.77 19.66 0.01% Cluster 31 0.00% 
4.12-80 19.19 10.06 8.49 11.25 10.59 10.22 0.33% Cluster 4 1.19% 
4.12-81 19.20 10.06 8.49 11.25 10.59 10.22 0.33% Cluster 4 1.19% 




4.12-83 19.92 14.94 16.47 14.89 14.68 16.17 0.03% Cluster 33 0.01% 
4.12-84 20.05 9.58 12.12 10.18 9.78 12.92 0.11% Cluster 20 0.05% 
4.12-85 20.06 9.58 12.12 10.18 9.78 12.92 0.11% Cluster 20 0.05% 
4.12-86 20.15 5.02 8.48 5.46 5.86 9.75 0.40% Cluster 11 0.24% 
4.12-87 20.16 5.02 8.48 5.46 5.86 9.75 0.40% Cluster 11 0.24% 
4.12-88 20.18 16.26 21.10 16.29 15.63 20.50 0.01% Cluster 38 0.00% 
4.12-89 20.19 16.26 21.10 16.29 15.63 20.50 0.01% Cluster 38 0.00% 
4.12-90 20.40 14.54 20.73 14.24 14.04 19.93 0.01% Cluster 37 0.00% 
4.12-91 20.41 14.54 20.73 14.24 14.04 19.93 0.01% Cluster 37 0.00% 
4.12-92 20.74 16.05 17.46 16.17 15.82 17.34 0.02% Cluster 35 0.01% 
4.12-93 20.77 16.05 17.46 16.17 15.82 17.34 0.02% Cluster 35 0.01% 
4.12-94 20.82 16.30 16.37 16.42 15.97 16.16 0.03% Cluster 32 0.01% 
4.12-95 20.83 16.30 16.37 16.42 15.97 16.16 0.03% Cluster 32 0.01% 
4.12-96 20.91 20.19 15.97 21.59 19.83 17.01 0.02% Cluster 31 0.01% 







Table 6.81: Calculated energies (in kJ mol−1) and DFT calculated population (BS1: B3LYP-D2 6-311G (d), BS2: B3LYP-D2 6-311G (d,p)) for all conformers 
of 4.5. 





4.5-1 0.00 3.02 4.33 3.00 2.38 3.67 6.73% 
4.5-2 1.03 0.00 0.00 0.00 0.00 0.00 29.62% 
4.5-3 8.76 8.05 7.45 8.05 7.91 7.32 1.54% 
4.5-4 10.08 6.14 4.34 7.59 5.96 5.62 3.06% 
4.5-5 10.84 7.58 12.38 7.51 7.31 12.03 0.23% 
4.5-6 10.89 8.05 7.45 8.05 7.91 7.32 0.00% 
4.5-7 11.02 9.37 11.32 10.33 8.54 11.46 0.29% 
4.5-8 11.04 9.03 13.92 8.89 8.20 12.94 0.16% 
4.5-9 11.73 13.55 14.22 13.64 13.05 13.81 0.11% 
4.5-10 12.73 11.70 12.82 11.71 10.88 12.00 0.23% 
4.5-11 12.86 9.50 9.32 9.64 9.31 9.28 0.70% 
4.5-12 12.88 9.40 8.88 9.26 9.22 8.54 0.94% 
4.5-13 13.26 12.10 11.61 12.26 11.65 11.32 0.31% 
4.5-14 13.97 8.93 9.19 9.14 8.51 8.98 0.79% 
4.5-15 14.25 7.88 8.74 8.21 7.45 8.63 0.91% 
4.5-16 14.41 9.97 13.64 10.43 9.76 13.89 0.11% 
4.5-17 14.56 7.38 9.96 8.19 7.50 10.90 0.36% 
4.5-18 14.57 9.42 8.32 9.70 9.19 8.36 1.01% 
4.5-19 14.68 11.47 12.90 11.78 11.02 12.77 0.17% 
4.5-20 15.09 13.96 18.48 14.34 13.80 18.70 0.02% 




4.5-22 15.47 8.30 10.98 9.38 7.93 11.69 0.26% 
4.5-23 15.57 9.63 11.36 10.25 9.20 11.56 0.28% 
4.5-24 15.62 8.30 10.98 9.38 7.93 11.69 0.00% 
4.5-25 15.99 9.05 15.31 9.26 9.00 15.48 0.06% 
4.5-26 16.09 10.00 7.38 11.23 9.82 8.43 0.98% 
4.5-27 16.57 13.41 13.21 13.46 13.27 13.11 0.15% 
4.5-28 16.71 12.53 13.21 12.60 12.42 13.16 0.15% 
4.5-29 17.64 19.74 24.32 20.19 18.76 23.80 0.00% 
4.5-30 18.02 13.50 14.27 13.48 13.31 14.05 0.10% 
4.5-31 18.19 13.50 14.26 13.48 13.31 14.05 0.10% 
4.5-32 18.62 13.41 13.50 14.77 12.96 14.40 0.09% 
4.5-33 19.01 14.36 14.78 14.25 14.08 14.40 0.09% 
4.5-34 19.24 15.94 21.22 15.88 14.99 20.21 0.01% 
4.5-35 19.28 19.07 20.93 19.36 18.49 20.63 0.01% 
4.5-36 19.62 19.56 22.09 19.71 18.99 21.66 0.00% 
4.5-37 19.66 14.61 16.64 15.66 14.00 17.09 0.03% 
4.5-38 20.06 10.82 14.53 11.55 10.44 14.87 0.07% 
4.5-39 20.24 15.23 16.80 15.36 15.01 16.70 0.03% 
4.5-40 20.33 14.13 17.05 14.21 13.63 16.64 0.04% 
4.5-41 20.42 17.49 21.05 17.66 16.97 20.70 0.01% 
4.5-42 20.56 16.34 18.24 16.44 15.91 17.91 0.02% 
4.5-43 20.69 11.45 13.75 12.65 11.36 14.85 0.07% 
4.5-44 20.86 11.45 13.75 12.65 11.36 14.85 0.07% 






Table 6.82: Calculated energies (in kJ mol−1) and DFT calculated energies and population for all conformers of 4.5. 
Functional mPW1PW91 B3LYP 
Basis set 6-31G (d) 6-311G (d) 6-311G (d,p) 6-311+G (d,p) 6-311G (d) 6-311G (d) 
toluene 
Conformer DG Population DG Population DG Population DG Population DG Population DG Pop. 
4.5-1 8.65 0.71% 6.41 1.77% 7.92 0.91% 6.95 1.33% 8.91 0.71% 9.70 0.68% 
4.5-2 0.82 16.74% 0.00 23.54% 0.00 22.38% 0.00 22.10% 0.00 25.83% 0.00 34.00% 
4.5-3 7.15 1.30% 7.72 1.04% 7.91 0.92% 8.26 0.79% 6.87 1.61% 8.57 1.07% 
4.5-4 0.00 23.30% 1.70 11.85% 1.32 13.14% 1.09 14.22% 3.37 6.61% 3.95 6.90% 
4.5-5 11.04 0.27% 19.96 0.01% 11.59 0.21% 11.33 0.23% 13.36 0.12% 14.84 0.08% 
4.5-6 7.15a - 7.04 1.37% 8.10 0.85% 8.32 0.77% 6.87a - 8.57 0.00% 
4.5-7 10.01 0.41% 9.85 0.44% 9.55 0.47% 8.96 0.59% 10.40 0.39% 11.38 0.34% 
4.5-8 14.74 0.06% 13.61 0.10% 14.72 0.06% 14.45 0.06% 13.36 0.12% 13.11 0.17% 
4.5-9 15.16 0.05% 14.35 0.07% 13.75 0.09% 13.61 0.09% 14.51 0.07% 14.20 0.11% 
4.5-10 17.30 0.02% 15.46 0.05% 16.30 0.03% 15.54 0.04% 15.23 0.06% 14.95 0.08% 
4.5-11 6.19 1.91% 5.70 2.35% 5.47 2.46% 5.47 2.43% 8.32 0.90% 8.39 1.15% 
4.5-12 6.37 1.78% 5.15 2.95% 4.15 4.18% 4.44 3.68% 7.17 1.43% 8.16 1.26% 
4.5-13 11.29 0.24% 10.17 0.39% 10.79 0.29% 10.16 0.37% 2.60 9.02% 10.20 0.55% 
4.5-14 11.96 0.19% 10.16 0.39% 10.92 0.27% 10.48 0.32% 12.16 0.19% 10.20 0.55% 
4.5-15 11.42 0.23% 10.54 0.33% 12.43 0.15% 12.26 0.16% 13.79 0.10% 13.38 0.15% 
4.5-16 13.90 0.08% 11.45 0.23% 13.96 0.08% 13.64 0.09% 13.69 0.10% 14.08 0.12% 
4.5-17 11.95 0.19% 11.53 0.22% 11.80 0.19% 12.11 0.17% 14.74 0.07% 15.64 0.06% 
4.5-18 11.59 0.22% 10.75 0.31% 11.09 0.25% 11.21 0.24% 12.85 0.14% 12.93 0.18% 
4.5-19 15.41 0.05% 14.07 0.08% 14.67 0.06% 14.19 0.07% 14.44 0.08% 14.63 0.09% 




4.5-21 19.77 0.01% 17.30 0.02% 18.24 0.01% 18.11 0.01% 19.48 0.01% 18.75 0.02% 
4.5-22 13.60 0.10% 13.08 0.12% 13.52 0.10% 12.99 0.12% 15.09 0.06% 15.77 0.06% 
4.5-23 13.60a - 13.08a - 13.52a 0.00% 12.99 0.12% 15.09a - 15.77a - 
4.5-24 13.60a - 13.08 0.00% 13.52a - 12.99 0.12% 15.09a - 15.77a - 
4.5-25 21.94 0.00% 21.21 0.00% 21.45 0.00% 21.03 0.00% 21.25 0.00% 23.64 0.00% 
4.5-26 6.86 1.46% 7.04a - 6.46 1.64% 7.32 1.15% 8.21 0.94% 10.19 0.56% 
4.5-27 14.15 0.08% 13.59 0.10% 13.40 0.10% 13.53 0.09% 12.03 0.20% 10.63 0.46% 
4.5-28 19.51 0.01% 12.20 0.17% 9.02 0.59% 19.69 0.01% 14.53 0.07% 15.51 0.06% 
4.5-29 24.68 0.00% 23.17 0.00% 23.75 0.00% 22.80 0.00% 22.30 0.00% 21.88 0.00% 
4.5-30 15.21 0.05% 16.10 0.04% 15.98 0.04% 16.08 0.03% 14.53a - 13.20 0.16% 
4.5-31 15.21a - 16.10a - 15.98a - 16.08a - 14.53a - 13.20 0.16% 
4.5-32 11.65 0.21% 11.05 0.27% 11.69 0.20% 10.94 0.27% 10.18 0.42% 11.02 0.40% 
4.5-33 13.19 0.11% 12.67 0.14% 13.29 0.10% 13.16 0.11% 13.68 0.10% 14.22 0.11% 
4.5-34 22.99 0.00% 23.57 0.00% 23.90 0.00% 23.61 0.00% 25.62 0.00% 24.51 0.00% 
4.5-35 20.39 0.01% 19.89 0.01% 19.98 0.01% 19.52 0.01% 19.18 0.01% 19.17 0.01% 
4.5-36 23.83 0.00% 24.77 0.00% 22.11 0.00% 21.68a - 17.77 0.02% 21.70 0.01% 
4.5-37 20.48 0.01% 20.57 0.01% 21.23 0.00% 20.66 0.01% 21.84 0.00% 21.91 0.00% 
4.5-38 17.92 0.02% 20.05 0.01% 17.59 0.02% 18.11 0.01% 18.29 0.02% 17.39 0.03% 
4.5-39 13.77 0.09% 14.10 0.08% 13.68 0.09% 13.98 0.08% 11.70 0.23% 12.21 0.25% 
4.5-40 21.32 0.00% 20.51 0.01% 20.93 0.00% 20.79 0.01% 22.41 0.00% 23.60 0.00% 
4.5-41 21.09 0.00% 20.36 0.01% 20.18 0.01% 19.86 0.01% 19.50 0.01% 19.27 0.01% 
4.5-42 17.16 0.02% 16.52 0.03% 16.41 0.03% 16.40 0.03% 18.28 0.02% 18.58 0.02% 
4.5-43 14.87 0.06% 14.96 0.06% 14.81 0.06% 14.45 0.06% 12.52 0.16% 14.67 0.09% 
4.5-44 14.87a - 14.97 0.06% 14.81a - 14.45a - 12.53 0.16% 14.67a - 
4.5-45 23.83a - 22.65 0.00% 22.11a - 21.68a - 23.60 0.00% 21.97 0.00% 




(Table 6.82 continued) 
Functional M06-2X B3LYP-D2  
Basis set 6-31G (d) 6-311G (d) 6-31G (d) 6-311G (d)   
Conformer DG Population DG Population DG Population DG Population    . 
4.5-1 8.46 0.97% 7.18 1.57% 5.50 2.19% 4.33 5.06%     
4.5-2 0.00 29.58% 0.00 28.38% 0.00 20.22% 0.00 29.11%     
4.5-3 8.45 0.97% 10.37 0.43% 4.07 3.91% 7.45 1.43%     
4.5-4 3.15 8.30% 2.45 10.56% 2.87 6.33% 4.34 5.04%     
4.5-5 13.22 0.14% 13.16 0.14% 10.60 0.28% 12.38 0.20%     
4.5-6 5.73 2.93% 7.37 1.45% 4.12 3.83% 7.45a -     
4.5-7 13.70 0.12% 13.50 0.12% 11.01 0.24% 11.32 0.30%     
4.5-8 14.00 0.10% 13.58 0.12% 12.58 0.13% 13.92 0.11%     
4.5-9 18.96 0.01% 19.79 0.01% 13.60 0.08% 14.22 0.09%     
4.5-10 16.50 0.04% 18.09 0.02% 14.85 0.05% 12.82 0.16%     
4.5-11 8.93 0.80% 7.97 1.13% 9.39 0.46% 9.32 0.67%     
4.5-12 8.01 1.17% 6.41 2.13% 7.89 0.84% 8.88 0.81%     
4.5-13 13.15 0.15% 13.90 0.10% 11.39 0.20% 11.61 0.27%     
4.5-14 9.68 0.59% 9.58 0.59% 7.70 0.90% 9.19 0.71%     
4.5-15 8.43 0.98% 8.10 1.08% 6.81 1.29% 8.74 0.85%     
4.5-16 16.29 0.04% 17.06 0.03% 12.03 0.16% 13.64 0.12%     
4.5-17 9.99 0.52% 10.87 0.35% 8.14 0.76% 9.96 0.52%     
4.5-18 10.11 0.50% 10.76 0.37% 5.87 1.89% 8.32 1.01%     
4.5-19 11.94 0.24% 13.50 0.12% 12.99 0.11% 12.90 0.16%     




4.5-21 17.62 0.02% 18.27 0.02% 13.90 0.07% 15.44 0.06%     
4.5-22 13.45 0.13% 12.80 0.16% 8.98 0.54% 10.98 0.35%     
4.5-23 13.45a - 12.80a - 10.54 0.29% 11.36 0.30%     
4.5-24 13.45a - 12.80a - 8.98a - 10.98a -     
4.5-25 16.64 0.04% 16.81 0.03% 12.89 0.11% 15.31 0.06%     
4.5-26 8.60 0.92% 9.44 0.63% 4.27 3.61% 7.38 1.48%     
4.5-27 15.40 0.06% 16.10 0.04% 12.22 0.15% 13.21 0.14%     
4.5-28 16.22 0.04% 18.22 0.02% 9.87 0.37% 13.21 0.14%     
4.5-29 25.60 0.00% 25.82 0.00% 24.58 0.00% 24.32 0.00%     
4.5-30 13.90 0.11% 16.79 0.03% 12.27 0.14% 14.27 0.09%     
4.5-31 13.90a - 16.79a - 12.28 0.14% 14.26 0.09%     
4.5-32 12.92 0.16% 13.61 0.12% 12.79 0.12% 13.50 0.13%     
4.5-33 12.48 0.19% 14.52 0.08% 12.75 0.12% 14.78 0.07%     
4.5-34 23.29 0.00% 22.98 0.00% 20.96 0.00% 21.22 0.01%     
4.5-35 22.83 0.00% 22.25 0.00% 21.15 0.00% 20.93 0.01%     
4.5-36 27.10 0.00% 27.88 0.00% 19.79 0.01% 22.09 0.00%     
4.5-37 18.40 0.02% 19.27 0.01% 15.51 0.04% 16.64 0.04%     
4.5-38 19.36 0.01% 20.59 0.01% 12.44 0.13% 14.53 0.08%     
4.5-39 16.19 0.04% 15.54 0.05% 15.83 0.03% 16.80 0.03%     
4.5-40 18.54 0.02% 18.72 0.01% 15.61 0.04% 17.05 0.03%     
4.5-41 21.29 0.01% 22.09 0.00% 19.83 0.01% 21.05 0.01%     
4.5-42 18.84 0.01% 18.78 0.01% 16.94 0.02% 18.24 0.02%     
4.5-43 16.06 0.05% 16.56 0.04% 11.84 0.17% 13.75 0.11%     
4.5-44 16.06a - 16.56a - 11.84a - 13.75 0.11%     






Table 6.83: Calculated energies (in kJ mol−1), DFT calculated population and conformer population after NOE-refinement for all conformers of 4.13. 










4.13-1 0.00 3.65 0.00 3.07 3.34 0.00 11.90% Cluster 1 14.8% 
4.13-2 0.02 3.65 0.00 3.07 3.34 0.00 11.90% Cluster 1 14.8% 
4.13-3 7.54 10.28 6.58 9.66 9.85 6.43 0.89% Cluster 9 0.4% 
4.13-4 7.54 10.28 6.58 9.66 9.85 6.43 0.89% Cluster 9 0.4% 
4.13-5 8.77 1.52 4.19 0.40 1.10 3.54 2.85% Cluster 4 1.4% 
4.13-6 8.77 1.52 4.19 0.40 1.10 3.54 2.84% Cluster 4 1.4% 
4.13-7 9.80 10.84 7.70 10.24 10.33 7.47 0.58% Cluster 11 0.2% 
4.13-8 9.80 10.84 7.70 10.24 10.33 7.47 0.58% Cluster 11 0.2% 
4.13-9 9.84 10.84 7.70 10.24 10.33 7.47 0.58% Cluster 11 0.2% 
4.13-10 10.00 10.84 7.70 10.24 10.33 7.47 0.58% Cluster 11 0.2% 
4.13-11 10.41 17.27 14.94 16.81 16.40 14.50 0.03% Cluster 41 0.0% 
4.13-12 10.43 17.27 14.94 16.81 16.40 14.50 0.03% Cluster 41 0.0% 
4.13-13 10.87 10.44 12.77 9.72 9.93 12.44 0.08% Cluster 28 0.0% 
4.13-14 10.88 10.44 12.77 9.72 9.93 12.44 0.08% Cluster 28 0.0% 
4.13-15 10.92 9.29 4.06 10.04 8.77 5.19 1.46% Cluster 7 24.3% 
4.13-16 10.98 9.05 6.79 8.35 9.08 7.01 0.70% Cluster 10 0.4% 
4.13-17 10.99 9.05 6.79 8.35 9.08 7.01 0.70% Cluster 10 0.4% 
4.13-18 11.01 9.29 4.07 10.04 8.77 5.19 1.46% Cluster 7 24.3% 
4.13-19 11.26 10.48 10.93 9.77 9.99 10.62 0.16% Cluster 23 0.1% 




4.13-21 11.82 9.63 10.91 9.01 8.86 10.41 0.18% Cluster 20 0.1% 
4.13-22 11.82 9.63 10.91 9.01 8.86 10.41 0.18% Cluster 20 0.1% 
4.13-23 12.21 14.71 13.72 14.26 13.90 13.36 0.05% Cluster 33 0.0% 
4.13-24 12.22 14.71 13.72 14.26 13.90 13.36 0.05% Cluster 33 0.0% 
4.13-25 12.27 12.70 13.59 12.24 12.17 13.50 0.05% Cluster 36 0.0% 
4.13-26 12.28 12.70 13.59 12.24 12.17 13.50 0.05% Cluster 36 0.0% 
4.13-27 12.88 12.40 10.58 11.81 11.92 10.41 0.18% Cluster 19 0.1% 
4.13-28 12.89 12.40 10.58 11.81 11.92 10.41 0.18% Cluster 19 0.1% 
4.13-29 13.19 9.70 10.16 9.44 8.87 9.97 0.21% Cluster 18 0.1% 
4.13-30 13.19 9.70 10.16 9.44 8.87 9.97 0.21% Cluster 18 0.1% 
4.13-31 13.30 13.89 12.41 13.80 13.12 12.45 0.08% Cluster 29 0.0% 
4.13-32 13.68 12.25 15.91 11.19 11.68 15.17 0.03% Cluster 35 0.0% 
4.13-33 13.69 12.25 15.91 11.19 11.68 15.17 0.03% Cluster 35 0.0% 
4.13-34 13.75 0.00 0.94 0.00 0.00 1.83 5.68% Cluster 3 0.7% 
4.13-35 13.75 0.00 0.94 0.00 0.00 1.83 5.68% Cluster 3 0.7% 
4.13-36 14.08 10.00 0.41 9.64 9.80 0.74 8.84% Cluster 2 1.6% 
4.13-37 14.10 10.00 0.41 9.64 9.80 0.74 8.83% Cluster 2 1.6% 
4.13-38 14.25 15.23 16.31 14.84 14.42 16.00 0.02% Cluster 49 0.0% 
4.13-39 14.26 15.23 16.31 14.84 14.42 16.00 0.02% Cluster 49 0.0% 
4.13-40 14.59 11.75 9.27 11.12 11.62 9.40 0.27% Cluster 17 0.1% 
4.13-41 14.60 11.29 7.09 11.21 11.30 7.91 0.49% Cluster 13 0.3% 
4.13-42 14.61 11.75 9.27 11.12 11.62 9.40 0.27% Cluster 17 0.1% 
4.13-43 14.61 11.29 7.09 11.21 11.30 7.91 0.49% Cluster 13 0.3% 
4.13-44 14.78 11.24 3.15 10.99 11.31 3.86 2.51% Cluster 5 1.2% 
4.13-45 14.79 11.24 3.15 10.99 11.31 3.86 2.51% Cluster 5 1.2% 
4.13-46 14.93 6.20 9.57 5.45 5.74 9.25 0.28% Cluster 16 0.2% 
4.13-47 14.94 6.20 9.58 5.45 5.74 9.26 0.28% Cluster 16 0.2% 
4.13-48 14.98 8.74 4.54 8.95 9.11 6.02 1.05% Cluster 8 0.6% 
4.13-49 14.99 8.74 4.54 8.95 9.11 6.02 1.05% Cluster 8 0.6% 
4.13-50 15.26 8.37 11.35 7.21 7.80 10.51 0.17% Cluster 21 0.1% 




4.13-52 15.29 14.86 15.46 14.68 15.02 16.33 0.02% Cluster 50 0.0% 
4.13-53 15.30 14.86 15.46 14.68 15.02 16.33 0.02% Cluster 50 0.0% 
4.13-54 15.32 14.58 13.20 14.32 14.35 13.60 0.05% Cluster 37 0.0% 
4.13-55 15.33 14.58 13.20 14.32 14.35 13.60 0.05% Cluster 37 0.0% 
4.13-56 15.55 14.86 13.71 14.24 14.35 13.48 0.05% Cluster 35 0.0% 
4.13-57 15.55 14.86 13.71 14.24 14.35 13.48 0.05% Cluster 35 0.0% 
4.13-58 15.75 10.09 5.27 10.17 9.85 5.99 1.06% Cluster 2 0.2% 
4.13-59 15.86 8.51 3.30 9.22 8.39 4.79 1.72% Cluster 6 0.7% 
4.13-60 15.87 8.51 3.30 9.22 8.39 4.79 1.72% Cluster 6 0.7% 
4.13-61 16.04 10.00 11.56 9.55 10.22 12.23 0.09% Cluster 27 0.0% 
4.13-62 16.05 10.00 11.56 9.55 10.22 12.23 0.09% Cluster 27 0.0% 
4.13-63 16.13 0.00 0.94 0.00 0.00 1.83 5.68% Cluster 3 0.7% 
4.13-64 16.15 0.00 0.94 0.00 0.00 1.83 5.68% Cluster 3 0.7% 
4.13-65 16.19 16.62 16.14 16.05 16.06 15.89 0.02% Cluster 48 0.0% 
4.13-66 16.20 16.62 16.14 16.05 16.06 15.89 0.02% Cluster 48 0.0% 
4.13-67 16.36 11.49 12.33 11.79 10.68 12.72 0.07% Cluster 30 0.0% 
4.13-68 16.38 11.49 12.33 11.79 10.68 12.72 0.07% Cluster 30 0.0% 
4.13-69 16.99 15.90 14.83 15.26 15.27 14.44 0.03% Cluster 40 0.0% 
4.13-70 17.00 15.90 14.83 15.26 15.27 14.44 0.03% Cluster 40 0.0% 
4.13-71 17.10 13.55 7.46 14.07 13.01 8.34 0.41% Cluster 14 0.2% 
4.13-72 17.11 13.55 7.46 14.07 13.01 8.34 0.41% Cluster 14 0.2% 
4.13-73 17.76 21.21 19.66 21.11 20.58 19.83 0.00% Cluster 57 0.0% 
4.13-74 17.78 21.21 19.66 21.11 20.58 19.83 0.00% Cluster 57 0.0% 
4.13-75 17.83 9.05 7.43 8.37 8.93 7.53 0.57% Cluster 12 0.3% 
4.13-76 17.84 9.05 7.43 8.37 8.93 7.53 0.57% Cluster 12 0.3% 
4.13-77 18.34 10.31 18.48 9.37 9.42 17.54 0.01% Cluster 54 0.0% 
4.13-78 18.35 10.31 18.48 9.37 9.42 17.54 0.01% Cluster 54 0.0% 
4.13-79 18.65 13.33 18.13 12.12 12.67 17.16 0.01% Cluster 52 0.0% 
4.13-80 18.66 14.93 13.16 14.25 14.87 13.32 0.05% Cluster 32 0.0% 
4.13-81 18.67 13.33 18.13 12.12 12.67 17.16 0.01% Cluster 52 0.0% 




4.13-83 18.67 16.33 17.62 15.61 15.72 17.19 0.01% Cluster 53 0.0% 
4.13-84 18.68 16.33 17.62 15.61 15.72 17.19 0.01% Cluster 53 0.0% 
4.13-85 18.88 22.76 21.30 22.44 21.80 20.90 0.00% Cluster 59 0.0% 
4.13-86 18.88 22.76 21.30 22.44 21.80 20.90 0.00% Cluster 59 0.0% 
4.13-87 19.33 17.45 15.55 16.86 16.78 15.19 0.03% Cluster 46 0.0% 
4.13-88 19.33 17.45 15.55 16.86 16.78 15.19 0.03% Cluster 46 0.0% 
4.13-89 19.61 16.99 11.22 17.60 16.16 11.90 0.10% Cluster 26 0.1% 
4.13-90 19.62 16.99 11.22 17.60 16.16 11.90 0.10% Cluster 26 0.1% 
4.13-91 19.78 22.21 25.23 21.66 21.20 24.55 0.00% Cluster 61 0.0% 
4.13-92 19.78 22.21 25.23 21.66 21.20 24.55 0.00% Cluster 61 0.0% 
4.13-93 19.83 14.57 12.69 15.40 14.29 14.14 0.04% Cluster 39 0.0% 
4.13-94 19.85 14.57 12.68 15.40 14.29 14.14 0.04% Cluster 39 0.0% 
4.13-95 19.86 18.46 14.97 18.09 17.95 14.99 0.03% Cluster 45 0.0% 
4.13-96 19.88 18.46 14.97 18.09 17.95 14.99 0.03% Cluster 45 0.0% 
4.13-97 19.92 6.05 10.92 6.22 5.90 11.83 0.10% Cluster 25 0.1% 
4.13-98 19.93 6.05 10.92 6.22 5.90 11.83 0.10% Cluster 25 0.1% 
4.13-99 19.97 18.29 14.21 18.45 17.75 14.72 0.03% Cluster 44 0.0% 
4.13-100 19.98 18.29 14.21 18.45 17.75 14.72 0.03% Cluster 44 0.0% 
4.13-101 20.19 14.57 12.68 15.40 14.29 14.14 0.04% Cluster 39 0.0% 
4.13-102 20.25 17.47 14.53 17.26 16.95 14.70 0.03% Cluster 43 0.0% 
4.13-103 20.25 17.47 14.53 17.26 16.95 14.69 0.03% Cluster 42 0.0% 
4.13-104 20.28 17.75 22.02 16.65 17.06 21.13 0.00% Cluster 60 0.0% 
4.13-105 20.28 17.75 22.02 16.65 17.06 21.13 0.00% Cluster 60 0.0% 
4.13-106 20.30 11.66 12.25 11.79 11.57 13.18 0.06% Cluster 31 0.0% 
4.13-107 20.31 11.66 12.25 11.79 11.57 13.18 0.06% Cluster 31 0.0% 
4.13-108 20.38 14.23 10.97 13.85 13.99 11.25 0.13% Cluster 24 0.1% 
4.13-109 20.39 14.23 10.97 13.85 13.99 11.25 0.13% Cluster 24 0.1% 
4.13-110 20.45 4.54 6.21 4.17 6.25 8.44 0.39% Cluster 15 0.2% 
4.13-111 20.46 4.54 6.21 4.17 6.25 8.44 0.39% Cluster 15 0.2% 
4.13-112 20.58 16.16 12.41 15.43 16.04 12.46 0.08% Cluster 29 0.0% 




4.13-114 20.60 5.86 9.95 5.66 5.76 10.55 0.17% Cluster 22 0.1% 
4.13-115 20.61 16.16 12.41 15.43 16.04 12.46 0.08% Cluster 29 0.0% 
4.13-116 20.61 5.86 9.95 5.66 5.76 10.55 0.17% Cluster 22 0.1% 
4.13-117 20.75 17.52 17.29 17.29 17.24 17.68 0.01% Cluster 56 0.0% 
4.13-118 20.76 17.52 17.29 17.29 17.24 17.68 0.01% Cluster 56 0.0% 
4.13-119 20.80 18.69 16.77 18.09 18.13 16.51 0.02% Cluster 51 0.0% 
4.13-120 20.81 18.31 21.23 17.43 17.45 20.38 0.00% Cluster 58 0.0% 
4.13-121 20.81 18.31 21.24 17.43 17.45 20.38 0.00% Cluster 58 0.0% 
4.13-122 20.82 18.69 16.77 18.09 18.13 16.51 0.02% Cluster 51 0.0% 
4.13-123 20.84 11.04 11.29 12.07 11.27 13.44 0.05% Cluster 34 0.0% 
4.13-124 20.88 17.46 15.34 16.96 17.34 15.62 0.02% Cluster 47 0.0% 
4.13-125 20.88 11.04 11.29 12.07 11.27 13.44 0.05% Cluster 34 0.0% 
4.13-126 20.89 17.46 15.34 16.96 17.34 15.62 0.02% Cluster 47 0.0% 
4.13-127 20.92 17.52 17.54 16.90 17.32 17.62 0.01% Cluster 55 0.0% 
4.13-128 20.92 17.52 17.54 16.90 17.32 17.62 0.01% Cluster 55 0.0% 
4.13-129 20.97 15.53 13.67 15.29 15.29 14.09 0.04% Cluster 38 0.0% 







Table 6.84: Calculated energies (in kJ mol−1), DFT calculated population and conformer population after NOE-refinement for all conformers of 4.15. 





4.15-1 0.00 5.82 4.67 5.77 4.11 7.96% 5.82 
4.15-2 4.99 0.00 0.00 0.00 0.00 41.85% 0.00 
4.15-3 10.31 7.48 5.16 7.54 5.54 4.47% 7.48 
4.15-4 10.65 12.00 13.00 11.82 12.14 0.31% 12.00 
4.15-5 10.96 10.85 10.52 10.69 10.22 0.67% 10.85 
4.15-6 11.78 12.13 13.03 11.92 12.19 0.31% 12.13 
4.15-7 11.80 13.95 13.78 14.25 13.62 0.17% 13.95 
4.15-8 12.60 10.81 8.18 10.90 7.89 1.73% 10.81 
4.15-9 12.66 6.05 8.48 6.04 8.42 1.40% 6.05 
4.15-10 13.00 14.39 13.78 14.31 13.09 0.21% 14.39 
4.15-11 13.07 14.16 12.02 14.22 11.27 0.44% 14.16 
4.15-12 13.16 9.37 7.12 9.56 7.75 1.83% 9.37 
4.15-13 13.39 9.58 7.25 9.83 7.20 2.29% 9.58 
4.15-14 14.01 7.59 9.41 7.91 9.39 0.94% 7.59 
4.15-15 14.29 6.68 2.40 8.05 3.38 10.69% 6.68 
4.15-16 14.31 12.75 12.49 13.12 12.77 0.24% 12.75 
4.15-17 14.39 8.59 8.40 9.14 8.64 1.28% 8.59 
4.15-18 14.92 12.49 7.09 12.69 7.25 2.24% 12.49 
4.15-19 15.07 13.87 14.58 14.09 14.19 0.14% 13.87 
4.15-20 15.16 8.69 7.80 8.84 7.89 1.73% 8.69 
4.15-21 15.22 6.05 8.48 6.04 8.42 1.40% 6.05 




4.15-23 15.45 17.01 14.83 17.33 15.13 0.09% 17.01 
4.15-24 15.63 16.43 13.74 16.63 13.56 0.17% 16.43 
4.15-25 15.66 13.01 18.40 13.11 18.04 0.03% 13.01 
4.15-26 15.83 8.59 8.40 9.14 8.64 0.00% 8.59 
4.15-27 15.90 12.09 12.04 12.18 12.20 0.30% 12.09 
4.15-28 16.00 8.68 9.60 9.63 10.34 0.64% 8.68 
4.15-29 16.12 12.09 13.71 11.93 13.50 0.18% 12.09 
4.15-30 16.70 16.68 13.16 17.37 13.41 0.19% 16.68 
4.15-31 16.84 9.32 10.59 9.48 10.58 0.58% 9.32 
4.15-32 17.02 16.68 13.16 17.37 13.41 0.19% 16.68 
4.15-33 17.22 14.52 13.03 14.78 13.84 0.16% 14.52 
4.15-34 17.48 12.56 13.05 12.85 12.95 0.22% 12.56 
4.15-35 17.66 7.67 11.46 7.77 12.05 0.32% 7.67 
4.15-36 17.86 2.70 6.59 3.45 7.89 1.73% 2.70 
4.15-37 17.86 10.36 11.64 10.43 11.65 0.38% 10.36 
4.15-38 17.98 11.90 7.11 13.40 8.16 1.55% 11.90 
4.15-39 18.06 22.63 21.17 23.07 20.83 0.01% 22.63 
4.15-40 18.21 13.59 12.92 13.61 13.23 0.20% 13.59 
4.15-41 18.31 16.02 18.95 16.31 19.15 0.02% 16.02 
4.15-42 18.32 12.39 14.90 12.57 14.65 0.11% 12.39 
4.15-43 18.37 11.29 13.71 11.62 13.61 0.17% 11.29 
4.15-44 18.41 2.70 6.59 3.45 7.89 0.00% 2.70 
4.15-45 18.45 12.51 8.41 13.62 9.66 0.84% 12.51 
4.15-46 18.57 3.96 10.47 4.28 10.40 0.63% 3.96 
4.15-47 18.72 7.00 11.79 8.16 12.59 0.26% 7.00 
4.15-48 19.05 11.26 11.21 11.76 11.16 0.46% 11.26 
4.15-49 19.24 15.71 16.15 15.74 16.41 0.06% 15.71 
4.15-50 19.42 4.54 14.00 4.93 14.36 0.13% 4.54 
4.15-51 19.47 8.83 8.61 9.82 9.14 1.04% 8.83 
4.15-52 19.51 23.75 18.43 24.63 18.44 0.02% 23.75 




4.15-54 19.60 18.79 19.31 18.70 18.43 0.02% 18.79 
4.15-55 19.76 15.09 13.31 15.12 13.53 0.18% 15.09 
4.15-56 19.77 16.12 15.77 16.24 15.42 0.08% 16.12 
4.15-57 20.26 10.62 5.00 11.78 5.84 3.97% 10.62 
4.15-58 20.39 13.08 16.59 13.19 16.53 0.05% 13.08 
4.15-59 20.43 16.27 14.10 16.62 14.04 0.14% 16.27 
4.15-60 20.48 13.68 11.45 14.03 11.51 0.40% 13.68 
4.15-61 20.62 19.48 15.99 19.96 15.37 0.08% 19.48 
4.15-62 20.77 13.51 12.94 14.21 13.43 0.18% 13.51 






Population refinement of meso compounds (4.11, 4.12 and 4.13) based on 1H-1H distances 
 
Table 6.85: Dihedral cluster of 4.11 with initial DFT energy derived population, NOE-refined DDG (in kJ mol−1) and NOE-refined population for each cluster. 
Cluster Φ1 Φ2 Φ3 Φ4 Φ5 Φ6 Initial Population 





ap g+ ap g+ ap g+ 
62.95% 0.83 44.62% 
g− ap g− ap g− ap 
2 
ap g+ ap g+ ap g− 
17.94% 4.69 2.68% 
g+ ap g− ap g− ap 
3 
g− ap g− ap −ac g− 
6.16% 2.28 2.43% 
g+ +ac ap g+ ap g+ 
4 
g− +ac ap g+ ap g+ 
2.86% −5.38 24.87% 
g− ap g− ap −ac g+ 
5 
g− ap −ac g+ ap g+ 
1.91% 0.60 1.48% 
g− ap g− +ac ap g+ 
6 
g− ap g− ap g− g− 
1.88% 1.21 1.14% 
g+ g+ ap g+ ap g+ 
7 
g+ +ac g− ap g− ap 
1.67% −5.98 18.49% 
ap g+ ap g+ −ac g− 
8 
ap g+ ap +ac ap g+ 
1.04% 0.13 0.97% 
g− ap −ac ap g− ap 
9 
g− ap g− ap −ac ap 
0.91% 0.74 0.67% 





g+ +ac ap g+ ap g− 
0.67% 1.25 0.40% 
g+ ap g− ap −ac ap 
11 
ap g+ ap g+ −ac ap 
0.44% −0.15 0.47% 
ap +ac g− ap g− ap 
12 
ap ap g− ap g− ap 
0.40% 0.49 0.33% 
g− ap g− +ac ap g− 
13 
g+ ap −ac g+ ap g+ 
0.23% 0.41 0.19% 
g− ap g− ap g− g+ 
14 
g− g+ ap g+ ap g+ 
0.23% −0.50 0.28% 
ap g+ ap +ac g− ap 
15 
ap g+ −ac ap g− ap 
0.32% −1.63 0.61% 
ap g+ ap g+ ap ap 
16 
g+ ap g− ap −ac g+ 
0.14% 0.25 0.12% 
g− +ac ap g+ ap g− 
17 
ap g+ ap +ac ap g− 
0.12% 0.20 0.11% 
g+ ap −ac ap g− ap 
18 
ap g− ap g+ ap g+ 
0.06% 0.13 0.06% 
g− ap g− ap g+ ap 
19 
g+ ap g− ap −ac ap 
0.06% 0.18 0.05% 
ap +ac ap g+ ap g− 
20 
g− ap g− ap ap ap 
0.01% 0.02 0.01% 
ap ap ap g+ ap g+ 
21 
ap g+ ap +ac ap ap 
0.01% 0.02 0.01% 














1 2.41 23.13% 0.89 18.75% 
2 5.76 1.71% 8.71 0.23% 
3 2.03 2.64% 4.40 0.44% 
4 −6.55 39.26% −6.65 17.88% 
5 1.67 0.94% −0.18 0.87% 
6 0.91 1.27% −1.33 1.37% 
7 −3.74 7.34% −7.10 12.50% 
8 1.59 0.53% 2.82 0.14% 
9 1.63 0.46% 4.61 0.06% 
10 1.58 0.34% 4.30 0.05% 
11 0.72 0.32% 2.94 0.06% 
12 1.24 0.24% 3.42 0.04% 
13 0.76 0.17% 2.20 0.04% 
14 −1.40 0.39% −14.00 27.54% 
15 −10.41 20.93% −12.34 19.93% 
16 0.41 0.11% 1.97 0.03% 
17 0.54 0.09% 1.77 0.02% 
18 0.33 0.05% 1.02 0.02% 
19 0.36 0.05% 1.81 0.01% 
20 0.06 0.01% 0.35 0.00% 







Table 6.86: Dihedral cluster of 4.12 with initial DFT energy derived population, NOE-refined DDG (in kJ mol−1) and NOE-refined population for each cluster. 
Cluster Φ1 Φ2 Φ3 Φ4 Φ5 Φ6 Φ7 Φ8 Initial Population NOErefined ΔΔG/kJ mol1 NOERefined Population 
1 
ap g+ ap g+ ap g+ ap g+ 
48.48% −1.33 39.52% 
g− ap g− ap g− ap g− ap 
2 
g− ap g− +ac ap g+ ap g+ 
6.85% 0.21 3.00% 
g− ap g− ap −ac g+ ap g+ 
3 
g+ +ac ap g+ ap g+ ap g+ 
8.64% 2.72 1.38% 
g− ap g− ap g− ap −ac g− 
4 
g− ap −ac g+ ap g+ ap g+ 
5.26% −4.98 18.77% 
g− ap g− ap g− +ac ap g+ 
5 
ap g+ ap ap g− +ac ap g+ 
4.21% −6.21 24.67% 
g− ap −ac g+ ap ap g− ap 
6 
g− +ac ap g+ ap g+ ap g+ 
2.41% 0.01 1.14% 
g− ap g− ap g− ap −ac g+ 
7 
ap g+ ap +ac ap g+ ap g+ 
3.35% 2.95 0.49% 
g− ap g− ap −ac ap g− ap 
8 
ap g+ ap g+ ap g+ ap g− 
5.96% −1.68 5.59% 
g+ ap g− ap g− ap g− ap 
9 
ap g+ ap ap g− +ac ap g− 
1.99% 1.96 0.43% 
g+ ap −ac g+ ap ap g− ap 
10 
ap g+ ap ap g− g+ ap g+ 
1.56% 1.74 0.37% 





g− ap −ac g+ g+ g+ ap g+ 
0.80% −0.51 0.47% 
g− ap g− g− g− +ac ap g+ 
12 
ap g+ ap g+ ap +ac ap g+ 
1.35% −0.08 0.66% 
g− ap −ac ap g− ap g− ap 
13 
g+ g+ ap g+ ap g+ ap g+ 
0.90% 1.38 0.25% 
g− ap g− ap g− ap g− g− 
14 
ap g+ ap +ac g− ap g− ap 
1.26% 2.01 0.27% 
ap g+ ap g+ −ac ap g− ap 
15 
ap +ac ap g+ ap g+ ap g+ 
1.07% −0.37 0.59% 
g− ap g− ap g− ap −ac ap 
16 
g+ ap ap g+ ap g+ ap g+ 
0.90% 0.49 0.35% 
g− ap g− ap g− ap ap g− 
17 
ap g+ ap ap g+ g+ ap g+ 
0.91% 0.62 0.34% 
g− ap g− g− ap ap g− ap 
18 
ap g+ −ac g+ ap ap g− ap 
1.65% 0.94 0.54% 
ap g+ ap ap g− +ac g− ap 
19 
g+ +ac ap g+ ap g+ ap g− 
0.30% 0.48 0.12% 
g+ ap g− ap g− ap −ac g− 
20 
g+ +ac g− +ac ap g+ ap g+ 
0.22% 0.16 0.10% 
g− ap g− ap −ac g+ −ac g− 
21 
ap +ac g− ap g− ap g− ap 
0.20% −0.44 0.11% 
ap g+ ap g+ ap g+ −ac ap 
22 
g− ap g− ap g− ap g− g+ 
0.15% −0.12 0.07% 
g− g+ ap g+ ap g+ ap g+ 
23 
ap ap g− ap g− ap g− ap 
0.31% −0.57 0.19% 
ap g+ ap g+ ap g+ ap ap 
24 
ap g+ −ac ap g− ap g− ap 
0.21% −0.24 0.11% 





ap g+ ap ap +ac g+ ap g+ 
0.13% −0.09 0.07% 
g− ap g− −ac ap ap g− ap 
26 
ap g+ ap +ac ap g+ ap g− 
0.19% 0.52 0.07% 
g+ ap g− ap −ac ap g− ap 
27 
ap g+ ap ap g− ap ap g+ 
0.10% 0.01 0.05% 
g− ap ap g+ ap ap g− ap 
28 
ap g+ ap ap g− ap g− ap 
0.13% 0.06 0.06% 
ap g+ ap g+ ap ap g− ap 
29 
ap g+ ap ap g− ap −ac g− 
0.10% 0.10 0.04% 
g+ +ac ap g+ ap ap g− ap 
30 
ap g+ ap g+ ap +ac ap g− 
0.08% 0.03 0.04% 
g+ ap −ac ap g− ap g− ap 
31 
ap ap ap g+ ap g+ ap g+ 
0.06% −0.11 0.03% 
g− ap g− ap g− ap ap ap 
32 
ap g− ap g+ ap g+ ap g+ 
0.06% 0.18 0.03% 
g− ap g− ap g− ap g+ ap 
33 
ap +ac ap g+ ap g+ ap g− 
0.06% 0.05 0.03% 
g+ ap g− ap g− ap −ac ap 
34 
ap g+ ap ap g+ g+ ap g− 
0.06% 0.09 0.03% 
g+ ap g− g− ap ap g− ap 
35 
ap g+ ap ap +ac g+ ap g− 
0.04% −0.01 0.02% 
g+ ap g− −ac ap ap g− ap 
36 
ap ap −ac g+ ap ap g− ap 
0.05% 0.00 0.02% 
ap g+ ap ap g− +ac ap ap 
37 
ap g+ ap g+ ap +ac g+ ap 
0.01% 0.04 0.01% 
ap g− −ac ap g− ap g− ap 
38 
ap +ac ap g+ ap ap g− ap 
0.01% 0.00 0.00% 





ap ap −ac ap g− ap g− ap 
0.01% 0.00 0.00% 
ap g+ ap g+ ap +ac ap ap 
 
 
Table 6.87: Dihedral cluster of 4.13 with initial DFT energy derived population, NOE-refined DDG (in kJ mol−1) and NOE-refined population for each cluster. 
Cluster Φ1 Φ2 Φ3 Φ4 Φ5 Φ6 Φ7 Φ8 Φ9 Φ10 Initial Population NOErefined ΔΔG/kJ mol1 NOERefined 
Population 1 
g− ap g− ap g− ap g− ap g− ap 
23.81% −2.04 29.58% 
ap g+ ap g+ ap g+ ap g+ ap g+ 
2 
g− ap g− ap −ac g+ ap g+ ap g+ 
18.72% 2.72 3.40% 
g− ap g− ap g− +ac ap g+ ap g+ 
3 
g− ap g− ap ap g+ −ac g+ ap g+ 
22.73% 3.86 2.60% 
g− ap g− +ac g− ap ap g+ ap g+ 
4 
g− ap g− ap ap g+ −ac ap g− ap 
5.69% 0.24 2.82% 
ap g+ ap +ac g− ap ap g+ ap g+ 
5 
g− ap g− ap g− ap g− +ac ap g+ 
5.01% 0.23 2.50% 
g− ap −ac g+ ap g+ ap g+ ap g+ 
6 
g− ap g− ap −ac g+ −ac g+ ap g+ 
3.44% 0.72 1.40% 
g− ap g− +ac g− +ac ap g+ ap g+ 
7 
g− ap g− +ac g− +ac g− ap g− ap 
2.93% −8.46 48.66% 
ap g+ ap g+ −ac g+ −ac g+ ap g+ 
8 
g− +ac g− +ac ap g+ ap g+ ap g+ 
2.09% 0.01 1.14% 





ap g+ ap g+ ap g+ ap g+ ap g− 
1.77% 0.62 0.75% 
g+ ap g− ap g− ap g− ap g− ap 
10 
g− ap g− ap g− ap g− ap −ac g− 
1.40% 0.06 0.75% 
g+ +ac ap g+ ap g+ ap g+ ap g+ 
11 
g+ +ac g− ap g− ap g− ap g− ap 
2.33% 0.70 0.96% 
ap g+ ap g+ ap g+ ap g+ −ac g− 
12 
g+ +ac ap +ac g− ap ap g+ ap g+ 
1.14% 0.12 0.59% 
g− ap g− ap ap g+ −ac ap −ac g− 
13 
g− ap g− ap g− ap g− ap −ac g+ 
0.98% −0.29 0.60% 
g− +ac ap g+ ap g+ ap g+ ap g+ 
14 
ap g+ ap g+ −ac g+ −ac g+ −ac g− 
0.82% 0.06 0.44% 
g+ +ac g− +ac g− +ac g− ap g− ap 
15 
g− ap g− ap ap g+ −ac ap −ac g+ 
0.79% −0.05 0.44% 
g− +ac ap +ac g− ap ap g+ ap g+ 
16 
g− ap g− ap ap g+ g− ap g− ap 
0.57% −0.05 0.32% 
ap g+ ap g+ g− ap ap g+ ap g+ 
17 
g− ap g− ap ap g+ ap g+ ap g+ 
0.54% 0.24 0.27% 
g− ap g− ap g− ap ap g+ ap g+ 
18 
ap g+ ap g+ ap +ac g− ap g− ap 
0.43% −0.01 0.23% 
ap g+ ap g+ −ac ap g− ap g− ap 
19 
ap +ac ap g+ ap g+ ap g+ ap g+ 
0.36% −0.02 0.20% 
g− ap g− ap g− ap g− ap −ac ap 
20 
ap g+ ap g+ ap g+ −ac ap g− ap 
0.36% 0.03 0.19% 
ap g+ ap +ac g− ap g− ap g− ap 
21 
g+ ap g− ap ap g+ −ac ap g− ap 
0.34% 0.13 0.18% 
ap g+ ap +ac g− ap ap g+ ap g− 
22 
g+ +ac g− +ac g− ap ap g+ ap g+ 
0.34% 0.31 0.16% 





ap g+ ap +ac ap g+ ap g+ ap g+ 
0.33% 0.11 0.17% 
g− ap g− ap g− ap −ac ap g− ap 
24 
g+ ap g− ap g− +ac ap g+ ap g+ 
0.25% 0.19 0.13% 
g− ap g− ap −ac g+ ap g+ ap g− 
25 
g+ ap g− ap ap g+ −ac g+ ap g+ 
0.20% 0.17 0.10% 
g− ap g− +ac g− ap ap g+ ap g− 
26 
ap +ac g− +ac g− +ac g− ap g− ap 
0.20% −0.02 0.11% 
ap g+ ap g+ −ac g+ −ac g+ −ac ap 
27 
g− ap g− ap g− ap g− ap g− g− 
0.17% −0.03 0.09% 
g+ g+ ap g+ ap g+ ap g+ ap g+ 
28 
ap g+ ap g+ ap +ac ap g+ ap g+ 
0.16% 0.04 0.08% 
g− ap g− ap −ac ap g− ap g− ap 
29 
g+ +ac g− ap g− ap g− ap −ac g− 
0.23% 0.11 0.12% 
g+ +ac ap g+ ap g+ ap g+ −ac g− 
30 
ap g+ ap +ac g− +ac g− +ac g− ap 
0.14% −0.01 0.08% 
ap g+ −ac g+ −ac g+ −ac ap g− ap 
31 
g− ap g− ap g− ap −ac g+ −ac g− 
0.12% 0.05 0.06% 
g+ +ac g− +ac ap g+ ap g+ ap g+ 
32 
g+ ap g− ap g− ap g− ap −ac g− 
0.11% 0.06 0.06% 
g+ +ac ap g+ ap g+ ap g+ ap g− 
33 
ap g+ ap g+ ap g+ ap g+ −ac ap 
0.11% 0.03 0.06% 
ap +ac g− ap g− ap g− ap g− ap 
34 
g− ap −ac g+ ap g+ −ac g+ ap g+ 
0.10% −0.02 0.06% 
g− ap g− +ac g− ap g− +ac ap g+ 
35 
g− ap g− ap ap g− g− ap g− ap 
0.15% −0.02 0.09% 
ap g+ ap g+ g+ ap ap g+ ap g+ 
36 
g− ap −ac ap g− ap g− ap g− ap 
0.10% −0.05 0.06% 





g+ ap −ac g+ ap g+ ap g+ ap g+ 
0.10% 0.04 0.05% 
g− ap g− ap g− ap g− +ac ap g− 
38 
g− ap g− ap g− +ac ap g+ ap g− 
0.08% 0.06 0.04% 
g+ ap g− ap −ac g+ ap g+ ap g+ 
39 
g− ap g− +ac g− +ac g− +ac ap g− 
0.12% 0.02 0.06% 
g+ ap −ac g+ −ac g+ −ac g+ ap g+ 
40 
g+ ap g− ap −ac ap g− ap g− ap 
0.07% 0.04 0.04% 
ap g+ ap g+ ap +ac ap g+ ap g− 
41 
ap g+ ap g+ ap g+ ap g+ ap +ac 
0.07% 0.00 0.04% 
−ac ap g− ap g− ap g− ap g− ap 
42 
g− ap g− ap ap g+ ap +ac g− ap 
0.06% 0.00 0.03% 
ap g+ −ac ap g− ap ap g+ ap g+ 
43 ap g+ ap g+ ap g+ −ac g+ −ac ap 0.08% 0.02 0.04% 
44 
g− +ac ap +ac g− ap g− ap g− ap 
0.06% −0.02 0.03% 
ap g+ ap g+ ap g+ −ac ap −ac g+ 
45 
ap g+ ap g+ ap g+ −ac ap −ac g− 
0.06% 0.00 0.03% 
g+ +ac ap +ac g− ap g− ap g− ap 
46 
g− ap g− ap g− ap g− +ac g+ ap 
0.05% 0.04 0.03% 
ap g− −ac g+ ap g+ ap g+ ap g+ 
47 
g+ +ac ap +ac ap g+ ap g+ ap g+ 
0.04% 0.01 0.02% 
g− ap g− ap g− ap −ac ap −ac g− 
48 
ap g+ ap g+ ap g+ ap +ac ap g− 
0.04% 0.00 0.02% 
g+ ap −ac ap g− ap g− ap g− ap 
49 
ap g+ −ac ap g− ap g− ap g− ap 
0.04% −0.02 0.02% 
ap g+ ap g+ ap g+ ap +ac g− ap 
50 
g− g+ ap g+ ap g+ ap g+ ap g+ 
0.03% −0.02 0.02% 
g− ap g− ap g− ap g− ap g− g+ 




51 g+ ap g− ap g− ap g− ap −ac ap 0.03% 0.01 0.02% 
52 
−ac ap g− ap ap g+ −ac ap g− ap 
0.02% 0.00 0.01% 
ap g+ ap +ac g− ap ap g+ ap +ac 
53 
ap g+ ap +ac ap g+ ap g+ ap g− 
0.02% 0.02 0.01% 
g+ ap g− ap g− ap −ac ap g− ap 
54 
ap g+ ap g+ g+ g+ −ac ap g− ap 
0.02% −0.01 0.01% 
ap g+ ap +ac g− g− g− ap g− ap 
55 
g− ap g− ap g− ap ap g+ ap g− 
0.02% 0.02 0.01% 
g+ ap g− ap ap g+ ap g+ ap g+ 
56 
g− ap −ac ap g− ap ap g+ ap g+ 
0.02% 0.00 0.01% 
g− ap g− ap ap g+ ap +ac ap g+ 
57 
−ac ap −ac g+ ap g+ ap g+ ap g+ 
0.01% 0.00 0.00% 
g− ap g− ap g− ap g− +ac ap +ac 
58 
ap g+ ap g+ ap g+ ap +ac g+ ap 
0.01% 0.00 0.00% 
ap g− −ac ap g− ap g− ap g− ap 
59 
−ac ap −ac ap g− ap g− ap g− ap 
0.01% 0.00 0.00% 
ap g+ ap g+ ap g+ ap +ac ap +ac 
60 
ap g+ ap g+ g+ ap ap g+ ap g− 
0.00% 0.00 0.00% 
g+ ap g− ap ap g− g− ap g− ap 
61 
−ac ap g− ap −ac ap g− ap g− ap 
0.00% 0.00 0.00% 







All NMR spectra were recorded in toluene-d6.
1H-1H scalar coupling constants were 
measured manually from multiplets in 1H spectra. 1H-13C scalar coupling constants of were 
measured from the Accordion In-Phase and Anti Phase (IPAP) HSQMBC NMR spectra (12 
scans, 1600 f1 increments and 8192 t2 data points, f1 spectra width 160.3 ppm (20161Hz), f2 
spectra width 10 ppm (5005Hz), matching JLR from 3Hz to 8 Hz.)
174 The spectra were 
processed using methods as discussed in the experimental section of Chapter 2.  
The interproton distances of were determined using  Equation 6.952, the 1D DPFGSE 
NOESY and 1D chemical shift selective filtered (CSSF) NOESY. PANIC was applied as 
discussed previously using the integrations in Table 6.88. 
Table 6.88: A summary of PANIC integration values used in this study. Protons being irradiated are 
highlighted in blue.  
Protons being irradiated 
Number of protons  
being irradiated 
















NMR experimental data.  
C2 symmetric compounds (4.9, 4.10 and 4.5). 
 
Table 6.89: Assignment table for 4.9. 
Proton Exp. H, Mult. (J/Hz) Calc. H, Multi. (J/Hz) 
H1 1.83, d (2.4) 1.78, d (4.21) 
H3 2.21, dqd (9.2, 6.9, 2.4) 2.39, dqd (9.42, 6.98, 4.21) 
H4 1.09, d (6.9) 1.18, d (6.98) 
H5 1.63, dqd (9.4, 6.9, 2.5) 1.47, dqd (9.42, 7.00, 4.16) 
H6 0.76, d (6.9) 0.79, d (7.00) 
H7 1.94, m 1.86, dqd (9.49, 7.01, 4.16) 
H8 0.76, d (6.5) 0.77, d (7.01) 
 
Table 6.90: Calculated Boltzmann averaged 1H chemical shifts (H) and experimental 1H chemical for 
4.9 with Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 
(reduced) values (2 (red.)). 
Proton Experimental H /ppm Calc. H /ppm Deviations/ppm 
H1 1.83 1.78 -0.05 
H3 2.21 2.39 0.18 
H4 1.09 1.18 0.09 
H5 1.63 1.47 -0.16 
H6 0.77 0.79 0.02 
H7 1.94 1.86 -0.08 
H8 0.76 0.77 0.01 
  MAD 0.09 
  StDev 0.11 




Table 6.91: Calculated Boltzmann averaged 13C chemical shifts (C) and experimental 13C chemical for 
4.9 with Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 
(reduced) values (2 (red.)). 
Carbon Experimental C /ppm Calc. C /ppm Deviations/ppm 
C1 69.54 70.76 1.22 
C2 88.67 87.67 -1.00 
C3 29.98 30.05 0.07 
C4 18.87 18.98 0.11 
C5 38.94 39.15 0.21 
C6 11.15 11.30 0.15 
C7 37.10 37.05 -0.05 
C8 11.65 10.95 -0.70 
  MAD 0.44 
  StDev 0.66 
  2 (red.) 0.19 
 
Table 6.92: Experimental nJHH values (in Hz) and Boltzmann averaged calculated nJHH (in Hz) before 
for 4.9 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations 
(StDev, in Hz) and 2 (reduced) values (2 (red.)). 
H Coupled H Exp. nJHH/Hz Calc. nJHH/Hz Deviation/Hz 
H1 H3 2.40 4.21 -* 
H3 H4 6.90 6.98 0.08 
H3 H5 9.20 9.42 0.22 
H5 H6 6.90 7.00 0.10 
H5 H7 2.50 4.16 1.66 
H7 H8 6.50 7.01 0.51 
      MAD 0.51 
   StDev 0.66 
   
2 (red.) 0.77 
*4JH1H3 was not used for comparison. 
 
Table 6.93: Experimental 1H-1H distances derived from 1D DPFGSE NOESY and CSSF NOESY 
spectra and the Boltzmann averaged computed 1H-1H distances for 4.9 with Mean Absolute Deviations 
(MAD),  Standard Deviations (StDev) and 2 (reduced) values (2 (red.)). 
HA HB ηeff Experimental reff/Å Calculated reff/Å % Error 
H3 H7 14.02 2.18 2.37 8.5% 
H7 H5 16.98 2.11 2.11 0.1% 
H7 H4 7.17 2.44 2.34 -3.9% 
H5 H4 16.94 2.11 2.12 0.2% 




H4 H6 36.89 1.86 1.82 -1.7% 
    MAD 2.92% 
    StDev 1.84% 






Table 6.94: Assignment table for 4.10. 
Proton Exp. H, Mult. (J/Hz) Calc. H, Multi. (J/Hz) 
H1 1.84, d (2.4) 1.83, d (4.0) 
H3 2.22, dqd (9.2, 6.9, 2.4) 2.43, dqd (9.1, 6.6, 4.0) 
H4 1.10, d (6.9) 1.20, d (6.6) 
H5 1.67, dqd (9.2, 6.9, 3.4) 1.55, dqd (9.1, 6.7, 3.5) 
H6 0.70, d (6.9) 0.79, d (6.7) 
H7 2.05, dqd (8.5, 6.8, 3.4) 1.98, dqd (8.6, 6.7, 3.5) 
H8 0.75, d (6.8) 0.76, d (6.7) 
H9 1.49, m 1.30, dqd (8.6, 6.7, 4.2) 
H10 0.88, d (6.7) 0.83, d (6.7) 
 
Table 6.95: Calculated Boltzmann averaged 1H chemical shifts (H) and experimental 1H chemical for 
4.10 with Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 
(reduced) values (2 (red.)). 
Proton Experimental H /ppm Calc. H /ppm Deviation/ppm 
H1 1.84 1.83 -0.01 
H3 2.22 2.43 0.21 
H4 1.10 1.20 0.10 
H5 1.67 1.55 -0.12 
H6 0.70 0.79 0.09 
H7 2.05 1.98 -0.07 
H8 0.75 0.76 0.01 
H9 1.49 1.31 -0.18 
H10 0.88 0.83 -0.05 
  MAD 0.09 
  StDev 0.12 
  2 (red.) 1.47 
 
Table 6.96: Calculated Boltzmann averaged 13C chemical shifts (C) and experimental 13C chemical for 
4.10 with Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 
(reduced) values (2 (red.)). 
Carbon Experimental C/ppm Calc. C/ppm Deviation/ppm 
C1 69.63 70.82 1.22 
C2 88.61 87.59 -1.01 




C4 18.86 19.03 0.13 
C5 38.77 39.13 0.33 
C6 11.41 11.80 0.40 
C7 37.07 37.25 0.15 
C8 11.88 11.24 -0.66 
C9 35.78 35.57 -0.23 
C10 11.65 11.43 -0.27 
  MAD 0.45 
  StDev 0.61 
  
2 (red.) 0.17 
 
Table 6.97: Experimental nJHH values (in Hz) and Boltzmann averaged calculated nJHH (in Hz) before 
for 4.10 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations 
(StDev, in Hz) and 2 (reduced) values (2 (red.)). 
H Coupled H Exp. nJHH/Hz Calc. nJHH /Hz Deviation/Hz 
H1 H3 2.44 4.20 - 
H3 H4 6.87 6.97 0.10 
H3 H5 9.15 9.50 0.35 
H5 H6 6.87 7.05 0.18 
H5 H7 3.40 3.72 0.32 
H7 H8 6.83 7.01 0.18 
H7 H9 8.45 9.00 0.55 
H9 H10 6.68 6.99 0.31 
  MAD 0.12 
  StDev 0.14 
  2 (red.) 0.02 
*4JH1H3 was not used for comparison. 
 
Table 6.98: Experimental 1H-1H distances derived from 1D DPFGSE NOESY and CSSF NOESY 
spectra and the Boltzmann averaged computed 1H-1H distances for 4.10 with Mean Absolute Deviations 
(MAD),  Standard Deviations (StDev) and 2 (reduced) values (2 (red.)). 
HA HB ηeff Exp. reff/Å Calc. reff/Å % Error 
H3 H7 7.96 2.49 2.73 9.3% 
H3 H9 15.70 2.22 2.53 13.0% 
H3 H8 33.70 1.96 1.91 −2.4% 
H3 H6 19.94 2.13 2.17 1.6% 
H7 H5 16.37 2.21 2.22 0.7% 
H7 H4 9.86 2.40 2.45 2.2% 
H7 H10 57.27 1.79 1.80 0.8% 
H7 H6 7.15 2.53 2.58 1.9% 
H5 H9 88.59 1.66 1.84 10.0% 




H5 H10 19.72 2.14 1.96 −8.7% 
H5 H8 6.94 2.55 2.55 0.3% 
H9 H8 27.66 2.15 2.05 −4.8% 
H9 H6 37.98 1.92 1.81 −5.6% 
H4 H3 39.74 (Ref) 1.90 1.93 0.0% 
H4 H6 49.37 1.83 1.83 −0.4% 
H10 H9 28.06 2.02 1.88 −6.8% 
H10 H8 48.44 1.84 1.77 −3.9% 
H8 H7 33.32 1.96 1.89 −3.5% 
H8 H6 41.08 1.89 1.84 −2.8% 
H6 H5 28.97 2.01 1.90 −5.3% 
    MAD 4.25% 
    StDev 5.37% 







Table 6.99: Assignment table for 4.5. 
Proton Exp. H, Mult. (J/Hz) Calc. H, Multi. (J/Hz) 
H1 1.85, d (2.38) 1.73 d (4.18) 
H3 2.24, dqd (9.23, 6.88, 2.38 ) 2.89 dqd (9.06, 7.00, 4.18) 
H4 1.11, d (6.88) 1.15 d (7.00) 
H5 1.71, dqd (9.23, 6.78, 3.3) 1.66 dqd (9.06, 7.05, 3.91) 
H6 0.74 , d (6.78) 0.99 d (7.05) 
H7 2.05, dqd  (8.6, 6.76, 3.3) 1.70 dqd (8.71, 6.96, 3.91) 
H8 0.77, d (6.76) 0.86 d (6.96) 
H9 1.52, dqd (8.6, 6.78,  3.2) 1.33 dqd (8.71, 6.99, 4.73) 
H10 0.81, d (6.78) 0.76 d (6.99) 
H11 1.62, m 1.41 dqd (8.20, 6.99, 4.73) 
H12 0.87, app. d (6.2) 0.82 d (7.05) 
 
Table 6.100: Calculated Boltzmann averaged 1H chemical shifts (H) and experimental 1H chemical for 
4.5 with Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 
(reduced) values (2 (red.)). 
Proton Exp. H/ppm Calc. H/ppm Deviations/ppm 
H1 1.85 1.85 0.00 
H3 2.24 2.53 0.29 
H4 1.11 1.21 0.10 
H5 1.71 1.64 -0.07 
H6 0.74 0.83 0.09 
H7 2.05 1.96 -0.09 
H8 0.77 0.79 0.02 
H9 1.52 1.39 -0.13 
H10 0.81 0.84 0.03 
H11 1.62 1.42 -0.20 
H12 0.87 0.84 -0.03 
  MAD 0.09 
  StDev 0.13 





Table 6.101: Calculated Boltzmann averaged 13C chemical shifts (C) and experimental 13C chemical 
for 4.5 with Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 
(reduced) values (2 (red.)). 
Carbon Exp. C/ppm Calc. Cppm Deviations/ppm 
C1 69.92 70.70 0.78 
C2 88.68 88.03 −0.65 
C3 30.10 29.61 −0.49 
C4 18.79 18.60 −0.19 
C5 38.82 39.12 0.30 
C6 11.58 12.05 0.47 
C7 37.21 37.40 0.19 
C8 11.90 11.83 −0.07 
C9 35.72 35.88 0.18 
C10 12.02 12.00 −0.02 
C11 35.71 35.59 −0.11 
C12 11.84 11.45 −0.39 
  MAD 0.32 
  StDev 0.41 
  2 (red.) 0.08 
 
Table 6.102: Experimental nJHH values (in Hz) and Boltzmann averaged calculated nJHH (in Hz) before 
for 4.5 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations 
(StDev, in Hz) and 2 (reduced) values (2 (red.)). 
H Coupled H Exp. nJHH/Hz Calc. nJHH/Hz Deviations/Hz 
H1 H3 2.38 4.18 * 
H3 H4 6.88 7.00 0.12 
H3 H5 9.23 9.06 −0.17 
H5 H6 6.78 7.05 0.27 
H5 H7 3.30 3.91 0.61 
H7 H8 6.76 6.96 0.20 
H7 H9 8.60 8.71 0.11 
H9 H10 6.78 6.99 0.21 
H9 H11 3.20 4.73 1.53 
H11 H12 6.20 6.99 0.79 
   MAD 0.44 
   StDev 0.51 
   2 (red.) 0.44 
*4JH1H3 was not used for comparison. 
 
Table 6.103: Experimental 1H-1H distances derived from 1D DPFGSE NOESY and CSSF NOESY 




geometries and conformer energies corrected after single point energy calculations for 4.5 with Mean 
Absolute Deviations (MAD),  Standard Deviations (StDev) and 2 (reduced) values (2 (red.)). 
HA HB ηeff Exp. reff/ Å Calc reff/ Å % error 
H3 H9 23.05 2.17 2.36 8.47% 
H3 H4 40.57 1.98 1.93 −2.41% 
H3 H8 37.63 2.00 1.93 −3.75% 
H3 H6 23.67 2.16 2.21 2.13% 
H7 H3 7.02 2.65 2.71 2.45% 
H7 H5 21.95 2.19 2.27 3.48% 
H7 H11 33.44 2.04 2.26 10.06% 
H7 H4 11.15 2.45 2.41 −1.47% 
H7 H12 47.30 1.93 1.90 −1.34% 
H7 H10 27.44 2.11 2.14 1.59% 
H7 H6 7.43 2.62 2.51 −4.53% 
H5 H11 98.74 1.70 1.87 9.51% 
H5 H9 11.59 2.43 2.50 2.68% 
H5 H4 34.67 2.03 2.18 7.35% 
H5 H12 17.53 2.27 2.08 −9.02% 
H5 H10 15.59 2.32 2.30 −0.96% 
H5 H8 8.13 2.58 2.50 −3.11% 
H5 H6 36.88 2.01 1.93 −4.06% 
H11 H10 49.18 1.91 1.88 −1.64% 
H11 H8 11.62 2.43 2.25 −7.68% 
H11 H6 12.83 2.39 2.32 −3.19% 
H9 H12 19.25 2.24 2.19 −2.18% 
H9 H10 52.58 1.89 1.78 −5.94% 
H9 H8 34.52 2.03 2.15 5.92% 
H9 H6 43.82 1.95 1.96 0.29% 
H4 H3 47.72 (Ref) 1.92 1.93 0.30% 
H4 H6 58.48 1.86 1.83 −1.66% 
H12 H11 68.29 1.81 1.81 −0.35% 
    MAD 3.84% 
    StDev 4.92% 






Table 6.104: Experimental 1H-1H distances derived from 1D DPFGSE NOESY and CSSF NOESY spectra and the Boltzmann averaged computed 1H-1H using 
different DFT methods for 4.5 with Mean Absolute Deviations (MAD),  Standard Deviations (StDev) and 2 (reduced) values (2 (red.)). 
 Functional MMFFs mPW1PW91 
 Basis set - 6-31G (d) 6-311G (d) 
HA HX Exp r /Å Calc./ Å % errora Exp r /Å Calc./ Å % errora Exp r /Å Calc./ Å % errora 
H3 H9 2.24 2.00 −11.32% 2.26 2.92 25.71% 2.25 2.72 19.24% 
H3 H4 2.03 1.92 −5.71% 2.05 1.92 −6.53% 2.04 1.92 −6.11% 
H3 H8 2.06 2.17 5.08% 2.08 1.92 −8.08% 2.07 1.92 −7.35% 
H3 H6 2.23 2.45 9.67% 2.25 2.20 −2.37% 2.24 2.20 −1.63% 
H7 H3 2.73 2.77 1.69% 2.75 2.57 −6.90% 2.74 2.59 −5.61% 
H7 H5 2.25 2.45 8.23% 2.28 2.26 −0.57% 2.26 2.26 −0.36% 
H7 H11 2.10 1.99 −5.67% 2.12 2.30 8.20% 2.11 2.27 7.45% 
H7 H4 2.52 2.19 −14.10% 2.55 2.78 8.57% 2.54 2.65 4.50% 
H7 H12 1.98 2.07 4.12% 2.00 1.90 −5.01% 1.99 1.88 −5.96% 
H7 H10 2.17 2.34 7.39% 2.19 2.22 1.17% 2.18 2.23 2.32% 
H7 H6 2.70 2.27 −17.12% 2.73 2.80 2.55% 2.71 2.73 0.80% 
H5 H11 1.75 2.11 18.22% 1.77 1.79 0.78% 1.76 1.79 1.45% 
H5 H9 2.51 2.80 11.04% 2.53 2.23 −12.51% 2.52 2.31 −8.54% 
H5 H4 2.09 2.43 14.99% 2.11 2.19 3.56% 2.10 2.19 4.06% 
H5 H12 2.34 2.54 8.30% 2.36 2.40 1.51% 2.35 2.37 0.90% 
H5 H10 2.39 2.05 −15.01% 2.41 2.44 1.05% 2.40 2.25 −6.29% 
H5 H8 2.66 2.28 −15.50% 2.69 2.78 3.57% 2.67 2.73 2.09% 
H5 H6 2.07 1.91 −7.65% 2.09 1.92 −8.40% 2.08 1.92 −7.89% 
H11 H10 1.97 1.98 0.65% 1.99 1.89 −5.34% 1.98 1.89 −4.58% 




H11 H6 2.46 2.71 9.56% 2.49 2.61 4.81% 2.48 2.55 2.94% 
H9 H12 2.30 1.91 −18.83% 2.33 2.58 10.18% 2.32 2.47 6.54% 
H9 H10 1.95 1.87 −4.11% 1.97 1.85 −6.41% 1.96 1.85 −5.66% 
H9 H8 2.09 2.35 11.87% 2.11 2.22 4.83% 2.10 2.22 5.37% 
H9 H6 2.01 2.21 9.48% 2.03 1.91 −5.84% 2.02 1.91 −5.68% 
H4 H3 1.98 1.92 −3.00% 2.00 1.92 −3.82% 1.99 1.92 −3.40% 
H4 H6 1.91 1.89 −1.50% 1.93 1.83 −5.26% 1.92 1.84 −4.53% 
H12 H11 1.87 1.84 −1.35% 1.88 1.81 −3.96% 1.87 1.80 −4.10% 
   MAD 9.89%  MAD 6.01%  MAD 5.07% 
   StDev 6.83%  StDev 7.89%  StDev 7.92% 
   2(red.) 11.57  2(red.) 5.08  2(red.) 3.20 
 Functional mPW1PW91 
mPW1PW91 
B3LYP 
 Basis set 6-311G(d,p) 6-311G+(d,p) 6-311G(d) 
HA HX Exp r /Å Calc./ Å % errora Exp r /Å Calc./ Å % errora Exp r /Å Calc./ Å % errora 
H3 H9 2.25 2.88 24.67% 2.25 2.76 20.58% 2.27 2.96 26.37% 
H3 H4 2.04 1.92 −6.09% 2.04 1.92 −6.11% 2.07 1.93 −6.93% 
H3 H8 2.07 1.91 −7.86% 2.07 1.90 −8.65% 2.09 1.93 −7.80% 
H3 H6 2.24 2.19 −2.12% 2.24 2.19 −2.19% 2.26 2.22 −1.95% 
H7 H3 2.74 2.60 −5.39% 2.74 2.61 −4.89% 2.77 2.52 −9.20% 
H7 H5 2.26 2.25 −0.81% 2.26 2.25 −0.86% 2.29 2.25 −1.64% 
H7 H11 2.11 2.31 9.00% 2.11 2.32 9.31% 2.13 2.44 13.48% 
H7 H4 2.54 2.68 5.47% 2.54 2.72 6.86% 2.56 2.68 4.44% 
H7 H12 1.99 1.87 −6.48% 1.99 1.89 −5.44% 2.01 1.88 −6.57% 
H7 H10 2.18 2.23 2.21% 2.18 2.18 −0.17% 2.20 2.16 −1.84% 
H7 H6 2.71 2.78 2.56% 2.71 2.76 1.56% 2.74 2.82 2.88% 




H5 H9 2.52 2.30 −9.07% 2.52 2.35 −7.11% 2.54 2.46 −3.42% 
H5 H4 2.10 2.18 3.63% 2.10 2.18 3.74% 2.12 2.21 3.99% 
H5 H12 2.35 2.36 0.20% 2.35 2.30 −2.15% 2.38 2.33 −2.03% 
H5 H10 2.40 2.28 −4.91% 2.40 2.43 1.52% 2.42 2.41 −0.33% 
H5 H8 2.67 2.77 3.70% 2.67 2.75 2.95% 2.70 2.82 4.37% 
H5 H6 2.08 1.92 −7.89% 2.08 1.92 −7.77% 2.10 1.93 −8.60% 
H11 H10 1.98 1.88 −5.03% 1.98 1.87 −5.83% 2.00 1.88 −6.11% 
H11 H8 2.52 2.78 9.77% 2.52 2.70 7.14% 2.54 2.87 12.05% 
H11 H6 2.48 2.53 2.12% 2.48 2.51 1.46% 2.50 2.52 0.76% 
H9 H12 2.32 2.54 9.08% 2.32 2.50 7.57% 2.34 2.58 9.69% 
H9 H10 1.96 1.85 −5.67% 1.96 1.83 −6.54% 1.98 1.84 −7.36% 
H9 H8 2.10 2.22 5.34% 2.10 2.18 3.72% 2.12 2.16 1.92% 
H9 H6 2.02 1.89 −6.43% 2.02 1.91 −5.37% 2.04 1.96 −4.15% 
H4 H3 1.99 1.92 −3.38% 1.99 1.92 −3.40% 2.01 1.93 −4.23% 
H4 H6 1.92 1.84 −4.58% 1.92 1.83 −4.80% 1.94 1.86 −4.34% 
H12 H11 1.87 1.80 −3.95% 1.87 1.81 −3.75% 1.89 1.80 −5.32% 
   MAD 5.65%  MAD 5.08%  MAD 5.78% 
   StDev 7.35%  StDev 6.02%  StDev 7.92% 
   2(red.) 4.41  2(red.) 3.47  2(red.) 5.12 
 Functional B3LYP M06-2X 
 Basis set 6-311 G(d) toluene (IEFPCM) 6-31G (d) 6-311G (d) 
HA HX Exp r /Å Calc./ Å % errora Exp r /Å Calc./ Å % errora Exp r /Å Calc./ Å % errora 
H3 H9 2.27 2.94 25.48% 2.22 2.83 23.83% 2.22 2.77 22.01% 
H3 H4 2.07 1.93 −7.18% 2.02 1.93 −4.84% 2.02 1.93 −4.88% 
H3 H8 2.10 1.90 −9.58% 2.05 1.90 −7.44% 2.05 1.91 −7.26% 




H7 H3 2.77 2.65 −4.61% 2.71 2.60 −4.03% 2.71 2.60 −4.18% 
H7 H5 2.29 2.24 −2.34% 2.24 2.26 0.72% 2.24 2.25 0.56% 
H7 H11 2.14 2.46 14.00% 2.09 2.40 13.88% 2.09 2.38 12.83% 
H7 H4 2.57 2.80 8.52% 2.51 2.63 4.67% 2.51 2.73 8.33% 
H7 H12 2.02 1.89 −6.62% 1.97 1.89 −4.32% 1.97 1.90 −3.57% 
H7 H10 2.21 2.15 −2.76% 2.16 2.12 −2.10% 2.16 2.11 −2.33% 
H7 H6 2.75 2.81 2.35% 2.69 2.71 0.88% 2.69 2.68 −0.12% 
H5 H11 1.79 1.78 −0.33% 1.75 1.79 2.60% 1.75 1.80 3.26% 
H5 H9 2.55 2.51 −1.47% 2.49 2.35 −5.82% 2.49 2.32 −7.36% 
H5 H4 2.13 2.18 2.53% 2.08 2.16 3.82% 2.08 2.16 3.92% 
H5 H12 2.38 2.32 −2.61% 2.33 2.12 −9.14% 2.33 2.14 −8.25% 
H5 H10 2.43 2.53 4.21% 2.37 2.46 3.40% 2.37 2.46 3.38% 
H5 H8 2.71 2.82 3.99% 2.65 2.71 2.46% 2.65 2.69 1.80% 
H5 H6 2.10 1.93 −8.71% 2.06 1.93 −6.57% 2.06 1.92 −6.68% 
H11 H10 2.00 1.87 −7.00% 1.96 1.87 −4.91% 1.96 1.87 −4.44% 
H11 H8 2.55 2.86 11.55% 2.49 2.68 7.35% 2.49 2.64 5.65% 
H11 H6 2.51 2.50 −0.13% 2.45 2.43 −1.00% 2.45 2.40 −1.99% 
H9 H12 2.34 2.59 9.90% 2.29 2.50 8.70% 2.29 2.47 7.52% 
H9 H10 1.98 1.84 −7.62% 1.94 1.78 −8.25% 1.94 1.79 −7.74% 
H9 H8 2.13 2.15 1.17% 2.08 2.12 1.79% 2.08 2.13 2.23% 
H9 H6 2.04 1.94 −5.35% 2.00 1.94 −2.94% 2.00 1.93 −3.45% 
H4 H3 2.02 1.93 −4.47% 1.97 1.93 −2.13% 1.97 1.93 −2.18% 
H4 H6 1.95 1.85 −5.24% 1.90 1.84 −3.62% 1.90 1.83 −3.90% 
H12 H11 1.90 1.80 −5.45% 1.86 1.79 −3.33% 1.86 1.80 −3.28% 
   MAD 6.02%  MAD 5.19%  MAD 5.14% 




   2(red.) 5.22  2(red.) 4.13  2(red.) 3.81 
 Functional B3LYP-D2  
 Basis set 6-31G (d) 6-311G (d)  
HA HX Exp r /Å Calc./ Å % errora Exp r /Å Calc./ Å % errora    
H3 H9 2.19 2.54 14.62% 2.18 2.54 15.13%    
H3 H4 1.99 1.93 −3.21% 1.98 1.93 −2.69%    
H3 H8 2.02 1.95 −3.44% 2.01 1.95 −2.92%    
H3 H6 2.18 2.19 0.40% 2.17 2.19 0.92%    
H7 H3 2.67 2.70 1.11% 2.66 2.70 1.62%    
H7 H5 2.21 2.27 2.59% 2.20 2.27 3.10%    
H7 H11 2.06 2.26 9.22% 2.05 2.26 9.74%    
H7 H4 2.47 2.32 −6.44% 2.46 2.32 −5.92%    
H7 H12 1.94 1.91 −1.63% 1.93 1.91 −1.11%    
H7 H10 2.13 2.17 1.95% 2.12 2.17 2.46%    
H7 H6 2.64 2.59 −2.10% 2.63 2.59 −1.58%    
H5 H11 1.72 1.84 6.68% 1.71 1.84 7.19%    
H5 H9 2.46 2.29 −6.81% 2.44 2.29 −6.29%    
H5 H4 2.05 2.16 5.41% 2.04 2.16 5.93%    
H5 H12 2.29 2.12 −7.91% 2.28 2.12 −7.40%    
H5 H10 2.34 2.34 0.27% 2.33 2.34 0.78%    
H5 H8 2.61 2.60 −0.41% 2.59 2.60 0.11%    
H5 H6 2.03 1.92 −5.09% 2.01 1.92 −4.57%    
H11 H10 1.93 1.89 −2.30% 1.92 1.89 −1.79%    
H11 H8 2.45 2.42 −1.47% 2.44 2.42 −0.96%    
H11 H6 2.41 2.36 −2.27% 2.40 2.36 −1.75%    




H9 H10 1.91 1.79 −6.32% 1.90 1.79 −5.80%    
H9 H8 2.05 2.17 5.62% 2.04 2.17 6.13%    
H9 H6 1.97 1.93 −2.06% 1.96 1.93 −1.54%    
H4 H3 1.94 1.93 −0.50% 1.93 1.93 0.02%    
H4 H6 1.88 1.85 −1.49% 1.87 1.85 −0.97%    
H12 H11 1.83 1.81 −1.05% 1.82 1.81 −0.54%    
   MAD 3.74%  MAD 3.54%    
   StDev 5.05%  StDev 4.80%    





Data for meso compounds (4.11, 4.12 and 4.13) 
 
Table 6.105: Calculated Boltzmann averaged 1H chemical shifts (H) and experimental 1H chemical for 
4.11 with Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 
(reduced) values (2 (red.)). 
 DFT population M and P helices only, 1:1 
H Exp H/ppm Calc. H/ppm Deviations/ppm Calc. H/ppm Deviations/ppm 
H1 1.83 1.75 -0.08 1.75 -0.08 
H3 2.37 2.62 0.25 2.62 0.25 
H4 1.04 1.07 0.03 1.06 0.02 
H5 1.62 1.49 -0.13 1.52 -0.10 
H6 0.79 0.84 0.05 0.82 0.03 
H7 1.8 1.64 -0.16 1.61 -0.19 
H8 0.76 0.89 0.13 0.88 0.12 
H9 1.24 1.13 -0.11 1.14 -0.10 
H10 0.7 0.71 0.01 0.74 0.04 
  MAD 0.11 MAD 0.10 
  StDev 0.14 StDev 0.13 
  2 (red.) 1.82 2 (red.) 1.8 
 
Table 6.106: Calculated Boltzmann averaged 1H chemical shifts (C) and experimental 13C chemical 
for 4.11 with Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 
(reduced) values (2 (red.)). 
  DFT population M and P helices only, 1:1 
C Exp C/ppm Calc. C/ppm Deviations/ppm Calc. C/ppm Deviations/ppm 
C3 29.08 29.08 0.00 28.79 -0.29 
C4 17.02 17.20 0.18 17.02 0.00 
C5 39.40 39.73 0.33 39.65 0.25 
C6 12.39 12.92 0.53 12.72 0.33 
C7 36.09 36.13 0.04 36.93 0.84 
C8 11.38 11.45 0.07 11.56 0.18 
C9 36.80 36.34 -0.46 35.89 -0.91 
C10 11.72 11.02 -0.70 11.31 -0.41 
      




  StDev 0.40 StDev 0.50 
  2 (red.) 0.07 2 (red.) 0.13 
 
Table 6.107: Experimental nJHH values (in Hz) and Boltzmann averaged calculated nJHH (in Hz) before 
for 4.11 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations 
(StDev, in Hz) and 2 (reduced) values (2 (red.)). 
 DFT population M and P helices only, 1:1 







H3 H4 6.99 7.13 0.14 7.10 0.11 
H3 H5 6.90 6.54 -0.36 7.00 0.10 
H5 H6 6.80 7.00 0.20 6.96 0.16 
H5 H7 5.40 5.79 0.39 6.51 1.11 
H7 H8 6.80 6.99 0.19 6.95 0.15 
H7 H9 6.70 6.94 0.24 7.08 0.38 
H9 H10 6.80 7.04 0.24 6.97 0.17 
   MAD 0.25 MAD 0.31 
   StDev 0.24 StDev 0.36 
   2 (red.) 0.08 2 (red.) 0.24 
 
Table 6.108: Experimental 1H-1H distances derived from 1D DPFGSE NOESY and CSSF NOESY 
spectra and the Boltzmann averaged computed 1H-1H distances for 4.11 with Mean Absolute Deviations 
(MAD),  Standard Deviations (StDev) and 2 (reduced) values (2 (red.)). 
 reff-6, DFT population M and P helices only, 1:1 
H H Exp reff/Å Calc reff/Å % Error Exp reff/Å Calc reff/Å % Error 
H3 H5 2.31 2.29 −0.7% 2.32 2.35 1.0% 
H3 H9 1.87 2.10 11.3% 1.88 2.06 8.9% 
H3 H6 2.19 2.25 2.6% 2.21 2.31 4.5% 
H3 H8 2.09 2.11 0.7% 2.11 2.04 −3.2% 
H3 H10 2.49 2.28 −8.7% 2.50 2.18 −13.8% 
H7 H3 2.42 2.76 12.9% 2.44 2.77 12.9% 
H7 H4 2.14 2.06 −4.0% 2.15 2.14 −0.3% 
H7 H10 2.24 2.33 3.9% 2.25 2.28 1.4% 
H7 H8 1.86 1.77 −5.0% 1.88 1.78 −5.2% 
H7 H6 2.11 2.11 −0.1% 2.12 2.07 −2.5% 
H5 H9 2.36 2.58 8.8% 2.38 2.91 20.0% 
H5 H4 2.14 2.17 1.3% 2.15 2.29 6.1% 
H5 H10 2.11 2.11 0.0% 2.12 2.08 −2.1% 




H9 H8 2.25 2.32 3.2% 2.26 2.28 0.6% 
H9 H6 2.19 2.15 −2.2% 2.21 2.12 −4.2% 
H9 H4 2.56 2.33 −9.4% 2.58 2.32 −10.6% 
H4 H3 1.93 1.92 −0.5% 1.95 1.93 −0.9% 
H4 H6 1.83 1.79 −2.4% 1.84 1.73 −6.2% 
H4 H8 2.82 2.57 −9.1% 2.83 2.86 0.8% 
H8 H7 1.76 1.77 0.6% 1.77 1.78 0.4% 
H8 H10 1.84 1.82 −0.7% 1.85 1.83 −0.7% 
   MAD 4.10%  MAD 5.1% 
   StDev 5.96%  StDev 7.4% 






Table 6.109: Experimental H values (in ppm) and population refined (using different constraints) Boltzmann averaged calculated H (in ppm) for 4.11 with 
Deviations (Dev, in ppm), Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 (reduced) values (2 (red.)) 
 Refined population,  
Sum(DDG2) = 100 
Refined population, 
SUM(DDG2) = 225 
Refined population, 
SUM((DDG2) = 625 
Proton Exp H/ppm Calc. H/ppm Dev./ppm Calc. H/ppm Dev./ppm Calc. H/ppm Dev./ppm 
H1 1.83 1.75 -0.08 1.74 -0.09 1.77 -0.06 
H3 2.37 2.58 0.21 2.59 0.22 2.60 0.23 
H4 1.04 1.09 0.05 1.07 0.03 1.05 0.01 
H5 1.62 1.46 -0.16 1.45 -0.17 1.47 -0.15 
H6 0.79 0.81 0.02 0.82 0.03 0.76 -0.03 
H7 1.8 1.72 -0.08 1.68 -0.12 1.53 -0.27 
H8 0.76 0.87 0.11 0.85 0.09 0.84 0.08 
H9 1.24 1.15 -0.09 1.24 0.00 1.46 0.22 
H10 0.7 0.72 0.02 0.70 0.00 0.68 -0.02 
  MAD 0.09 MAD 0.08 MAD 0.12 
  StDev 0.12 StDev 0.12 StDev 0.16 
  2 (red.) 1.34 2 (red.) 1.4 2 (red.) 2.6 
 
Table 6.110: Experimental C values (in ppm) and population refined (using different constraints) Boltzmann averaged calculated C (in ppm) for 4.11 with 
Deviations (Dev, in ppm), Mean Absolute Deviations (MAD, in ppm), Standard Deviations (StDev, in ppm) and 2 (reduced) values (2 (red.)) 
 Refined population, 
Sum(DDG2) = 100 
Refined population, 
Sum(DDG2) = 225 
Refined population, 
Sum(DDG2) = 625 
Carbon Exp C/ppm Calc. C/ppm Dev./ppm Calc. C/ppm Dev./ppm Calc. C/ppm Dev./ppm 




C2 88.94 86.02 -2.92 83.84 -5.10 85.88 -3.06 
C3 29.08 29.11 0.03 28.85 -0.23 28.85 -0.23 
C4 17.02 17.46 0.44 17.20 0.18 17.22 0.20 
C5 39.40 39.39 -0.01 39.36 -0.04 39.39 -0.01 
C6 12.39 12.84 0.45 13.17 0.78 12.88 0.49 
C7 36.09 35.11 -0.98 35.57 -0.52 36.79 0.70 
C8 11.38 10.91 -0.47 11.25 -0.13 11.40 0.02 
C9 36.80 37.64 0.84 37.45 0.65 36.23 -0.57 
C10 11.72 11.43 -0.29 11.03 -0.69 11.11 -0.61 
  MAD 0.70 MAD 1.09 MAD 0.69 
  StDev 1.05 StDev 1.78 StDev 1.06 
  2 (red.) 0.55 2 (red.) 1.70 2 (red.) 0.58 
 
Table 6.111: Experimental nJHH values (in Hz) and population refined (using different constraints) Boltzmann averaged calculated nJHH values (in Hz) for 4.11 
with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations (StDev, in Hz) and 2 (reduced) values (2 (red.)) 
 Refined population, 
Sum(DDG2) = 100 
Refined population, 
Sum(DDG2) = 225 
Refined population, 
Sum(DDG2) = 625 
HA HB Exp. nJHH/Hz Calc. nJHH /Hz Deviation/Hz Calc. nJHH/Hz Deviation/Hz Calc. nJHH /Hz Deviation/Hz 
H3 H4 6.99 7.09 0.10 7.09 0.10 7.14 0.15 
H3 H5 6.90 7.07 0.17 7.24 0.34 6.95 0.05 
H5 H6 6.80 7.06 0.26 7.05 0.25 7.08 0.28 
H5 H7 5.40 5.07 -0.33 5.55 0.15 6.54 1.14 
H7 H8 6.80 7.10 0.30 7.16 0.36 7.09 0.29 
H7 H9 6.70 6.95 0.25 6.21 -0.49 5.92 -0.78 
H9 H10 6.80 7.03 0.23 7.12 0.32 7.00 0.20 




   StDev 0.22 StDev 0.30 StDev 0.56 
   2 (red.) 0.07 2 (red.) 0.11 2 (red.) 0.36 
 
Table 6.112: Experimental effective 1H-1H distances (reff, in Å) and population refined (using different constraints) Boltzmann averaged calculated 1H-1H 
distances (reff, in Å)  for 4.11 with Deviations (Dev), Mean Absolute Deviations (MAD), Standard Deviations (StDev) and 2 (reduced) values (2 (red.)) 
 Refined population, 
Sum(DDG2) = 100 
Refined population, 
Sum(DDG2) = 225 
Refined population, 
Sum(DDG2) = 625 
H H Exp reff/Å Calc reff/Å % Error Exp reff/Å Calc reff/Å % Error Exp reff/Å Calc reff/Å % Error 
H3 H5 2.33 2.31 −0.8% 2.34 2.35 0.6% 2.34 2.35 0.5% 
H3 H9 1.89 2.15 13.0% 1.90 2.10 10.3% 1.90 2.07 8.6% 
H3 H6 2.21 2.22 0.4% 2.22 2.26 1.5% 2.22 2.20 −0.9% 
H3 H8 2.11 2.09 −1.1% 2.12 2.10 −1.0% 2.12 2.14 0.8% 
H3 H10 2.51 2.44 −2.7% 2.52 2.45 −3.0% 2.52 2.49 −1.0% 
H7 H3 2.44 2.63 7.2% 2.46 2.52 2.7% 2.46 2.44 −0.6% 
H7 H4 2.16 2.06 −4.4% 2.17 2.10 −2.9% 2.17 2.10 −3.3% 
H7 H10 2.26 2.35 4.0% 2.27 2.40 5.8% 2.27 2.38 4.6% 
H7 H8 1.88 1.79 −5.2% 1.89 1.79 −5.3% 1.89 1.79 −5.4% 
H7 H6 2.13 2.15 0.8% 2.14 2.14 0.2% 2.14 2.11 −1.4% 
H5 H9 2.38 2.43 1.8% 2.40 2.36 −1.4% 2.40 2.45 2.3% 
H5 H4 2.16 2.15 −0.2% 2.17 2.22 2.3% 2.17 2.23 2.9% 
H5 H10 2.13 2.15 1.0% 2.14 2.15 0.7% 2.14 2.11 −1.1% 
H5 H8 2.09 2.07 −1.1% 2.10 2.09 −0.7% 2.10 2.10 −0.1% 
H9 H8 2.27 2.34 3.1% 2.28 2.39 5.0% 2.28 2.38 4.2% 
H9 H6 2.21 2.15 −2.9% 2.22 2.20 −1.0% 2.22 2.22 −0.2% 
H9 H4 2.59 2.54 −1.9% 2.60 2.54 −2.3% 2.60 2.60 0.0% 




H4 H6 1.84 1.80 −2.6% 1.85 1.81 −2.5% 1.85 1.80 −2.7% 
H4 H8 2.84 2.68 −5.8% 2.85 2.77 −3.0% 2.85 2.82 −1.2% 
H8 H7 1.78 1.79 0.4% 1.79 1.79 0.3% 1.79 1.79 0.2% 
H8 H10 1.85 1.81 −2.1% 1.86 1.82 −2.3% 1.86 1.82 −2.4% 
   MAD 2.9%  MAD 2.7%  MAD 2.2% 
   StDev 4.2%  StDev 3.6%  StDev 3.1% 







Table 6.113: Experimental 1H-1H distances derived from 1D DPFGSE NOESY and CSSF NOESY 
spectra and the Boltzmann averaged computed 1H-1H distances for 4.12 with Mean Absolute Deviations 
(MAD),  Standard Deviations (StDev) and 2 (reduced) values (2 (red.)). 
  DFT calculated population Refined population, Sum(DDG2) ≤ 100 
HA HB Exp reff/Å Calc reff/Å % Error Exp reff/Å Calc reff/Å % Error 
H3 H9 1.90 2.11 10.7% 1.90 2.10 10.3% 
H3 H6 2.32 2.28 −1.8% 2.32 2.30 −0.8% 
H7 H3 2.58 2.70 4.7% 2.58 2.68 4.1% 
H7 H9 1.85 1.97 6.3% 1.85 1.92 3.6% 
H7 H4 2.29 2.15 −6.2% 2.29 2.19 −4.2% 
H5 H9 2.32 2.39 3.2% 2.32 2.30 −0.6% 
H5 H4 2.22 2.25 1.6% 2.22 2.28 2.6% 
H11 H7 2.43 2.44 0.5% 2.43 2.45 1.0% 
H11 H5 1.90 2.04 6.9% 1.90 2.10 10.1% 
H9 H7 1.81 1.97 8.7% 1.81 1.92 6.0% 
H9 H4 2.62 2.35 −10.7% 2.62 2.38 −9.7% 
H4 H3 2.01 1.92 −4.6% 2.01 1.93 −4.4% 
H12 H5 2.51 2.28 −9.5% 2.51 2.40 −4.3% 
H12 H11 2.31 2.16 −6.6% 2.31 2.16 −6.5% 
H12 H9 2.27 2.35 3.3% 2.27 2.36 3.8% 
H6 H3 2.26 2.28 0.8% 2.26 2.30 1.8% 
H6 H7 2.21 2.29 3.4% 2.21 2.22 0.6% 
H6 H11 2.75 2.50 −9.6% 2.75 2.56 −7.2% 
H6 H4 1.92 1.85 −3.8% 1.92 1.83 −4.8% 
   MAD 5.4%  MAD 4.5% 
   StDev 6.5%  StDev 5.6% 







Table 6.114: Experimental 1H-1H distances derived from 1D DPFGSE NOESY and CSSF NOESY 
spectra and the Boltzmann averaged computed 1H-1H distances for 4.13 with Mean Absolute Deviations 
(MAD),  Standard Deviations (StDev) and 2 (reduced) values (2 (red.)). 
  DFT calculated population Refined population, Sum(DDG2) ≤ 100 
HA HB Exp reff/Å Calc reff/Å Exp reff/Å Calc reff/Å Exp reff/Å Calc reff/Å 
H3 H9 1.90 2.33 20.1% 1.90 2.04 7.1% 
H7 H3 2.52 2.73 7.9% 2.52 2.60 2.9% 
H7 H4 2.28 2.37 3.9% 2.28 2.14 -6.5% 
H5 H9 2.41 2.54 5.3% 2.41 2.44 1.2% 
H5 H4 2.19 2.15 -2.3% 2.19 2.29 4.1% 
H9 H4 2.69 2.72 0.9% 2.69 2.66 -1.3% 
H4 H3 2.00 1.93 -3.4% 2.00 1.93 -3.4% 
H12 H5 2.40 2.07 -14.9% 2.40 2.30 -4.0% 
H12 H9 2.17 2.25 3.6% 2.17 2.21 2.0% 
H6 H3 2.27 2.21 -2.8% 2.27 2.33 2.5% 
H6 H7 2.33 2.50 6.8% 2.33 2.39 2.7% 
H6 H4 1.96 1.79 -8.6% 1.96 1.82 -6.9% 
   MAD 6.7%  MAD 3.7% 
   StDev 8.9%  StDev 4.4% 






NMR data of 4.15 
 
Table 6.115: Experimental nJHH values (in Hz) and Boltzmann averaged calculated nJHH (in Hz) before 
for 4.15 with Deviations (Dev, in Hz), Mean Absolute Deviations (MAD, in Hz), Standard Deviations 
(StDev, in Hz) and 2 (reduced) values (2 (red.)). 
H Coupled H Exp. nJHH/Hz Calc. nJHH/Hz Deviations/Hz 
H3 H1 2.50 4.20 1.70* 
H3 H4 6.90 7.02 0.12 
H3 H5 7.80 8.95 1.15 
H5 H6 6.80 7.07 0.27 
H5 H7 4.20 3.60 −0.60 
H7 H8 6.90 7.01 0.11 
H7 H9 7.30 8.92 1.62 
H9 H10 6.80 7.02 0.22 
H9 H11 4.20 4.20 0.00 
H15 H17 7.20 8.98 1.78 
H17 H18 6.81 7.05 0.24 
H17 H19 4.80 3.31 −1.49 
H19 H20 6.80 7.29 0.49 
   MAD 0.69 
   StDev 0.91 
   2 (red.) 0.93 
*4JH1H3 was not used for comparison. 
 
Table 6.116: Experimental 1H-1H distances derived from 1D DPFGSE NOESY and CSSF NOESY 
spectra and the Boltzmann averaged computed 1H-1H distances for 4.15 with Mean Absolute Deviations 
(MAD),  Standard Deviations (StDev) and 2 (reduced) values (2 (red.)). 
HA HB ηeff Exp. reff/Å Calc. reff/Å % Error 
H21 H17 8.49 2.61 2.85 8.8% 
H21 H19 12.58 2.45 2.71 0.0% 
H21 H24 37.02 2.04 1.90 −7.5% 
H21 H22 19.28 2.28 2.17 −4.9% 
H21 H18 13.47 2.42 2.22 −8.5% 
H3 H7 4.73 2.88 3.06 5.9% 
H3 H5 7.65 2.66 2.75 3.2% 




2.29 2.16 −5.7% 




H7 H5 9.61 2.56 2.54 −0.7% 
H7 H9 6.38 2.74 2.82 3.0% 
H7 H4 7.46 2.67 2.63 −1.7% 
H7 H8 19.21 2.28 2.16 −5.5% 
H9 H5 5.18 2.84 2.87 1.1% 
H9 H4 3.85 2.98 3.22 7.6% 
H9 H8 12.65 2.45 2.46 0.6% 
    MAD 5.74% 
    StDev 7.52% 
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